Prevalence Estimate Name,Publication Date,First Author Full Name,Grade of Estimate Scope,Country,Geography (Organization),Study Dates,Sample Frame (groups of interest),Sample Frame (age),Denominator Value,Seroprevalence (95% CI),Sampling Method,"Test Manufacturer, Type (Sn, Sp)",Overall Risk of Bias (JBI),Source Type,URL,Date Created,Last modified time
210220_Tirana_UniversityofMedicineandUniversityHospitalCenterofTirana_July_Adults,2/20/2021,Genc Sulcebe,Local,Albania,"Tirana; Albania
(University of Medicine and University Hospital Center of Tirana)",06/27 - 07/03,Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),266,7.5% (4.3-10.7%),Stratified probability,"Euroimmun; NR
(0%; 0%)",High,Preprint,https://doi.org/10.1101/2021.02.18.21251776,3/21/2021,3/21/2021
210220_Tirana_UniversityofMedicineandUniversityHospitalCenterofTirana_December_Adults,2/20/2021,Genc Sulcebe,Local,Albania,"Tirana; Albania
(University of Medicine and University Hospital Center of Tirana)",12/21 - 12/28,Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),815,48.2% (44.8-51.7%),Stratified probability,"Euroimmun; NR
(0%; 0%)",High,Preprint,https://doi.org/10.1101/2021.02.18.21251776,3/21/2021,3/21/2021
201204_Andorra_ISGlobal_Overall,12/4/2020,Cristina Royo-Cebrecos,National,Andorra,"Andorra
(ISGlobal)",05/04 - 05/28,Household and community samples,Multiple groups,70494,11% (NR),Self-referral,"nCOV 2019 IgG/IgM- Zhuhai Livzon Diagnostics, Inc.; NR
(90.6%; 99.2%)",Moderate,Preprint,https://www.researchsquare.com/article/rs-119323/v1,1/23/2021,3/1/2021
"200718_BuenosAires_MinisterofHealth,BuenosAiresCity_GenPop",7/18/2020,Silvana Figar,Sublocal,Argentina,"Buenos Aires; Buenos Aires; Argentina
(Minister of Health, Buenos Aires City)",06/10 - 07/01,Persons living in slums,Multiple groups,873,53.4% (52.8-54.1%),Simplified probability,"Laboratio Lemos; IgG; ELISA
(95%; 100%)",Moderate,Preprint,https://www.medrxiv.org/content/10.1101/2020.07.14.20153858v1,7/17/2020,3/1/2021
"200718_BuenosAires_MinisterofHealth,BuenosAiresCity_Homeless",7/18/2020,Silvana Figar,Sublocal,Argentina,"Buenos Aires; Buenos Aires; Argentina
(Minister of Health, Buenos Aires City)",06/10 - 07/01,Persons living in slums,Multiple groups,60,36% (NR),Convenience,"Laboratio Lemos; IgG; ELISA
(95%; 100%)",High,Preprint,https://www.medrxiv.org/content/10.1101/2020.07.14.20153858v1,7/17/2020,3/1/2021
200909_BuenosAires_InstitutoNacionalDeEpidemiologia_Overall,9/9/2020,Andrea Silva,Sublocal,Argentina,"Buenos Aires; Buenos Aires; Argentina
(Instituto Nacional de Epidemiologia)",06/03 - 07/06,Health care workers and caregivers,Multiple groups,738,0.8% (NR),Stratified probability,"CONICET; IgG, IgM; ELISA
(91%; 100%)",Moderate,Preprint,https://www.medrxiv.org/content/10.1101/2020.09.07.20189050v1,11/10/2020,3/1/2021
201201_BuenosAires_HospitalGeneraldeNiñosPedrodeElizalde_overall,12/1/2020,Claudia Insúa,Sublocal,Argentina,"Autonomous City of Buenos Aires; Province of Buenos Aires; Argentina
(Hospital General de Niños Pedro de Elizalde)",06/08 - 06/09,Health care workers and caregivers,Adults (18-64 years),116,0.9% (0.1-5.5%),Simplified probability,"Snibe (Shenzen New Industries); NR
(95.6%; 96%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.5546/aap.2020.eng.381,1/25/2021,3/1/2021
210107_BuenosAires_UniversityOfBuenosAires_Primary,1/7/2021,Puia Sebastian ,Sublocal,Argentina,"Buenos Aires; Argentina
(University of Buenos Aires)",03/01 - 10/31,Health care workers and caregivers,Adults (18-64 years),317,3% (2-5%),Stratified non-probability,"NR; NR
(85%; 95%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1016/j.jobcr.2021.01.006,2/18/2021,3/16/2021
200630_Yerevan_ArmeniaMinistryofHealth_HCWs,6/30/2020,Anna Grigoryan,Local,Armenia,"Yerevan; Armenia
(Ministry of Health of the Republic of Armenia)",NR - 06/29,Health care workers and caregivers,Adults (18-64 years),380,16.1% (NR),Convenience,"Not reported; Not reported; Not reported
(100%; 99.8%)",High,News and Media,https://www.google.com/url?rct=j&sa=t&url=https://armenpress.am/eng/news/1020040/&ct=ga&cd=CAEYFioTMTc0ODAyMDA0NzI0ODEyNTQxODIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNHN-cSj3u7JgQAyBjN07fSTGAdlgA,8/1/2020,3/1/2021
200803_NewSouthWales_UniversityOfSydney_IndividualsInEducationalSetting,8/3/2020,Kristine Macartney,Regional,Australia,"New South Wales; Australia
(University of Sydney)",01/25 - 04/10,Contacts of COVID patients,Multiple groups,173,2.3% (NR),Convenience,"Author-designed; IgG, IgA, IgM; immunofluorescence assay (IFA)
(91.3%; 98.9%)",Moderate,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1016/S2352-4642(20)30251-0,10/16/2020,3/1/2021
200914_Australia_AustralianNationalUniversity_ElectiveSurgeryPatients_Overall_TestAdj,10/3/2020,Sarah Hicks,National,Australia,"Australia
(Australian National University)",05/15 - 06/15,Patients seeking care for non-COVID-19 reasons,Multiple groups,2991,0.3% (0-0.7%),Unclear,"In House; NR
(100%; 98.91%)",Unclear,Journal Article (Peer-Reviewed),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7665523/pdf/jiaa623.pdf,2/13/2021,3/1/2021
210203_Sydney_Children'sHospitalAtWestmead_GeneralPathology_overall_TestAdj,2/3/2021,Heather F Gidding,Local,Australia,"Sydney; New South Wales; Australia
(Children's Hospital at Westmead)",04/20 - 05/22,Residual sera,Multiple groups,3231,0.2% (0-0.4%),Stratified probability,"N/A - Authors designed; NR
(90.7%; 99.3%)",Moderate,Journal Article (Peer-Reviewed),https://onlinelibrary.wiley.com/doi/10.5694/mja2.50940,3/18/2021,3/19/2021
210203_Sydney_Children'sHospitalAtWestmead_PlasmapheresisDonors_overall_TestAdj,2/3/2021,Heather F Gidding,Local,Australia,"Sydney; New South Wales; Australia
(Children's Hospital at Westmead)",05/05 - 06/02,Blood donors,Adults (18-64 years),1548,0.3% (0-0.8%),Stratified probability,"N/A - Authors designed; NR
(90.7%; 99.3%)",Moderate,Journal Article (Peer-Reviewed),https://onlinelibrary.wiley.com/doi/10.5694/mja2.50940,3/19/2021,3/19/2021
210203_Sydney_Children'sHospitalAtWestmead_PlasmapheresisDonors_overall_TestAdj,2/3/2021,Heather F Gidding,Local,Australia,"Sydney; New South Wales; Australia
(Children's Hospital at Westmead)",05/04 - 05/23,Pregnant or parturient women,Adults (18-64 years),560,0.8% (NR),Stratified probability,"N/A - Authors designed; NR
(90.7%; 99.3%)",Moderate,Journal Article (Peer-Reviewed),https://onlinelibrary.wiley.com/doi/10.5694/mja2.50940,3/19/2021,3/19/2021
210109_Australia_AustralianNationalUniversity_overall_adj,,Nicholas Coatsworth ,National,Australia,"Australia
(Australian National University)",06/02 - 07/17,Patients seeking care for non-COVID-19 reasons,Multiple groups,2991,0.2% (0-0.5%),Sequential,"Icahn School of Medicine; NR
(100%; 98.9%)",Low,Journal Article (Peer-Reviewed),https://onlinelibrary.wiley.com/doi/full/10.1111/ans.16564,3/19/2021,3/19/2021
200720_Tyrol_InnsbruckClinicalMicrobiologyLaboratory_Physicians_IgG,7/20/2020,Dorothea Orth-Höller,Regional,Austria,"Tyrol; Austria
(Innsbruck Clinical Microbiology Laboratory)",03/20 - 03/27,Health care workers and caregivers,Adults (18-64 years),377,0.3% (0-1.5%),Convenience,"EUROIMMUN; IgG; ELISA
(0%; 0%)",High,Journal Article (Peer-Reviewed),https://www.tandfonline.com/doi/pdf/10.1080/22221751.2020.1793690,8/1/2020,3/1/2021
200726_Vienna_MedicalUniversityofVienna_hcw,7/26/2020,Thomas Reiter,Sublocal,Austria,"Vienna; Austria
(Medical University of Vienna)",03/15 - 03/29,Health care workers and caregivers,Adults (18-64 years),235,25.5% (20.4-31.5%),Convenience,"ImmunoDiagnostics; IgM, IgG; ELISA
(0%; 0%)",High,Preprint,https://www.medrxiv.org/content/10.1101/2020.07.21.20136218v1,9/28/2020,3/1/2021
200822_Ischgl_MedicalUniversityofInnsbruck_GenPop,8/22/2020,Ludwig Knabl,Local,Austria,"Ischgl; Tyrol; Austria
( Medical University of Innsbruck )",04/21 - 04/27,Household and community samples,Multiple groups,1473,42.4% (39.8-44.7%),Entire sample,"Abbott, EUROIMMUN; IgG; ELISA, Immunoassay
(0%; 100%)",Moderate,Preprint,https://www.medrxiv.org/content/10.1101/2020.08.20.20178533v1,10/16/2020,3/1/2021
200819_Autria_UniversityHospitalKrems_hcw_ELISA_IgGIgM,8/19/2020,Klaus Hackner,Sublocal,Austria,"Austria
(Karl Landsteiner University of Health Sciences)",04/01 - 04/30,Health care workers and caregivers,Adults (18-64 years),130,2.3% (NR),Convenience,"Epitope Diagnostics; IgG, IgM; ELISA
(0%; 0%)",High,Preprint,https://www.researchsquare.com/article/rs-50887/v1,10/18/2020,3/1/2021
200808_Vienna_MedicalUniversityOfVienna_HCP,9/2/2020,Thorsten Fuereder,Sublocal,Austria,"Vienna; Vienna; Austria
(Medical University of Vienna)",04/01 - 06/04,Health care workers and caregivers,Adults (18-64 years),62,3.2% (0.4-11.2%),Convenience,"Roche, Abbott; Total Antibody, IgG; Electro chemiluminescence immunoassay, Chemiluminescence Immunoassay
(0%; 0%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1136/esmoopen-2020-000889,11/5/2020,3/1/2021
200808_Vienna_MedicalUniversityOfVienna_Patients,9/2/2020,Thorsten Fuereder,Sublocal,Austria,"Vienna; Vienna; Austria
(Medical University of Vienna)",03/20 - 06/04,Patients seeking care for non-COVID-19 reasons,Multiple groups,84,2.4% (0.3-8.3%),Convenience,"Roche, Abbott; Total Antibody, IgG; Electro chemiluminescence immunoassay, Chemiluminescence Immunoassay
(0%; 0%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1136/esmoopen-2020-000889,11/5/2020,3/1/2021
201104_Austria_DanubePrivateUniversity_IgG_Overall,11/4/2020,Dennis Ladage,Local,Austria,"Weißenkirchen, St. Michael, Wösendorf, Joching; Austria
(Danube Private University)",06/01 - 06/15,Household and community samples,Multiple groups,835,8.5% (NR),Entire sample,"N/A - Author Designed; NR
(0%; 0%)",High,Preprint,https://www.medrxiv.org/content/10.1101/2020.11.03.20219121v1,1/18/2021,3/1/2021
201222_Vienna_MedicalUniversityofVienna_overall,12/22/2020,Angelika Wagner,Sublocal,Austria,"Vienna; Austria
(Medical University of Vienna)",04/02 - 04/17,Household and community samples,Adults (18-64 years),1655,10.2% (NR),Convenience,"Euroimmun Medizinische Labordiagnostika; NR
(0%; 0%)",High,Preprint,10.1101/2020.12.22.20248604,1/23/2021,3/5/2021
210129_Vienna_WroclawMedicalUniversity_overall,1/29/2021,Zsolt Szépfalusi,Local,Austria,"Vienna; Austria
(Wroclaw Medical University)",05/18 - 07/02,Students and Daycares,Children and Youth (0-17 years),2042,1.2% (NR),Convenience,"1) Beijing Wantai Biological Pharmacy Enterprise

2) N/A - author designed

3) EUROIMMUN

4) EUROIMMUN; NR
(90.87%; 98.8%)",Moderate,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1111/pai.13459,2/16/2021,3/1/2021
210203_Austria_MedicalUniversityOfVienna_Overall,2/3/2021,Iris Leister,National,Austria,"Austria
(Medical University of Vienna)",05/11 - 12/21,Health care workers and caregivers,Adults (18-64 years),3301,0.5% (NR),Convenience,"LFA: TAmiRNA GmbH Austria
Roche
Diasorin; NR
(0%; 0%)",High,Preprint,10.1101/2021.02.01.21250898,2/17/2021,3/1/2021
210107_Austria_UniversityCollegeLondon_PaediatricHCW,1/27/2021,D. Goldblatt,Sublocal,Austria,"Austria
(University College London)",07/17 - 07/24,Health care workers and caregivers,Adults (18-64 years),196,NA,Convenience,"Epitope Diagnostics; NR
(100%; 88.7%)",High,Journal Article (Peer-Reviewed),http://dx.doi.org/10.1016/j.jhin.2020.12.019,3/13/2021,3/16/2021
210108_Linz_OrdensklinikumLinzBarmherzigeSchwestern_OverallHCW,1/8/2021,Margot Egger,Sublocal,Austria,"Linz; Upper Austria; Austria
(Ordensklinikum Linz Barmherzige Schwestern and Konventhospital Barmherzige Brueder Linz  )",06/15 - 07/15,Health care workers and caregivers,Adults (18-64 years),1757,2% (NR),Convenience,"Roche Diagnostics, Abbott Diagnostics; NR
(100%; 99.5%)",Moderate,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1515/cclm-2020-1681,3/19/2021,3/19/2021
200615_Belgium_ZiekenhuisOost-Limburg_HealthCareWorkers,6/15/2020,Deborah Steensels,Sublocal,Belgium,"Genk; Limburg; Belgium
(ZiekenhuisOost-Limburg)",04/22 - 04/30,Health care workers and caregivers,Adults (18-64 years),3056,6.4% (5.5-7.3%),Convenience,"Multi-G; IgG; LFIA: Lateral flow immunoassay
(92.2%; 97%)",High,Journal Article (Peer-Reviewed),https://jamanetwork.com/journals/jama/fullarticle/2767382,6/18/2020,3/1/2021
200625_Brussels_UniversitéLibredeBruxelles_OverallHCW,6/25/2020,Charlotte Martin,Local,Belgium,"City of Brussels; Brussels; Belgium
(Université Libre de Bruxelles)",04/15 - 05/18,Health care workers and caregivers,Adults (18-64 years),326,11% (NR),Convenience,"EUROIMMUN; IgG; ELISA
(0%; 0%)",High,Journal Article (Peer-Reviewed),https://www.journalofhospitalinfection.com/article/S0195-6701(20)30313-3/fulltext,7/21/2020,3/1/2021
200730_Belgium_UniversityofAntwerp_GenPop_PopAdj_Period_1,7/30/2020,Sereina Herzog,National,Belgium,"Wallonia, Brussels, Flanders; Belgium
(University of Antwerp)",03/30 - 04/05,Household and community samples,Multiple groups,3910,2.9% (2.3-3.4%),Stratified non-probability,"EUROIMMUN; IgG; ELISA
(0%; 99.2%)",Moderate,Preprint,https://www.medrxiv.org/content/10.1101/2020.06.08.20125179v2,9/27/2020,3/1/2021
200730_Belgium_UniversityofAntwerp_GenPop_PopAdj_Period_2,7/30/2020,Sereina Herzog,National,Belgium,"Wallonia, Brussels, Flanders; Belgium
(University of Antwerp)",04/20 - 04/26,Household and community samples,Multiple groups,3397,6% (5.1-7.1%),Stratified non-probability,"EUROIMMUN; IgG; ELISA
(0%; 99.2%)",Moderate,Preprint,https://www.medrxiv.org/content/10.1101/2020.06.08.20125179v2,9/27/2020,3/1/2021
200730_Belgium_UniversityofAntwerp_GenPop_PopAdj_Period_3,7/30/2020,Sereina Herzog,National,Belgium,"Wallonia, Brussels, Flanders; Belgium
(University of Antwerp)",05/18 - 05/25,Household and community samples,Multiple groups,3242,6.9% (5.9-8%),Stratified non-probability,"EUROIMMUN; IgG; ELISA
(0%; 99.2%)",Moderate,Preprint,https://www.medrxiv.org/content/10.1101/2020.06.08.20125179v2,9/27/2020,3/1/2021
200730_Belgium_UniversityofAntwerp_GenPop_PopAdj_Period_4,7/30/2020,Sereina Herzog,National,Belgium,"Wallonia, Brussels, Flanders; Belgium
(University of Antwerp)",06/08 - 06/13,Household and community samples,Multiple groups,2960,5.5% (4.7-6.5%),Stratified non-probability,"EUROIMMUN; IgG; ELISA
(0%; 99.2%)",Moderate,Preprint,https://www.medrxiv.org/content/10.1101/2020.06.08.20125179v2,9/27/2020,3/1/2021
200730_Belgium_UniversityofAntwerp_GenPop_PopAdj_Period_5,7/30/2020,Sereina Herzog,National,Belgium,"Wallonia, Brussels, Flanders; Belgium
(University of Antwerp)",06/29 - 07/04,Household and community samples,Multiple groups,3023,4.5% (3.7-5.4%),Stratified non-probability,"EUROIMMUN; IgG; ELISA
(0%; 99.2%)",Moderate,Preprint,https://www.medrxiv.org/content/10.1101/2020.06.08.20125179v2,9/27/2020,3/1/2021
200730_Belgium_IrisHospitalsSouth_HCW_UnAdj,7/30/2020,Laurent Blairon,Local,Belgium,"City of Brussels; Brussels; Belgium
(Iris Hospitals South)",05/25 - 06/19,Health care workers and caregivers,Multiple groups,1485,14.6% (NR),Convenience,"DiaSorin; IgG; Chemiluminescence Immunoassay
(100%; 0%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1016/j.jinf.2020.07.033,10/5/2020,3/1/2021
200811_Belgium_universitairesSaint-Luc_Overall,8/10/2020,Silvia Berardis,Local,Belgium,"City of Brussels; Belgium
(Cliniques universitaires Saint-Luc)",04/16 - 05/19,Patients seeking care for non-COVID-19 reasons,Multiple groups,149,2.7% (NR),Convenience,"""SNIBE – Shenzhen New Industries Biomedical Engineering Co., Ltd""; IgG, IgM; Chemiluminescence Immunoassay
(95.6%; 96%)",High,Journal Article (Peer-Reviewed),https://www.sciencedirect.com/science/article/pii/S1569199320308213,10/24/2020,3/17/2021
201018_Belgium_UniversityHospitalsLeuven_Overall_unadj,10/18/2020,Frank Buntinx,Sublocal,Belgium,"Lanaken; Limburg; Belgium
(University of Leuven)",04/14 - 04/16,Multiple populations,Multiple groups,188,18.6% (NR),Convenience,"SureScreen Diagnostics, Derby, UK; NR
(74.7%; 95.1%)",High,Journal Article (Peer-Reviewed),http://dx.doi.org/10.1080/17843286.2020.1834285,1/16/2021,3/1/2021
201217_Belgium_Sciensano_Overall,12/17/2020,Els Duysburgh,National,Belgium,"Belgium
(Sciensano)",04/22 - 09/30,Health care workers and caregivers,Adults (18-64 years),850,9.5% (NR),Unclear,"Euroimmun Medizinische Labordiagnostika; NR
(0%; 0%)",Unclear,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1016/S1473-3099(20)30943-9,1/26/2021,3/1/2021
210120_Antwerp_UniversityofAntwerp_primary,1/20/2021,Kawtar El Abdellat,Local,Belgium,"Antwerp; Belgium
(University of Antwerp)",06/03 - 06/17,Health care workers and caregivers,Multiple groups,431,3.2% (1.9-5.4%),Convenience,"Euroimmune, AG, Lubeck; NR
(80%; 98.5%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1192/bjo.2020.172,2/6/2021,3/1/2021
200517_SaoPaolo_GrupoFleury_GenPop,5/17/2020,Phillippe Watanabe,Sublocal,Brazil,"São Paulo; São Paulo; Brazil
(Grupo Fleury)",05/04 - 05/12,Household and community samples,Not reported,520,5.2% (NR),Stratified probability,"Not reported; Not reported; Not reported
(90%; 0%)",Unclear,News and Media,https://www1.folha.uol.com.br/equilibrioesaude/2020/05/nos-bairros-de-sp-mais-afetados-pela-covid-19-so-5-tiveram-contato-com-o-virus.shtml,6/2/2020,3/1/2021
200616_Brazil_SecretariadeEstadodaSaúdedoEspíritoSanto_GenPopUrban,6/16/2020,Cristiana Gomes,Regional,Brazil,"Espírito Santo; Brazil
(Secretaria de Estado da Saúde do Espírito Santo)",05/13 - 05/15,Household and community samples,Multiple groups,4612,2.1% (1.7-2.5%),Stratified probability,"Celer Technologies Inc.; IgG, IgM; Rapid immunochromatographic test
(86.4%; 97.63%)",Moderate,Preprint,https://www.medrxiv.org/content/10.1101/2020.06.13.20130559v1.full.pdf,6/18/2020,3/1/2021
200616_Brazil_SecretariadeEstadodaSaúdedoEspíritoSanto_GenPop2Sub-urban,6/16/2020,Cristiana Gomes,Regional,Brazil,"Espírito Santo; Brazil
(Secretaria de Estado da Saúde do Espírito Santo)",05/13 - 05/15,Household and community samples,Multiple groups,1163,0.3% (0.1-0.8%),Stratified probability,"Celer Technologies Inc.; IgG, IgM; Rapid immunochromatographic test
(86.4%; 97.63%)",Moderate,Preprint,https://www.medrxiv.org/content/10.1101/2020.06.13.20130559v1.full.pdf,6/18/2020,3/1/2021
200629_SaoPaulo_UniversidadedeSaoPaulo_GenPopulation,6/29/2020,Beatriz Tess,Local,Brazil,"São Paulo; São Paulo; Brazil
(Universidade de São Paulo)",05/04 - 05/12,Household and community samples,Multiple groups,517,4.7% (3-6.6%),Simplified probability,"SNIBE – Shenzhen New Industries Biomedical Engineering Co.; IgG, IgM; Chemiluminescence Immunoassay
(100%; 99.5%)",Moderate,Preprint,http://medrxiv.org/cgi/content/short/2020.06.29.20142331,6/30/2020,3/1/2021
200706_RiodeJaneiro_UniversidadedoEstadodoRiodeJaneiro_BloodDonors_OverallAdj,7/6/2020,Amorim Filho,Local,Brazil,"Rio de Janeiro; Rio de Janeiro; Brazil
(Universidade do Estado do Rio de Janeiro)",04/14 - 04/27,Blood donors,Adults (18-64 years),2857,3.3% (2.6-4.1%),Sequential,"MedLevensohn; IgG, IgM; Rapid immunochromatographic test
(85%; 99%)",Moderate,Journal Article (Peer-Reviewed),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7334006/,7/10/2020,3/1/2021
200708_RioGrandeDoSul_UniversidadeFederalDePelotas_Round1_GenPop,8/7/2020,Mariângela Silveira,Regional,Brazil,"Ijui, Passo Fundo, Caxias, Canoas, Porto Alegre, Pelotas, Santa Maria, Santa Cruz do Sul, Uruguaiana; Rio Grande do Sul; Brazil
(Universidade Federal de Pelotas)",04/11 - 04/13,Household and community samples,Multiple groups,4151,0% (0-0.2%),Stratified probability,"Wondfo Biotech Co.; IgM, IgG; LFIA: Lateral flow immunoassay
(84.8%; 99%)",Low,Journal Article (Peer-Reviewed),https://www.nature.com/articles/s41591-020-0992-3,7/16/2020,3/1/2021
200708_RioGrandeDoSul_UniversidadeFederalDePelotas_Round2_GenPop,8/7/2020,Mariângela Silveira,Regional,Brazil,"Ijui, Passo Fundo, Caxias, Canoas, Porto Alegre, Pelotas, Santa Maria, Santa Cruz do Sul, Uruguaiana; Rio Grande do Sul; Brazil
(Universidade Federal de Pelotas)",04/25 - 04/27,Household and community samples,Multiple groups,4501,0.1% (0-0.3%),Stratified probability,"Wondfo Biotech Co.; IgM, IgG; LFIA: Lateral flow immunoassay
(84.8%; 99%)",Low,Journal Article (Peer-Reviewed),https://www.nature.com/articles/s41591-020-0992-3,7/16/2020,3/1/2021
200708_RioGrandeDoSul_UniversidadeFederalDePelotas_Round3_GenPop,8/7/2020,Mariângela Silveira,Regional,Brazil,"Ijui, Passo Fundo, Caxias, Canoas, Porto Alegre, Pelotas, Santa Maria, Santa Cruz do Sul, Uruguaiana; Rio Grande do Sul; Brazil
(Universidade Federal de Pelotas)",05/09 - 05/11,Household and community samples,Multiple groups,4500,0.2% (0.1-0.4%),Stratified probability,"Wondfo Biotech Co.; IgM, IgG; LFIA: Lateral flow immunoassay
(84.8%; 99%)",Low,Journal Article (Peer-Reviewed),https://www.nature.com/articles/s41591-020-0992-3,7/16/2020,3/1/2021
200703_Teresina_CentrodeOperaçõesdeEmergênciasemSaúdePública_Apr19,7/3/2020,Marcelo Vieira,Local,Brazil,"Teresina; Piaui; Brazil
( Centro de Operações de Emergências em Saúde Pública)",04/19 - 04/19,Household and community samples,Not reported,900,0.6% (0.2-1.3%),Stratified probability,"Wondfo Biotech Co.; IgG, IgM; RDT
(86%; 99%)",Moderate,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1590/0037-8682-0351-2020,7/30/2020,3/1/2021
200703_Teresina_CentrodeOperaçõesdeEmergênciasemSaúdePública_Apr26,7/3/2020,Marcelo Vieira,Local,Brazil,"Teresina; Piaui; Brazil
( Centro de Operações de Emergências em Saúde Pública)",04/26 - 04/26,Household and community samples,Not reported,900,0.9% (0.4-1.8%),Stratified probability,"Wondfo Biotech Co.; IgG, IgM; RDT
(86%; 99%)",Moderate,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1590/0037-8682-0351-2020,7/30/2020,3/1/2021
200703_Teresina_CentrodeOperaçõesdeEmergênciasemSaúdePública_May3,7/3/2020,Marcelo Vieira,Local,Brazil,"Teresina; Piaui; Brazil
( Centro de Operações de Emergências em Saúde Pública)",05/03 - 05/03,Household and community samples,Not reported,900,1.4% (0.8-2.5%),Stratified probability,"Wondfo Biotech Co.; IgG, IgM; RDT
(86%; 99%)",Moderate,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1590/0037-8682-0351-2020,7/30/2020,3/1/2021
200703_Teresina_CentrodeOperaçõesdeEmergênciasemSaúdePública_May10,7/3/2020,Marcelo Vieira,Local,Brazil,"Teresina; Piaui; Brazil
( Centro de Operações de Emergências em Saúde Pública)",05/10 - 05/10,Household and community samples,Not reported,900,2% (1.2-3.1%),Stratified probability,"Wondfo Biotech Co.; IgG, IgM; RDT
(86%; 99%)",Moderate,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1590/0037-8682-0351-2020,7/30/2020,3/1/2021
200703_Teresina_CentrodeOperaçõesdeEmergênciasemSaúdePública_May17,7/3/2020,Marcelo Vieira,Local,Brazil,"Teresina; Piaui; Brazil
( Centro de Operações de Emergências em Saúde Pública)",05/17 - 05/17,Household and community samples,Not reported,900,3.8% (2.6-5.2%),Stratified probability,"Wondfo Biotech Co.; IgG, IgM; RDT
(86%; 99%)",Moderate,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1590/0037-8682-0351-2020,7/30/2020,3/1/2021
200703_Teresina_CentrodeOperaçõesdeEmergênciasemSaúdePública_May24,7/3/2020,Marcelo Vieira,Local,Brazil,"Teresina; Piaui; Brazil
( Centro de Operações de Emergências em Saúde Pública)",05/24 - 05/24,Household and community samples,Not reported,900,5.8% (4.3-7.3%),Stratified probability,"Wondfo Biotech Co.; IgG, IgM; RDT
(86%; 99%)",Moderate,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1590/0037-8682-0351-2020,7/30/2020,3/1/2021
200703_Teresina_CentrodeOperaçõesdeEmergênciasemSaúdePública_May31,7/3/2020,Marcelo Vieira,Local,Brazil,"Teresina; Piaui; Brazil
( Centro de Operações de Emergências em Saúde Pública)",05/31 - 05/31,Household and community samples,Not reported,900,8.3% (6.6-10.3%),Stratified probability,"Wondfo Biotech Co.; IgG, IgM; RDT
(86%; 99%)",Moderate,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1590/0037-8682-0351-2020,7/30/2020,3/1/2021
200812_Brazil_UniversidadeFederaldePelotas_Overall,8/12/2020,Ana Maria Baptista Menezes,National,Brazil,"Brazil
(Universidade Federal de Pelotas)",06/21 - 06/24,Household and community samples,Multiple groups,31869,2.7% (NR),Stratified probability,"Wondfo Biotech Co.; IgG, IgM; LFIA: Lateral flow immunoassay
(84.4%; 99.95%)",Moderate,Preprint,https://www.medrxiv.org/content/10.1101/2020.08.10.20171942v1,10/7/2020,3/1/2021
200702_Brazil_UniversidadeFederaldePelotas_Round2,7/2/2020,Universidade Federal de Pelotas,National,Brazil,"Brazil
(Universidade Federal de Pelotas)",06/04 - 06/07,Household and community samples,Multiple groups,31165,3.1% (2.8-3.4%),Simplified probability,"Wondfo Biotech Co.; IgG, IgM; LFIA: Lateral flow immunoassay
(84.8%; 99%)",Moderate,Institutional Report,https://bit.ly/Epicovid19BRfases1-3,10/24/2020,3/1/2021
200901_Maranhao_FederalUniversityOfMaranhao_Overall_Popadj,9/1/2020,Antonio daSilva,Regional,Brazil,"Maranhao; Brazil
(Federal University of Maranhao)",07/27 - 08/08,Household and community samples,Multiple groups,3156,40.4% (35.6-45.3%),Stratified probability,"Roche Diagnostics; IgG, IgM; Chemiluminescence Immunoassay
(89.2%; 99.7%)",Moderate,Preprint,https://www.medrxiv.org/content/10.1101/2020.08.28.20180463v1,11/5/2020,3/1/2021
200916_Lajeado_UniversidadedoValedodoTaquari_Survey1,9/16/2020,Rafael Picon,Local,Brazil,"Lajeado; Rio Grande do Sul; Brazil
(Universidade do Vale do Taquari)",05/30 - 06/04,Household and community samples,Multiple groups,1450,4% (3.1-5.2%),Stratified probability,"Guangzhou Wondfo Biotech; IgM, IgG; LFIA: Lateral flow immunoassay
(76.24%; 99.57%)",Moderate,Journal Article (Peer-Reviewed),http://dx.doi.org/10.1016/j.ijid.2020.09.028,11/12/2020,3/1/2021
200916_Lajeado_UniversidadedoValedodoTaquari_Survey2,9/16/2020,Rafael Picon,Local,Brazil,"Lajeado; Rio Grande do Sul; Brazil
(Universidade do Vale do Taquari)",06/13 - 06/17,Household and community samples,Multiple groups,1127,2.6% (1.8-3.7%),Stratified probability,"Guangzhou Wondfo Biotech; IgM, IgG; LFIA: Lateral flow immunoassay
(76.24%; 99.57%)",Moderate,Journal Article (Peer-Reviewed),http://dx.doi.org/10.1016/j.ijid.2020.09.028,11/12/2020,3/1/2021
200921_Manaus_UniversityofSaoPaulo_Manaus0806-0819TestAdj0.4,9/21/2020,Lewis Buss,Local,Brazil,"Manaus; Brazil
(University of Sao Paulo)",08/06 - 08/19,Blood donors,Multiple groups,881,45.7% (41.3-50.2%),Sequential,"Abbott; IgG; Chemiluminsescent microparticle immunoassay
(92.2%; 96.7%)",Moderate,Preprint,https://www.medrxiv.org/content/10.1101/2020.09.16.20194787v1,11/13/2020,3/1/2021
200921_Manaus_UniversityofSaoPaulo_SaoPaulo0810-0821TestAdj0.4,9/21/2020,Lewis Buss,Local,Brazil,"Sao Paulo; Brazil
(University of Sao Paulo)",08/10 - 08/21,Blood donors,Multiple groups,813,15.1% (12-18.5%),Sequential,"Abbott; IgG; Chemiluminsescent microparticle immunoassay
(92.2%; 96.7%)",Moderate,Preprint,https://www.medrxiv.org/content/10.1101/2020.09.16.20194787v1,11/13/2020,3/1/2021
200930_Sergipe_FederalUniversityofSergipe_OverallIgG,9/30/2020,Mônica de Melo,Regional,Brazil,"Sergipe; Brazil
(Federal University of Sergipe)",06/01 - 06/30,Health care workers and caregivers,Multiple groups,471,13.6% (NR),Convenience,"Boditech Med Inc.; IgG; immunofluorescence assay (IFA)
(95.8%; 97%)",High,Preprint,https://www.medrxiv.org/content/medrxiv/early/2020/09/30/2020.09.24.20200873.full.pdf,11/23/2020,3/1/2021
201006_Brazil_FederalUniversityofSergipe_genpop_IgG,10/6/2020,Lysandro Pinto Borges,Regional,Brazil,"Aracaju, Simão Dias, Itabaiana, Itabaianinha, Nossa Senhora do, São Cristóvão, Estância, Lagarto, Tobias Barreto, Nossa Senhora da Glória; Sergipe; Brazil
(Federal University of Fergipe )",05/02 - 05/09,Household and community samples,Multiple groups,2635,8.3% (7.2-9.4%),Convenience,"Boditech Med Inc.; NR
(0%; 0%)",High,Journal Article (Peer-Reviewed),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7541966/,12/20/2020,3/17/2021
200901_Petrópolis_CentrodeTerapiaOncológica_HCW_IGGorIGM,9/1/2020,P. Ismael Amaral Silva,Sublocal,Brazil,"Petrópolis; Rio de Janeiro; Brazil
(Centro de Terapia Oncológica)",04/09 - 04/29,Health care workers and caregivers,Adults (18-64 years),61,4.9% (NR),Convenience,"NR; NR
(0%; 0%)",High,Journal Article (Peer-Reviewed),http://dx.doi.org/10.1016/j.annonc.2020.08.1825,1/4/2021,3/1/2021
201027_Cuiabá_UniversidadeFederaldeMatoGrosso_Overall,10/27/2020,Cristiane Coimbra de Paula,Sublocal,Brazil,"Cuiabá; Mato Grosso; Brazil
(Universidade Federal de Mato Grosso (UFMT))",04/01 - 07/31,Residual sera,Multiple groups,6392,22.1% (NR),Entire sample,"NR; NR
(0%; 0%)",High,Preprint,https://www.medrxiv.org/content/10.1101/2020.10.26.20219683v1,1/15/2021,3/17/2021
201021_SaoPaulo_AdolfoLutzCentralInstitute,10/21/2020,Valéria Oliveira Silva,Sublocal,Brazil,"Sao Paulo; State of Sao Paulo; Brazil
(Adolfo Lutz Central Institute)",06/05 - 07/31,Multiple populations,Multiple groups,406,8.6% (NR),Convenience,"Guangzhou Wondfo Biotech Co., Ltd., China; Roche Diagnostics, Rotkreuz, Switzerland; NR
(0%; 0%)",High,Preprint,https://www.medrxiv.org/content/10.1101/2020.10.19.20213421v1,1/17/2021,3/1/2021
201213_SaoPaulo_ FaculdadeDeMedicinaDaUniversidade_Overall,12/13/2020,Silvia Costa,Sublocal,Brazil,"São Paulo ; São Paulo State; Brazil
(Faculdade De Medicina da Universidade)",05/14 - 05/28,Health care workers and caregivers,Adults (18-64 years),4987,14.1% (13.1-15%),Convenience,"Wondfo-China; NR
(0%; 0%)",Moderate,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1093/cid/ciaa1845,1/23/2021,3/2/2021
201119_SaoPaulo_ClínicaDeReumatologia_RheumaticPatients,11/19/2020,Felipe Santana,Local,Brazil,"São Paulo; Sao Paulo Province; Brazil
(Clínica de Reumatologia)",03/15 - 08/15,Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),100,21% (NR),Convenience,"Snibe Diagnostics; NR
(0%; 0%)",High,Preprint,https://www.researchsquare.com/article/rs-97191/v1,1/23/2021,3/17/2021
201113_SaoPaulo_UniversidadeSaoPaulo_primary,11/13/2020,Luanda Mara da Silva Oliveira,Sublocal,Brazil,"Sao Paulo; Sao Paulo; Brazil
(Universidade de São Paulo)",06/30 - 08/04,Residual sera,Multiple groups,439,13.9% (NR),Sequential,"DiaSorin S.p.A., Roche Diagnostics; NR
(97.8%; 99.1%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1590/S1678-9946202062091,1/23/2021,3/17/2021
201130_Sergipe_FederalUniversityofSergipe_residualsera_primary,11/30/2020,Ricardo Queiroz Gurgel,Local,Brazil,"Aracaju; Sergipe; Brazil
(Federal University of Sergipe)",01/15 - 04/15,Residual sera,Multiple groups,987,1.6% (NR),Sequential,"Nantong Egens Biotechnology CO, Ltd., China and Bodytech Med Inc.; NR
(96.9%; 100%)",Moderate,Journal Article (Peer-Reviewed),http://dx.doi.org/10.1016/j.jinf.2020.11.037,1/29/2021,3/1/2021
210106_EspiritoSanto_SecretariadeEstadodaSaúdedoEspíritoSanto_primary,1/6/2021,Lorenzzo Lyrio Stringari,Regional,Brazil,"Espirito Santo; Brazil
(Secretaria de Estado da Saúde do Espírito Santo)",12/01 - 06/30,Patients seeking care for non-COVID-19 reasons,Multiple groups,7370,2.9% (NR),Convenience,"Abbott Laboratories; NR
(0%; 0%)",Moderate,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1371/journal.pone.0244937,1/30/2021,3/1/2021
0128_XikrinofBacaja_InstitutodeCiênciasBiológicasdaUniversidadeFederaldoPará_overall,,Eliene Putira Sacuema Rodrigues,Local,Brazil,"Xikrin of Bacaja Villages; Brazil
(Instituto de Ciências Biológicas da Universidade Federal do Pará)",09/01 - 09/30,Household and community samples,Multiple groups,100,73% (NR),Unclear,"NR; NR
(0%; 0%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1186/s12939-021-01392-8,3/9/2021,3/16/2021
210129_Botuacato_InstitutoButantan_Primary,1/29/2021,Eliana Nogueira Castro de Barros,Sublocal,Brazil,"Botucato; Sao Paolo; Brazil
(Instituto Butantan)",06/22 - 07/08,Assisted living and long-term care facilities,Multiple groups,209,11.5% (7.1-16.6%),Convenience,"Guangzhou Wondfo Biotech Co., Ltd; NR
(86.4%; 99.6%)",Moderate,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1590/S1678-9946202163010,3/18/2021,3/18/2021
200527_Varna_MedicalDiagnosticLaboratory_IgG/IgM,5/27/2020,Denitsa Tsaneva-Damyanova,Local,Bulgaria," Varna; Varna; Bulgaria
(Medical Diagnostic Laboratory ""STATUS"" )",03/26 - 04/20,Residual sera,Multiple groups,586,4.8% (3.2-6.8%),Self-referral,"""Zhejiang Orient Gene Biotech Co., LTD""; IgG, IgM; LFIA: Lateral flow immunoassay
(0%; 0%)",High,Journal Article (Peer-Reviewed),https://www.tandfonline.com/doi/pdf/10.1080/13102818.2020.1772105?needAccess=true,7/20/2020,3/17/2021
200715_GreaterVancouverArea_BC-Centre-For-Disease-Control_MarchSnapshot_OverallPopAdj,7/15/2020,Danuta Skowronski,Regional,Canada,"British Columbia; Canada
(British Columbia Centre for Disease Control)",03/05 - 03/13,Residual sera,Multiple groups,869,0.3% (0-1%),Stratified probability,"Abbott, Ortho-Clinical Diagnostics; IgA, IgM, IgG; Chemiluminescence Immunoassay
(97.75%; 100%)",Moderate,Preprint,https://www.medrxiv.org/content/10.1101/2020.07.13.20153148v1,7/16/2020,3/1/2021
200715_GreaterVancouverArea_BC-Centre-for-Disease-Control_MaySnapshot_OverallPopAdj,7/15/2020,Danuta Skowronski,Regional,Canada,"British Columbia; Canada
(British Columbia Centre for Disease Control)",05/15 - 05/27,Residual sera,Multiple groups,885,0.6% (0.2-1.4%),Stratified probability,"Abbott, Ortho-Clinical Diagnostics, Siemens Healthineers; IgA, IgM, IgG; Chemiluminescence Immunoassay
(97.75%; 100%)",Moderate,Preprint,https://www.medrxiv.org/content/10.1101/2020.07.13.20153148v1,7/16/2020,3/1/2021
200805_Quebec_Héma-Québec_BloodDonors,"8/5/2020, 8/5/2020","Héma-Québec, COVID-19 Immunity Task Force ",Regional,Canada,"Quebec; Canada
(Héma-Québec)",05/25 - 07/09,Blood donors,Adults (18-64 years),7691,2.2% (NR),Stratified probability,"Not reported; Not reported; Not reported
(0%; 0%)",Unclear,"Institutional Report, Institutional Report","https://www.hema-quebec.qc.ca/publications/communiques/archives/2020/communiques-2020/etude-seroprevalence-resultats.en.html, https://www.covid19immunitytaskforce.ca/the-covid-19-immunity-task-force-welcomes-the-results-of-the-blood-donor-seroprevalence-study-led-by-hema-quebec/",8/6/2020,3/1/2021
200730_Ontario_PublicHealthOntario_March_GenPop_PopTestAdj,"7/30/2020, 7/30/2020","Public Health Ontario, COVID-19 Immunity Task Force ",Regional,Canada,"Ontario; Canada
(Public Health Ontario)",03/27 - 04/30,Residual sera,Multiple groups,827,0.5% (0.1-1.5%),Stratified probability,"Abbott, Ortho-Clinical Diagnostics; IgG; Chemiluminescence Immunoassay
(90.4%; 100%)",Moderate,"Institutional Report, Institutional Report","https://www.publichealthontario.ca/-/media/documents/ncov/epi/2020/07/covid-19-epi-seroprevalence-in-ontario.pdf?la=en, https://www.covid19immunitytaskforce.ca/covid-19-immunity-task-force-welcomes-first-results-from-public-health-ontarios-serosurveillance-program/",8/6/2020,3/1/2021
200730_Ontario_PublicHealthOntario_June_GenPop_PopTestAdj,"7/30/2020, 7/30/2020","Public Health Ontario, COVID-19 Immunity Task Force ",Regional,Canada,"Ontario; Canada
(Public Health Ontario)",06/05 - 06/30,Residual sera,Multiple groups,7014,1.1% (0.8-1.3%),Stratified probability,"Abbott, Ortho-Clinical Diagnostics; IgG; Chemiluminescence Immunoassay
(90.4%; 100%)",Moderate,"Institutional Report, Institutional Report","https://www.publichealthontario.ca/-/media/documents/ncov/epi/2020/07/covid-19-epi-seroprevalence-in-ontario.pdf?la=en, https://www.covid19immunitytaskforce.ca/covid-19-immunity-task-force-welcomes-first-results-from-public-health-ontarios-serosurveillance-program/",8/6/2020,3/1/2021
200730_Ontario_PublicHealthOntario_May_GenPop_PopTestAdj,"7/30/2020, 7/30/2020","Public Health Ontario, COVID-19 Immunity Task Force ",Regional,Canada,"Ontario; Canada
(Public Health Ontario)",05/26 - 05/31,Residual sera,Multiple groups,1061,1.5% (0.7-2.2%),Stratified probability,"Abbott, Ortho-Clinical Diagnostics; IgG; Chemiluminescence Immunoassay
(90.4%; 100%)",Moderate,"Institutional Report, Institutional Report","https://www.publichealthontario.ca/-/media/documents/ncov/epi/2020/07/covid-19-epi-seroprevalence-in-ontario.pdf?la=en, https://www.covid19immunitytaskforce.ca/covid-19-immunity-task-force-welcomes-first-results-from-public-health-ontarios-serosurveillance-program/",8/6/2020,3/1/2021
200819_Canada_CBS_BloodDonors_Overall_Adjusted,8/19/2020,Canadian Blood Services,National,Canada,"Ontario, British Columbia, Alberta, Saskatchewan, Manitoba, New Brunswick, Nova Scotia, Prince Edward Island, Newfoundland and Labrador; Canada
(Canadian Blood Services)",05/09 - 06/18,Blood donors,Multiple groups,37737,0.7% (0.6-0.8%),Sequential,"Abbott; IgG; chemiluminescent microparticle immunoassay
(92.7%; 99.9%)",Moderate,Institutional Report,https://www.covid19immunitytaskforce.ca/wp-content/uploads/2020/09/COVID-19-Public-Report_2.pdf,10/3/2020,3/1/2021
201106_BC_BCChildrensHospital_Overall_Adj,11/6/2020,Abdelilah Majdoubi,Local,Canada,"Vancouver; British Columbia; Canada
(BC Children’s Hospital )",05/17 - 06/19,Multiple populations,Adults (18-64 years),276,0.6% (0-2.7%),Convenience,"Ortho-Clinical Diagnostics, Meso Scale Diagnostics; IgA, IgG, IgM, Total Antibody; Chemiluminescence Immunoassay
(96%; 99%)",High,Preprint,https://www.medrxiv.org/content/10.1101/2020.10.05.20206664v7,11/24/2020,3/17/2021
201017_Vancouver_UniversityofBritishColumbia_LTCF_overall,10/17/2020,Rohit Vijh,Sublocal,Canada,"Vancouver; British Columbia; Canada
(University of British Columbia)",05/04 - 05/14,Assisted living and long-term care facilities,Multiple groups,291,39% (NR),Convenience,"DiaSorin, Ortho Vitros , Abbott, Siemens; NR
(0%; 0%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1016/j.ajic.2020.10.009,12/18/2020,3/1/2021
210112_Canada_CBS_BloodDonors_Overall_PopAdjTestAdj,1/12/2021,Canadian Blood Services,National,Canada,"British Columbia, Alberta, Saskatchewan, Manitoba, Ontario, New Brunswick, Nova Scotia, Prince Edward Island, Newfoundland and Labrador; Canada
(Canadian Blood Services)",11/07 - 11/25,Blood donors,Multiple groups,17049,1.5% (1.3-1.7%),Sequential,"Abbott; NR
(92.7%; 99.9%)",Moderate,Institutional Report,https://slack-files.com/files-pri-safe/T011KSPAYPR-F01K401T9J9/covid-19_report_november_2020_final_12jan2021-1.pdf?c=1611144789-a5afc223a057856a,1/20/2021,3/1/2021
201218_Canada_CBS_BloodDonors_Overall_PopTestAdj,12/18/2020,Canadian Blood Services,National,Canada,"British Columbia, Alberta, Saskatchewan, Manitoba, Ontario, New Brunswick, Nova Scotia, Prince Edward Island, Newfoundland and Labrador; Canada
(Canadian Blood Services)",10/12 - 10/31,Blood donors,Multiple groups,16811,0.9% (0.7-1%),Sequential,"Abbott; NR
(92.7%; 99.9%)",Moderate,Institutional Report,N/A,1/21/2021,3/1/2021
201203_Edmonton_UniversityofAlberta_Children,12/3/2020,Emilie Manny,Local,Canada,"Edmonton; Alberta; Canada
(University of Alberta)",08/14 - 10/23,Household and community samples,Children and Youth (0-17 years),565,1.6% (NR),Convenience,"Abbott Laboratories; NR
(84.2%; 100%)",High,Preprint,https://poseidon01.ssrn.com/delivery.php?ID=579098091025087124113094013092119126025046084059055038121105001063029013061117127066089088099029120125126127122027092067006090071077064116068026070083111035094021057114045098065076072116064007032059100097072054064094007027094015098095104082088098074069111094090004070124099079094007105068078&EXT=pdf&INDEX=TRUE,1/31/2021,3/1/2021
210205_Ontario_PublicHealthOntario_March_Apr_primary,2/2/2021,Shelly Bolotin,Regional,Canada,"Ontario; Canada
(Public health Ontario)",03/27 - 04/30,Residual sera,,827,0.6% (NR),Convenience,"Abbott Laboratories, USA; NR
(0%; 0%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1093/infdis/jiaa796,2/5/2021,3/1/2021
210205_Ontario_PublicHealthOntario_June_primary,2/2/2021,Shelly Bolotin,Regional,Canada,"Ontario; Canada
(Public health Ontario)",03/27 - 04/30,Residual sera,,7023,1.5% (NR),Convenience,"Abbott Laboratories, USA; NR
(0%; 0%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1093/infdis/jiaa796,2/5/2021,3/1/2021
210205_Ontario_PublicHealthOntario_May_primary,2/2/2021,Shelly Bolotin,Regional,Canada,"Ontario; Canada
(Public health Ontario)",03/27 - 04/30,Residual sera,,1061,1.9% (NR),Convenience,"Abbott Laboratories, USA; NR
(0%; 0%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1093/infdis/jiaa796,2/5/2021,3/1/2021
210208_Canada_CBS_BloodDonors_Overall_PopTestAdj,2/8/2021,Canadian Blood Services,National,Canada,"British Columbia, Alberta, Manitoba, ; Canada
(Canadian Blood Services)",12/10 - 12/23,Blood donors,Multiple groups,16961,1.4% (1.2-1.6%),Sequential,"Abbott; NR
(92.7%; 99.9%)",Moderate,Institutional Report,N/A,2/19/2021,3/1/2021
210125_Canada_UniversityofToronto_Phase1_Overall_Popdj_sp,1/25/2021,Xuyang Tang,National,Canada,"Ontario, British Columbia, Yukon, Quebec, Alberta, Saskatchewan, Manitoba, Northwest Territories, New Brunswick, Newfoundland and Labrador, Nova Scotia, Prince Edward Island; Canada
(University of Toronto)",05/15 - 06/15,Household and community samples,Multiple groups,7068,1.7% (NR),Stratified non-probability,"NR; NR
(0%; 0%)",Moderate,Preprint,https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3752659,2/23/2021,3/1/2021
210125_Canada_UniversityofToronto_Phase2_Overall_PopAdj,1/25/2021,Xuyang Tang,National,Canada,"Ontario, British Columbia, Yukon, Quebec, Prairies, Northwest Territories, New Brunswick, Newfoundland and Labrador, Nova Scotia, Prince Edward Island; Canada
(University of Toronto)",08/15 - 09/15,Household and community samples,Multiple groups,1899,1.9% (NR),Stratified non-probability,"NR; NR
(0%; 0%)",High,Preprint,https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3752659,2/27/2021,3/15/2021
201123_Quebec_InstitutNationaldeSantePublique_overall,11/23/2020,Nicholas Brousseau,Regional,Canada,"Quebec; Canada
(Institut National de Sante Publique)",07/06 - 09/24,Health care workers and caregivers,Multiple groups,2056,11.7% (NR),Stratified non-probability,"DiaSorin; NR
(88.4%; 0%)",High,Institutional Report,https://www.inspq.qc.ca/publications/3084-etude-seroprevalence-travailleurs-sante-centres-hospitaliers-quebec-covid19,3/4/2021,3/9/2021
210131_Calgary_UniversityOfCalgary_overall,1/31/2021,James Kellner,Local,Canada,"Calgary; Alberta; Canada
(University of Calgary)",07/30 - 11/18,Household and community samples,Children and Youth (0-17 years),911,0.3% (0.1-1%),Self-referral,"Abbott; NR
(76.1%; 0%)",Moderate,Institutional Report,https://prism.ucalgary.ca/bitstream/handle/1880/113084/AB3C%20Aim%203%201st%20Interim%20Report-final.pdf?sequence=5&isAllowed=y,3/11/2021,3/16/2021
210201_Canada_UniversityofOttawa_Overall_adj,,Sahar Saeed,National,Canada,"Canada
(University of Ottawa)",05/09 - 07/21,Blood donors,Multiple groups,74642,7% (6.3-7.6%),Self-referral,"Abbott; NR
(92.7%; 99.9%)",Low,Journal Article (Peer-Reviewed),http://dx.doi.org/10.1111/trf.16296,3/21/2021,3/21/2021
200710_Santiago_UniversidadDeChile_AllStudents,7/10/2020,Juan Pablo Torres,Sublocal,Chile,"Vitacura; Santiago; Chile
(Universidade de Chile)",05/04 - 05/19,Students and Daycares,Children and Youth (0-17 years),1009,9.9% (8.6-11.5%),Stratified probability,"Genrui Biotech; IgG, IgM; Colloidal gold
(91.01%; 95.37%)",High,Journal Article (Peer-Reviewed),https://academic.oup.com/cid/article/doi/10.1093/cid/ciaa955/5869860,7/27/2020,3/1/2021
200710_Santiago_UniversidadDeChile_AllStaff,7/10/2020,Juan Pablo Torres,Sublocal,Chile,"Vitacura; Santiago; Chile
(Universidade de Chile)",05/04 - 05/19,Essential non-healthcare workers,Adults (18-64 years),235,16.6% (12.1-21.9%),Stratified probability,"Genrui Biotech; IgG, IgM; Colloidal gold
(91.01%; 95.37%)",High,Journal Article (Peer-Reviewed),https://academic.oup.com/cid/article/doi/10.1093/cid/ciaa955/5869860,7/27/2020,3/1/2021
200602_Wuhan_HuazhongUniversityofScienceandTechnology_HealthCareWorkers,6/2/2020,Shue Xiong,Local,China,"Wuhan; Hubei; China
(Huazhong University of Science and Technology)",02/12 - 03/17,Health care workers and caregivers,Adults (18-64 years),797,4.4% (NR),Convenience,"Not reported; IgG; ELISA
(0%; 0%)",Unclear,Preprint,https://www.medrxiv.org/content/10.1101/2020.05.28.20110767v1.full.pdf,6/4/2020,3/1/2021
200605_China_NationalClinicalResearchCentre_CommunitySetting,6/5/2020,Xin Xu,National,China,"Wuhan, Guangzhou, Chengdu; Hubei, Sichuan, Guangdong; China
(National Clinical Research Centre for Kidney Disease)",03/09 - 04/10,Multiple populations,Adults (18-64 years),10449,0.8% (NR),Self-referral,"Bioscience; IgG, IgM; Chemiluminescence Immunoassay
(0%; 99.3%)",High,Journal Article (Peer-Reviewed),https://www.nature.com/articles/s41591-020-0949-6,6/6/2020,3/1/2021
200602_Wuhan_SunYat-senUniversity_HCW_IgG,6/10/2020,Min Liu,Local,China,"Wuhan; Hubei; China
(Sun Yat-sen University)",02/07 - 04/21,Health care workers and caregivers,Adults (18-64 years),420,NA,Convenience,"YHLO; IgG; Chemiluminescence Immunoassay
(97.8%; 97.9%)",High,Journal Article (Peer-Reviewed),https://www.bmj.com/content/369/bmj.m2195,6/12/2020,3/1/2021
200616_Wuhan_ZhongnanHospitalofWuhanUniversity_HealthCareWorkers_IgG,11/2/2020,Tao Liu,Local,China,"Wuhan; Hubei; China
(Zhongnan Hospital of Wuhan University)",02/29 - 04/29,Health care workers and caregivers,Multiple groups,3832,4% (3.4-4.7%),Convenience,"YHLO; IgG; Chemiluminescence Immunoassay
(97.8%; 97.9%)",Moderate,Preprint,https://www.researchsquare.com/article/rs-99748/v1,6/18/2020,3/1/2021
200616_Wuhan_ZhongnanHospitalofWuhanUniversity_GenPopWorkers_IgG,11/2/2020,Tao Liu,Local,China,"Wuhan; Hubei; China
(Zhongnan Hospital of Wuhan University)",02/29 - 04/29,Household and community samples,Multiple groups,19555,4.6% (4.3-4.9%),Convenience,"YHLO; IgG; Chemiluminescence Immunoassay
(97.8%; 97.9%)",Moderate,Preprint,https://www.researchsquare.com/article/rs-99748/v1,6/18/2020,3/1/2021
200616_Wuhan_ZhongnanHospitalofWuhanUniversity_NonCOVIDPatients_IgG,11/2/2020,Tao Liu,Local,China,"Wuhan; Hubei; China
(Zhongnan Hospital of Wuhan University)",02/29 - 04/29,Residual sera,Multiple groups,1616,1% (0.5-1.5%),Sequential,"YHLO; IgG; Chemiluminescence Immunoassay
(97.8%; 97.9%)",Moderate,Preprint,https://www.researchsquare.com/article/rs-99748/v1,6/18/2020,3/17/2021
200603_WuhantoUSAtravel_CDC_PassengersGenPop,7/3/2020,Benjamin Hallowell,Sublocal,China,"Wuhan; Hubei; China
(US Centers for Disease Control and Prevention)",01/28 - 01/28,Household and community samples,Multiple groups,186,0.5% (NR),Convenience,"SeraCare Life Sciences; IgG, IgA, IgM; ELISA
(0%; 0%)",Moderate,Journal Article (Peer-Reviewed),https://wwwnc.cdc.gov/eid/article/26/9/20-1590_article,7/7/2020,3/1/2021
200604_Nanjing_NanjingUniversityMedicalSchool_HCWs/ContactsofCOVID-19patients,6/4/2020,Yuxin Chen,Local,China,"Nanjing; Jiangsu; China
(Nanjing University Medical School)",02/19 - 02/19,Health care workers and caregivers,Adults (18-64 years),105,17.1% (NR),Convenience,"Author-designed; IgG, IgM; ELISA
(93.3%; 100%)",High,Journal Article (Peer-Reviewed),https://pmlegacy.ncbi.nlm.nih.gov/pubmed/32504745,7/17/2020,3/1/2021
200723_Wuhan_HubeiProvincialHospital_GenpopPopAdj,7/23/2020,Ruijie Ling,Local,China,"Wuhan; Hubei; China
( Chinese Center for Disease Control and Prevention)",03/25 - 04/28,Household and community samples,Multiple groups,18712,3.3% (3-3.5%),Self-referral,"Innovita; IgG, IgM; Colloidal gold
(89.5%; 99%)",Moderate,Preprint,https://www.medrxiv.org/content/10.1101/2020.06.16.20132423v1,7/17/2020,3/1/2021
200420_Wuhan_CR&WISCOGeneralHospital_HospitalizedPatients,4/20/2020,Xiaodong Wu,Sublocal,China,"Wuhan; Hubei; China
(Wuhan University)",04/03 - 04/15,Residual sera,Not reported,381,10.5% (NR),Unclear,"Innovita Biological Technology Co. Ltd; IgG, IgM; Colloidal Gold Immunochromatography Assay (LFIA)
(87.3%; 100%)",High,Journal Article (Peer-Reviewed),https://onlinelibrary.wiley.com/doi/full/10.1002/jmv.25904,7/19/2020,3/17/2021
200420_Wuhan_CR&WISCOGeneralHospital_PeopleSeekingReturntoWork,4/20/2020,Xiaodong Wu,Sublocal,China,"Wuhan; Hubei; China
(Wuhan University)",04/03 - 04/15,Essential non-healthcare workers,Adults (18-64 years),1021,9.6% (NR),Unclear,"Innovita Biological Technology Co. Ltd; IgG, IgM; Colloidal Gold Immunochromatography Assay (LFIA)
(87.3%; 100%)",High,Journal Article (Peer-Reviewed),https://onlinelibrary.wiley.com/doi/full/10.1002/jmv.25904,7/19/2020,3/1/2021
200714_Shijiazhuang_PekingUnionMedicalCollege_BloodDonors,7/14/2020,Le Chang,Local,China,"Shijiazhuang; Hebei; China
(Beijing Hospital)",01/23 - 03/15,Blood donors,Multiple groups,13540,0% (0-0%),Sequential,"Wantai Biological Pharmacy Enterprise; IgA, IgG, IgM; ELISA
(0%; 0%)",High,Preprint,https://www.medrxiv.org/content/10.1101/2020.07.13.20153106v1.full.pdf,7/19/2020,3/1/2021
200714_Shenzhen_PekingUnionMedicalCollege_BloodDonors,7/14/2020,Le Chang,Local,China,"Shenzhen; Guangdong; China
(Beijing Hospital)",02/02 - 03/15,Blood donors,Multiple groups,6810,0% (0-0.1%),Sequential,"Wantai Biological Pharmacy Enterprise; IgA, IgG, IgM; ELISA
(0%; 0%)",High,Preprint,https://www.medrxiv.org/content/10.1101/2020.07.13.20153106v1.full.pdf,7/19/2020,3/1/2021
200714_Wuhan_PekingUnionMedicalCollege_BloodDonors,7/14/2020,Le Chang,Local,China,"Wuhan; Hubei; China
(Beijing Hospital)",01/15 - 04/30,Blood donors,Multiple groups,17794,2.3% (2.1-2.5%),Sequential,"Wantai Biological Pharmacy Enterprise; IgA, IgG, IgM; ELISA
(0%; 0%)",High,Preprint,https://www.medrxiv.org/content/10.1101/2020.07.13.20153106v1.full.pdf,7/19/2020,3/1/2021
200605_China_NationalClinicalResearchCentre_HospitalSetting,6/5/2020,Xin Xu,National,China,"Wuhan, Guangzhou, Jinzhou, Honghu, Chongqing, Chengdu, Foshan; Hubei, Sichuan, Guangdong; China
(National Clinical Research Centre for Kidney Disease)",03/09 - 04/10,Multiple populations,Adults (18-64 years),6919,2.5% (NR),Self-referral,"Bioscience; IgG, IgM; Chemiluminescence Immunoassay
(0%; 99.3%)",High,Journal Article (Peer-Reviewed),https://www.nature.com/articles/s41591-020-0949-6,7/25/2020,3/1/2021
200720_Guangzhou_GuangzhouMedicalUniversity_OverallIgG/IgM,7/20/2020,Wenhua Liang,Local,China,"Guangzhou; Guangdong; China
(The First Affiliated Hospital of Guangzhou Medical University)",01/20 - 04/30,Multiple populations,Multiple groups,8782,0.6% (NR),Convenience,"Shenzhen YHLO Biotech Co; IgG, IgM; Chemiluminescence Immunoassay
(0%; 100%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1038/s41422-020-0371-0,8/1/2020,3/17/2021
200720_Wuhan_GuangzhouMedicalUniversity_OverallIgG/IgM,7/20/2020,Wenhua Liang,Local,China,"Wuhan; Hubei; China
(The First Affiliated Hospital of Guangzhou Medical University)",01/19 - 04/30,Multiple populations,Multiple groups,8272,2.1% (NR),Convenience,"Innovita; IgG, IgM; Colloidal gold
(87.3%; 100%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1038/s41422-020-0371-0,8/1/2020,3/17/2021
200703_WuhanHemodialysis_TongjiMedicalCollege_HemodialysisPatients_IgGandorIgM,7/3/2020,Hui Tang,Local,China,"Wuhan; Hubei; China
( Tongji Medical College)",03/08 - 03/21,Patients seeking care for non-COVID-19 reasons,Multiple groups,1027,4.6% (NR),Convenience,"""Tangshan Yingnuote Biotechnology Enterprise Co., Ltd.""; IgG, IgM; Colloidal Gold Immunochromatography Assay (LFIA)
(87.3%; 100%)",Moderate,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1053/j.ajkd.2020.06.008,8/2/2020,3/1/2021
200725_Wuhan_WuhanInstituteofVirology_IgG,7/25/2020,Danna Tu,Sublocal,China,"Wuhan; Hubei; China
(Wuhan Institute of Virology)",03/19 - 03/20,Health care workers and caregivers,Adults (18-64 years),325,43.1% (NR),Stratified probability,"Vazyme, Zhu Hai Livzon Diagnostics Ins, NZK Biotech Co; IgG; ELISA, Colloidal gold, Dual-target immuno-fluorescence assay (DTFA)
(0%; 0%)",High,Journal Article (Peer-Reviewed),http://dx.doi.org/10.1016/j.jinf.2020.07.023,9/29/2020,3/1/2021
200729_Wuhan_WuhanUniversity_Overall,8/3/2020,Dong Zhao,Sublocal,China,"Wuhan; Hubei; China
(Renmin Hospital of Wuhan University)",01/14 - 02/21,Health care workers and caregivers,Not reported,1060,8.3% (NR),Convenience,"Shenzhen YHLO Biotech Co; IgG, IgM; Chemiluminescence Immunoassay
(0%; 0%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1016/j.ijid.2020.07.082,10/1/2020,3/1/2021
200725_Shenzhen_ ShenzhenSecondPeoplesHospital_Builders,7/25/2020,Cantong Zhang,Local,China,"Shenzhen; Guangdong; China
(Shenzhen Second People's Hospital)",02/29 - 03/18,Non-essential workers and unemployed persons,Multiple groups,1589,0.4% (NR),Convenience,"Shenzhen Sciarray Biotech Ltd; IgG; ELISA
(0%; 0%)",High,Journal Article (Peer-Reviewed),http://dx.doi.org/10.1002/jmv.26355,10/4/2020,3/1/2021
200829_Hubei_HuazhongUniversity_HospitalizedChildren,8/29/2020,Song-mi Want,Local,China,"Wuhan, Xiangyang; Hubei; China
(Huazhong University of Science and Technology)",01/23 - 04/24,Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),299,NA,Unclear,"Not reported; IgG, IgM; magnetic particle chemiluminescence
(0%; 0%)",Unclear,Journal Article (Peer-Reviewed),https://link.springer.com/article/10.1007/s11596-020-2228-7,10/4/2020,3/17/2021
200730_Shenyang_ShengjingHospitalofChinaMedicalUniversity_Total_IgG,"7/30/2020, 7/30/2020","Jin Zhang, Jin Zhang",Regional,China,"Shenyang; Liaoning; China
(Shengjing Hospital of China Medical University)",01/21 - 02/16,Multiple populations,Multiple groups,510,0.6% (NR),Convenience,"Shenzhen Yahuilong Biotechnology Co.; IgG; Chemiluminescence Immunoassay
(100%; 99.56%)",High,"Journal Article (Peer-Reviewed), Preprint","https://dx.doi.org/10.1016/j.intimp.2020.106861, https://www.medrxiv.org/content/medrxiv/early/2020/03/10/2020.03.04.20030916.full.pdf",10/7/2020,3/1/2021
200701_HongKong_QueenMaryHospital_Evacuees_EnzymeImmunoAssay,6/3/2020,Kelvin To,Regional,China,"Hubei; China
(Queen Mary Hospital)",03/04 - 03/17,Household and community samples,Multiple groups,452,2.9% (NR),Convenience,"Author-designed; IgG; Enzyme immunoassay
(73.3%; 100%)",Moderate,Journal Article (Peer-Reviewed),https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(20)30053-7/fulltext,10/9/2020,3/1/2021
200701_HongKong_QueenMaryHospital_Jan2020_EnzymeImmunoAssay,6/3/2020,Kelvin To,Regional,China,"Hong Kong; China
(Queen Mary Hospital)",01/01 - 01/31,Household and community samples,Multiple groups,580,2.6% (1.5-4.2%),Sequential,"Author-designed; IgG; Enzyme immunoassay
(73.3%; 100%)",High,Journal Article (Peer-Reviewed),https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(20)30053-7/fulltext,10/9/2020,3/1/2021
200701_HongKong_QueenMaryHospital_Feb2020_EnzymeImmunoAssay,6/3/2020,Kelvin To,Regional,China,"Hong Kong; China
(Queen Mary Hospital)",02/01 - 02/13,Household and community samples,Multiple groups,233,0.4% (0-2.4%),Sequential,"Author-designed; IgG; Enzyme immunoassay
(73.3%; 100%)",High,Journal Article (Peer-Reviewed),https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(20)30053-7/fulltext,10/9/2020,3/1/2021
200811_Wuhan_HuazhongUniversityofScienceandTechnologyIgG,8/11/2020,Ai Zhang,Sublocal,China,"Wuhan; Hubei; China
(Huazhong University of Science and Technology)",01/23 - 03/27,Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),44,NA,Sequential,"Not reported; IgG, IgM; Chemiluminescence Immunoassay
(0%; 0%)",High,Journal Article (Peer-Reviewed),https://onlinelibrary.wiley.com/doi/full/10.1002/pbc.28424,10/9/2020,3/1/2021
200820_Hubei_NanjingUniversity_hcw_IgG,8/20/2020,Xin Tong,Local,China,"Wuhan; Hubei; China
(Nanjing University Medical School)",05/12 - 05/15,Health care workers and caregivers,Adults (18-64 years),191,NA,Convenience,"Shenzhen YHLO Biotech Co; IgG; Chemiluminescence Immunoassay
(0%; 0%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1002/iid3.340,10/13/2020,3/1/2021
200819_Guangzhou_InstituteofBloodTransfusion_BloodDonors_TotalAnti,8/19/2020,Ru Xu,Local,China,"Guangzhou; Guangdong; China
(Institute of Blood Transfusion)",03/23 - 04/02,Blood donors,Adults (18-64 years),2199,0.3% (NR),Simplified probability,"Wantai Biological Pharmacy Enterprise, Lizhu Diagnostics; IgA, IgG; ELISA
(0%; 0%)",High,Journal Article (Peer-Reviewed),http://dx.doi.org/10.1002/jmv.26445,10/18/2020,3/1/2021
200824_Wuhan_WuhanUniversity_IgG_T2,8/24/2020,Lu He,Sublocal,China,"Wuhan; Hubei; China
(Wuhan University)",05/13 - 06/10,Health care workers and caregivers,Adults (18-64 years),1059,9.3% (NR),Convenience,"Livzon Diagnostics; IgG; Colloidal Gold Immunochromatography Assay (LFIA)
(0%; 0%)",High,Journal Article (Peer-Reviewed),http://dx.doi.org/10.1016/j.jinf.2020.08.027,10/19/2020,3/1/2021
200901_Wuhan_ZhongnanHospitalofWuhanUniversity_IgGTotal,9/14/2020,Fuling Zhou,Sublocal,China,"Wuhan; Hubei; China
(Zhongnan Hospital of Wuhan University)",03/16 - 03/25,Health care workers and caregivers,Adults (18-64 years),3674,1.7% (NR),Convenience,"Shenzhen Yahuilong Biotechnology Co.; IgG; Chemiluminescence Immunoassay
(0%; 0%)",Moderate,Journal Article (Peer-Reviewed),http://dx.doi.org/10.1016/j.eclinm.2020.100510,10/29/2020,3/1/2021
200923_Wuhan_NationalCenterforMedicalServiceAdministration_Overall,9/23/2020,Yaqing Li,Sublocal,China,"Wuhan; Hubei; China
(National Center for Medical Service Administration)",02/10 - 03/22,Contacts of COVID patients,Multiple groups,300,47.7% (NR),Convenience,"Innovita Biological Technology Co. Ltd; IgG, IgM; Colloidal Gold Immunochromatography Assay (LFIA)
(97.1%; 95.3%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.5858/arpa.2020-0310-SA,11/19/2020,3/1/2021
200923_Beijing_PekingUniversity_Overall,9/23/2020,Xiaoli Wang,Local,China,"Beijing; Hebei; China
(Peking University)",04/15 - 04/18,Household and community samples,Multiple groups,2184,0.2% (NR),Stratified probability,"Wondfo Biotech Co., Innovita Biological Technology Co Ltd; IgG, IgM; Colloidal gold
(0%; 0%)",Moderate,Preprint,https://www.medrxiv.org/content/10.1101/2020.09.23.20197756v1,11/22/2020,3/1/2021
200921_Wuhan_TongjiMedicalCollege_Overall,9/21/2020,Qing Lei,Local,China,"Wuhan; Hubei; China
( Tongji Medical College)",02/17 - 04/28,Multiple populations,Multiple groups,11766,0.5% (NR),Sequential,"YHLO; IgM, IgG; Chemiluminescence Immunoassay
(66.7%; 99.5%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1111/all.14622,11/25/2020,3/1/2021
201119_Shanghai_FudanUniversity_Overall,11/19/2020,Shengjie Li,Sublocal,China,"Shanghai; Shanghai Municipality; China
(Fudan University)",05/15 - 10/15,Patients seeking care for non-COVID-19 reasons,Not reported,6414,0.3% (NR),Convenience,"Bioscience; NR
(0%; 0%)",High,Preprint,https://www.medrxiv.org/content/10.1101/2020.09.22.20198465v1,11/30/2020,3/1/2021
200922_Wuhan_WuhanUniversity_IgM/IgG,10/6/2020,Yunbao Pan,Local,China,"Wuhan; Hubei; China
(Wuhan University)",05/15 - 05/26,Household and community samples,Multiple groups,61437,2.4% (2.3-2.5%),Stratified probability,"Nanjing Vazyme Medical technology Co., Ltd; NR
(91.54%; 97.02%)",Low,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1016/j.cmi.2020.09.044,12/8/2020,3/1/2021
201023_Wuhan_HuazhongUniversityofScienceandTechnology_Overall_unadj,10/23/2020,Anding Liu,Local,China,"Wuhan; Hubei; China
(Huazhong University of Science and Technology)",03/27 - 05/26,Household and community samples,Multiple groups,35040,3.9% (3.7-4.1%),Unclear,"Bioscience, Tianjin, China; NR
(0%; 0%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamanetworkopen.2020.25717,1/23/2021,3/1/2021
201225_Wuhan_RenminHospitalofWuhanUniversity_Community,12/25/2020,Lu He,Local,China,"Wuhan; Hubei; China
(Renmin Hospital of Wuhan University)",05/15 - 05/29,Household and community samples,Multiple groups,4454,2.9% (NR),Unclear,"Livzon Diagnostics Inc.; NR
(0%; 0%)",Unclear,Journal Article (Peer-Reviewed),https://dx.doi.org/10.7883/yoken.JJID.2020.691,1/28/2021,3/7/2021
201225_Wuhan_RenminHopsitalofWuhanUniversity_HCW,12/25/2020,Lu He,Sublocal,China,"Wuhan; Hubei; China
(Renmin Hospital of Wuhan University)",05/15 - 05/29,Health care workers and caregivers,Adults (18-64 years),4614,3.3% (NR),Convenience,"Livzon Diagnostics Inc.; NR
(0%; 0%)",Unclear,Journal Article (Peer-Reviewed),https://dx.doi.org/10.7883/yoken.JJID.2020.691,1/28/2021,3/7/2021
201228_Beijing_CapitalMedicalUniversity_IgG,12/28/2020,Ran Wang,Sublocal,China,"Beijing; China
(Capital Medical University )",01/01 - 08/31,Residual sera,Children and Youth (0-17 years),19797,0.6% (NR),Sequential,"Beijing Innovita Biological Technology; NR
(0%; 0%)",Moderate,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1002/ped4.12231,1/31/2021,3/17/2021
210107_China_WuhanUniversity,1/7/2021,Shuhui Duan,Regional,China,"30 provinces in China (78.05% from Hubei province); China
(Wuhan University)",03/06 - 05/03,,Multiple groups,63107,0.7% (NR),Unclear,"Innovita, Tangshan, China; NR
(0%; 0%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1371/journal.pntd.0008975,2/7/2021,3/1/2021
210119_Shenzen_ShenzhenCenterforDiseaseControlandPrevention_contacts_TotalAb_TestAdj,1/19/2021,Zhen Zhang,Local,China,"Shenzen; China
(Shenzhen Center for Disease Control and Prevention)",04/12 - 05/04,Contacts of COVID patients,Multiple groups,880,4.1% (2.9-5.7%),Convenience,"Beijing Wantai Biological Pharmacy Enterprise; NR
(98%; 99%)",Moderate,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1016/S2666-5247(20)30200-7,2/24/2021,3/1/2021
210119_Shenzen_ShenzhenCenterforDiseaseControlandPrevention_NeighbourhoodNoCases_TotalAb_TestAdj,1/19/2021,Zhen Zhang,Local,China,"Shenzen; China
(Shenzhen Center for Disease Control and Prevention)",04/17 - 04/23,,Not reported,350,NA,Convenience,"Beijing Wantai Biological Pharmacy Enterprise; NR
(98%; 99%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1016/S2666-5247(20)30200-7,2/24/2021,3/1/2021
210119_Shenzen_ShenzhenCenterforDiseaseControlandPrevention_NeighbourhoodReportedCases_TotalAb_TestAdj,1/19/2021,Zhen Zhang,Local,China,"Shenzen; China
(Shenzhen Center for Disease Control and Prevention)",04/17 - 04/23,,Not reported,50,NA,Convenience,"Beijing Wantai Biological Pharmacy Enterprise; NR
(98%; 99%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1016/S2666-5247(20)30200-7,2/24/2021,3/1/2021
210109_Taiwan_NationalTaiwanUniversityHospital_HCW_Overall,1/9/2021,Sung-Ching Pan,Sublocal,China,"Taipei; Taiwan; China
(National Taiwan University Hospital)",07/01 - 08/31,Health care workers and caregivers,Adults (18-64 years),194,NA,Convenience,"Abbott; Roche; Mikrogen Diagnostik; NR
(0%; 0%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1016/j.jfma.2021.01.002,3/14/2021,3/14/2021
201102_Wuhan_WuhanUniversity_HealthcareProviders_overall,,Tao Liu,Local,China,"Wuhan; Hubei; China
(Wuhan University
)",02/29 - 04/29,Health care workers and caregivers,Multiple groups,3832,4% (3.4-4.7%),Convenience,"NR; NR
(96%; 98%)",Moderate,Preprint,10.21203/rs.3.rs-99748/v1,3/20/2021,3/20/2021
201102_Wuhan_WuhanUniversity_GeneralWorkers_overall,,Tao Liu,Local,China,"Wuhan; Hubei; China
(Wuhan University
)",02/29 - 04/29,Household and community samples,Multiple groups,19555,4.6% (4.3-4.9%),Convenience,"NR; NR
(96%; 98%)",Moderate,Preprint,10.21203/rs.3.rs-99748/v1,3/20/2021,3/20/2021
201102_Wuhan_WuhanUniversity_OtherPatientsNonCovid_overall,,Tao Liu,Local,China,"Wuhan; Hubei; China
(Wuhan University
)",02/29 - 04/29,Patients seeking care for non-COVID-19 reasons,Multiple groups,1616,1% (0.5-1.5%),Convenience,"NR; NR
(96%; 98%)",Moderate,Preprint,10.21203/rs.3.rs-99748/v1,3/20/2021,3/20/2021
200918_Bogota_PontificiaUniversidadJaveriana_HCW_FinalEndpoint_UnAdj,"1/3/2021, 9/18/2020","Beatriz Ariza, Beatriz Ariza",Sublocal,Colombia,"Bogotá; Capital District Cundinamarca; Colombia
(Pontificia Universidad Javeriana)",06/25 - 08/10,Health care workers and caregivers,Adults (18-64 years),351,8.3% (5.8-11.6%),Self-referral,"Abbott, Columbia
SD Biosensor; IgG; Not reported
(100%; 100%)",High,"Journal Article (Peer-Reviewed), Preprint","http://www.revistainfectio.org/index.php/infectio/article/view/938, https://www.medrxiv.org/content/10.1101/2020.09.15.20195313v1",10/6/2020,3/1/2021
201030_Colombia_UniversidadIndustrialdeSantander_primary,10/30/2020,Alvaro J Idrovo,National,Colombia,"Colombia
(Universidad Industrial de Santander)",04/17 - 07/14,Non-essential workers and unemployed persons,Multiple groups,4234,4% (NR),Unclear,"NR; NR
(0%; 0%)",Unclear,Journal Article (Peer-Reviewed),https://dx.doi.org/10.7705/biomedica.5829,1/23/2021,3/17/2021
201112_Monteria_UniversidaddeCórdoba_GenPopAdj,11/12/2020,Salim Mattar,Local,Colombia,"Monteria; Caribbean Region; Colombia
(Universidad de Córdoba)",08/04 - 09/01,Household and community samples,Multiple groups,1368,55.3% (52.5-57.8%),Stratified probability,"Ingenasa; NR
(92%; 100%)",Moderate,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1093/ofid/ofaa550,2/5/2021,3/1/2021
210122_Bogota_InstitutoNacionaldeSalud_OverallTestAdj,1/22/2021,Jeadran Malagón-Rojas,Sublocal,Colombia,"Bogota; Capital District; Colombia
(Instituto Nacional de Salud)",06/01 - 09/30,Essential non-healthcare workers,Adults (18-64 years),212,16% (10.4-21.6%),Convenience,"Abbott Laboratories; NR
(85.5%; 97.3%)",High,Journal Article (Peer-Reviewed),https://academic.oup.com/jtm/advance-article/doi/10.1093/jtm/taab006/6106252?searchresult=1,3/13/2021,3/13/2021
20 1222_Brazzaville_FondationCongolaisePourLaRechercheMédicale_GenPop_Overall,12/22/2020, Armel Batchi-Bouyou,Local,Congo,"Brazzaville; Congo
(Fondation Congolaise pour la Recherche Médicale)",04/01 - 07/31,Household and community samples,Adults (18-64 years),754,19.7% (NR),Self-referral,"Wuhan UNniscience Biotechnology; NR
(0%; 0%)",High,Preprint,https://dx.doi.org/10.1016/j.ijid.2020.12.065,1/30/2021,3/4/2021
210129_IvoryCoast_ CentreHospitalierRegionald’Orleans_primary,1/29/2021,Jean Marie Milleliri,Sublocal,Côte d'Ivoire,"Abidjan; Côte d'Ivoire
( Centre Hospitalier Regional d’Orleans)",07/15 - 10/13,,Adults (18-64 years),1687,25.1% (NR),Convenience,"AAZ LMB; NR
(0%; 0%)",High,Preprint,https://www.medrxiv.org/content/10.1101/2021.01.27.21249186v1,2/16/2021,3/1/2021
200515_Croatia_UniversityofSplit_IndustryWorkers_Overall,5/15/2020,Ivan Jerkovic,Local,Croatia,"Croatia
(University of Split)",04/23 - 04/28,Essential non-healthcare workers,Multiple groups,1494,1.3% (0.8-2%),Convenience,"AMP Diagnostics; IgM, IgG; Rapid immunochromatographic test
(91.8%; 96.4%)",High,Journal Article (Peer-Reviewed),https://journals.lww.com/joem/Abstract/9000/SARS_CoV_2_Antibody_Seroprevalence_in_Industry.98091.aspx,7/17/2020,3/1/2021
200826_Croatia_UniversityofZagreb_HCWsIgG,8/26/2020,Tatjana Vilibic-Cavlek,National,Croatia,"Croatia
(University of Zagreb)",04/25 - 05/24,Health care workers and caregivers,Adults (18-64 years),592,2.7% (NR),Convenience,"Vircell Spain S.L.U; IgG; ELISA
(0%; 0%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1590/0037-8682-0458-2020,10/17/2020,3/1/2021
201231_Zagreb_ZagrebUniversity_overall,12/31/2020,Ivana Lapić,Sublocal,Croatia,"Zagreb; Croatia
(Zagreb University)",05/01 - 05/31,Health care workers and caregivers,Adults (18-64 years),1678,0.6% (NR),Convenience,"Abbott Laboratories; NR
(100%; 99.6%)",Moderate,Journal Article (Peer-Reviewed),https://pubmed.ncbi.nlm.nih.gov/33410294/,2/1/2021,3/8/2021
201104_Croatia_CroatianFootballFederation_FootballPlayers&ClubStaff,11/4/2020,Adriana Vince,Sublocal,Croatia,"Croatia
(Croatian Football Federation)",05/29 - 07/31,Non-essential workers and unemployed persons,Adults (18-64 years),305,20% (NR),Convenience,"Euroimmun Medizinische Labordiagnostika AG; NR
(100%; 97.7%)",Moderate,Preprint,https://www.medrxiv.org/content/10.1101/2020.10.30.20223230v1,2/6/2021,3/3/2021
200802_AguadadePasajeros_UniversityofMedicalSciencesofCienfuegos,8/23/2020,Alain Morejón Giraldoni,Local,Cuba,"Aguada de Pasajeros; Cienfuegos; Cuba
(University of Medical Sciences of Cienfuegos)",03/23 - 04/06,Contacts of COVID patients,Multiple groups,200,NA,Convenience,"NR; NR
(0%; 0%)",Unclear,Journal Article (Peer-Reviewed),http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1727-897X2020000400721,1/7/2021,3/1/2021
200714_CzechRepublic_ResearchCenterIBD_HCW,7/14/2020, Karin Malickova,Sublocal,Czechia,"Prague; Central Bohemian; Czechia
(Clinical and Research Center for Inflammatory Bowel Disease)",NR - 04/15,Health care workers and caregivers,Adults (18-64 years),92,2.2% (NR),Convenience,"EUROIMMUN; IgG; ELISA
(0%; 0%)",Unclear,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1080/00365521.2020.1791244,8/2/2020,3/1/2021
201112_Prague_CharlesUniversityandThomayer'sHospital_Roche,11/12/2020,Marketa Bloomfield,Sublocal,Czechia,"Prague; Prague; Czechia
(Charles University and Thomayer’s Hospital)",07/03 - 08/19,Residual sera,Children and Youth (0-17 years),200,NA,Sequential,"Roche Diagnostics; NR
(99.5%; 99.8%)",High,Journal Article (Peer-Reviewed),http://dx.doi.org/10.3389/fped.2020.597736,1/23/2021,3/17/2021
210216_Bukavu_UniversitéLibredeBruxelles_OverallELISA,,Denis Mukwege ,Sublocal,Democratic Republic of the Congo,"Bukavu; South-Kivu; Democratic Republic of the Congo
(Université Libre de Bruxelles (ULB))",07/02 - 08/19,Health care workers and caregivers,Adults (18-64 years),359,41.2% (NR),Convenience,"Euroimmun; NR
(61.7%; 98.6%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.4269/ajtmh.20-1526,3/14/2021,3/16/2021
210217_Kinhasa_InstitutNationaldeRechercheBiomedicale_EUROIMMUN,2/17/2021,Antoine Nkuba Ndaye,Local,Democratic Republic of the Congo,"Kinhasa; Kinhasa; Democratic Republic of the Congo
(Institut National de Recherche Biomedicale)",07/17 - 08/13,Health care workers and caregivers,Adults (18-64 years),562,36% (NR),Stratified probability,"EUROIMMUN, Lübeck, Germany; NR
(94.6%; 99.8%)",Moderate,Journal Article (Peer-Reviewed),https://www.thelancet.com/journals/langlo/article/PIIS2214-109X(21)00060-7/fulltext,3/21/2021,3/21/2021
200625_Denmark_GeneralPopTestAdj,6/25/2020,Christian Erikstrup,National,Denmark,"Denmark
(Copenhagen University Hospital)",04/06 - 05/03,Blood donors,Adults (18-64 years),20640,1.9% (0.8-2.3%),Entire sample,"Livzon Diagnostics; IgG, IgM; LFIA: Lateral flow immunoassay
(82.58%; 99.54%)",Moderate,Journal Article (Peer-Reviewed),https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciaa849/5862661,6/26/2020,3/1/2021
200803_CapitalRegionDenmark_UniversityofCopenhagen_hcw_IgG_ANDOR_IgM_adj,8/3/2020,Kasper Iversen,Regional,Denmark,"Capital Region of Denmark; Denmark
(University of Copenhagen)",04/15 - 04/22,Health care workers and caregivers,Adults (18-64 years),28792,4.4% (4.1-4.7%),Entire sample,"Livzon Diagnostics; IgM, IgG; LFIA: Lateral flow immunoassay
(73.4%; 99.9%)",Low,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1016/S1473-3099(20)30589-2,9/30/2020,3/1/2021
200803_CapitalRegionDenmark_UniversityofCopenhagen_blooddonors_IgG_ANDOR_IgM,8/3/2020,Kasper Iversen,Regional,Denmark,"Capital Region of Denmark; Denmark
(University of Copenhagen)",04/15 - 04/22,Blood donors,Adults (18-64 years),4672,3% (2.6-3.6%),Sequential,"Livzon Diagnostics; IgM, IgG; LFIA: Lateral flow immunoassay
(73.4%; 99.9%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1016/S1473-3099(20)30589-2,10/1/2020,3/1/2021
200812_WestCentralDenmark_AarhusUniversityHospital_BloodDonors,8/12/2020,Sanne Jespersen,Regional,Denmark,"Central Denmark Region; Denmark
(Aarhus University Hospital)",06/17 - 06/30,Blood donors,Not reported,180,1.2% (0-4.4%),Unclear,"Wantai Biological Pharmacy Enterprise; Total Antibody; ELISA
(96.7%; 99.5%)",High,Preprint,https://www.medrxiv.org/content/10.1101/2020.08.10.20171850v1,10/7/2020,3/1/2021
200812_EastCentralDenmark_AarhusUniversityHospital_BloodDonors,8/12/2020,Sanne Jespersen,Regional,Denmark,"Central Denmark Region; Denmark
(Aarhus University Hospital)",06/17 - 06/30,Blood donors,Not reported,180,0.6% (0-3.5%),Unclear,"Wantai Biological Pharmacy Enterprise; Total Antibody; ELISA
(96.7%; 99.5%)",High,Preprint,https://www.medrxiv.org/content/10.1101/2020.08.10.20171850v1,10/7/2020,3/1/2021
200812_CentralDenmark_AarhusUniversityHospital_HCW_PopAdjTestAdj,8/12/2020,Sanne Jespersen,Regional,Denmark,"Central Denmark Region; Denmark
(Aarhus University Hospital)",05/18 - 06/19,Health care workers and caregivers,Multiple groups,17971,3.4% (2.4-3.8%),Convenience,"Wantai Biological Pharmacy Enterprise; Total Antibody; ELISA
(96.7%; 99.5%)",Moderate,Preprint,https://www.medrxiv.org/content/10.1101/2020.08.10.20171850v1,10/20/2020,3/1/2021
200928_Denmark_CopenhagenUniversityHospital_Overall,9/28/2020,Jannie Laursen,National,Denmark,"Denmark
(Copenhagen University Hospital)",06/22 - 08/10,Multiple populations,Multiple groups,2024,2.8% (NR),Self-referral,"Livzon Diagnostics; IgG, IgM; LFIA: Lateral flow immunoassay
(82.58%; 99.54%)",High,Preprint,https://www.medrxiv.org/content/10.1101/2020.09.26.20202259v1,11/26/2020,3/1/2021
201003_Denmark_AarhusUniversity_HCW_popadj_testadj,10/3/2020,Senne Jespersen,Regional,Denmark,"NA; Central Denmark Region; Denmark
(University of Aarhus)",05/18 - 06/19,Health care workers and caregivers,Adults (18-64 years),17948,3.4% (2.4-3.8%),Convenience,"Wantai Biological Pharmacy Enterprise Co, Ltd, Beijing,
China; NR
(96.7%; 99.5%)",Moderate,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1093/cid/ciaa1471,12/19/2020,3/1/2021
201027_Copenhagen_CopenhagenUniversityHospitalHvidovre_ParturientWomen_TestAdj,10/27/2020,Pia Egerup,Sublocal,Denmark,"Copenhagen; Capital Region of Denmark; Denmark
(Copenhagen University Hospital Hvidovre)",04/04 - 07/03,Pregnant or parturient women,Adults (18-64 years),1313,2.6% (1.7-4%),Sequential,"Shenzhen Yhlo Biotech; NR
(94%; 99.3%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1097/AOG.0000000000004199,1/9/2021,3/1/2021
201027_Copenhagen_CopenhagenUniversityHospitalHvidovre_PartnersofParturientWomen_TestAdj,10/27/2020,Pia Egerup,Sublocal,Denmark,"Copenhagen ; Capital Region of Denmark; Denmark
(Copenhagen University Hospital Hvidovre)",04/04 - 07/03,Hospital visitors,Adults (18-64 years),1188,3.5% (2.3-5.1%),Sequential,"Shenzhen Yhlo Biotech; NR
(94%; 99.3%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1097/AOG.0000000000004199,1/9/2021,3/1/2021
201027_Copenhagen_CopenhagenUniversityHospitalHvidovre_Newborns,10/27/2020,Pia Egerup,Sublocal,Denmark,"Copenhagen ; Capital Region of Denmark; Denmark
(Copenhagen University Hospital Hvidovre)",04/04 - 07/03,Perinatal,Children and Youth (0-17 years),1206,1.4% (NR),Sequential,"Shenzhen Yhlo Biotech; NR
(94%; 99.3%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1097/AOG.0000000000004199,1/10/2021,3/1/2021
201026_Denmark_CopenhagenUniversityHospitalRigshospitalet_retired_adj,10/26/2020,Ole Birger Pedersen,National,Denmark,"Denmark
(Copenhagen University Hospital Rigshospitalet)",06/02 - 06/19,Blood donors,Seniors (65+ years),1200,1.4% (0.3-2.5%),Simplified probability,"Beijing Wantai Biological Pharmacy Enterprise; NR
(96.7%; 99.5%)",Moderate,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1093/cid/ciaa1627,1/10/2021,3/1/2021
201026_Denmark_CopenhagenUniversityHospitalRigshospitalet_Active_adj,10/26/2020,Ole Birger Pedersen,National,Denmark,"Denmark
(Copenhagen University Hospital Rigshospitalet)",06/01 - 06/26,Blood donors,Adults (18-64 years),1110,2.5% (1.3-3.8%),Sequential,"Beijing Wantai Biological Pharmacy Enterprise; NR
(96.7%; 99.5%)",Moderate,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1093/cid/ciaa1627,1/12/2021,3/1/2021
201227_Denmark_CopenhagenUniversityHospital_PregnancyLoss2_Overall,12/27/2020, ‪Nina Freiesleben,Sublocal,Denmark,"Copenhagen; Copenhagen; Denmark
(Copenhagen University Hospital)",02/17 - 04/17,Pregnant or parturient women,Adults (18-64 years),36,NA,Self-referral,"YHLO Biotechnology; NR
(0%; 0%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1093/humrep/deaa311,1/15/2021,3/1/2021
201027_Aarhus_AarhusDepartmentofPublicHealth_IgGorIgM,11/20/2020,Signe Storgaard,Local,Denmark,"Aarhus; Central Denmark Region; Denmark
(Aarhus Department of Public Health )",06/01 - 06/04,Persons experiencing homelessness,Adults (18-64 years),129,4.7% (2.1-9.8%),Convenience,"NR; NR
(98.9%; 97.6%)",High,Journal Article (Peer-Reviewed),"https://pubmed.ncbi.nlm.nih.gov/33269697/#:~:text=Conclusions%3A%20Despite%20their%20vulnerable%20profile,funded%20by%20Aarhus%20University%20Hospital.",1/23/2021,3/17/2021
201227_Denmark_CopenhagenUniversityHospital_Pregnant1_Overall,12/27/2020, ‪Nina Freiesleben,Sublocal,Denmark,"Copenhagen; Copenhagen; Denmark
(Copenhagen University Hospital)",02/17 - 04/17,Pregnant or parturient women,Adults (18-64 years),1019,1.8% (NR),Convenience,"YHLO Biotechnology; NR
(0%; 0%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1093/humrep/deaa311,2/13/2021,3/1/2021
201227_Denmark_CopenhagenUniversityHospital_Pregnant1_Overall_IgGOnly,12/27/2020, ‪Nina Freiesleben,Sublocal,Denmark,"Copenhagen; Copenhagen; Denmark
(Copenhagen University Hospital)",02/17 - 04/17,Pregnant or parturient women,Adults (18-64 years),1019,1.6% (NR),Convenience,"YHLO Biotechnology; NR
(94%; 99.7%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1093/humrep/deaa311,2/13/2021,3/1/2021
210121_Denmark_CopenhagenUniversityHospital_Denmark,1/21/2021,Jannie Laursen,National,Denmark,"Denmark
(Copenhagen University Hospital)",06/22 - 08/10,Health care workers and caregivers,,2024,2.8% (NR),Convenience,"Livson Diagnostics, Zhuhai, Gunangdong, China; NR
(82.58%; 99.54%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.3390/ijerph18030923,2/25/2021,3/1/2021
210212_Copenhagen_Herlev-GentofteHospital_Overall,2/12/2021,Johannes R. Madsen,Sublocal,Denmark,"Copenhagen; Capital Region; Denmark
(Herlev-Gentofte Hospital)",10/19 - 10/26,Health care workers and caregivers,Adults (18-64 years),1096,34.6% (31.8-37.5%),Convenience,"Beijing Wantai Biological Pharmacy Enterprise; NR
(97%; 99.5%)",Moderate,Preprint,https://www.medrxiv.org/content/10.1101/2021.02.09.21251421v1,3/18/2021,3/18/2021
201202_DominicanRepublic_UniversidadIberoamericana_genpop_IgG,12/2/2020,Robert Paulino-Ramirez,National,Dominican Republic,"Dominican Republic
(Universidad Iberoamericana)",04/15 - 06/15,Household and community samples,Multiple groups,12897,5.5% (NR),Simplified probability,"GenBody Inc.; NR
(56.7%; 100%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.4269/ajtmh.20-0907,1/12/2021,3/1/2021
200715_Ecuador_TheAtahualpaProject_Overall,7/15/2020,Oscar Del Brutto,Local,Ecuador,"Paccha; El Oro; Ecuador
(The Atahualpa Project)",05/01 - 05/31,Household and community samples,Seniors (65+ years),319,44.2% (NR),Convenience,"Biohit Health Care Ltd; IgG, IgM; Colloidal gold
(96.7%; 95%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1007/s10900-020-00887-9,8/1/2020,3/1/2021
200727_Atahualpa_UniversidadPeruanaCayetanoHeredia_RuralOver40_Overall,7/27/2020,Oscar Del Brutto,Local,Ecuador,"El Oro; Ecuador
(Universidad Peruana Cayetano Heredia)",05/25 - 05/31,Household and community samples,Multiple groups,673,45% (NR),Entire sample,"Biohit Health Care Ltd; IgG, IgM; LFIA: Lateral flow immunoassay
(97.5%; 100%)",High,Journal Article (Peer-Reviewed),http://dx.doi.org/10.1093/cid/ciaa1055,10/2/2020,3/1/2021
200721_Egypt_CairoUniversity_TotalHCW_Overall,7/21/2020,Abdel Meguid Kassem,Local,Egypt,"Cairo; Egypt
(Cairo University)",06/01 - 06/14,Health care workers and caregivers,Adults (18-64 years),74,12.2% (NR),Convenience,"Artron Laboratories; IgG, IgM; LFIA: Lateral flow immunoassay
(93.4%; 97.7%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1016/j.ajg.2020.07.005,9/29/2020,3/1/2021
210115_Cairo_CairoUniversity,1/15/2021,Reham Abdelmoniem,Sublocal,Egypt,"Cairo; Egypt
(Cairo University )",06/01 - 06/14,Health care workers and caregivers,Adults (18-64 years),203,18.2% (NR),Convenience,"Artron Laboratories, Burnaby, Canada; NR
(93.4%; 97.7%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1016/j.jcv.2020.104710,1/23/2021,3/1/2021
201023_Egypt_AinShamsUniversity_Overall,10/23/2020,Aya Mostafa,Local,Egypt,"Cairo; Cairo Governorate; Egypt
(Ain Shams University)",04/22 - 05/14,Health care workers and caregivers,Multiple groups,4040,1.3% (NR),Convenience,"Artron Laboratories; NR
(83.3%; 100%)",High,Journal Article (Peer-Reviewed),https://academic.oup.com/ije/advance-article/doi/10.1093/ije/dyaa173/5936053,1/23/2021,3/1/2021
201023_Tallinn_UniversityofTartu_Overall,10/23/2020,Piia Jogi,Local,Estonia,"Tallinn; Estonia
(University of Tartu)",05/08 - 07/31,Household and community samples,Multiple groups,1006,1.5% (0.9-2.5%),Stratified probability,"Abbott
DiaSorin
SD Biosensor; NR
(92.7%; 99.9%)",Moderate,Preprint,https://www.medrxiv.org/content/10.1101/2020.10.21.20216820v1,1/8/2021,3/17/2021
201023_Saaremaa_UniversityofTartu_Overall,10/23/2020,Piia Jogi,Local,Estonia,"Saaremaa; Estonia
(University of Tartu)",05/08 - 07/31,Household and community samples,Multiple groups,954,6.3% (5-7.9%),Stratified probability,"Abbott
DiaSorin
SD Biosensor; NR
(92.7%; 99.9%)",Moderate,Preprint,https://www.medrxiv.org/content/10.1101/2020.10.21.20216820v1,1/8/2021,3/17/2021
210226_Estonia_UniversityofTartu_primary,2/26/2021,University of Tartu,National,Estonia,"Estonia
(University of Tartu)",02/11 - 02/22,Household and community samples,Multiple groups,2626,11.5% (10.3-12.8%),Stratified probability,"Synlab; NR
(0%; 0%)",Moderate,Institutional Report,https://www.ut.ee/et/teadus/koroonaviiruse-levimuse-uuring-covid-19-aktiivne-seire,2/26/2021,3/1/2021
210107_Estonia_UniversityCollegeLondon_PaediatricHCW,1/27/2021,D. Goldblatt,Sublocal,Estonia,"Estonia
(University College London)",06/10 - 06/12,Health care workers and caregivers,Adults (18-64 years),130,NA,Convenience,"Epitope Diagnostics; NR
(100%; 88.7%)",High,Journal Article (Peer-Reviewed),http://dx.doi.org/10.1016/j.jhin.2020.12.019,3/13/2021,3/16/2021
200924_Estonia_UniversityofTartu_overall,9/24/2020,Piret Veerus,National,Estonia,"Estonia
(University of Tartu)",05/04 - 06/10,Pregnant or parturient women,Adults (18-64 years),433,0.5% (NR),Convenience,"Abbott; NR
(0%; 0%)",High,Journal Article (Peer-Reviewed),https://obgyn.onlinelibrary.wiley.com/doi/full/10.1111/aogs.13995,3/20/2021,3/20/2021
200623_AddisAbaba_KuwaitUniversity_GenPop,6/23/2020,John Kempen,Local,Ethiopia,"Addis Ababa; Oromia; Ethiopia
( Kuwait University)",05/18 - 05/21,Residual sera,Multiple groups,99,3% (0.6-8.6%),Convenience,"Abbott; IgG; Chemiluminescence Immunoassay
(100%; 99.9%)",High,Preprint,https://www.medrxiv.org/content/10.1101/2020.06.23.20137521v1,6/25/2020,3/1/2021
200922_Addis Ababa_Harvard Medical School_GenPop,9/22/2020,John Kempen,Local,Ethiopia,"Addis Ababa; Ethiopia
(Kuwait University)",05/18 - 05/21,Residual sera,Multiple groups,99,3% (0.6-8.6%),Convenience,"Abbott; NR
(100%; 99.9%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.4269/ajtmh.20-0816,12/6/2020,3/17/2021
201013_AddisAbaba_MinistryOfHealthEthiopia_TestAdj_PopUnAdj,10/13/2020,Berhanu Alemu,Local,Ethiopia,"Addis Ababa; Ethiopia
(Ministry of Health, Ethiopia)",04/23 - 04/28,Household and community samples,Adults (18-64 years),301,8.8% (5.5-11.6%),Simplified probability,"Zhejiang Orient Gene Biotech Co Ltd, Huzhou, Zhejiang, China; NR
(87.9%; 100%)",Moderate,Preprint,https://www.biorxiv.org/content/10.1101/2020.10.13.337287v1,12/11/2020,3/1/2021
200727_ FaroeIslands_TheFaroeseHospitalSystem_GenPop_TestAdj,7/27/2020,Maria Skaalum Petersen,Regional,Faroe Islands,"Faroe Islands; Faroe Islands
(University of the Faroe Islands)",04/27 - 05/01,Household and community samples,Adults (18-64 years),1075,0.7% (NR),Simplified probability,"Beijing Wantai Biological Pharmacy Enterprise; IgG, IgM; ELISA
(94.4%; 100%)",Low,Journal Article (Peer-Reviewed),http://dx.doi.org/10.3201/eid2611.202736,9/27/2020,3/1/2021
201213_Helsinki_UniversityofHelsinki_HCW_unadj,12/13/2020,Anu Kantele,Sublocal,Finland,"Helsinki; Uusimaa; Finland
(University of Helsinki)",04/22 - 05/15,Health care workers and caregivers,Adults (18-64 years),1095,3% (NR),Convenience,"Euroimmun, Abbott Laboratories, University of Helsinki (In-House); NR
(71%; 87%)",Moderate,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1016/j.tmaid.2020.101949,2/1/2021,3/2/2021
200902_Lille_InstitutPasteur_BloodDonors_ELISA-N,9/2/2020,Ludivine Grzelak,Local,France,"Clermont, Noyon, Lille; Hauts-de-France; France
(Institut Pasteur)",03/20 - 03/24,Blood donors,Not reported,200,NA,Sequential,"Author-designed; IgA, IgE, IgD, IgM, IgG, Total Antibody; ELISA-N
(0%; 95%)",Unclear,Journal Article (Peer-Reviewed),https://stm.sciencemag.org/content/12/559/eabc3103,4/28/2020,3/1/2021
200723_Paris_Association Clinique et Thérapeutique Infantile du Val-de-Marne_AsymptomaticChildren,7/23/2020,Robert Cohen,Local,France,"Paris; Paris; France
(Association Clinique et Thérapeutique Infantile du Val-de-Marne)",04/14 - 05/12,Residual sera,Children and Youth (0-17 years),605,10.7% (8.4-13.5%),Sequential,"Biosynex; IgG, IgM; Rapid immunochromatographic test
(91.8%; 99.2%)",High,Preprint,https://www.medrxiv.org/content/10.1101/2020.06.12.20129221v2,6/16/2020,3/1/2021
200629_Crepy-en-Valois_PasteurInstitute_Overall,6/29/2020,Arnaud Fontanet,Local,France,"Crepy-en-Valois; Hauts-de-France; France
(Institut Pasteur)",04/28 - 04/30,Household and community samples,Multiple groups,1340,10.4% (NR),Convenience,"Institut Pasteur; Not reported; Flow cytometry assay
(99.4%; 100%)",Moderate,Preprint,https://www.medrxiv.org/content/10.1101/2020.06.25.20140178v2,7/16/2020,3/1/2021
200501_France_ CentreLeonBerard_HCW,5/1/2020,M Solodky,Sublocal,France,"Lyon; Auvergne-Rhone-Alpes; France
(Centre Leon Berard)",03/01 - 04/16,Health care workers and caregivers,Adults (18-64 years),85,5.9% (NR),Self-referral,"TODA Pharma; IgG, IgM; LFIA: Lateral flow immunoassay
(100%; 100%)",High,Journal Article (Peer-Reviewed),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7252166/,7/19/2020,3/1/2021
200501_France_ CentreLeonBerard_CancerPatient,5/1/2020,M Solodky,Sublocal,France,"Lyon; Auvergne-Rhone-Alpes; France
(Centre Leon Berard)",03/01 - 04/16,Patients seeking care for non-COVID-19 reasons,Not reported,244,5.3% (NR),Sequential,"TODA Pharma; IgG, IgM; LFIA: Lateral flow immunoassay
(100%; 100%)",High,Journal Article (Peer-Reviewed),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7252166/,7/19/2020,3/1/2021
200715_France_UnitedesVirusEmergents_BloodDonors,7/15/2020,Pierre Gallian,National,France,"Provence-Alpes-Côte d'Azur, Grand Est, Hauts-de-France, Ile-de-France; France
(Unite des Virus Emergents)",03/25 - 04/07,Blood donors,Adults (18-64 years),998,2.7% (NR),Sequential,"Author-designed; Not reported; Neutralization assay
(0%; 100%)",High,Journal Article (Peer-Reviewed),https://reader.elsevier.com/reader/sd/pii/S0166354220302941?token=72010A825B9F560E0F15AF8D56563D596F45421D41A05764732590DB465F0C2C839E77D689CCDEDEFB85BA331FE13C72,8/1/2020,3/1/2021
200722_France_PicardieUniversity_IBDPatients_Overall,7/22/2020,Mathurin Fumery,Sublocal,France,"Amiens; Somme; France
(Picardie University)",03/25 - 05/11,Patients seeking care for non-COVID-19 reasons,Multiple groups,146,4.8% (NR),Convenience,"DiaSorin; IgG; Chemiluminescence Immunoassay
(0%; 0%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1093/ecco-jcc/jjaa154,8/2/2020,3/1/2021
200827_Paris_RothschildFoundationHospital_HealthcareProfessionals,8/27/2020,Malcie Mesnil,Sublocal,France,"Paris; Paris; France
(Rothschild Foundation Hospital)",06/06 - 06/22,Health care workers and caregivers,Adults (18-64 years),646,12% (NR),Convenience,"Roche; IgG; ELISA
(99.5%; 99.8%)",High,Journal Article (Peer-Reviewed),http://dx.doi.org/10.1016/j.accpm.2020.08.003,10/21/2020,3/1/2021
200911_Lille_BiologyPathologyCenter_Overall,9/11/2020,Nicolas Germain,Regional,France,"Lille; Hauts-de-France; France
(Biology Pathology Center)",11/01 - 03/16,Tissue donor,Seniors (65+ years),235,1.7% (NR),Sequential,"Abbott, Beijing Wantai Biological Pharmacy Enterprise; IgG; chemiluminescent microparticle immunoassay, ELISA
(100%; 99.6%)",High,Preprint,https://www.medrxiv.org/content/10.1101/2020.09.11.20192518v1,11/3/2020,3/17/2021
200903_Paris_HopitalEuropeenGeorgesPompidou_Overall,9/3/2020,Helene Pere,Sublocal,France,"Paris; Ile-de-France; France
(Hopital Europeen Georges Pompidou)",05/02 - 06/26,Health care workers and caregivers,Adults (18-64 years),3569,11.9% (NR),Convenience,"Abbott; IgG; Chemiluminescence Immunoassay
(0%; 0%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1016/j.jcv.2020.104617,11/10/2020,3/1/2021
201007_Toulouse_ToulouseUniversityHospital_Overall,9/30/2020,Chloe Dimeglio,Sublocal,France,"Toulouse; Occitanie; France
(CHU Toulouse)",06/10 - 07/10,Health care workers and caregivers,Adults (18-64 years),8758,3.2% (2.8-3.5%),Convenience,"Wantai Biological Pharmacy Enterprise; Total Antibody; ELISA
(0%; 0%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1016/j.jinf.2020.09.035,11/27/2020,3/1/2021
200918_France_ParisUniversity_Overall,9/18/2020,Fabrice Carrat,National,France,"France
(Paris University)",05/04 - 06/23,Household and community samples,Multiple groups,14628,6.7% (NR),Simplified probability,"Euroimmun; NR
(97.9%; 97.7%)",Moderate,Preprint,https://www.medrxiv.org/content/10.1101/2020.09.16.20195693v1,1/13/2021,3/1/2021
201015_Paris_ParisSaclayUniversity_unadj,10/15/2020,Jérémie Mattern,Sublocal,France,"Paris; Paris; France
(Paris Saclay University)",05/04 - 05/31,Pregnant or parturient women,Adults (18-64 years),249,8% (NR),Sequential,"Abbott, Ortho-Clinical Diagnostics; NR
(0%; 0%)",High,Journal Article (Peer-Reviewed),http://dx.doi.org/10.1371/journal.pone.0240782,1/16/2021,3/1/2021
201106_Lyon_UniversitéClaudeBernardLyon_Overall,11/6/2020,Antonin Bal,Sublocal,France,"Lyon; Auvergne-Rhône-Alpes; France
(Université Claude Bernard Lyon)",04/10 - 05/28,Health care workers and caregivers,Adults (18-64 years),190,3.7% (NR),Unclear,"Wantai, Beijing, China
bioMérieux, Lyon, France; NR
(0%; 0%)",High,Preprint,https://www.medrxiv.org/content/10.1101/2020.11.04.20225862v1,1/17/2021,3/1/2021
201105_Corsica_UniversitédeCorse_Totaladj,11/5/2020,Lisandru Capai,Regional,France,"Ajaccio
Corte; Corsica; France
(Université de Corse)",04/16 - 06/15,Residual sera,Multiple groups,1973,5.5% (4.5-6.6%),Sequential,"EUROIMMUN, Bussy-Saint Martin, France; NR
(86.4%; 96.2%)",Moderate,Journal Article (Peer-Reviewed),https://www.mdpi.com/2077-0383/9/11/3569,1/18/2021,3/5/2021
201021_France_SantePubliqueFrance_March1_Overall_PopTestAdj,10/21/2020,Stéphane Le Vu,National,France,"Guadeloupe, Martinique, French Guiana, La Reunion, Île-de-france, Centre-Val-de-Loire  Bourgogne-Franche Comté, Normandie, Hauts-de-France, Grand-Est, Pays de la Loire, Bretagne, Nouvelle-Aquitaine, Occitanie, Auvergne-Rhône-Alpes, Corse, Provence-Alpes-Côte d'Azur; France
(Santé publique France)",03/09 - 03/15,Residual sera,Multiple groups,3834,0.4% (0.1-0.9%),Convenience,"N/A - Author Designed; NR
(100%; 100%)",Moderate,Preprint,https://www.medrxiv.org/content/10.1101/2020.10.20.20213116v1,1/19/2021,3/9/2021
201021_France_SantePubliqueFrance_April2_Overall_PopTestAdj,10/21/2020,Stéphane Le Vu,National,France,"Guadeloupe, Martinique, French Guiana, La Reunion, Île-de-france, Centre-Val-de-Loire  Bourgogne-Franche Comté, Normandie, Hauts-de-France, Grand-Est, Pays de la Loire, Bretagne, Nouvelle-Aquitaine, Occitanie, Auvergne-Rhône-Alpes, Corse, Provence-Alpes-Côte d'Azur; France
(Santé publique France)",04/06 - 04/12,Residual sera,Multiple groups,3595,4.1% (3.3-5%),Convenience,"N/A - Author Designed; NR
(100%; 100%)",Moderate,Preprint,https://www.medrxiv.org/content/10.1101/2020.10.20.20213116v1,1/19/2021,3/9/2021
201021_France_SantePubliqueFrance_May3_Overall_PopTestAdj,10/21/2020,Stéphane Le Vu,National,France,"Guadeloupe, Martinique, French Guiana, La Reunion, Île-de-france, Centre-Val-de-Loire  Bourgogne-Franche Comté, Normandie, Hauts-de-France, Grand-Est, Pays de la Loire, Bretagne, Nouvelle-Aquitaine, Occitanie, Auvergne-Rhône-Alpes, Corse, Provence-Alpes-Côte d'Azur; France
(Santé publique France)",05/11 - 05/17,Residual sera,Multiple groups,3592,4.9% (4-5.9%),Convenience,"N/A - Author Designed; NR
(100%; 100%)",Moderate,Preprint,https://www.medrxiv.org/content/10.1101/2020.10.20.20213116v1,1/19/2021,3/9/2021
201117_Paris_InstitutCurie_HCW_Overall,11/17/2020,François Anna,Sublocal,France,"Paris; France
(Institut Curie)",04/28 - 07/31,Health care workers and caregivers,Adults (18-64 years),1847,11.6% (10.2-13.2%),Convenience,"; NR
(0%; 99%)",High,Preprint,https://www.medrxiv.org/content/10.1101/2020.10.25.20219030v2,1/23/2021,3/1/2021
210205_IledeFrance_Epicentre_Shelters,2/5/2021,Thomas Roederer,Local,France,"Paris; Ile de France; France
(Médecins sans Frontières (Epicentre) )",06/23 - 07/02,Persons experiencing homelessness,Multiple groups,818,52% (NR),Convenience,"N/A - Author Designed; NR
(0%; 0%)",High,Journal Article (Peer-Reviewed),https://www.thelancet.com/action/showPdf?pii=S2468-2667%2821%2900001-3,1/23/2021,3/15/2021
201104_Paris_CochinAPHP_HCW,11/4/2020,Chantal Delmas,Sublocal,France,"Paris; Île-de-France; France
(Cochin APHP)",05/14 - 06/17,Health care workers and caregivers,Adults (18-64 years),4607,11.5% (10.6-12.4%),Convenience,"Abbott Laboratories; NR
(0%; 0%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1017/ice.2020.1309,1/23/2021,3/1/2021
201130_Strasbourg_StrasbourgUniversityHospital_Abbott,11/30/2020,Floriane Gallais,Local,France,"Strasbourg; Grand Est; France
(Strasbourg University Hospital)",05/07 - 06/26,Contacts of COVID patients,Adults (18-64 years),11,NA,Unclear,"Abbott Laboratories; NR
(100%; 100%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.3201/eid2701.203611,1/23/2021,3/1/2021
201210_ Paris_UniversitéParis-Saclay,12/10/2020,Vassilis Tsatsarisa,Sublocal,France,"Paris ; Île-de-France; France
(Université Paris-Saclay)",04/29 - 06/26,Pregnant or parturient women,Adults (18-64 years),529,4.7% (3-6.7%),Sequential,"Abbott; NR
(92.7%; 99%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1016/j.jogoh.2020.102041,1/23/2021,3/1/2021
210208_Paris_JeanVerdierHospital_DaycareChildren1_Overall_TestAdj,2/8/2021,Eric Lachassinne,Local,France,"Paris; France
(Jean Verdier Hospital)",TBD,Household and community samples,Children and Youth (0-17 years),,NA,Convenience,"; NR
(0%; 0%)",,Journal Article (Peer-Reviewed),https://www.thelancet.com/journals/lanchi/article/PIIS2352-4642(21)00024-9/fulltext,2/19/2021,3/15/2021
200930_Toulouse_CentreHospitalierUniversitaireDeToulouse_HCW&Staff,9/30/2020,Chloé Dimeglio,Sublocal,France,"Toulouse; France
(Centre Hospitalier Universitaire (CHU) de Toulouse)",06/10 - 07/10,Health care workers and caregivers,Adults (18-64 years),8758,3.2% (2.8-3.5%),Convenience,"Beijing Wantai Biological Pharmacy Enterprise Co.; NR
(0%; 0%)",High,Journal Article (Peer-Reviewed),http://dx.doi.org/10.1016/j.jinf.2020.09.035,2/20/2021,3/1/2021
210118_France_SorbonneUniversité_primary,1/18/2021,Nathanael Lapidus,National,France,"Île-de-France and Grand Est ; France
(Sorbonne Université)",05/15 - 06/15,Household and community samples,Multiple groups,9782,3.5% (NR),Simplified probability,"1) EuroImmun

2) EuroImmun

3) N/A - author desgined; NR
(85%; 95%)",Moderate,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1016/j.idnow.2020.12.007,2/26/2021,3/16/2021
201119_Paris_CentreHospitalierIntercommunalDeCréteil_Children,11/19/2020,Robert Cohen,Local,France,"Paris; Île-de-France; France
(Centre Hospitalier Intercommunal de Créteil)",04/14 - 05/12,Residual sera,Children and Youth (0-17 years),605,10.7% (8.4-13.5%),Sequential,"Biosynex; NR
(91.8%; 99.2%)",High,Journal Article (Peer-Reviewed),http://dx.doi.org/10.1136/bmjpo-2020-000887,2/28/2021,3/17/2021
210115_France_InstitutNationaldelaStatistiqueetdesÉtudesÉconomiques_Overall,1/15/2021,Josiane Warszawski,National,France,"France
(l’Institut national de la santé et de la recherche médicale (Inserm) )",05/02 - 06/02,Household and community samples,Multiple groups,12114,4.5% (3.9-5%),Stratified probability,"EUROIMMUN; NR
(94.4%; 100%)",Low,Institutional Report,https://drees.solidarites-sante.gouv.fr/sites/default/files/2021-01/er1167-en.pdf,3/11/2021,3/16/2021
210201_France_TissueBankofLille_overall_unadj,2/1/2021,Nicolas Germain,Local,France,"Lille; France
(CHU Lille)",11/01 - 03/16,Tissue donor,Multiple groups,235,1.7% (NR),Sequential,"1) Abbott 

2)Wantai; NR
(100%; 99.6%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1007/s10561-021-09901-3,3/13/2021,3/19/2021
201223_Paris_InstitutCurie_overall,12/23/2020,François Anna,Local,France,"Paris; Ile de France; France
( Institut Curie)",04/28 - 07/31,Health care workers and caregivers,Multiple groups,1847,11.6% (10.2-13.2%),Convenience,"Institut Curie - author designed; NR
(0%; 99%)",Moderate,Journal Article (Peer-Reviewed),https://onlinelibrary.wiley.com/doi/epdf/10.1002/eji.202049058,3/19/2021,3/19/2021
200928_FrenchGuiana_InstitutPasteur_OverallPopAdj,9/28/2020,Claude Flamand,National,French Guiana,"French Guiana
(Institut Pasteur )",07/15 - 07/23,Residual sera,Multiple groups,480,15.4% (9.3-24.4%),Sequential,"Euroimmun; NR
(93.8%; 97.9%)",Moderate,Preprint,https://www.medrxiv.org/content/10.1101/2020.09.27.20202465v1,1/19/2021,3/17/2021
200918_Tbilisi_InfectiousDiseaseResearchCenter_Total_PopTestAdj,9/18/2020,Tengiz Tsertsvadze,Local,Georgia,"Tbilisi; Tbilisi; Georgia
(Infectious Diseases, AIDS and Clinical Immunology Research Center)",05/18 - 05/27,Household and community samples,Multiple groups,1086,1% (0.4-2.2%),Convenience,"Zhejiang Orient Gene Biotech Co Ltd; IgG; LFIA: Lateral flow immunoassay
(93.1%; 99.2%)",Low,Preprint,https://www.medrxiv.org/content/10.1101/2020.09.18.20195024v1,11/22/2020,3/1/2021
200602_Gangelt_UniversityofBonn_ GenPopUnadj_TestAdj_IgG,6/2/2020,Hendrik Streeck,Local,Germany,"Gangelt; Heinsberg; Germany
(University of Bonn)",03/31 - 04/06,Household and community samples,Multiple groups,919,14.1% (11.2-17.3%),Simplified probability,"EUROIMMUN; IgG; ELISA
(90.9%; 99.1%)",Low,Preprint,https://www.medrxiv.org/content/10.1101/2020.05.04.20090076v1,5/16/2020,3/1/2021
200513_Germany_UniversityHospitalEssen_HCW,5/13/2020,Johannes Korth,Sublocal,Germany,"Essen; North Rhine; Germany
(University Hospital Essen)",03/25 - 04/21,Health care workers and caregivers,Adults (18-64 years),316,1.6% (NR),Convenience,"EUROIMMUN; IgG; ELISA
(0%; 0%)",High,Journal Article (Peer-Reviewed),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7219425/,5/19/2020,3/1/2021
200525_Frankfurt_Goethe-UniversityFrankfurt_Employees,5/25/2020,Verena Kraehling,Local,Germany,"Frankfurt; Hesse; Germany
( Goethe-University Frankfurt)",04/06 - 04/14,Essential non-healthcare workers,Adults (18-64 years),998,0.4% (0.2-1%),Self-referral,"Author-designed; IgG; ELISA
(0%; 99.2%)",Moderate,Preprint,https://www.medrxiv.org/content/10.1101/2020.05.20.20107730v1,5/27/2020,3/1/2021
200514_Saalfeld_Thuringia_IgG,5/14/2020,Igor Harsch,Sublocal,Germany,"Saalfeld; Thuringia; Germany
(Thuringia Clinic)",04/16 - 04/21,Health care workers and caregivers,Adults (18-64 years),18,NA,Convenience,"EUROIMMUN; IgG; ELISA
(0%; 98.5%)",High,Journal Article (Peer-Reviewed),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273321/pdf/HIC-15-09.pdf,6/19/2020,3/1/2021
200615_Germany_UniversityofHannover_hcw,6/15/2020,Simone Schmidt,Sublocal,Germany,"Hannover; Lower Saxony; Germany
(University of Hannover)",04/20 - 04/30,Health care workers and caregivers,Multiple groups,385,2.9% (NR),Convenience,"EUROIMMUN; IgG; ELISA
(94.6%; 99.8%)",High,Journal Article (Peer-Reviewed),https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0235417,6/26/2020,3/1/2021
200717_Ilm-Kreis_JenaUniversityHospital_Overall,7/17/2020,Sebastian Weis ,Local,Germany,"Thuringia; Germany
(Jena University Hospital)",05/12 - 05/22,Household and community samples,Multiple groups,620,8.4% (NR),Entire sample,"Epitope Diagnostics, EUROIMMUN, DiaSorin, Snibe Diagnostic, Abbott, Roche; IgG; ELISA, Chemiluminescence Immunoassay
(0%; 0%)",Moderate,Preprint,https://www.medrxiv.org/content/10.1101/2020.07.15.20154112v1,7/18/2020,3/1/2021
200717_Saxony_TechnischeUniversitätDresden_Overall,7/17/2020,Jakob Armann,Regional,Germany,"Saxony; Germany
(Technische Universität Dresden)",05/25 - 06/30,Multiple populations,Multiple groups,2045,0.6% (NR),Convenience,"DiaSorin LIAISON, Abbott, EUROIMMUN; IgG; Chemiluminescence Immunoassay, ELISA
(0%; 0%)",High,Preprint,https://www.medrxiv.org/content/10.1101/2020.07.16.20155143v2,7/18/2020,3/1/2021
200622_Rostock_UniversitätsmedizinRostock_Mothers_IgGorIgA,6/22/2020,Emil Reisinger ,Sublocal,Germany,"Rostock; Mecklenburg-Westpomerania; Germany
(Universitätsmedizin Rostock)",04/20 - 04/22,Household and community samples,Adults (18-64 years),401,3% (NR),Self-referral,"EUROIMMUN; IgG, IgA; ELISA
(0%; 0%)",High,Journal Article (Peer-Reviewed),https://www.thieme-connect.de/products/ejournals/abstract/10.1055/a-1197-4293,8/5/2020,3/1/2021
200807_Bavaria_UniversityHospitalMunich,8/7/2020,Korbinian Lackermair,Regional,Germany,"Dachau; Bavaria; Germany
(University Hospital Munich)",04/02 - 04/06,Health care workers and caregivers,Adults (18-64 years),151,2.6% (0.8-7.1%),Convenience,"EUROIMMUN; IgG; ELISA
(0%; 0%)",High,Journal Article (Peer-Reviewed),http://dx.doi.org/10.1093/fampra/cmaa078,9/25/2020,3/1/2021
200904_Hannover_HannoverMedicalSchool_HCWs_S1IgG,"9/4/2020, 6/10/2020","Georg Behrens, Georg Behrens",Local,Germany,"Hannover; Lower Saxony; Germany
( Hannover Medical School)",03/23 - 04/17,Health care workers and caregivers,Adults (18-64 years),217,1.4% (NR),Self-referral,"EUROIMMUN; IgG; ELISA
(87.2%; 99.3%)",High,"Journal Article (Peer-Reviewed), Journal Article (Peer-Reviewed)","https://link.springer.com/article/10.1007/s40121-020-00334-1, https://link.springer.com/article/10.1007%2Fs15010-020-01461-0",9/28/2020,3/1/2021
200824_Jena_UniversitätsklinikumJena_Pregnantwomen_Overall,8/24/2020,Janine Zöllkau,Local,Germany,"Jena; Thuringia; Germany
(Universitätsklinikum Jena)",04/06 - 05/13,Pregnant or parturient women,Not reported,217,0.6% (0-1.7%),Unclear,"Epitope Diagnostics; IgG; ELISA
(0%; 0%)",High,Journal Article (Peer-Reviewed),https://www.thieme-connect.com/products/ejournals/abstract/10.1055/a-1206-1033,9/28/2020,3/1/2021
200717_Germany_NorthRhineWestphaliaLowerSaxonyHesse_BloodDonors_PrimaryEstimate,7/16/2020,Bastian Fischer,Regional,Germany,"North Rhine-Westphalia, Lower Saxony, Hesse; Germany
(Heart and Diabetes Center NRW)",03/09 - 06/03,Residual sera,Not reported,3186,0.9% (0.6-1.2%),Sequential,"Abbott, EUROIMMUN, DiaSorin; IgG; ELISA
(0%; 0%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.2807/1560-7917.ES.2020.25.28.2001285,10/1/2020,3/1/2021
200723_Germany_ThuringiaClinicSaalfeld_CleaningStaffIgG,7/23/2020,Jörg Epstude,Sublocal,Germany,"Saalfeld; Thuringia; Germany
(Thuringia Clinic)",06/15 - 06/30,Health care workers and caregivers,Adults (18-64 years),45,NA,Convenience,"PerkinElmer Inc; IgG; ELISA
(0%; 98.5%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.3205/dgkh000353,10/1/2020,3/1/2021
200723_Germany_ThuringiaClinicSaalfeld_OncologyStaffIgG,7/23/2020,Jörg Epstude,Sublocal,Germany,"Saalfeld; Thuringia; Germany
(Thuringia Clinic)",06/15 - 06/30,Health care workers and caregivers,Adults (18-64 years),20,5% (NR),Convenience,"PerkinElmer Inc; IgG; ELISA
(0%; 98.5%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.3205/dgkh000353,10/1/2020,3/1/2021
200629_Fulda_UniversitätsmedizinMarburg_Entirecohort_IgG,6/29/2020,Peter Kern,Sublocal,Germany,"Fulda; Germany
(Universitätsmedizin Marburg)",04/09 - 04/16,Multiple populations,Multiple groups,1780,1% (0.6-1.5%),Unclear,"EUROIMMUN; IgG; ELISA
(93.8%; 99%)",High,Journal Article (Peer-Reviewed),http://dx.doi.org/10.1055/a-1198-1243,10/11/2020,3/17/2021
201004_Heidelberg_UniversityHospitalHeidelberg_Overall,10/4/2020,Conrad Rauber,Local,Germany,"Heidelberg; Baden-Württemberg; Germany
(University Hospital Heidelberg)",05/05 - 08/06,Patients seeking care for non-COVID-19 reasons,Multiple groups,219,3.2% (NR),Sequential,"EUROIMMUN™; IgG; ELISA
(0%; 99.6%)",High,Preprint,10.1101/2020.09.30.20204537,11/27/2020,3/1/2021
200929_Jena_JenaUniversityHospital_Overall,9/29/2020,Christina Bahrs,Sublocal,Germany,"Jena; Thuringia; Germany
(Jena University Hospital)",05/19 - 06/19,Health care workers and caregivers,Adults (18-64 years),660,2.7% (NR),Convenience,"Epitope Diagnostics, Roche; IgG; ELISA, Chemiluminescence Immunoassay
(0%; 0%)",High,Preprint,https://www.medrxiv.org/content/10.1101/2020.09.29.20203737v1,11/28/2020,3/1/2021
200929_Oberspreewald-Lausitz_BrandenburgUniversityofTechnologyCottbus-Senftenberg_HCW,9/29/2020,Stephanie Hoffmann,Sublocal,Germany,"Oberspreewald-Lausitz; Brandenburg; Germany
(Brandenburg University of Technology Cottbus-Senftenberg)",07/01 - 07/31,Health care workers and caregivers,Adults (18-64 years),156,1.3% (NR),Convenience,"Author-designed; Total Antibody; chemiluminescent microparticle immunoassay
(99.5%; 99.8%)",High,Preprint,https://doi.org/10.21203/rs.3.rs-84703/v1,11/28/2020,3/1/2021
200806_Regensburg_UniversityofRegensburg_12Wks,8/6/2020,Sara Malfertheiner,Sublocal,Germany,"Regensburg; Bavaria; Germany
(University of Regensburg)",03/15 - 06/07,Health care workers and caregivers,Adults (18-64 years),102,NA,Convenience,"EUROIMMUN AG, Roche Diagnostics; NR
(0%; 0%)",High,Journal Article (Peer-Reviewed),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7406471/pdf/main.pdf,12/2/2020,3/1/2021
200813_Northrhine-Westfalia_SpecialistPracticeAndLaboratory_IgGandOverall,8/13/2020,Burkhard Herrmann,Regional,Germany,"North Rhine-Westphalia; Germany
(Internal medicine and laboratory medicine specialist practice and laboratory)",03/26 - 06/04,Residual sera,Multiple groups,415,1.2% (NR),Convenience,"Euroimmun; NR
(94.4%; 99.6%)",High,Journal Article (Peer-Reviewed),http://dx.doi.org/10.1007/s15006-020-0750-y,1/5/2021,3/17/2021
201103_Germany_UniversityofWitten,11/3/2020,Silke Schwarz,National,Germany,"Germany
(University of Witten)",06/15 - 09/01,Residual sera,Children and Youth (0-17 years),731,11.2% (NR),Convenience,"Euroimmun IgG, Diasorin IgG, Microgen IgG, Roche IgM, Cleartest IgM, Nadal IgM, Euroimmun IgA; NR
(0%; 0%)",Unclear,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1007/s00112-020-01050-3,1/7/2021,3/17/2021
200610_Munich_TechnicalUniversityofMunich_hcw,10/6/2020,Johanna Erber,Sublocal,Germany,"Munich; Bavaria; Germany
(Technical University of Munich)",04/14 - 05/29,Health care workers and caregivers,Multiple groups,4554,2.4% (1.9-2.9%),Convenience,"Unclear; NR
(0%; 0%)",High,Preprint,https://www.medrxiv.org/content/10.1101/2020.10.04.20206136v1,1/8/2021,3/6/2021
201023_Berlin_CharitéUniversity_primary,10/23/2020,Mira Choi,Sublocal,Germany,"Berlin; Berlin; Germany
(Charité University)",03/19 - 05/19,Patients seeking care for non-COVID-19 reasons,Multiple groups,223,7.1% (NR),Unclear,"Euroimmun Medizinische Labordiagnostika AG; NR
(0%; 0%)",High,Journal Article (Peer-Reviewed),https://pubmed.ncbi.nlm.nih.gov/33114149/,1/13/2021,3/17/2021
201126_Germany_RobertKochInstitute_BloodDonors_TestAdj,11/26/2020,Robert Koch Institute,National,Germany,"Germany
(Robert Koch Institute)",04/15 - 11/05,Blood donors,Multiple groups,48976,1.4% (NR),Simplified probability,"NR; NR
(0%; 0%)",Moderate,Institutional Report,https://www.rki.de/DE/Content/InfAZ/N/Neuartiges_Coronavirus/Projekte_RKI/SeBluCo_Zwischenbericht.html;jsessionid=0C30892A66A0F7CDD897F3809AA3F10F.internet102,1/14/2021,3/1/2021
201130_Hamburg_UniversityMedicalCenterHamburg-Eppendorf_S3,11/30/2020,Thomas Brehm,Sublocal,Germany,"Hamburg; Hamburg; Germany
(University Medical Center Hamburg-Eppendorf)",06/22 - 07/17,Health care workers and caregivers,Adults (18-64 years),1253,1.8% (1-2.5%),Convenience,"Euroimmun; NR
(94.4%; 99.6%)",Moderate,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1016/j.ijheh.2020.113671,1/21/2021,3/1/2021
210103_Munich_LudwigMaximillianUniversityofMunich_Overall,1/3/2021,Tobias Weinberger,Sublocal,Germany,"Munich; Germany
(Ludwig Maximillian University of Munich)",03/24 - 07/07,Health care workers and caregivers,Adults (18-64 years),300,4.7% (NR),Convenience,"EuroImmun, Roche, DiaSorin, Abbott; NR
(0%; 0%)",Moderate,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1093/cid/ciaa1935,1/23/2021,3/1/2021
201212_Bavaria_UniversityofRegensburg_overall,12/12/2020,Otto Laub,Regional,Germany,"Bavaria; Germany
(University of Regensburg)",05/22 - 07/22,Household and community samples,Children and Youth (0-17 years),2832,5.7% (NR),Convenience,"1. Roche Diagnostics; NR
(96%; 99.3%)",Moderate,Preprint,https://www.authorea.com/users/382535/articles/498454-coronavirus-antibody-screening-identifies-children-with-mild-to-moderate-courses-of-pmis,1/25/2021,3/2/2021
201111_NeustadtAmRennsteig_FriedrichSchillerUniversity_Overall,11/19/2020,Sebastian Weis,Sublocal,Germany,"Thuringia; Germany
(Friedrich Schiller University)",05/13 - 05/16,Household and community samples,Multiple groups,620,8.4% (NR),Self-referral,"Epitope Diagnostics Inc., San Diego, USA
Euroimmun, Lübeck, Germany
DiaSorin, Saluggia, Italy
Snibe Co., Ltd., Shenzhen, China
Abbott, Chicago, USA
Roche, Basel Switzerland; NR
(0%; 0%)",Moderate,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1016/j.cmi.2020.11.009,1/27/2021,3/10/2021
201203_Tirschenreuth_MunichClinic_HCW_Overall,12/3/2020,T Finkenzeller,Sublocal,Germany,"Tirschenreuth, Wieden; Bavaria; Germany
(Munich Clinic)",06/29 - 07/29,Health care workers and caregivers,Adults (18-64 years),1838,15.1% (NR),Convenience,"Roche Diagnostics; NR
(99.5%; 99.8%)",Moderate,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1007/s00063-020-00761-5,1/27/2021,3/1/2021
201203_Tirschenreuth_MunichClinic_NMU_Overall,12/3/2020,T Finkenzeller,Sublocal,Germany,"Tirschenreuth, Wieden; Bavaria; Germany
(Munich Clinic)",06/29 - 07/29,Essential non-healthcare workers,Adults (18-64 years),986,3.7% (NR),Convenience,"Roche DIagnostics; NR
(99.5%; 99.8%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1007/s00063-020-00761-5,1/27/2021,3/1/2021
200101_Hamburg_UniversityHospitalsoftheRuhr-UniversityofBochum_Overall,10/16/2020,Jonas Herzberg,Sublocal,Germany,"Hamburg; Schleswig-Holstein; Germany
(University Hospitals of the Ruhr‑University of Bochum)",04/14 - 06/16,Health care workers and caregivers,Multiple groups,871,2.6% (NR),Convenience,"Mikrogen Diagnostik, Euroimmun; NR
(0%; 0%)",Moderate,Journal Article (Peer-Reviewed),http://dx.doi.org/10.1016/j.ijid.2020.10.026,1/30/2021,3/1/2021
201204_Germany_SaarlandUniversity_overall,12/4/2020,Dietrich Mack,National,Germany,"Germany
(Saarland University)",06/16 - 06/30,Non-essential workers and unemployed persons,Multiple groups,1007,2.1% (1.4-3.2%),Self-referral,"EUROimmun, Lübeck, Germany; Roche, Mannheim, Germany; Not reported; NR
(0%; 0%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1016/j.cmi.2020.11.033,1/31/2021,3/1/2021
201126_Kupferzell_RobertKochInstitute_OverallAdj,11/26/2020,Claudia Santos-Hovener,Local,Germany,"Kupferzell; Baden-Wurttemberg; Germany
(Robert Koch Institute)",05/20 - 06/09,Household and community samples,Multiple groups,2203,12% (10.4-14%),Simplified probability,"Euroimmun; NR
(88.3%; 99.2%)",Low,Journal Article (Peer-Reviewed),https://dx.doi.org/10.2807/1560-7917.ES.2020.25.47.2001752,2/4/2021,3/1/2021
201209_Berlin_BerlinInstituteofHealth_overall_unadj,12/9/2020,Marlene Thielecke,Local,Germany,"Berlin; City State of Berlin; Germany
(Berlin Institute of Health)",09/28 - 10/02,Multiple populations,Multiple groups,672,0.2% (NR),Stratified probability,"Euroimmun AG, Germany; NR
(0%; 0%)",Moderate,Preprint,https://www.medrxiv.org/content/10.1101/2020.12.08.20245910v1,2/5/2021,3/1/2021
201216_Germany_Ruhr-UniversityBochum_overall,12/16/2020,Constantin J. Thieme,Local,Germany,"Germany
(Ruhr-University Bochum)",04/01 - 05/31,Patients seeking care for non-COVID-19 reasons,Multiple groups,99,3% (NR),Sequential,"NR; NR
(0%; 0%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1016/j.transproceed.2020.12.001,2/6/2021,3/16/2021
200829_Bonn_UniversityOfBonn_RhinelandStudy1_ELISAPositive,8/29/2020,Ahmad Aziz,Local,Germany,"Bonn; North Rhine-Westphalia; Germany
(University of Bonn)",04/24 - 06/30,Household and community samples,Multiple groups,4771,1% (0.7-1.3%),Convenience,"EUROIMMUN; IgG; ELISA
(94.4%; 99.6%)",High,Preprint,https://www.medrxiv.org/content/10.1101/2020.08.24.20181206v1,2/13/2021,3/1/2021
200829_Bonn_UniversityOfBonn_Voluntary2,8/29/2020,Ahmad Aziz,Local,Germany,"Bonn; North Rhine-Westphalia; Germany
(University of Bonn)",04/24 - 06/30,Household and community samples,Multiple groups,360,1.9% (0.8-4.4%),Self-referral,"EUROIMMUN; IgG; ELISA
(94.4%; 99.6%)",High,Preprint,https://www.medrxiv.org/content/10.1101/2020.08.24.20181206v1,2/13/2021,3/1/2021
210129_Germany_LaborDrWisplinghoff_IgG,1/29/2021,Martin Platten,Sublocal,Germany,"Germany
(Labor Dr. Wisplinghoff)",04/27 - 05/20,Health care workers and caregivers,Multiple groups,1212,3.3% (NR),Convenience,"EUROIMMUN; NR
(94.4%; 99.6%)",Moderate,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1055/a-1322-5355,2/14/2021,3/1/2021
210122_Germany_HeidelbergUniversity_Parents_Overall_unadj,1/22/2021,Burkhard Tonshoff,Regional,Germany,"Freiburg, Heidelberg, Tübingen, Ulm; Baden-Württemberg; Germany
(Heidelberg University)",04/22 - 05/15,,Adults (18-64 years),2482,1.9% (NR),Convenience,"Euroimmun; Roche Elecsys' Mikrogen in-house; NR
(0%; 99.6%)",Moderate,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamapediatrics.2021.0001,2/19/2021,3/15/2021
210122_Germany_HeidelbergUniversity_Children_Overall_unadj,1/22/2021,Burkhard Tonshoff,Regional,Germany,"Freiburg, Heidelberg, Tübingen, Ulm; Baden-Württemberg; Germany
(Heidelberg University)",04/22 - 05/15,,Children and Youth (0-17 years),2482,1.4% (NR),Convenience,"Euroimmun; Roche Elecsys' Mikrogen in-house; NR
(0%; 99.6%)",Moderate,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamapediatrics.2021.0001,2/19/2021,3/15/2021
210129_Berlin_UniversitätsmedizinBerlin_Students_Overall,1/29/2021,Stefanie Theuring,Local,Germany,"Berlin; Germany
(Universitätsmedizin Berlin)",11/02 - 11/16,Students and Daycares,Children and Youth (0-17 years),347,2% (0.8-4.1%),Stratified probability,"NR; NR
(0%; 0%)",Moderate,Preprint,10.1101/2021.01.27.21250517,2/22/2021,3/1/2021
210129_Berlin_UniversitätsmedizinBerlin_Staff_Overall ,1/29/2021,Stefanie Theuring,Local,Germany,"Berlin; Germany
(Universitätsmedizin Berlin)",11/02 - 11/16,Essential non-healthcare workers,Adults (18-64 years),141,1.4% (0.2-5%),Stratified probability,"NR; NR
(0%; 0%)",Moderate,Preprint,10.1101/2021.01.27.21250517,2/22/2021,3/1/2021
210129_Berlin_UniversitätsmedizinBerlin_HouseholdMembers_Overall,1/29/2021,Stefanie Theuring,Local,Germany,"Berlin; Germany
(Universitätsmedizin Berlin)",11/02 - 11/16,Household and community samples,Multiple groups,576,1.4% (0.6-2.7%),Stratified probability,"NR; NR
(0%; 0%)",High,Preprint,10.1101/2021.01.27.21250517,2/22/2021,3/19/2021
210203_Dusseldorf_InstituteOfMedicalSociology_overall_TestAdj,2/3/2021,Insa Backhaus,Local,Germany,"Düsseldorf; Germany
(Institute Of Medical Sociology)",11/02 - 11/23,Household and community samples,Adults (18-64 years),2186,3.1% (2.4-4%),Simplified probability,"Roche; NR
(90%; 99.8%)",Low,Institutional Report,https://www.uniklinik-duesseldorf.de/patienten-besucher/klinikeninstitutezentren/institut-fuer-medizinische-soziologie/das-institut/forschung/serodus,3/9/2021,3/10/2021
210203_Dusseldorf_InstituteOfMedicalSociology_SERODUSII_overall_TestAdj,2/3/2021,Insa Backhaus,Local,Germany,"Düsseldorf; Germany
(Institute Of Medical Sociology)",11/23 - 11/27,Essential non-healthcare workers,Adults (18-64 years),745,4.4% (3.1-6.2%),Convenience,"Roche; NR
(90%; 99.8%)",High,Institutional Report,https://www.uniklinik-duesseldorf.de/patienten-besucher/klinikeninstitutezentren/institut-fuer-medizinische-soziologie/das-institut/forschung/serodus,3/9/2021,3/10/2021
200731_Bremen_UniversityOfBremen_IgG/IgA,7/31/2020,Jan Neumann,Local,Germany,"Bremen; Germany
(University of Bremen)",03/31 - 05/16,Multiple populations,Adults (18-64 years),281,2.1% (NR),Unclear,"Euroimmun; NR
(93.8%; 99.6%)",Unclear,Journal Article (Peer-Reviewed),https://www.asu-arbeitsmedizin.com/node/153868/print,3/11/2021,3/13/2021
210106_Munich_LudwigMaximilianUniversityOfMunich_Overall_TestAdj,1/6/2021,Michael Pritsch,Local,Germany,"Munich; Bavaria; Germany
(Ludwig Maximilian Unviersity of Munich)",04/05 - 06/12,Household and community samples,Multiple groups,5313,1.8% (1.3-2.4%),Stratified probability,"Roche; NR
(88.6%; 99.72%)",Low,Preprint,https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3745128,3/11/2021,3/17/2021
210219_Jena_JenaUniversityHospital_Overall,2/19/2021,Christina Bahrs,Sublocal,Germany,"Jena; Urban district; Germany
(Jena University Hospital)",05/19 - 06/19,Health care workers and caregivers,Adults (18-64 years),660,2.7% (1.6-4.3%),Convenience,"Epitope Diagnostics Inc.; Roche Diagnostics; NR
(98%; 98%)",Moderate,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1111/tbed.14041,3/13/2021,3/13/2021
201001_SouthwesternGermany_UniversityMedicalCenterofTheJohannesGutenbergUniversityMainz_BloodDonors_Overall,10/1/2020,Stefan Runkel,Regional,Germany,"Southwest; Germany
(University Medical Center of The Johannes Gutenberg-University Mainz)",03/15 - 06/15,Blood donors,Multiple groups,3880,0.9% (NR),Unclear,"Abbott Laboratories; NR
(0%; 99.6%)",High,Journal Article (Peer-Reviewed),https://pubmed.ncbi.nlm.nih.gov/33073955/,3/14/2021,3/15/2021
210212_Bavaria_ GermanResearchCenterForEnvironmentalHealth_Children_overall,2/12/2021,Markus Hippich,Regional,Germany,"Bavaria; Germany
( German Research Center for Environmental Health)",01/01 - 07/31,Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),11884,0.7% (NR),Convenience,"N/A - author desgined; NR
(97.3%; 100%)",Moderate,Journal Article (Peer-Reviewed),https://www.cell.com/med/fulltext/S2666-6340(20)30020-9?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS2666634020300209%3Fshowall%3Dtrue,3/18/2021,3/18/2021
210212_Bavaria_ GermanResearchCenterForEnvironmentalHealth_Newborns_overall,2/12/2021,Markus Hippich,Regional,Germany,"Bavaria; Germany
( German Research Center for Environmental Health)",04/01 - 06/30,Pregnant or parturient women,Adults (18-64 years),1916,0.5% (NR),Convenience,"N/A - author desgined; NR
(97.3%; 100%)",High,Journal Article (Peer-Reviewed),https://www.cell.com/med/fulltext/S2666-6340(20)30020-9?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS2666634020300209%3Fshowall%3Dtrue,3/18/2021,3/18/2021
201127_Germany_IfoInstitue_overall_PopAdj,11/27/2020,Clemens Fuest,National,Germany,"Germany
(ifo Institute)",10/01 - 11/15,Household and community samples,Multiple groups,9929,1.1% (0.9-1.3%),Simplified probability,"Roche; NR
(0%; 99.8%)",Unclear,Institutional Report,https://www.ifo.de/en/publikationen/2020/monograph-authorship/die-deutschen-und-corona,3/21/2021,3/21/2021
200623_Greece_NationalandKapodistrianUniversityofAthens_HealthCareWorkers,6/23/2020,Mina Psichogiou,Local,Greece,"Athens; Attica; Greece
(National and Kapodistrian University of Athens)",04/13 - 05/15,Health care workers and caregivers,Multiple groups,1495,1.1% (0.4-2.8%),Convenience,"Genebody Inc.; IgG, IgM; Rapid immunochromatographic test
(87%; 100%)",Moderate,Preprint,https://www.medrxiv.org/content/10.1101/2020.06.23.20137620v1.full.pdf,6/25/2020,3/1/2021
200806_Greece_UniversityofThessaly_Overall,8/6/2020,Zacharoula Bogogiannidou,National,Greece,"Central Macedonia, Attica, Peloponnese, Thessaly, Western Macedonia, Central Greece, Western Greece, Epirus; Greece
(University of Thessaly)",03/01 - 04/30,Residual sera,Multiple groups,6586,0.4% (NR),Convenience,"Abbott; IgG; Chemiluminescence Immunoassay
(84%; 99.7%)",Moderate,Journal Article (Peer-Reviewed),https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2020.25.31.2001369,10/3/2020,3/1/2021
200921_Athens_NationalandKapodistrianUniversityofAthens_OverallAdj,9/21/2020,Ourania Tsitsilonis ,Sublocal,Greece,"Athens; Greece
(National and Kapodistrian University of Athens)",06/15 - 07/15,Non-essential workers and unemployed persons,Multiple groups,2500,0.9% (0.3-2.1%),Convenience,"Roche Diagnostics; Total Antibody; Electro chemiluminescence immunoassay
(100%; 99.81%)",Moderate,Journal Article (Peer-Reviewed),https://dx.doi.org/10.3390/life10090214,11/9/2020,3/1/2021
201027_Athens_NationalandKapodistrianUniversityofAthens_Overall,10/27/2020,Panayiotis Vlachoyiannopoulosa,Sublocal,Greece,"Athens; Attica; Greece
(National and Kapodistrian University of Athens/Laiko University Hospital)",04/25 - 05/10,Health care workers and caregivers,Adults (18-64 years),321,2.2% (NR),Unclear,"EUROIMMUN, Germany; NR
(93%; 100%)",High,Journal Article (Peer-Reviewed),http://dx.doi.org/10.1016/j.clim.2020.108619,1/12/2021,3/1/2021
201203_Athens_UniversityOfAthens_Overall_BothAdj,12/3/2020,Mina Psichogiou,Sublocal,Greece,"Athens; Attica; Greece
(University of Athens)",04/13 - 05/15,Health care workers and caregivers,Multiple groups,1495,1.3% (0.4-3.3%),Convenience,"Genebody Inc; NR
(74.1%; 100%)",Moderate,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1371/journal.pone.0243025,2/7/2021,3/1/2021
210107_Greece_UniversityCollegeLondon_PaediatricHCW,1/27/2021,D. Goldblatt,Sublocal,Greece,"Greece
(University College London)",06/19 - 07/16,Health care workers and caregivers,Adults (18-64 years),77,1.3% (0.2-7%),Convenience,"Epitope Diagnostics; NR
(100%; 88.7%)",High,Journal Article (Peer-Reviewed),http://dx.doi.org/10.1016/j.jhin.2020.12.019,3/13/2021,3/16/2021
200717_Hungary_SemmelweisUniversity__GenPop_PopAdj,7/17/2020,Béla Merkely,National,Hungary,"Hungary
(Semmelweis University)",05/01 - 05/16,Household and community samples,Multiple groups,10474,0.7% (0.5-0.9%),Stratified probability,"Abbott; IgG; Chemiluminescence Immunoassay
(0%; 0%)",Moderate,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1007/s11357-020-00226-9,8/1/2020,3/1/2021
200901_Iceland_deCODEGenetics_OverallPopAdj,9/1/2020,Daniel Gudbjartsson,National,Iceland,"Iceland
(deCODE Genetics)",04/27 - 06/12,Household and community samples,Multiple groups,23452,0.3% (NR),Convenience,"Roche International, Wantai/Nordic BioSite; IgG, IgM, IgA; Chemiluminescence Immunoassay
(91.1%; 99.8%)",Low,Journal Article (Peer-Reviewed),http://dx.doi.org/10.1056/NEJMoa2026116,10/13/2020,3/1/2021
200622_India_IndianCouncilofMedicalResearch_GenPop,"6/22/2020, 5/25/2020, 6/8/2020, 6/16/2020","Swatee Kher, Rhythma Kaul, Sumi Dutta, Jacob Koshy",National,India,"Andhra Pradesh, Assam, Bihar, Chhattisgarh, Gujarat, Jharkhand, Karnataka, Kerala, Madhya Pradesh, Maharashtra, Odisha, Punjab, Haryana, Rajasthan, Tamil Nadu, Telangana, Uttar Pradesh, Uttarakhand, Himachal Pradesh, West Bengal, Jammu, Kashmir; India
(Indian Council of Medical Research)",05/11 - 05/25,Household and community samples,Not reported,26400,0.7% (NR),Stratified probability,"ICMR-National Institute of Virology; IgG; ELISA
(0%; 0%)",Moderate,"News and Media, News and Media, News and Media, News and Media","https://timesofindia.indiatimes.com/city/pune/6-maha-districts-have-higher-ncov-prevalence-than-nations-finding/articleshow/76500273.cms, https://www.google.com/url?rct=j&sa=t&url=https://www.hindustantimes.com/india-news/over-24k-samples-collected-for-random-antibody-tests/story-Pec8jZE03DMQ0zOQwr4KEN.html&ct=ga&cd=CAAYDTIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNGcW3JvLyfXSvgW5ufbrsvCZIK5Cg, https://www.google.com/url?rct=j&sa=t&url=https://www.newindianexpress.com/nation/2020/jun/08/15-30-people-in-containment-areas-exposed-to-covid-19-icmrs-serosurvey-2153893.html&ct=ga&cd=CAAYHDIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNG7hdULnqHWatDy0FOZfa_fab9k9g, https://www.google.com/url?rct=j&sa=t&url=https://www.thehindu.com/news/national/news-analysis-india-may-have-undercounted-cases/article31822079.ece&ct=ga&cd=CAAYFDIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNH2njMg_YAc93gwu8ZxyGEMwYvnnQ",6/24/2020,3/1/2021
200606_Bengaluru_SJICSR_Staff,6/6/2020,Sunitha Rao,Sublocal,India,"Bengaluru; Karnataka; India
(Sri Jayadeva Institute of Cardiovascular Sciences and Research)",05/23 - 06/06,Health care workers and caregivers,Adults (18-64 years),1000,1% (NR),Convenience,"New Life Healthcare; IgG; Not reported
(0%; 0%)",Unclear,News and Media,https://www.google.com/url?rct=j&sa=t&url=https://timesofindia.indiatimes.com/city/bengaluru/covid-19-jayadeva-says-its-survey-hints-at-herd-immunity/articleshow/76228490.cms&ct=ga&cd=CAAYADIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNHrh7Scfh82driNisE_8HVxMcpd8Q,6/27/2020,3/1/2021
200614_Thiruvananthapuram_HealthDepartment_GenPop,6/14/2020,Aswin Kumar,Local,India,"Thiruvananthapuram; Kerala; India
(Thiruvanathapuram Health Department)",06/09 - 07/10,Household and community samples,Multiple groups,450,2.7% (NR),Unclear,"Not reported; IgM, IgG; Not reported
(0%; 0%)",Unclear,News and Media,https://www.google.com/url?rct=j&sa=t&url=https://timesofindia.indiatimes.com/city/thiruvananthapuram/initial-trend-positivity-rate-low-in-antibody-testing/articleshow/76363847.cms&ct=ga&cd=CAAYADIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNHcN3WpGsIDw6iptLnm7KkY9Nl-tg,7/6/2020,3/1/2021
200721_Haryana_IntegratedDiseaseSurveillanceProgramme_GenPop,7/21/2020,Archana Mishra,Regional,India,"Gurugram, Faridabad, Ambala, Panchkula, Sonipat; Haryana; India
(Haryana Health Department)",06/21 - 07/15,Household and community samples,Adults (18-64 years),1544,12% (NR),Stratified probability,"Not reported; IgG; ELISA
(0%; 0%)",High,News and Media,https://www.google.com/url?rct=j&sa=t&url=https://www.hindustantimes.com/gurugram/sero-survey-1-544-tested-180-found-with-covid-19-antibodies-in-haryana/story-k7DUZ8WH4jYqAzCsUmXkEJ.html&ct=ga&cd=CAAYEDIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNHS65YBS1xHpw-8TGWw9ZqDMQDIog,7/31/2020,3/1/2021
200719_Lucknow_India_KingGeorgeMedicalUniversity_BloodDonors,7/19/2020,Yusra Husain,Local,India,"Lucknow; Uttar Pradesh; India
(King George's Medical University)",07/05 - 07/19,Blood donors,Not reported,1235,3.7% (NR),Convenience,"Not reported; IgG; Not reported
(0%; 0%)",High,News and Media,https://www.google.com/url?rct=j&sa=t&url=https://timesofindia.indiatimes.com/city/lucknow/4-healthy-blood-donors-in-city-found-with-covid-antibodies/articleshow/77044828.cms&ct=ga&cd=CAAYBjIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNHrdF6GLOiOPUVeEg19jMKbusa8DA,8/1/2020,3/1/2021
200723_Delhi_IndianCentreforDiseaseControl_GenPop,"7/23/2020, 7/21/2020","Astha Saxena , Ministry of Health and Family Welfare",Regional,India,"Delhi; India
(Indian Center for Disease Control)",06/27 - 07/10,Household and community samples,Multiple groups,21387,23.5% (NR),Stratified probability,"Zydus Cadila Healthcare; IgG; ELISA
(98.7%; 100%)",Moderate,"News and Media, Institutional Report","https://www.google.com/url?rct=j&sa=t&url=https://indianexpress.com/article/cities/delhi/delhi-coronavirus-latest-updates-sero-surveys-6518032/&ct=ga&cd=CAAYJjIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNGCf7pxljsAyKyKKRtaj_xafKiFPw, https://pib.gov.in/PressReleaseIframePage.aspx?PRID=1640137",8/2/2020,3/1/2021
200723_India_Thyrocare_GenPop,"7/23/2020, 7/22/2020","India.com News Desk, HT Correspondent",National,India,"New Delhi, Thane, Madurai, Chennai, Samastipur, Mumbai, Tiruvallur, Valsad, Hooghly, Gautam Buddha Nagar, Ghaziabad, Erode, Nalgonda, Faridabad, Howrah, Surat, Bhojpur, Hyderabad, Kolkata, Kvrangareddy, Aurangabad, Ananthapur, Vaishali, Patna, Bhagalpur, South 24 Parganas, Mahabub Nagar, Ahmedabad, Gurgaon, Khammam, Muzaffarpur, Navi Mumbai, Ganjam, North 24 Parganas, Vadodara, Karim Nagar, Bangalore, Nashik, Khorda, Bulandshahr, West Godavari, East Godavari, Jaipur, Mahesana, Ranchi, Warangal, Pune, Medak, Bardhaman, South Goa, Dharwad, Visakhapatnam, Katihar, Guntur, Chittoor, Lucknow, Bhopal, East Singhbhum, Pondicherry, Kolhapur, Thanjavur, Alibaug, Coimbatore, Bellary, Mahendragarh; India
(Thyrocare)",06/28 - 07/19,Household and community samples,Not reported,53000,15% (NR),Simplified probability,"Not reported; Not reported; ELISA, Chemiluminescence Immunoassay
(0%; 0%)",High,"News and Media, News and Media","https://www.google.com/url?rct=j&sa=t&url=https://www.india.com/news/india/covid-19-people-from-bhiwandi-anand-vihar-have-antibodies-against-corona-check-report-4092355/&ct=ga&cd=CAAYBTIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNGDZBY0JyrN9eer5kq9FJfLncpL8Q, https://www.google.com/url?rct=j&sa=t&url=https://www.hindustantimes.com/india-news/15-per-cent-population-may-have-virus-antibodies-says-private-lab-data/story-mUddIj9kxI4vRzYu4KMUiI.html&ct=ga&cd=CAAYBDIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNEuq1rkJ7vFZU1Rp4WmYN2Cr32JNA",8/4/2020,3/1/2021
200819_Delhi_DelhiGovernment_BloodDonors,8/19/2020,Aneesha Bedi,Regional,India,"Delhi; India
(Delhi National Centre for Disease Control)",08/01 - 08/07,Blood donors,Not reported,15289,28.3% (NR),Unclear,"Not reported; Not reported; Not reported
(0%; 0%)",Unclear,News and Media,https://theprint.in/health/28-3-of-delhis-population-now-exposed-to-covid-shows-second-sero-survey-up-from-23-4/484455/,10/2/2020,3/1/2021
200901_Mumbai_UChicago_Slums_TestAdjusted,"9/1/2020, 7/28/2020","Anup Malani, Suresh Kakani",Local,India,"Mumbai; India
( University of Chicago)",06/29 - 07/14,Persons living in slums,Multiple groups,4202,55.8% (54.3-57.2%),Stratified probability,"Abbott; IgG; Chemiluminescence Immunoassay
(96.9%; 99.9%)",Low,"Preprint, Institutional Report","https://www.medrxiv.org/content/10.1101/2020.08.27.20182741v1, https://www.idfcinstitute.org/site/assets/files/15834/sero_press__28_07_2020.pdf",10/3/2020,3/15/2021
200901_Mumbai_UChicago_NonSlums_TestAdjusted,"9/1/2020, 7/28/2020","Anup Malani, Suresh Kakani",Regional,India,"Mumbai; Maharashtra; India
( University of Chicago)",07/03 - 07/19,Household and community samples,Multiple groups,2702,16.4% (15.1-17.6%),Stratified probability,"Abbott; IgG; Chemiluminescence Immunoassay
(96.9%; 99.9%)",Low,"Preprint, Institutional Report","https://www.medrxiv.org/content/10.1101/2020.08.27.20182741v1, https://www.idfcinstitute.org/site/assets/files/15834/sero_press__28_07_2020.pdf",10/3/2020,3/1/2021
200724_Ahmedabad_AhmedabadMunicipalCorporation_Overall,7/24/2020,Unclear,Local,India,"Ahmedabad; Gujarat; India
(Ahmedabad Municipal Corporation)",06/16 - 07/11,Multiple populations,Not reported,30054,17.6% (NR),Unclear,"Not reported; Not reported; Not reported
(0%; 0%)",Unclear,News and Media,https://timesofindia.indiatimes.com/city/ahmedabad/ahmedabad-has-no-herd-immunity-only-17-6-have-antibodies/articleshow/77137851.cms,10/6/2020,3/1/2021
200826_India_AllIndiaInstituteofMedicalSciences_HospitalPatients_UnAdj,8/26/2020,Animesh Ray,Local,India,"New Delhi; Punjab; India
(All India Institute of Medical Sciences)",06/08 - 08/08,Residual sera,Multiple groups,212,19.8% (14.7-25.8%),Convenience,"""Translational Health Science and Technology Institute (THSTI), Faridabad""; IgG; ELISA
(88.24%; 99.79%)",High,Preprint,https://www.medrxiv.org/content/10.1101/2020.08.22.20179937v2,10/13/2020,3/17/2021
200904_Srinagar_GovernmentMedicalCollegeSrinagar_PopAdj,9/4/2020,Muhammed Khan,Regional,India,"District Srinagar; Srinagar; India
(Government Medical College Srinagar)",07/01 - 07/15,Residual sera,Multiple groups,2906,3.6% (2.9-4.3%),Convenience,"Abbott; IgG; Chemiluminsescent microparticle immunoassay
(100%; 99.6%)",Low,Preprint,https://www.biorxiv.org/content/10.1101/2020.09.04.282640v1,10/19/2020,3/17/2021
200914_PaschimMedinipur_MedicalCollegeKolkata_Overall,9/14/2020,Parthasarathi Satpati,Regional,India,"West Bengal; India
(Medical College Kolkata)",07/26 - 08/08,Household and community samples,Multiple groups,458,4.2% (2.5-6.4%),Stratified probability,"Calbiotech Inc.; IgG; ELISA
(98.3%; 98.1%)",Moderate,Preprint,https://www.medrxiv.org/content/10.1101/2020.09.12.20193219v1,11/5/2020,3/1/2021
200916_Kerala_AmritaInstituteofMedicalSciencesandResearchCentre,9/16/2020,Anil Kumar,Sublocal,India,"Kerala; India
(Amrita Institute of Medical Sciences & Research Centre)",07/11 - 07/24,Health care workers and caregivers,Multiple groups,635,0.3% (NR),Convenience,"Abbott; IgG; Not reported
(0%; 0%)",High,Journal Article (Peer-Reviewed),http://dx.doi.org/10.1016/j.cmi.2020.09.013,11/5/2020,3/17/2021
200903_NewDelhi_MaxSuperSpecialtyHospital_Overall,9/3/2020,Samreen Siddiqui,Local,India,"New Delhi; NCT Delhi; India
(Max Super Specialty Hospital)",04/15 - 08/15,Multiple populations,Multiple groups,780,19.5% (NR),Convenience,"Roche Diagnostics; Not reported; Electrochemiluminescence
(94.5%; 99.4%)",High,Preprint,https://www.medrxiv.org/content/10.1101/2020.09.02.20186486v1,11/6/2020,3/1/2021
200922_Delhi_NationalCenterforDiseaseControlIndia_Survey1_PopAdj,9/22/2020,Smarajit Dey,Local,India,"New Delhi; Delhi; India
(National Centre for Disease Control)",06/26 - 07/10,Household and community samples,Not reported,21387,23.5% (23-24%),Unclear,"ICMR-National Institute of Virology; IgG; ELISA
(92.37%; 97.9%)",Unclear,Preprint,https://www.researchsquare.com/article/rs-80259/v1,11/18/2020,3/1/2021
200922_Delhi_NationalCenterforDiseaseControlIndia_Survey2_PopAdj,9/22/2020,Smarajit Dey,Local,India,"New Delhi; Delhi; India
(National Centre for Disease Control)",08/01 - 08/07,Household and community samples,Not reported,15311,29.1% (28.5-30%),Unclear,"ICMR-National Institute of Virology; IgG; ELISA
(92.37%; 97.9%)",Unclear,Preprint,https://www.researchsquare.com/article/rs-80259/v1,11/18/2020,3/1/2021
200917_India_MinistryofHealth&FamilyWelfare_OverallPopAdj,9/17/2020,Manoj Murhekar,National,India,"India
(Indian Council of Medical Research)",05/11 - 06/04,Household and community samples,Multiple groups,28000,0.6% (0.3-1%),Stratified probability,"Cadila Healthcare Limited, EUROIMMUN; IgG; ELISA
(92.4%; 97.9%)",Low,Journal Article (Peer-Reviewed),http://dx.doi.org/10.4103/ijmr.IJMR_3290_20,11/26/2020,3/1/2021
201207_Mumbai_KokilabenDhirubhaiAmbaniHospital_hcw_primaryest,12/7/2020,Tanu Singhal,Sublocal,India,"Mumbai; Maharashtra; India
(Kokilaben Dhirubhai Ambani Hospital and Medical Research Institute)",06/01 - 06/30,Health care workers and caregivers,Adults (18-64 years),208,12.5% (NR),Convenience,"1) Abbott 2) Roche; NR
(74%; 100%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.4103/ijmm.IJMM_20_308,1/12/2021,3/1/2021
201109_Kokalta_ApolloGleneaglesHospitals_HCW_Overall,11/9/2020,Mahesh Goenka,Sublocal,India,"Kolkata; West Bengal; India
(Apollo Gleneagles Hospitals)",07/12 - 08/23,Health care workers and caregivers,Adults (18-64 years),1122,11.9% (NR),Stratified probability,"Ortho Clinical Diagnostics; NR
(90%; 100%)",Moderate,Journal Article (Peer-Reviewed),https://www.japi.org/x264a444/seroprevalence-of-covid-19-amongst-health-care-workers-in-a-tertiary-care-hospital-of-a-metropolitan-city-from-india,1/18/2021,3/7/2021
201104_India_HindujaHospital_GenPop,11/4/2020,Nishant Kumar,Local,India,"Mumbai; Maharashtra; India
(Postgraduate Institute of Medical Education and Research)",06/01 - 06/30,Health care workers and caregivers,Multiple groups,801,11.1% (9.1-13.5%),Unclear,"Roche Diagnostics; NR
(99.8%; 100%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1016/j.vaccine.2020.10.094,1/18/2021,3/2/2021
201013_Odisha_ICMR-RMRC_genpop,10/13/2020,Jaya Singh Kshatri,Local,India,"Bhubaneswar, Berhampur or Rourkela; Odisha; India
(Indian Council of Medical Research-Regional Medical Research Centre in Bhubaneswar (ICMR-RMRC) Serosurvey group)",08/01 - 08/31,Household and community samples,Multiple groups,4146,20.8% (19.6-22.1%),Stratified probability,"NR; NR
(0%; 0%)",High,Preprint,https://www.medrxiv.org/node/100529.external-links.html,1/23/2021,3/1/2021
201130_DrDYPatilMedicalCollege_Pimpri-Chinchwad_DashboardPrimary,11/30/2020,Amitav Banerjee,Local,India,"Pune ; Maharashtra; India
(Dr DY Patil Medical College )",10/07 - 10/17,Household and community samples,Multiple groups,5000,34% (31.3-36.8%),Stratified probability,"Abbott Chicago, IL, USA.; NR
(92.7%; 99.9%)",Moderate,Preprint,https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3729394,1/23/2021,3/7/2021
201211_Karnatka_IndianInstituteofPublicHealth_primary_adj,12/11/2020,Giridhara R Babu,Regional,India,"Karnatka; India
(Indian Institute of Public Health)",09/03 - 09/16,Household and community samples,Multiple groups,15624,16.4% (15.1-17.7%),Stratified non-probability,"Zydus Cadila, India; NR
(92.1%; 99.77%)",Moderate,Preprint,https://www.medrxiv.org/content/10.1101/2020.12.04.20243949v1.full,1/29/2021,3/1/2021
201109_Kolkata_ApolloGleneaglesHospitalsGastroDept_Overall,11/9/2020,Mahesh Goenka,Sublocal,India,"Kolkata; West Bengal; India
(Apollo Gleneagles Hospitals)",08/01 - 08/31,Health care workers and caregivers,Adults (18-64 years),117,32.5% (NR),Convenience,"Ortho Clinical Diagnostics; NR
(0%; 0%)",High,Journal Article (Peer-Reviewed),http://dx.doi.org/10.1002/jgh3.12447,1/30/2021,3/7/2021
201214_Ahmedabad_ MunicipalMedicalCollege_genpop_primary,12/14/2020,Om Prakash,Local,India,"Ahmedabad; Gujarat; India
( Municipal Medical College )",06/16 - 07/07,Residual sera,Multiple groups,29891,17.6% (17.2-18%),Convenience,"Zydus Diagnostics; NR
(92.37%; 97.9%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1136/bmjopen-2020-044101,2/2/2021,3/17/2021
210104_Chennai_KanchiKamakotiCHILDSTrustHospital_overall,1/4/2021,Manoj Madhusudan,Sublocal,India,"Chennai; Tamil Nadu; India
(Kanchi Kamakoti CHILDS Trust Hospital,)",07/30 - 08/07,Health care workers and caregivers,Adults (18-64 years),95,16.8% (NR),Convenience,"Shenzhen YHLO Biotech Co; NR
(0%; 0%)",High,Preprint,https://pubmed.ncbi.nlm.nih.gov/33408287/,2/4/2021,3/1/2021
200916_Kerala_AmritaInstituteofMedicalSciencesandResearchCentre copy,9/16/2020,Anil Kumar,Sublocal,India,"Kerala; India
(Amrita Institute of Medical Sciences & Research Centre)",07/11 - 07/24,Health care workers and caregivers,Multiple groups,635,0.2% (NR),Convenience,"Roche Diagnostics; Total Antibody; Not reported
(0%; 0%)",High,Journal Article (Peer-Reviewed),http://dx.doi.org/10.1016/j.cmi.2020.09.013,2/6/2021,3/17/2021
200916_Kerala_AmritaInstituteofMedicalSciencesandResearchCentre copy copy,9/16/2020,Anil Kumar,Sublocal,India,"Kerala; India
(Amrita Institute of Medical Sciences & Research Centre)",07/11 - 07/24,Health care workers and caregivers,Multiple groups,635,NA,Convenience,"Abbott, Roche Diagnostics, Ortho-Clinical Diagnostics; IgG, Total Antibody; Not reported
(0%; 0%)",High,Journal Article (Peer-Reviewed),http://dx.doi.org/10.1016/j.cmi.2020.09.013,2/6/2021,3/17/2021
201214_Delhi_MaulanaAzadMedicalCollege_Oct_PopTestAdj,12/14/2020,Nandini Sharma,Regional,India,"Delhi; India
(Government of National Capital Territory of Delhi)",10/15 - 10/21,Household and community samples,Multiple groups,15015,24.7% (24-25.4%),Stratified probability,"NR; NR
(99.12%; 99.33%)",Low,Preprint,https://www.medrxiv.org/content/10.1101/2020.12.13.20248123v1,2/7/2021,3/17/2021
201214_Delhi_MaulanaAzadMedicalCollege_Sept_PopTestAdj,12/14/2020,Nandini Sharma,Regional,India,"Delhi; India
(Government of National Capital Territory of Delhi)",09/01 - 09/07,Household and community samples,Multiple groups,17409,24.1% (23.4-24.7%),Stratified probability,"NR; NR
(99.12%; 99.33%)",Low,Preprint,https://www.medrxiv.org/content/10.1101/2020.12.13.20248123v1,2/7/2021,3/17/2021
201214_Delhi_GovernmentofNationalCapitalTerritory_Aug1_PopTestAdj,12/14/2020,Nandini Sharma,Regional,India,"Delhi; India
(Government of National Capital Territory of Delhi)",08/01 - 08/07,Household and community samples,Multiple groups,15046,28.4% (27.7-29.1%),Stratified non-probability,"NR; NR
(92.1%; 97.7%)",Low,Preprint,https://www.medrxiv.org/content/10.1101/2020.12.13.20248123v1,2/7/2021,3/17/2021
211104_Karnataka_Mapmygenome_primary_adj,2/4/2021,Manoj Mohanan,Regional,India,"Karnataka; India
(Mapmygenome)",06/15 - 08/29,Household and community samples,Multiple groups,1197,46.7% (43.3-50%),Stratified probability,"Translational Health Science and Technology Institute, India; NR
(84.7%; 100%)",Moderate,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jama.2021.0332,2/8/2021,3/1/2021
201130_PuneCity_IndianInstituteOfScienceEducationAndResearch_OverallAdj,11/30/2020,Aurnab Ghose,Local,India,"Pune; Maharashtra; India
(Indian Institute of Science Education and Research)",07/20 - 08/05,Household and community samples,Multiple groups,1659,51.3% (39.9-62.4%),Stratified probability,"In-house developed.; NR
(0%; 0%)",Low,Preprint,https://www.medrxiv.org/content/10.1101/2020.11.17.20228155v2.full-text,2/12/2021,3/1/2021
210114_Puducherry_JawaharlalInstitute_August_primary,1/14/2021,Sitanshu Sekhar Kar,Regional,India,"Puducherry; India
(Jawaharlal Institute)",08/11 - 08/16,,Multiple groups,869,4.9% (3.5-6.4%),Stratified probability,"Roche; NR
(99.5%; 99.8%)",Low,Journal Article (Peer-Reviewed),https://dx.doi.org/10.3201/2702.204480,2/16/2021,3/17/2021
210114_Puducherry_JawaharlalInstitute_Sep_primary,1/14/2021,Sitanshu Sekhar Kar,Regional,India,"Puducherry; India
(Jawaharlal Institute)",09/10 - 09/16,,Multiple groups,898,20.7% (18-23.3%),Stratified probability,"Roche; NR
(99.5%; 99.8%)",Low,Journal Article (Peer-Reviewed),https://dx.doi.org/10.3201/2702.204480,2/16/2021,3/17/2021
210114_Puducherry_JawaharlalInstitute_Oct_primary,1/14/2021,Sitanshu Sekhar Kar,Regional,India,"Puducherry; India
(Jawaharlal Institute)",10/12 - 10/16,,Multiple groups,900,34.5% (31.5-37.7%),Stratified probability,"Roche; NR
(99.5%; 99.8%)",Low,Journal Article (Peer-Reviewed),https://dx.doi.org/10.3201/2702.204480,2/16/2021,3/17/2021
210120_Chennai_NationalInstituteOfEpidemiology_primary_adj,1/20/2021,Sriram Selvaraju,Local,India,"Chennai; India
(National Institute of Epidemiology)",07/01 - 07/31,Household and community samples,Multiple groups,12405,18.4% (14.8-22.6%),Stratified probability,"Abbott; NR
(100%; 99.6%)",Low,Journal Article (Peer-Reviewed),https://dx.doi.org/10.3201/eid2702.203938,2/21/2021,3/1/2021
210205_Mumbai_HindujaHospital_HCW,2/5/2021,Nishant Kumar,Local,India,"Mumbai; Maharashtra; India
(Hinduja Hospital)",06/01 - 06/30,Health care workers and caregivers,Adults (18-64 years),801,11.1% (9.1-13.5%),Convenience,"Roche Diagnostics; NR
(100%; 99.8%)",Moderate,Journal Article (Peer-Reviewed),http://dx.doi.org/10.1016/j.vaccine.2020.10.094,2/21/2021,3/19/2021
201113_Mumbai_TataInstituteforFundamentalResearch_slums_testpopadj,11/13/2020,Anup Malani,Local,India,"Mumbai; India
(Tata Institute for Fundamental Research)",06/29 - 07/19,Persons living in slums,Multiple groups,4202,58.3% (56.8-59.9%),Stratified probability,"Abbott Laboratories; NR
(90%; 99%)",Low,Journal Article (Peer-Reviewed),http://dx.doi.org/10.1016/S2214-109X%2820%2930467-8,2/22/2021,3/8/2021
201113_Mumbai_TataInstituteforFundamentalResearch_nonslums_adj,11/13/2020,Anup Malani,Local,India,"Mumbai; India
(Tata Institute for Fundamental Research)",06/29 - 07/19,Household and community samples,Multiple groups,2702,17.1% (15.8-18.4%),Stratified probability,"Abbott Laboratories; NR
(90%; 99%)",Low,Journal Article (Peer-Reviewed),http://dx.doi.org/10.1016/S2214-109X%2820%2930467-8,2/22/2021,3/8/2021
210131_Thissur_JubileeMissionHospital_primary,1/31/2021,Aboobacker Mohamed Rafi,Sublocal,India,"Thrissur; Kerala; India
(Jubilee Mission Hospital)",09/05 - 12/15,Health care workers and caregivers,Adults (18-64 years),423,8.8% (6.2-11.9%),Convenience,"Vitros; NR
(90%; 100%)",High,Preprint,10.1101/2021.01.27.21250502,2/28/2021,3/16/2021
210201_Chennai_KanchiKamakotiCHILDSTrustHospital_overall_IgG,2/1/2021,Aishwarya Venkataraman,Sublocal,India,"Chennai; India
(Kanchi Kamakoti CHILDS Trust Hospital)",06/01 - 09/30,Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),463,19.6% (15.4-22.5%),Convenience,"YHLO Biotechnology Corporation; NR
(0%; 0%)",High,Preprint,10.1101/2021.01.29.21250660,3/3/2021,3/3/2021
201031_Bhubaneswar_RegionalMedicalResearchCentre_overall,10/31/2020,Riyan Ramanath,Local,India,"Bhubaneswar; India
(The Regional Medical Research Centre in Bhubaneswar)",10/16 - 10/18,Household and community samples,Not reported,1403,50% (NR),Simplified probability,"NR; NR
(0%; 0%)",Unclear,News and Media,https://timesofindia.indiatimes.com/city/bhubaneswar/survey-50-of-bhubaneswar-residents-have-antibodies/articleshow/78966615.cms,3/7/2021,3/7/2021
200915_Delhi_NationalCentreForDiseaseControl_overall,"9/15/2020, 8/19/2020","Hindustan Times, Aneesha Bedi",Local,India,"Delhi; India
(National Centre for Disease Control)",08/01 - 08/07,Household and community samples,Not reported,15000,29.1% (NR),Unclear,"NR; NR
(0%; 0%)",Unclear,"News and Media, News and Media","https://www.hindustantimes.com/delhi-news/sero-survey-2-0-30-of-covid-positive-patients-in-august-did-not-have-antibodies/story-6TFKUpeUEoyhsRSamTKktL.html, https://theprint.in/health/28-3-of-delhis-population-now-exposed-to-covid-shows-second-sero-survey-up-from-23-4/484455/",3/8/2021,3/9/2021
201027_DistrictSrinagar_GovernmentMedicalCollege_Overall,10/27/2020,Muhammad Salim Khan,Local,India,"Kashmir; India
(Government Medical College)",06/15 - 06/29,Health care workers and caregivers,Adults (18-64 years),2905,2.5% (2-3.1%),Convenience,"Abbott Laboratories; NR
(100%; 0%)",High,Preprint,https://www.medrxiv.org/content/10.1101/2020.10.23.20218164v1.full-text,3/16/2021,3/19/2021
210127_India_ICRM_overall_adj,1/27/2021,Manoj V Murhekar,National,India,"India
(The Indian Council of Medical Research (ICMR))",08/18 - 09/20,Household and community samples,Multiple groups,29082,6.6% (5.8-7.4%),Stratified probability,"Abbott; NR
(100%; 99.6%)",Low,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1016/S2214-109X(20)30544-1,3/17/2021,3/17/2021
210205_India_ICRM_overall,2/5/2021,BBC News,National,India,"India
(The Indian Council of Medical Research (ICMR))",12/17 - 01/08,Household and community samples,Multiple groups,28589,21.5% (NR),Stratified probability,"NR; NR
(0%; 0%)",Unclear,News and Media,https://www.bbc.com/news/world-asia-india-55945382,3/17/2021,3/17/2021
210208_TamilNadu_GovernmentofTamilNadu_Overall,2/8/2021,Anup Malani,Regional,India,"Tamil Nadu; India
(Government of Tamil Nadu)",10/19 - 11/30,Household and community samples,Multiple groups,26135,31.6% (20.4-32.8%),Stratified probability,"Shenzhen YHLO Biotech; Ortho-Clinical Diagnostics; NR
(90%; 100%)",Low,Preprint,https://www.medrxiv.org/content/10.1101/2021.02.03.21250949v1,3/18/2021,3/18/2021
200426_Guilan_GuilanUniversity_GenPop_PopTestAdj,5/1/2020,Maryam Shakiba,Regional,Iran (Islamic Republic of),"Guilan; Iran (Islamic Republic of)
(Guilan University)",04/01 - 04/30,Household and community samples,Multiple groups,528,33% (28-39%),Stratified probability,"VivaChek; IgM, IgG; RDT
(63.3%; 100%)",Moderate,Preprint,https://www.medrxiv.org/content/10.1101/2020.04.26.20079244v1,8/1/2020,3/1/2021
200915_Tehran_IranUniversityOfMedicalSciences_Patients_Overall,9/1/2020,Shahrzad Ossareh,Sublocal,Iran (Islamic Republic of),"Tehran; Tehran; Iran (Islamic Republic of)
(Iran University of Medical Sciences)",02/20 - 03/20,Multiple populations,Multiple groups,178,18% (NR),Convenience,"Pishtaz Diagnostics Iran; IgG, IgM; ELISA
(0%; 0%)",High,Journal Article (Peer-Reviewed),http://www.ijkd.org/index.php/ijkd/article/view/5832/1205,10/30/2020,3/17/2021
201221_Guilan_TehranUniversityofMedicalSciences_overall,12/21/2020,Maryam Shakiba,Regional,Iran (Islamic Republic of),"Guilan; Iran (Islamic Republic of)
(Tehran University of Medical Sciences)",04/11 - 04/19,Household and community samples,Multiple groups,528,22.2% (16.4-28.5%),Stratified probability,"VivaChek; NR
(83.3%; 99%)",Low,Journal Article (Peer-Reviewed),https://dx.doi.org/10.3201/eid2702.201960,1/23/2021,3/5/2021
201110_Tehran_TehranUniversityofMedicalSciences_unadj,11/10/2020,Peyman Saberian,Sublocal,Iran (Islamic Republic of),"Tehran; Tehran Province; Iran (Islamic Republic of)
(Tehran University of Medical Sciences)",03/20 - 05/20,Essential non-healthcare workers,Adults (18-64 years),243,41.6% (NR),Convenience,"KarmaAzmaAndish Co.; NR
(71.1%; 58.7%)",High,Journal Article (Peer-Reviewed),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7720855/,1/23/2021,3/1/2021
201206_Tehran_HighInstituteforResearchandEducationinTransfusionMedicine,12/6/2020,Shahnaz Armin,Sublocal,Iran (Islamic Republic of),"Tehran; Tehran; Iran (Islamic Republic of)
(High Institute for Research and Education in Transfusion Medicine)",04/20 - 05/05,Health care workers and caregivers,Adults (18-64 years),475,29.4% (NR),Convenience,"Hangzhou AllTest Biotech Co.; NR
(99.9%; 98%)",High,Journal Article (Peer-Reviewed),https://sites.kowsarpub.com/jjm/articles/108592.html,1/27/2021,3/4/2021
201223_RafsanjanCounty_UniversityofPecs,12/23/2020,Reza Vazirinejad,Local,Iran (Islamic Republic of),"Kerman Province; Iran (Islamic Republic of)
(University of Pecs)",03/01 - 04/30,Contacts of COVID patients,Multiple groups,257,15.3% (10.9-19.7%),Sequential,"NR; NR
(0%; 0%)",High,Preprint,https://europepmc.org/article/ppr/ppr257302#fulltext--permissions-,2/2/2021,3/5/2021
201215_Iran_TehranUniversityofMedicalSciences_GenPop1_overall_PopTestAdj,12/15/2020,Hossein Poustchi,National,Iran (Islamic Republic of),"Ahvaz, Ardabil, Babol , Esfahan , Gorgan, Hamedan, Kerman, Kermanshah, Mashhad, Qom, Rasht, Sanandaj, Sari, Shiraz, Tabriz, Tehran, Urmia, Zahedan; Iran (Islamic Republic of)
(Tehran University of Medical Sciences)",04/17 - 06/02,Household and community samples,Multiple groups,3530,17.1% (14.6-19.5%),Stratified probability,"Pishtaz Teb; NR
(66.9%; 98.2%)",Low,Journal Article (Peer-Reviewed),http://dx.doi.org/10.1016/S1473-3099%2820%2930858-6,2/6/2021,3/6/2021
210120_Tehran_TehranUniversityofMedicalSciences_InPatients,1/20/2021,Zeinab Tabanejad,Sublocal,Iran (Islamic Republic of),"Tehran; Iran (Islamic Republic of)
(Tehran University of Medical Sciences)",04/15 - 10/31,Patients seeking care for non-COVID-19 reasons,Multiple groups,1375,21.2% (NR),Convenience,"IDEAL TASHKHIS Co; NR
(82%; 0%)",High,Preprint,https://www.medrxiv.org/content/10.1101/2021.01.18.20248911v1.full-text,2/6/2021,3/1/2021
201215_Iran_TehranUniversityofMedicalSciences_HighRisk2_overall_PopTestAdj ,12/15/2020,Hossein Poustchi,National,Iran (Islamic Republic of),"Ahvaz, Ardabil, Babol , Esfahan , Gorgan, Hamedan, Kerman, Kermanshah, Mashhad, Qom, Rasht, Sanandaj, Sari, Shiraz, Tabriz, Tehran, Urmia, Zahedan; Iran (Islamic Republic of)
(Tehran University of Medical Sciences)",04/17 - 06/02,Multiple populations,Multiple groups,5372,20% (18.5-21.7%),Stratified probability,"Pishtaz Teb; NR
(66.9%; 98.2%)",Moderate,Journal Article (Peer-Reviewed),http://dx.doi.org/10.1016/S1473-3099%2820%2930858-6,2/6/2021,3/6/2021
210201_Guilan_TehranUniversityofMedicalSciences_overall_adj,2/1/2021,Maryam Shakiba,Regional,Iran (Islamic Republic of),"Guilan; Iran (Islamic Republic of)
(Tehran University of Medical Sciences)",04/11 - 04/19,Household and community samples,Multiple groups,528,22.2% (16.4-28.5%),Stratified probability,"VivaChek; NR
(83.3%; 99%)",Moderate,Journal Article (Peer-Reviewed),http://dx.doi.org/10.3201/eid2702.201960,2/21/2021,3/15/2021
2101_Zahedan_TehranUniversityofMedicalSciences,1/1/2021,Zahra Mohammadi,Local,Iran (Islamic Republic of),"Zahedan; Sistan and Balouchestan; Iran (Islamic Republic of)
(Tehran University of Medical Sciences)",07/01 - 07/31,,Adults (18-64 years),167,9.7% (NR),Convenience,"Pishtaz Teb, Tehran, Iran; NR
(0%; 0%)",High,Journal Article (Peer-Reviewed),http://dx.doi.org/10.34172/mejdd.2021.206,3/14/2021,3/15/2021
2101_Zahedan_TehranUniversityofMedicalSciences_NonDrugUsers,1/1/2021,Zahra Mohammadi,Local,Iran (Islamic Republic of),"Zahedan; Sistan and Balouchestan; Iran (Islamic Republic of)
(Tehran University of Medical Sciences)",07/01 - 07/31,Household and community samples,Adults (18-64 years),134,4.8% (NR),Simplified probability,"Pishtaz Teb Tehran, Iran; NR
(0%; 0%)",High,Journal Article (Peer-Reviewed),http://dx.doi.org/10.34172/mejdd.2021.206,3/14/2021,3/15/2021
210105_Mazandaran_MazandaranUniversityofMedicalSciences_OverallPopAdj,1/5/2021,Seyed Abbas Mousavi,Regional,Iran (Islamic Republic of),"Mazandaran; Iran (Islamic Republic of)
(Mazandaran University of Medical Sciences)",03/15 - 05/15,Household and community samples,Multiple groups,1588,17.3% (14.8-17.8%),Stratified probability,"Danesh Bonyan Pishtaz Teb Company; NR
(59%; 100%)",Moderate,Journal Article (Peer-Reviewed),https://www.apjtm.org/article.asp?issn=1995-7645;year=2021;volume=14;issue=1;spage=10;epage=16;aulast=Mousavi,3/17/2021,3/17/2021
201223_ Rafsanjan_RafsanjanUniversityOfMedicalSciences_overall,12/23/2020,Reza Vazirinejad,Local,Iran (Islamic Republic of),"Kerman; Iran (Islamic Republic of)
(Rafsanjan University of Medical Sciences)",03/01 - 04/30,Contacts of COVID patients,Multiple groups,257,15.3% (10.9-19.7%),Entire sample,"NR; NR
(0%; 0%)",Unclear,Preprint,10.21203/rs.3.rs-121829/v1,3/19/2021,3/19/2021
200817_Ireland_HPSC_genpop_popadj,8/17/2020,Derval Igoe ,National,Ireland,"Dublin, Sligo; Connaught, Leinster; Ireland
(HSE Health Protection Surveillance Centre (HPSC) )",06/22 - 07/16,Household and community samples,Adults (18-64 years),1733,1.7% (1.1-2.4%),Stratified probability,"Abbott; IgG; Chemiluminescence Immunoassay
(93%; 100%)",Moderate,Institutional Report,https://www.hpsc.ie/a-z/respiratory/coronavirus/novelcoronavirus/scopi/SCOPI%20report%20preliminary%20results%20final%20version.pdf,10/18/2020,3/17/2021
200601_Israel_PandemicTaskForce_GenPop,"6/2/2020, 6/2/2020","Ido Efrati, Michael Bachner",National,Israel,"Israel; Israel
(Israeli Pandemic Task Force)",NR - 06/02,Household and community samples,Multiple groups,1700,2.5% (NR),Stratified probability,"Not reported; IgG; Not reported
(0%; 0%)",High,"News and Media, News and Media","https://www.google.com/url?rct=j&sa=t&url=https://www.haaretz.com/israel-news/.premium-up-to-270-000-israelis-had-coronavirus-new-study-concludes-1.8888435&ct=ga&cd=CAAYETIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNExqw1wlJNVBFrKKUd7hGTplMnR5A, https://www.google.com/url?rct=j&sa=t&url=https://www.timesofisrael.com/initial-antibody-tests-indicate-200000-israelis-have-had-covid-19-report/&ct=ga&cd=CAAYBjIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNHYeXqD2hIEiNnZoH5qLiVlZKxQjg",6/3/2020,3/1/2021
200508_Bari_IstitutoTumoriGPaolo_HCW_IgG,5/8/2020,Angelo Virgilio Paradiso,Sublocal,Italy,"Bari; Puglia; Italy
(Istituto Tumori G. Paolo II)",03/26 - 04/17,Health care workers and caregivers,Adults (18-64 years),606,0.3% (NR),Convenience,"Snibe Diagnostic; IgG; Chemiluminescence Immunoassay
(0%; 0%)",High,Preprint,https://www.medrxiv.org/content/10.1101/2020.05.05.20086017v1,5/14/2020,3/1/2021
210203_Milan_FondazioneIRCCSCa'GrandaOspedaleMaggiore_GenPop_UnAdj,2/3/2021,,Local,Italy,"Milan; Lombardy; Italy
( Fondazione IRCCS Ca' Granda Ospedale Maggiore )",02/24 - 04/08,Blood donors,Adults (18-64 years),789,5.1% (NR),Convenience,"Prima Lab; IgG, IgM; LFIA: Lateral flow immunoassay
(0%; 0%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.2450/2021.0324-20,5/21/2020,3/15/2021
200526_Lombardy_HumanitasClinicalandResearchCenter_HealthCareWorkers,5/26/2020,Maria Sandri,Regional,Italy,"Milan, Varese, Castellanza; Lombardy; Italy
(Humanitas Clinical and Research Center)",04/28 - 05/16,Health care workers and caregivers,Multiple groups,3985,13.1% (NR),Self-referral,"DiaSorin; IgG; Chemiluminescence Immunoassay
(100%; 100%)",Moderate,Preprint,https://www.medrxiv.org/content/10.1101/2020.05.24.20111245v1,5/28/2020,3/1/2021
200430_Bergamo_ATSBergamo_GeneralPopulation_AnalyzedLab1,4/30/2020,Armando Di Landro,Local,Italy,"Alzano, Nembro; Lombardy; Italy
(ATS Bergamo)",04/23 - 04/28,Household and community samples,Not reported,750,61% (NR),Unclear,"Not reported; Not reported; Not reported
(0%; 0%)",Unclear,News and Media,https://bergamo.corriere.it/notizie/cronaca/20_aprile_30/coronavirus-bergamo-primi-risultati-test-61percento-positivi-85e8e36c-8a6b-11ea-94d3-9879860c12b6.shtml?refresh_ce-cp,6/2/2020,3/1/2021
200430_Bergamo_HospitalofBergamo_HCW,4/30/2020,Armando Di Landro,Sublocal,Italy,"Bergamo; Lombardy; Italy
(Hospital of Bergamo)",NR - 04/24,Health care workers and caregivers,Adults (18-64 years),3000,13% (NR),Unclear,"Not reported; Not reported; Not reported
(0%; 0%)",Unclear,News and Media,https://bergamo.corriere.it/notizie/cronaca/20_aprile_30/coronavirus-bergamo-primi-risultati-test-61percento-positivi-85e8e36c-8a6b-11ea-94d3-9879860c12b6.shtml?refresh_ce-cp,6/2/2020,3/1/2021
200609_Milan_UniMilan_OverallAb,6/9/2020,Gregorio Milani,Local,Italy,"Milan; Lombardy; Italy
(University of Milan)",03/30 - 03/31,Household and community samples,Adults (18-64 years),197,10% (NR),Self-referral,"Beijing Wantai Biological Pharmacy Enterprise , EUROIMMUN; IgG, IgM, IgA; ELISA
(0%; 0%)",High,Journal Article (Peer-Reviewed),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7280100/pdf/main.pdf,6/23/2020,3/1/2021
200618_Italy_IRCCSPoliclinicoSanMatteo_BloodDonors,6/18/2020,Elena Percivalle,Local,Italy,"Lodi; Lombardy; Italy
(IRCCS Policlinico San Matteo)",03/18 - 04/06,Blood donors,Multiple groups,390,23% (NR),Sequential,"Author-designed; Not reported; Neutralization assay
(95%; 100%)",High,Journal Article (Peer-Reviewed),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7315724/,6/26/2020,3/1/2021
200609_Bergamo_HealthAgency_GenPop,6/9/2020,Angelo Amante,Regional,Italy,"Lombardy; Italy
(Bergamo Health Agency)",04/23 - 06/03,Household and community samples,Not reported,9965,57% (NR),Simplified probability,"Not reported; Not reported; Not reported
(0%; 0%)",Moderate,News and Media,https://www.google.com/url?rct=j&sa=t&url=https://www.thejakartapost.com/news/2020/06/09/over-half-of-people-tested-in-italys-bergamo-have-covid-19-antibodies.html&ct=ga&cd=CAAYAjIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNEF-NEDdVnSHZTUUTQEQL5px8dXmw,7/6/2020,3/1/2021
200617_Italy_D.CotugnoHospital_HCW_IgG,6/17/2020,Francesco Fusco,Sublocal,Italy,"Naples; Campania; Italy
(D. Cotugno’ Hospital)",03/23 - 04/02,Health care workers and caregivers,Adults (18-64 years),115,1.7% (NR),Convenience,"Snibe Diagnostic; IgG; Chemiluminescence Immunoassay
(0%; 0%)",High,Journal Article (Peer-Reviewed),https://www.journalofhospitalinfection.com/article/S0195-6701(20)30306-6/fulltext,7/18/2020,3/1/2021
200619_Rome_UniversityofRome_IgG,6/19/2020,Edith Lahner,Sublocal,Italy,"Rome; Lazio; Italy
(University of Rome)",04/07 - 04/27,Health care workers and caregivers,Adults (18-64 years),1084,0.7% (NR),Convenience,"Medical Systems; IgG; Chemiluminescence Immunoassay
(50%; 99.1%)",High,Journal Article (Peer-Reviewed),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7345358/,7/22/2020,3/1/2021
200704_Milan_SantagostinoMedicalCenter_HCWs+Family,7/4/2020,Dioscoridi Lorenzo,Local,Italy,"Milan; Lombardy; Italy
(Santagostino Medical Center)",05/02 - 05/31,Family of essential workers,Multiple groups,119,42.6% (NR),Convenience,"Prima Lab; IgM, IgG; Serological rapid test
(0%; 0%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1016/j.ijid.2020.06.106,7/30/2020,3/17/2021
200707_Turin_University of Turin_PregnantWomen_IgGonly,7/7/2020,Stefano Cosma,Local,Italy,"Turin; Piedmont; Italy
(University of Turin)",04/16 - 06/04,Pregnant or parturient women,Adults (18-64 years),138,5.8% (NR),Sequential,"Boditech; IgG; LFIA: Lateral flow immunoassay
(0%; 0%)",High,Journal Article (Peer-Reviewed),https://onlinelibrary.wiley.com/doi/epdf/10.1002/jmv.26267,8/1/2020,3/1/2021
200808_Italy_UniversityofTurin_CLLPatients_Overall,8/8/2020,Marco Denina ,Local,Italy,"Turin, Novara, Alessandria, Verbania; Piedmont; Italy
(University of Turin)",03/08 - 04/30,Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),24,12.5% (NR),Convenience,"DiaSorin, In3diagnostic, Medical Systems; IgG; Chemiluminescence Immunoassay, ELISA
(0%; 0%)",High,Journal Article (Peer-Reviewed),http://dx.doi.org/10.1016/j.jaad.2020.08.021,9/25/2020,3/1/2021
200813_Foggia_UniversityofFoggia_OverallIgG/IgM,8/13/2020,Josè Ramòn Fiore,Local,Italy,"Foggia;  Apulia; Italy
(University of Foggia)",05/01 - 05/31,Blood donors,Adults (18-64 years),904,1% (NR),Convenience,"""New Industries Biomedical Engineering Co., Ltd""; IgG, IgM; Chemiluminescence Immunoassay
(0%; 0%)",High,Journal Article (Peer-Reviewed),https://onlinelibrary.wiley.com/doi/full/10.1002/jmv.26425,9/27/2020,3/1/2021
200804_Tuscany_ArezzoHospital_HealthcareWorkers_Overall,8/4/2020,Francesca Carozzi,Regional,Italy,"Tuscany; Italy
(Arezzo Hospital)",04/01 - 04/30,Health care workers and caregivers,Adults (18-64 years),17098,3.4% (NR),Convenience,"Screen Italia S.R.L, ""Zhejiang Orient Gene Biotech Co., LTD""; IgG, IgM; LFIA: Lateral flow immunoassay
(97%; 88%)",High,Preprint,https://www.medrxiv.org/content/10.1101/2020.07.30.20149567v1,9/27/2020,3/1/2021
200721_Arezzo_OspedaleSanDonato_Total,7/21/2020,Alessandro Pancrazzi,Local,Italy,"Arezzo; Tuscany; Italy
(Ospedale San Donato)",03/17 - 03/21,Residual sera,Adults (18-64 years),516,13% (NR),Sequential,"Acro Biotech Inc.; IgG, IgM; Rapid immunochromatographic test
(37%; 94%)",High,Journal Article (Peer-Reviewed),http://dx.doi.org/10.1016/j.clinbiochem.2020.07.002,9/28/2020,3/17/2021
200728_Prato_SantoStefanoHospital_Overall,7/28/2020,Anna Cavaliere,Local,Italy,"Prato; Tuscany; Italy
(Santo Stefano Hospital)",04/04 - 05/16,Pregnant or parturient women,Adults (18-64 years),134,4.5% (NR),Sequential,"Acro Biotech Inc.; IgG, IgM; Rapid point-of care
(0%; 0%)",High,Journal Article (Peer-Reviewed),http://dx.doi.org/10.1080/14767058.2020.1793317,9/29/2020,3/1/2021
200729_Milan_UniversitadegliStudidiMilano_Overall_IgG,7/29/2020,Giovanni Sotgiu,Local,Italy,"Milan; Lombardy; Italy
(Università degli Studi di Milano )",04/02 - 04/16,Health care workers and caregivers,Adults (18-64 years),202,7.4% (3.8-11%),Convenience,"BioMedomics; IgG; LFIA: Lateral flow immunoassay
(88.7%; 90.6%)",High,Journal Article (Peer-Reviewed),https://bmcpulmmed.biomedcentral.com/articles/10.1186/s12890-020-01237-0,9/29/2020,3/1/2021
200724_Veneto_UniversityHospitalOfPadova_HealthCareWorkers_UnAdj,7/24/2020,Mario Plebani,Regional,Italy,"Veneto; Italy
(University of Padova)",Not reported,Health care workers and caregivers,Adults (18-64 years),8285,4.6% (4.1-5%),Unclear,"SNIBE – Shenzhen New Industries Biomedical Engineering Co.; IgG, IgM; Chemiluminescence Immunoassay
(73%; 98%)",High,Preprint,https://www.medrxiv.org/content/10.1101/2020.07.23.20160457v1,10/1/2020,3/1/2021
200803_Italy_ItalianMinistryOfHealth_Overall,8/3/2020,Italian Ministry of Health,National,Italy,"Abruzzo, Basilicata, Calabria, Campania, Emilia Romagna, FRIULI VENEZIA GIULIA, Lazio, Liguria, Lombardy, Marche, Molise, Piemonte, PROV. AUTON. BOLZANO, Puglia, Sardegna, Sicily, Tuscany, Umbria, Valle D'Aosta, Veneto; Italy
(Italian Ministry of Health)",05/25 - 07/15,Household and community samples,Multiple groups,64660,2.5% (NR),Stratified non-probability,"Abbott; IgG; Chemiluminescence Immunoassay
(0%; 0%)",Unclear,News and Media,http://www.salute.gov.it/portale/nuovocoronavirus/dettaglioNotizieNuovoCoronavirus.jsp?lingua=italiano&menu=notizie&p=dalministero&id=4998,10/4/2020,3/1/2021
200907_Bari_PoliclinicoHospital_Overall,9/7/2020,Daniela Loconsole,Local,Italy,"Bari;  Apulia; Italy
(Policlinico Hospital)",03/23 - 04/21,Residual sera,Multiple groups,819,8.6% (NR),Sequential,"VivaCheck Biotech; IgG, IgM; Colloidal gold
(35.1%; 97.3%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.3390/ijerph17186493,10/14/2020,3/17/2021
200823_Bergamo_HospitalPapaGiovanniXXIII_Overall,8/26/2020,Lorenzo Norsa,Sublocal,Italy,"Bergamo; Lombardy; Italy
(Papa Giovani XXII)",03/04 - 07/10,Patients seeking care for non-COVID-19 reasons,Multiple groups,90,21.1% (NR),Convenience,"VivaChek; IgG, IgM; LFIA: Lateral flow immunoassay
(0%; 0%)",High,Journal Article (Peer-Reviewed),http://dx.doi.org/10.1053/j.gastro.2020.08.046,10/15/2020,3/17/2021
200827_LiguriaLombardia_UniversityofGenoa_Overall,8/27/2020,Antonio Vena,Regional,Italy,"Lombardy, Liguria; Italy
(University of Genoa)",03/01 - 04/30,Residual sera,Adults (18-64 years),3609,11% (10-12.1%),Convenience,"Maglumi, Realy-Tech, Biosynex; IgG, IgM; Chemiluminescence Immunoassay, Rapid immunochromatographic test, LFIA: Lateral flow immunoassay
(0%; 0%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.3390/jcm9092780,10/15/2020,3/17/2021
200818_Brescia_UniversityofBrescia_Overall,8/18/2020,Alberto Dalla Volta,Sublocal,Italy,"Brescia; Lombardy; Italy
(University of Brescia)",04/27 - 04/27,Health care workers and caregivers,Adults (18-64 years),76,11.8% (NR),Convenience,"DiaSorin; IgG; Not reported
(0%; 0%)",High,Journal Article (Peer-Reviewed),http://dx.doi.org/10.3389/fonc.2020.01574,10/15/2020,3/1/2021
200828_CastiglioneD'Adda_UniversitadegliStudidiMilano_overall,8/28/2020, Gabriele Pagani,Local,Italy,"Castiglione D’Adda; Lombardy; Italy
(Università degli Studi di Milano)",05/18 - 06/07,Household and community samples,Multiple groups,509,22.6% (17.2-29.1%),Stratified probability,"Abbott; IgG; Chemiluminescence Immunoassay
(0%; 0%)",Moderate,Preprint,https://www.medrxiv.org/content/10.1101/2020.06.24.20138875v1.full.pdf,10/24/2020,3/1/2021
200806_Milan_UniversityofMilan_Overall,8/6/2020,Antonella Amendola,Sublocal,Italy,"Milan; Lombardy; Italy
(University of Milan)",04/15 - 04/15,Health care workers and caregivers,Adults (18-64 years),663,5.1% (NR),Convenience,"EUROIMMUN; IgG; ELISA
(0%; 0%)",High,Journal Article (Peer-Reviewed),http://dx.doi.org/10.1017/ice.2020.401,10/25/2020,3/1/2021
200919_Castiglioned'Adda_UniversityofMilan_Overall,9/19/2020,Gabriele Pagani,Local,Italy,"Castiglione D’Adda; Lombardy; Italy
(University of Milan)",05/18 - 06/07,Household and community samples,Multiple groups,509,22.6% (17.2-29.1%),Stratified probability,"Abbott; IgG; Chemiluminescence Immunoassay
(0%; 0%)",Moderate,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1016/j.jinf.2020.09.021,11/9/2020,3/1/2021
201006_Turin_UniversityofTorino_TotalHCWs,10/6/2020,Andrea Calcagno,Local,Italy,"Torino (Turin); Piemonte; Italy
(University of Torino)",04/17 - 05/20,Health care workers and caregivers,Adults (18-64 years),5444,6.9% (NR),Convenience,"DiaSorin; NR
(97.9%; 98.5%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.3201/eid2701.203027,12/10/2020,3/1/2021
200915_Naples_AziendaOspedalieradiRilievoNazionaleSantobonoPausilipon_Patients&Caregivers,9/15/2020,Pio Stellato,Sublocal,Italy,"Naples; Campania; Italy
(Azienda Ospedaliera di Rilievo Nazionale Santobono Pausilipon)",04/03 - 05/29,Multiple populations,Not reported,1397,0.4% (NR),Convenience,"VivaDiag, N/A, N/A; NR
(0%; 0%)",High,Journal Article (Peer-Reviewed),http://dx.doi.org/10.1136/bmjpo-2020-000818,12/15/2020,3/17/2021
200915_Naples_AziendaOspedalieradiRilievoNazionaleSantobonoPausilipon_HCW,9/15/2020,Pio Stellato,Sublocal,Italy,"Naples; Campania; Italy
(Azienda Ospedaliera di Rilievo Nazionale Santobono Pausilipon)",04/03 - 05/29,Health care workers and caregivers,Adults (18-64 years),249,2% (NR),Convenience,"VivaDiag, N/A, N/A; NR
(0%; 0%)",High,Journal Article (Peer-Reviewed),http://dx.doi.org/10.1136/bmjpo-2020-000818,12/15/2020,3/1/2021
200901_Bergamo_ASSTPapaGiovanniXXIII,9/1/2020,Alberto Zambelli,Sublocal,Italy,"Bergamo; Lombardy; Italy
(ASST Papa Giovanni XXIII)",04/01 - 04/30,Patients seeking care for non-COVID-19 reasons,Not reported,560,31% (NR),Sequential,"NADAL (Moers, Germany); NR
(0%; 0%)",High,Journal Article (Peer-Reviewed),http://dx.doi.org/10.1016/j.annonc.2020.08.1741,1/9/2021,3/1/2021
201103_Cagliari_UniversityofCagliari_SurgicalPatients_IGGorIGM,11/3/2020,Fabio Medas,Sublocal,Italy,"Cagliari; Sardinia; Italy
( University of Cagliari)",03/31 - 06/30,Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),86,5.8% (NR),Convenience,"Snibe; NR
(0%; 0%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1016/j.amsu.2020.11.006,1/9/2021,3/1/2021
201027_Perugia_UniversityofPerugia_HIVPositive1_PLWHIgG,10/27/2020,Chiara Papalini,Sublocal,Italy,"Perugia; Umbria; Italy
(University of Perugia)",05/04 - 05/31,Patients seeking care for non-COVID-19 reasons,Multiple groups,270,2.7% (NR),Sequential,"Screen Italia; NR
(0%; 0%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.4084/MJHID.2020.080,1/10/2021,3/17/2021
201031_Milan_SanRaffaeleScientificInstitute_HCW_IgG,10/31/2020,Diana Canetti,Sublocal,Italy,"Milan; Lombardy; Italy
(San Raffaele Scientific Institute)",03/15 - 04/15,Health care workers and caregivers,Adults (18-64 years),40,5% (NR),Convenience,"Prima lab SA; NR
(0%; 0%)",High,Journal Article (Peer-Reviewed),https://pubmed.ncbi.nlm.nih.gov/33135083/,1/12/2021,3/1/2021
201021_Italy_IRCCS_Overall_IgG_unadj,10/21/2020,Antonio Marra,Regional,Italy,"Lombardy; Italy
(Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS))",03/30 - 05/11,Multiple populations,Multiple groups,166,42% (NR),Convenience,"PRIMA Lab SA; NR
(0%; 0%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1016/j.annonc.2020.10.473,1/16/2021,3/15/2021
201008_Udine_UniversityofUdine_SCTrecipients,10/8/2020,Alessandra Sperotto,Sublocal,Italy,"Udine; Udine; Italy
(The University of Udine)",04/01 - 05/30,Patients seeking care for non-COVID-19 reasons,Multiple groups,70,1.4% (NR),Sequential,"Cellex; NR
(93.75%; 96.4%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1002/jmv.26586,1/18/2021,3/1/2021
201111_Italy_IstitutoNazionaleTumori_primaryest,11/11/2020,Giovanni Apolone,National,Italy,"Italy
(Istituto Nazionale Tumori )",09/01 - 03/10,Patients seeking care for non-COVID-19 reasons,Multiple groups,959,11.6% (NR),Sequential,"Mazzini et al; NR
(0%; 0%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1177/0300891620974755,1/21/2021,3/1/2021
200806_Lombardy_BrunoKesslerFoundation,8/6/2020,Piero Poletti,Regional,Italy,"Lombardy; Italy
(Bruno Kessler Foundation)",04/16 - 05/25,Contacts of COVID patients,Multiple groups,4120,53.1% (NR),Stratified non-probability,"LIAISON®; NR
(94.4%; 98.3%)",Moderate,Journal Article (Peer-Reviewed),http://dx.doi.org/10.2807/1560-7917.ES.2020.25.31.2001383,1/21/2021,3/1/2021
201031_VillaCaldari_IstitutoZooprofilatticoSperimentaleDell’AbruzzoEdelMoliseG.Caporale_Overall,10/31/2020,Francesa Cito,Local,Italy,"Villa Caldari; Abruzzo; Italy
(Istituto Zooprofilattico Sperimentale dell’Abruzzo e del Molise G. Caporale )",04/18 - 04/19,Household and community samples,Multiple groups,687,10.9% (8.8-13.5%),Entire sample,"Beijing Wantai Biological Pharmacy Enterprise Co., Beijing, China; NR
(93%; 100%)",Moderate,Journal Article (Peer-Reviewed),https://dx.doi.org/10.3390/microorganisms8111711,1/22/2021,3/1/2021
201022_Bergamo_IstitutodiRicercheFarmacologicheMarioNegri_unadj,10/22/2020,Luca Perico,Sublocal,Italy,"Bergamo; Italy
(Istituto di Ricerche Farmacologiche Mario Negri)",starting 05/11,Non-essential workers and unemployed persons,Adults (18-64 years),423,38.5% (NR),Convenience,"DIA.PRO, Sesto San Giovanni, Milan Italy; Prima LAB SA Balerna, Switzerland; NR
(0%; 0%)",High,Journal Article (Peer-Reviewed),http://dx.doi.org/10.1016/j.ebiom.2020.103069,1/22/2021,3/17/2021
201222_Rome_EleemosynariaApostolica_overall,12/22/2020,Massimo Ralli,Local,Italy,"Rome; Lazio region; Italy
(Eleemosynaria Apostolica)",04/14 - 07/31,Multiple populations,Multiple groups,173,1.8% (NR),Convenience,"Inzek B.V; NR
(96%; 96%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.4081/jphr.2020.1986,1/23/2021,3/1/2021
201219_Tuscany_UniversityOfFlorence_Overall,12/19/2020,Vieri Lastrucci,Regional,Italy,"Prato; Italy
(University of Florence)",05/01 - 05/31,Multiple populations,Multiple groups,4656,3% (2.5-3.5%),Convenience,"Hangzhou Laihe Biotech Co., Ltd, Hangzhou China; NR
(100%; 98.8%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.3390/vaccines8040778,1/23/2021,3/1/2021
201119_Italy_UniversityofCagliari_Milano1_IBDPatients,11/19/2020,Roberto Berte,Local,Italy,"Milan, Cagliari, Erlangen; Italy
(University of Cagliari)",04/15 - 06/15,Patients seeking care for non-COVID-19 reasons,Multiple groups,354,2.3% (0.8-3.8%),Convenience,"University of Cagliari; NR
(97.64%; 95.2%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1093/ecco-jcc/jjaa237,1/23/2021,3/15/2021
201119_Italy_UniversityofCagliari_MilanoGenPop3_GenPop,11/19/2020,Roberto Berte,Local,Italy,"Milan; Lombardy; Italy
(University of Cagliari)",04/15 - 06/15,Household and community samples,Multiple groups,129,7% (4.4-9.6%),Sequential,"University of Cagliari; NR
(97.64%; 95.2%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1093/ecco-jcc/jjaa237,1/23/2021,3/7/2021
201127_Trento_AziendaProvincialeperiServiziSanitari_OverallAdj,11/27/2020,Paola Stefanelli,Regional,Italy,"Trento; Italy
(Azienda Provinciale per i Servizi Sanitari)",05/05 - 05/15,Household and community samples,Multiple groups,6075,25.7% (NR),Entire sample,"Abbott Laboratories; NR
(90%; 100%)",Low,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1016/j.cmi.2020.11.013,1/23/2021,3/4/2021
201109_Milan_UniversitadegliStudidiMilano_patients_antiN,11/20/2020,Valeria Cento,Sublocal,Italy,"Milan; Lombardy ; Italy
(Universita degli Studi di Milano)",05/11 - 07/05,Residual sera,Multiple groups,2753,5.1% (4.3-5.9%),Sequential,"Abbott, Abbott Park, Illinois, US; NR
(92.1%; 99.8%)",Moderate,Journal Article (Peer-Reviewed),http://dx.doi.org/10.1371/journal.pone.0242765,1/23/2021,3/17/2021
201201_Verona_InstitutoDiRicoveroECuraACaratterre_Overall,12/1/2020,Massimo Guerriero,Local,Italy,"Verona; Veneto; Italy
(Instituto di Ricovero e Cura A Caratterre)",04/25 - 05/08,Household and community samples,Multiple groups,1515,2.7% (NR),Simplified probability,"Abbott Laboratories; NR
(0%; 0%)",Moderate,Journal Article (Peer-Reviewed),https://dx.doi.org/10.3201/eid2701.202740,1/30/2021,3/11/2021
201126_Naples_UniversityofNaples_MS,11/26/2020,Nicola Capasso,Sublocal,Italy,"Naples; Campania; Italy
(University of Naples)",05/11 - 06/15,Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),310,2.9% (NR),Sequential,"Shanghai  Kehua  Bio-engineering  Co.,  Ltd.,  Shanghai,  China; NR
(66%; 96.6%)",Moderate,Journal Article (Peer-Reviewed),https://dx.doi.org/10.3390/jcm9124066,1/31/2021,3/17/2021
201126_Naples_UniversityofNaples_LowRisk,11/26/2020,Nicola Capasso,Sublocal,Italy," Naples; Campania; Italy
(University of Naples)",05/11 - 06/15,Health care workers and caregivers,Adults (18-64 years),862,1.3% (NR),Convenience,"Shanghai  Kehua  Bio-engineering  Co.,  Ltd.,  Shanghai,  China; NR
(66%; 96.6%)",Moderate,Journal Article (Peer-Reviewed),https://dx.doi.org/10.3390/jcm9124066,1/31/2021,3/1/2021
201126_Naples_UniversityofNaples_HighRisk,11/26/2020,Nicola Capasso,Sublocal,Italy,"Naples; Campania; Italy
(University of Naples)",05/11 - 06/15,Health care workers and caregivers,Adults (18-64 years),253,10.6% (NR),Convenience,"Shanghai  Kehua  Bio-engineering  Co.,  Ltd.,  Shanghai,  China; NR
(66%; 96.6%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.3390/jcm9124066,1/31/2021,3/1/2021
210109_GiglioIsland_UniversitàdegliStudidiMilano,1/9/2021,Antonio Bognanni,Local,Italy,"Giglio Island; Tuscany; Italy
(Università degli Studi di Milano)",04/29 - 05/03,Household and community samples,Adults (18-64 years),723,0.4% (NR),Self-referral,"Zhejiang Orient Gene Biotech Co Ltd, Huzhou, Zhejiang, China; NR
(87.9%; 100%)",High,Preprint,https://www.medrxiv.org/content/10.1101/2021.01.08.20248948v1,1/31/2021,3/1/2021
201217_Naples_UniversityofCampania_ELISA,12/17/2020,Antonio Russo,Sublocal,Italy,"Naples; Campania; Italy
(University of Campania)",03/27 - 08/30,Health care workers and caregivers,Adults (18-64 years),65,NA,Convenience,"Xiamen; NR
(100%; 100%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.2147/IDR.S282652,2/1/2021,3/7/2021
201223_Bergamo_OspedalePapaGiovanniXXIII_overall,12/23/2020,Alberto Zambelli,Sublocal,Italy,"Bergamo; Lombardy; Italy
(Ospedale Papa Giovanni XXIII)",04/01 - 04/30,Patients seeking care for non-COVID-19 reasons,Multiple groups,560,31% (NR),Sequential,"Moers, Germany; NR
(0%; 0%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1002/onco.13654,2/3/2021,3/5/2021
210111_Pavia_University of Pavia_overall,1/13/2021,,Sublocal,Italy,"Pavia; Italy
(University of Pavia)",05/04 - 06/03,Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),104,13.5% (NR),Convenience,"Roche; NR
(0%; 0%)",Moderate,Preprint,https://doi.org/10.1016/j.msard.2021.102754,2/3/2021,3/1/2021
201213_Foggia_AziendaOspedalieraUniversitariaPoliclinicoRiunitiDiFoggia_HCW,12/13/2020,Armando De Carlo,Sublocal,Italy,"Foggia; Apulia, Province of Foggia; Italy
(Azienda Ospedaliera-Universitaria Policlinico Riuniti di Foggia)",03/17 - 05/18,Health care workers and caregivers,Adults (18-64 years),3242,1.9% (1.4-2.3%),Convenience,"Shenzhen YHLO Biotech; NR
(97%; 98.8%)",Moderate,Journal Article (Peer-Reviewed),https://dx.doi.org/10.3390/ijerph17249324,2/5/2021,3/2/2021
201101_ Borgosesia_ASLVercelli_overall,11/1/2020,Daniela Alessi,Local,Italy,"Borgosesia; Piedmont; Italy
(ASL Vercelli)",05/23 - 05/24,Household and community samples,Multiple groups,4987,4.9% (4.3-5.6%),Self-referral,"Prima Lab SA; NR
(100%; 98%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.19191/EP20.5-6.S2.119,2/8/2021,3/8/2021
210204_Milan_ASSTFatebenefratelliSacco_PhaseI_overall,2/4/2021,Laura Milazzo,Sublocal,Italy,"Mlilan; Italy
(ASST Fatebenefratelli Sacco)",03/04 - 03/12,Health care workers and caregivers,Adults (18-64 years),679,0.4% (NR),Convenience,"Beijing Wantai Biolog- ical Pharmacy Enterprise; NR
(78%; 100%)",Moderate,Journal Article (Peer-Reviewed),http://dx.doi.org/10.1136/oemed-2020-107060,2/12/2021,3/1/2021
210204_Milan_ASSTFatebenefratelliSacco_PhaseIII,2/4/2021,Laura Milazzo,Sublocal,Italy,"Mlilan; Italy
(ASST Fatebenefratelli Sacco)",05/20 - 05/27,Health care workers and caregivers,Adults (18-64 years),629,4.6% (NR),Convenience,"Beijing Wantai Biolog- ical Pharmacy Enterprise; NR
(78%; 100%)",Moderate,Journal Article (Peer-Reviewed),http://dx.doi.org/10.1136/oemed-2020-107060,2/12/2021,3/1/2021
210204_Milan_ASSTFatebenefratelliSacco_PhaseII,2/4/2021,Laura Milazzo,Sublocal,Italy,"Mlilan; Italy
(ASST Fatebenefratelli Sacco)",04/04 - 04/22,Health care workers and caregivers,Adults (18-64 years),608,4.2% (NR),Convenience,"Beijing Wantai Biolog- ical Pharmacy Enterprise; NR
(78%; 100%)",Moderate,Journal Article (Peer-Reviewed),http://dx.doi.org/10.1136/oemed-2020-107060,2/12/2021,3/1/2021
_Modena_OspedaleCivileS.AgostinoEstense_overall,,Valentina Pecoraro,Sublocal,Italy,"Modena; Emilia-Romagna Region; Italy
(Ospedale Civile S.Agostino Estense)",03/30 - 05/31,,Adults (18-64 years),7711,5% (NR),,"; NR
(0%; 0%)",Unclear,Journal Article (Peer-Reviewed),https://pesquisa.bvsalud.org/global-literature-on-novel-coronavirus-2019-ncov/resource/en/covidwho-984696,2/12/2021,3/16/2021
210105_SanGiovaniRotondo_FondazioneCasaSollievoDellaSofferenza_overall,1/5/2021,Fabrizio Bossa,Sublocal,Italy,"San Giovanni Rotondo; Italy
(Fondazione Casa Sollievo della Sofferenza)",05/01 - 06/15,Patients seeking care for non-COVID-19 reasons,Multiple groups,245,2.9% (NR),Convenience,"1) Kehua Bio- engineering

2) Tecan; NR
(90%; 96.3%)",High,Journal Article (Peer-Reviewed),http://dx.doi.org/10.1016/j.dld.2020.12.120,2/13/2021,3/22/2021
201022_Bergamo_IstitutodiRicercheFarmacologicheMarioNegri_MEIcohort,10/22/2020,Luca Perico,Sublocal,Italy,"Bergamo; Italy
(Istituto di Ricerche Farmacologiche Mario Negri)",starting 05/11,Non-essential workers and unemployed persons,Adults (18-64 years),153,39.9% (NR),Convenience,"Prima LAB SA Balerna, Switzerland; NR
(98%; 92%)",High,Journal Article (Peer-Reviewed),http://dx.doi.org/10.1016/j.ebiom.2020.103069,2/23/2021,3/17/2021
201022_Bergamo_IstitutodiRicercheFarmacologicheMarioNegri_MEIcohort_males,10/22/2020,Luca Perico,Sublocal,Italy,"Bergamo; Italy
(Istituto di Ricerche Farmacologiche Mario Negri)",starting 05/11,Non-essential workers and unemployed persons,Adults (18-64 years),115,38.3% (NR),Convenience,"Prima LAB SA Balerna, Switzerland; NR
(98%; 92%)",High,Journal Article (Peer-Reviewed),http://dx.doi.org/10.1016/j.ebiom.2020.103069,2/23/2021,3/17/2021
201022_Bergamo_IstitutodiRicercheFarmacologicheMarioNegri_MEIcohort_females,10/22/2020,Luca Perico,Sublocal,Italy,"Bergamo; Italy
(Istituto di Ricerche Farmacologiche Mario Negri)",starting 05/11,Non-essential workers and unemployed persons,Adults (18-64 years),38,18.4% (NR),Convenience,"Prima LAB SA Balerna, Switzerland; NR
(98%; 92%)",High,Journal Article (Peer-Reviewed),http://dx.doi.org/10.1016/j.ebiom.2020.103069,2/23/2021,3/17/2021
201022_Bergamo_IstitutodiRicercheFarmacologicheMarioNegri_MEIcohort_Covid19Contact,10/22/2020,Luca Perico,Sublocal,Italy,"Bergamo; Italy
(Istituto di Ricerche Farmacologiche Mario Negri)",starting 05/11,Non-essential workers and unemployed persons,Adults (18-64 years),21,28.6% (NR),Convenience,"Prima LAB SA Balerna, Switzerland; NR
(98%; 92%)",High,Journal Article (Peer-Reviewed),http://dx.doi.org/10.1016/j.ebiom.2020.103069,2/23/2021,3/17/2021
201022_Bergamo_IstitutodiRicercheFarmacologicheMarioNegri_MEIcohort_SuspectedCovid19Contact,10/22/2020,Luca Perico,Sublocal,Italy,"Bergamo; Italy
(Istituto di Ricerche Farmacologiche Mario Negri)",starting 05/11,Non-essential workers and unemployed persons,Adults (18-64 years),55,43.6% (NR),Convenience,"Prima LAB SA Balerna, Switzerland; NR
(98%; 92%)",High,Journal Article (Peer-Reviewed),http://dx.doi.org/10.1016/j.ebiom.2020.103069,2/23/2021,3/17/2021
210127_Merano_FranzTappeinerHospital_patients_primary,1/27/2021,Dominic Fong,Sublocal,Italy,"Merano; Italy
(Franz Tappeiner Hospital)",06/22 - 07/17,Patients seeking care for non-COVID-19 reasons,Not reported,250,0.8% (NR),Sequential,"Abbott; NR
(100%; 99.6%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1007/s00508-020-01807-6,2/23/2021,3/1/2021
210127_Merano_FranzTappeinerHospital_HCW_primary,1/27/2021,Dominic Fong,Sublocal,Italy,"Merano; Italy
(Franz Tappeiner Hospital)",06/22 - 07/17,Health care workers and caregivers,Adults (18-64 years),36,5.5% (NR),Convenience,"Abbott; NR
(100%; 99.6%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1007/s00508-020-01807-6,2/23/2021,3/1/2021
210112_ArianoIrpino_Zoo-ProphylacticInstituteOfSouthernItaly_overall,1/12/2021,Pellegrino Cerino,Local,Italy,"Ariano Irpino; Province of Avellino in the Campania region; Italy
(The Zoo-Prophylactic Institute of Southern Italy)",05/16 - 05/19,Household and community samples,Multiple groups,13218,5.6% (5.2-6%),Convenience,"Roche; NR
(0%; 0%)",Moderate,Preprint,10.2144/fsoa-2020-0203,3/4/2021,3/4/2021
210127_UniversityHospitalofBari_UniversityofBari_overall_IgG_unadj,1/27/2021,Luigi Vimercati,Sublocal,Italy,"Bari; Puglia; Italy
(University of Bari)",04/08 - 06/07,Health care workers and caregivers,Adults (18-64 years),2407,2.4% (NR),Convenience,"Abbott; NR
(50%; 97.99%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1016/j.envres.2021.110793,3/11/2021,3/15/2021
210209_Catania_UniversityofCatania,2/9/2021,Caterina Ledda ,Local,Italy,"Catania; Sicily; Italy
(University of Catania)",06/15 - 07/15,Health care workers and caregivers,Adults (18-64 years),133,3% (NR),Convenience,"NovaTec Immundiagnostics GmbH, Dietzenbach, Germany; NR
(0%; 0%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.3390/tropicalmed6010021,3/14/2021,3/15/2021
201031_Veneto_NationalAssociationofCompanyandCompetentDoctors,10/31/2020,Danilo Bontadi,Regional,Italy,"Veneto; Italy
(National Association of Company and Competent Doctors)",04/11 - 04/29,Non-essential workers and unemployed persons,Adults (18-64 years),1267,1.6% (NR),Convenience,"NR, MAGLUMI, NR; NR
(0%; 0%)",High,Journal Article (Peer-Reviewed),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7809981/,3/16/2021,3/16/2021
210204_Milan_UniversityOfMilan_Overall,2/4/2021,Marco Farronato ,Local,Italy,"Milan; Lombardy; Italy
(University of Milan)",06/13 - 08/06,Contacts of COVID patients,Children and Youth (0-17 years),49,16.3% (NR),Convenience,"Livzon; NR
(0%; 0%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.3390/ijerph18041488,3/19/2021,3/19/2021
200505_Kobe_KobeMedicalCenterGeneralHospital_Outpatients_PopAdj,5/5/2020,Asako Doi,Local,Japan,"Kobe; Hyogo Prefecture; Japan
(Kobe City Medical Center General Hospital)",03/31 - 04/07,Residual sera,Multiple groups,1000,2.7% (1.8-3.9%),Simplified probability,"Kurabo Industries; IgG; LFIA: Lateral flow immunoassay
(76.38%; 100%)",High,Preprint,https://www.medrxiv.org/content/10.1101/2020.04.26.20079822v1,5/1/2020,3/17/2021
200520_Japan_NationalHospitalOrganizationKyotoMedicalCenter_HCW,5/20/2020,Kohei Fujita,Sublocal,Japan,"Kyoto; Kansai; Japan
(National Hospital Organization Kyoto Medical Center)",04/10 - 04/20,Health care workers and caregivers,Multiple groups,92,5.4% (NR),Stratified non-probability,"DRG International; IgG; ELISA
(0%; 0%)",High,Preprint,https://www.medrxiv.org/content/10.1101/2020.05.12.20098962v2,5/21/2020,3/1/2021
200721_Tokyo_NavitasClinicTachikawa_Overall,"6/4/2020, 7/21/2020","Morihito Takita, Morihito Takita",Local,Japan,"Tokyo, Kangawa, Saitama, Chiba, Yamanashi; Kanto, Chūbu ; Japan
(Navitas Clinic Tachikawa)",04/20 - 05/20,Household and community samples,Multiple groups,1071,3.8% (2.8-5.2%),Self-referral,"Kurabo Industries; IgG; Rapid immunochromatographic test
(76.4%; 100%)",High,"Preprint, Journal Article (Peer-Reviewed)","https://www.medrxiv.org/content/10.1101/2020.06.03.20121020v1, https://dx.doi.org/10.1177/2150132720942695",7/17/2020,3/1/2021
200618_Japan_IwatePrefecturalCentralHospital_HealthCareWorkersAbbot/Roche,6/19/2020,Akihiro Nakamura,Local,Japan,"Iwate; Honshu; Japan
(Iwate Prefectural Central Hospital)",05/18 - 05/29,Health care workers and caregivers,Adults (18-64 years),1000,NA,Convenience,"Roche elecsys, Abbott; IgG, IgM; Chemiluminescence Immunoassay, Electro chemiluminescence immunoassay
(0%; 0%)",High,Preprint,https://www.medrxiv.org/content/10.1101/2020.06.15.20132316v2,7/17/2020,3/1/2021
200621_Japan_SoftBank_Overall,"6/21/2020, 6/10/2020","Simon Denyer, Kyodo Jiji",Sublocal,Japan,"Japan
(SoftBank)",05/12 - 05/18,Multiple populations,Not reported,44066,0.4% (NR),Convenience,"Innovita, ""Zhejiang Orient Gene Biotech Co., LTD""; Not reported; Not reported
(0%; 0%)",Unclear,"News and Media, News and Media","https://www.google.com/url?rct=j&sa=t&url=https://www.lmtonline.com/news/article/Japanese-firm-s-blanket-testing-of-employees-15355433.php&ct=ga&cd=CAEYHCoUMTM4NjAwODY3NjE3NzkyOTU2ODYyGjkwZGVhOTg5OTRlOTE4NTk6Y29tOmVuOlVT&usg=AFQjCNGl9_tc35Q3fUbB67SoWaNsH2ltMw, https://www.japantimes.co.jp/news/2020/06/10/national/softbank-coronavirus-antibody-tests/",7/25/2020,3/17/2021
200726_UtsunomiyaCity_TokyoMedicalandDentalUniversity_genpop_popadj,7/26/2020,Nobutoshi Nawa,Local,Japan,"Utsunomiya City; Kantō region; Japan
(Tokyo Medical and Dental University)",06/14 - 07/05,Household and community samples,Multiple groups,742,1.2% (0.2-1.2%),Simplified probability,"Shenzhen YHLO Biotech Co; IgG; Chemiluminescence Immunoassay
(97.3%; 96.3%)",Moderate,Preprint,https://www.medrxiv.org/content/10.1101/2020.07.20.20155945v1,9/24/2020,3/1/2021
200730_Sapporo_HokkaidoUniversityGraduateSchoolofMedicine_LiverDiseasePatientsMay2020,7/30/2020,Goki Suda,Sublocal,Japan,"Sapporo; Hokkaido; Japan
(Hokkaido University Graduate School of Medicine)",05/01 - 05/31,Patients seeking care for non-COVID-19 reasons,Multiple groups,300,NA,Unclear,"Roche Diagnostics; IgG; Electro chemiluminescence immunoassay
(100%; 99.8%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1111/hepr.13551,10/1/2020,3/17/2021
200730_Sapporo_HokkaidoUniversityGraduateSchoolofMedicine_LiverDiseasePatientsMarch2020,7/30/2020,Goki Suda,Sublocal,Japan,"Sapporo; Hokkaido; Japan
(Hokkaido University Graduate School of Medicine)",03/01 - 03/31,Patients seeking care for non-COVID-19 reasons,Multiple groups,300,0.3% (0-1.8%),Unclear,"Roche Diagnostics; IgG; Electro chemiluminescence immunoassay
(100%; 99.8%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1111/hepr.13551,10/1/2020,3/17/2021
200923_Tokyo_MedicalCorporationKoshikai_0819-0902,9/23/2020,Sawako Hibino,Sublocal,Japan,"Tokyo; Japan
(Medical Corporation Koshikai)",08/19 - 09/02,Non-essential workers and unemployed persons,Adults (18-64 years),62,46.8% (NR),Convenience,"Aurora Biomed; IgG, IgM; Not reported
(0%; 0%)",High,Preprint,https://www.medrxiv.org/content/10.1101/2020.09.21.20198796v1,10/7/2020,3/1/2021
200911_Osaka_ToyonakaMunicipalHospital_Overall,9/11/2020,Tsutomu Nishida,Sublocal,Japan,"Osaka; Kansai; Japan
(Toyonaka Municipal Hospital)",06/12 - 06/19,Health care workers and caregivers,Adults (18-64 years),925,0.4% (0.2-1.1%),Convenience,"Abbott; IgG; Chemiluminsescent microparticle immunoassay
(100%; 99.6%)",Moderate,Preprint,https://www.medrxiv.org/content/10.1101/2020.09.10.20191866v1,10/22/2020,3/1/2021
200826_Japan_KanenokumaHospital_Overall_June,8/26/2020,Yong Chong,Sublocal,Japan,"Fukuoka City; Kyushu; Japan
(Kanenokuma Hospital)",06/12 - 06/15,Assisted living and long-term care facilities,Multiple groups,108,2.8% (NR),Convenience,"Hangzhou Alltest Biotech Co. Ltd.; IgG; Rapid immunochromatographic test
(0%; 0%)",High,Preprint,https://www.researchsquare.com/article/rs-64266/v1,10/27/2020,3/1/2021
201008_Fujisawa_ShonanFujisawaTokushukaiHospital_MedicalStaff,10/8/2020,M. Hibino,Sublocal,Japan,"Fujisawa; Kanagawa; Japan
(Shonan Fujisawa Tokushukai Hospital)",06/01 - 07/30,Health care workers and caregivers,Adults (18-64 years),806,0.7% (0.3-1.6%),Convenience,"Abbott; IgG; Chemiluminescence Immunoassay
(100%; 0%)",Moderate,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1016/j.jhin.2020.10.001,11/24/2020,3/1/2021
201013_Okinawa_OkinawaInstituteOfScienceAndTechnology,10/13/2020,Melissa Matthews,Sublocal,Japan,"Okinawa; Okinawa Prefecture; Japan
(Okinawa Institute of Science and Technology)",08/01 - 08/31,Multiple populations,Adults (18-64 years),675,NA,Convenience,"Krammer Lab at the Icahn School of Medicine; Not reported; ELISA
(92.5%; 100%)",High,Preprint,https://www.medrxiv.org/content/10.1101/2020.10.09.20209858v1,11/25/2020,3/1/2021
201023_Tokyo_JuntendoUniversity_Overall,10/23/2020,Hiroshi Fukuda,Sublocal,Japan,"Tokyo; Kanto; Japan
(Juntendo Univesity)",07/06 - 08/21,Health care workers and caregivers,Multiple groups,4147,0.3% (0.2-0.6%),Convenience,"Roche Diagnostics; NR
(0%; 0%)",Moderate,Journal Article (Peer-Reviewed),10.21203/rs.3.rs-96870/v1,1/8/2021,3/1/2021
201207_Kyoto_NationalHospitalOrganizationKyotoMedicalCenter,12/7/2020,Kohei Fujita,Sublocal,Japan,"Kyoto; Kansai; Japan
(National Hospital Organization Kyoto Medical Center)",04/10 - 04/20,Health care workers and caregivers,Adults (18-64 years),92,5.4% (NR),Convenience,"DRG international, Inc.; NR
(0%; 0%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.3389/fpubh.2020.595348,2/1/2021,3/10/2021
201120_Japan_TokyoNationalHospital_overall,11/20/2020,Shomi Oka,Sublocal,Japan,"Tokyo; Japan
(Tokyo National Hospital)",06/01 - 10/30,Patients seeking care for non-COVID-19 reasons,Seniors (65+ years),93,16.1% (NR),Convenience,"1) Roche Diagnostics
2) GenBody; NR
(0%; 0%)",High,Preprint,https://www.researchsquare.com/article/rs-112294/v1,2/7/2021,3/1/2021
210113_Wakayama_WakayamaMedicalUniversity_overall,1/13/2021,Sadahiro Iwabuchi,Sublocal,Japan,"Wakayama; Japan
(Wakayama Medical University)",07/07 - 09/15,Health care workers and caregivers,Multiple groups,1528,0.8% (0.3-1.2%),Convenience,"Kurabo Industries Ltd; NR
(76.4%; 100%)",High,Preprint,https://www.medrxiv.org/content/10.1101/2021.01.10.21249421v1,2/7/2021,3/1/2021
201230_Fukushima_ HirataCentralHospital_CLIA_IgG,12/30/2020,Yurie Kobashi,Sublocal,Japan,"Hirata; Fukushima Prefecture; Japan
( Hirata Central Hospital)",05/08 - 05/28,Health care workers and caregivers,Multiple groups,637,0.9% (NR),Unclear,"YHLO Biotech Shenzhen, China; NR
(0%; 0%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1016/j.intimp.2020.107360,2/16/2021,3/6/2021
210120_Japan_ResearchInstituteOfTuberculosis_GenPop,1/20/2021,Takashi Yoshiyama,National,Japan,"Tokyo, Osaka, Miyagi; Japan
(Government of Japan)",06/01 - 06/07,Household and community samples,Multiple groups,7950,0.1% (0-0.2%),Stratified probability,"Roche; NR
(100%; 99.8%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.3201/eid2702.204088,2/28/2021,3/1/2021
210129_Hyogo_KobeUniversityGraduateSchoolOfMedicine_Overall,1/29/2021,Koichi Furukawa,Regional,Japan,"Kansai; Japan
()",08/06 - 10/01,Residual sera,Multiple groups,10377,0.6% (NR),Sequential,"Roche Diagnostics, Sysmex,; NR
(0%; 0%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.31662/jmaj.2020-0094,3/20/2021,3/20/2021
200520_Jersey_JerseyStatistics_Round2_GenPop_TestAdj,6/9/2020,Statistics Jersey,Regional,Jersey,"Jersey; Jersey
(Statistics Jersey)",05/15 - 05/27,Household and community samples,Multiple groups,1062,4.2% (2.9-5.5%),Stratified probability,"CTK Biotech; IgG, IgM; Rapid immunochromatographic test
(90%; 99.39%)",Moderate,Institutional Report,https://www.gov.je/SiteCollectionDocuments/Government%20and%20administration/R%20Prevalence%20of%20antibodies%2020200609%20SJ.pdf,7/25/2020,3/1/2021
200607_Jordan_KingHusseinCancerCentre_BloodDonors,6/7/2020,Maher Sughayer,Regional,Jordan,"Amman; Jordan; Jordan
(King Hussein Cancer Centre)",01/15 - 06/15,Blood donors,Adults (18-64 years),734,NA,Simplified probability,"Roche elecsys; IgG, IgM, IgA; Chemiluminescence Immunoassay
(100%; 98.1%)",High,Preprint,https://www.medrxiv.org/content/10.1101/2020.06.06.20123919v1.full.pdf,6/8/2020,3/1/2021
200729_Kenya_KEMRI-WellcomeTrust_Overall_PopTestAdj,7/29/2020,Sophie Uyoga,National,Kenya,"Mombasa, Nairobi, Kisumu, Eldoret; Rift Valley, Coast, Central, Nyanza; Kenya
(KEMRI-Wellcome Trust Research Programme)",04/30 - 06/16,Blood donors,Multiple groups,3098,5.2% (3.7-7.1%),Convenience,"Krammer; IgG; ELISA
(83%; 99%)",High,Preprint,https://www.medrxiv.org/content/10.1101/2020.07.27.20162693v1.full.pdf,8/8/2020,3/1/2021
210101_Kenya_KEMRI-WellcomeTrustResearchProgramme_Adj,1/1/2021,Sophie Uyoga,National,Kenya,"Kenya
(KEMRI-Wellcome Trust Research Programme)",04/30 - 06/16,Blood donors,Adults (18-64 years),3098,4.3% (2.9-5.8%),Sequential,"N/A - Designed by an author; NR
(92.7%; 99%)",Moderate,Journal Article (Peer-Reviewed),http://dx.doi.org/10.1126/science.abe1916,2/10/2021,3/1/2021
210217_Kenya_KEMRI-WellcomeTrustResearchProgramme_TestAdj,2/17/2021,E Wangeci Kagucia,National,Kenya,"Kenya
(KEMRI-Wellcome Trust Research Programme)",09/30 - 10/23,Essential non-healthcare workers,Adults (18-64 years),830,42.3% (38.4-46.3%),Convenience,"NR; NR
(93%; 99%)",Moderate,Preprint,https://www.medrxiv.org/content/10.1101/2021.02.12.21251294v1,3/16/2021,3/16/2021
201205_Kuwait_KuwaitUniversity_Overall_unadj,12/5/2020,Walid Q. Alali,National,Kuwait,"Kuwait
(University of Kuwait)",05/23 - 06/26,Essential non-healthcare workers,Adults (18-64 years),525,38.1% (34-42.3%),Stratified probability,"Biozek Medical, Netherlands; NR
(66%; 97%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1093/jtm/taaa223,1/23/2021,3/1/2021
210107_Latvia_UniversityCollegeLondon_PaediatricHCW,1/27/2021,D. Goldblatt,Sublocal,Latvia,"Latvia
(University College London)",05/19 - 06/20,Health care workers and caregivers,Adults (18-64 years),177,NA,Convenience,"Epitope Diagnostics; NR
(100%; 88.7%)",High,Journal Article (Peer-Reviewed),http://dx.doi.org/10.1016/j.jhin.2020.12.019,3/13/2021,3/16/2021
200526_AlzintanCity_Al-ZintanUniversity_HealthCareWorkers,5/26/2020,Abdulwahab Kammon,Local,Libya,"Alzintan City; Libya; Libya
(Al-Zintan University)",04/02 - 05/18,Health care workers and caregivers,Multiple groups,77,NA,Stratified probability,"Guangzhou Wondfo Biotech; IgM, IgG; LFIA: Lateral flow immunoassay
(86.4%; 99.6%)",High,Preprint,https://www.medrxiv.org/content/10.1101/2020.05.25.20109470v1,5/30/2020,3/1/2021
200526_AlzintanCity_Al-ZintanUniversity_GenPopulation,5/26/2020,Abdulwahab Kammon,Local,Libya,"Alzintan City; Libya; Libya
(Al-Zintan University)",04/02 - 05/18,Multiple populations,Multiple groups,142,4.2% (NR),Simplified probability,"Guangzhou Wondfo Biotech; IgM, IgG; LFIA: Lateral flow immunoassay
(86.4%; 99.6%)",High,Preprint,https://www.medrxiv.org/content/10.1101/2020.05.25.20109470v1,5/30/2020,3/1/2021
201209_Liechtenstein_KantonsspitalGraubunden_Overall,12/9/2020,Anna Schaffner,National,Liechtenstein,"Principality of Liechtenstein (small country); Liechtenstein
(Kantonsspital Graunbunden)",06/02 - 10/06,Multiple populations,Not reported,1159,7.8% (6.4-9.5%),Convenience,"Roche Diagnostics, Rotkreuz, Switzerland
Abbott Diagnostics Baar, Switzerland
Diasorin
Euroimmun; NR
(97.6%; 99.8%)",Unclear,Journal Article (Peer-Reviewed),https://dx.doi.org/10.3390/jcm9123989,1/28/2021,3/17/2021
210107_Lithuania_UniversityCollegeLondon_PaediatricHCW,1/27/2021,D. Goldblatt,Sublocal,Lithuania,"Lithuania
(University College London)",06/01 - 06/12,Health care workers and caregivers,Adults (18-64 years),300,0.7% (0.2-2.4%),Convenience,"Epitope Diagnostics; NR
(100%; 88.7%)",High,Journal Article (Peer-Reviewed),http://dx.doi.org/10.1016/j.jhin.2020.12.019,3/13/2021,3/16/2021
210206_Kaunas_HospitalofLithuanianUniversityofHealthSciencesKaunoKlinikos_LFIAIgG,2/6/2021,Laura Pereckaitė ,Local,Lithuania,"Kaunas; Lithuania
(The Hospital of Lithuanian University of Health Sciences Kauno Klinikos)",06/15 - 09/21,Health care workers and caregivers,Multiple groups,432,1.2% (NR),Convenience,"AMEDA Labordiagnostik GmbH; NR
(91.8%; 96.4%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.3390/medicina57020148,3/16/2021,3/16/2021
200518_Luxembourg_LuxembourgInstituteofHealth_GenPop_IgGPopAdj,5/18/2020,Chantal Snoeck,National,Luxembourg,"Luxembourg
(Luxembourg Institute of Health)",04/15 - 05/05,Household and community samples,Multiple groups,1820,2.1% (1.4-2.8%),Stratified probability,"EUROIMMUN; IgG; ELISA
(85.7%; 97.8%)",Moderate,Preprint,https://www.medrxiv.org/content/10.1101/2020.05.11.20092916v1,7/12/2020,3/1/2021
200805_Blantyre_Malawi-Liverpool-WellcomeTrust_HCW_TestAdj,8/5/2020,Marah Chibwana,National,Malawi,"Blantyre; Southern Region Malawi; Malawi
(Malawi-Liverpool-Wellcome Trust Clinical Research Programme)",05/22 - 06/19,Health care workers and caregivers,Adults (18-64 years),500,12.3% (8.2-16.5%),Convenience,"Omega diagnostics; IgG; ELISA
(88.1%; 93.2%)",High,Preprint,https://www.medrxiv.org/content/10.1101/2020.07.30.20164970v3.full.pdf,8/8/2020,3/1/2021
200813_Selangor_UniversityMalaya_OverallPopAdj,8/13/2020,I-Ching Sam,Regional,Malaysia,"Kuala Lumpur; Selangor; Malaysia
(University Malaya)",01/29 - 06/06,Residual sera,Multiple groups,588,0.4% (0-0.9%),Convenience,"Author-designed; IgG; ELISA
(97%; 100%)",High,Journal Article (Peer-Reviewed),https://onlinelibrary.wiley.com/doi/full/10.1002/jmv.26426,10/2/2020,3/1/2021
201002_CityOfGuadalupe_MinistryOfHealth_GovernmentEmployees_Genpop_TestAdj,11/2/2020,Cristina Díaz-Salazar,Local,Mexico,"Guadalupe; Nuevo Leon; Mexico
(Universidad Autonoma de Nuevo Leon)",07/09 - 07/23,Multiple populations,Multiple groups,3268,5.7% (4.9-6.6%),Convenience,"Roche elecsys; IgM, IgG; Chemiluminescence Immunoassay
(99.5%; 99.8%)",Moderate,Preprint,https://www.researchsquare.com/article/rs-84890/v1,11/27/2020,3/17/2021
201021_VeracruzCity_UniversidadVeracruzana_unadj,10/21/2020,Jose María Remes-Troche,Sublocal,Mexico,"Veracruz City; Mexico
(Universidad Veracruzana)",06/01 - 07/31,Residual sera,Multiple groups,2174,29.5% (27.6-31.5%),Sequential,"Abbott, Ortho-Clinical Diagnostics; NR
(0%; 0%)",High,Preprint,https://www.medrxiv.org/content/10.1101/2020.10.19.20215558v1,1/17/2021,3/17/2021
201202_MexicoCity_InstitutoNacionaldeRehabilitacion_HCW_overall,12/2/2020,Esteban Cruz-Arenas,Sublocal,Mexico,"Mexico City; Mexico
(Instituto Nacional de Rehabilitacion)",08/10 - 09/09,Health care workers and caregivers,Adults (18-64 years),300,13.7% (NR),Stratified probability,"LFA: Hangzhou Biotest Biotech Co. Ltd.,
ELISA: (Euroimmun Medizinische Labordiagnostika; NR
(79.5%; 100%)",Moderate,Preprint,https://www.medrxiv.org/content/10.1101/2020.11.30.20241331v1,1/22/2021,3/1/2021
201130_NuevoLeon_AutonomousUniversityofNuevoLeon_primary,11/30/2020,Natalia Martinez-Acuña,Regional,Mexico,"Nuevo Leon; Mexico
(Autonomous University of Nuevo Leon)",01/01 - 08/30,Blood donors,Adults (18-64 years),1968,4% (NR),Sequential,"Abbott Laboratories; NR
(0%; 0%)",High,Preprint,https://www.medrxiv.org/content/10.1101/2020.11.28.20240325v1.full,2/4/2021,3/1/2021
201112_Netherlands_AmsterdamUMC_GenPop_Overall_1Test,11/12/2020,Ed Slot,National,Netherlands,"Netherlands
(Amsterdam UMC)",04/01 - 04/15,Blood donors,Multiple groups,7361,3.4% (NR),Sequential,"Wantai Biological Pharmacy Enterprise; IgG, IgA, IgM; ELISA
(100%; 99.1%)",Moderate,Journal Article (Peer-Reviewed),https://www.nature.com/articles/s41467-020-19481-7,5/25/2020,3/4/2021
200824_Rotterdam_ErasmusMedicalCentre_1_March,8/24/2020,Brenda Westerhuis,Sublocal,Netherlands,"Rotterdam; Netherlands
(Erasmus Medical Centre)",03/02 - 03/06,Patients seeking care for non-COVID-19 reasons,Multiple groups,879,0.1% (NR),Convenience,"Author-designed; IgG; Not reported
(0%; 0%)",High,Preprint,https://www.medrxiv.org/content/10.1101/2020.08.21.20177857v1,10/19/2020,3/17/2021
200824_Rotterdam_ErasmusMedicalCentre_2_April,8/24/2020,Brenda Westerhuis,Sublocal,Netherlands,"Rotterdam; Netherlands
(Erasmus Medical Centre)",04/03 - 04/07,Patients seeking care for non-COVID-19 reasons,Multiple groups,729,2.3% (NR),Convenience,"Author-designed; IgG; Not reported
(0%; 0%)",High,Preprint,https://www.medrxiv.org/content/10.1101/2020.08.21.20177857v1,10/19/2020,3/17/2021
201128_Netherlands_CentreforInfectiousDiseaseControl_genpop_overall,11/28/2020,Eric Vos,National,Netherlands,"Netherlands
(Centre for Infectious Disease Control)",03/31 - 05/11,Household and community samples,Multiple groups,2637,2.8% (2.1-3.7%),Stratified probability,"NR; NR
(84.4%; 99%)",Low,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1136/jech-2020-215678,1/24/2021,3/5/2021
201128_Netherlands_CentreforInfectiousDiseaseControl_LowVaccineCoverage_overall,11/28/2020,Eric Vos,National,Netherlands,"Netherlands
(Centre for Infectious Disease Control)",03/31 - 05/11,Household and community samples,Multiple groups,570,2.9% (1.4-6.3%),Stratified probability,"NR; NR
(84.4%; 99%)",Low,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1136/jech-2020-215678,1/24/2021,3/5/2021
201023_NewZealand_SouthernCommunityLaboratories_MultipleTest,10/23/2020,Alyson Craigie,Regional,New Zealand,"Southern Region; New Zealand
(Southern Community Laboratories)",06/04 - 08/04,Contacts of COVID patients,Multiple groups,1127,0.7% (NR),Convenience,"Abbott, Beijing Wantai Biological Pharmacy Enterprise, Euroimmun,; NR
(0%; 0%)",High,Journal Article (Peer-Reviewed),https://www.medrxiv.org/content/10.1101/2020.10.20.20215616v1,1/23/2021,3/1/2021
200724_Nigeria_JosephUkpoHospitalsandResearchInstitutes_HCWPatients_IgG_T1,7/24/2020,Marcus Inyama Asuquo,Sublocal,Nigeria,"Calabar; Cross River State; Nigeria
(Joseph Ukpo Hospitals and Research Institutes)",06/17 - 06/24,Multiple populations,Adults (18-64 years),66,26% (NR),Unclear,"Healgen Scientific; IgG; LFIA: Lateral flow immunoassay
(0%; 0%)",High,Preprint,https://www.medrxiv.org/content/10.1101/2020.07.02.20145441v2,9/27/2020,3/1/2021
200805_Niger_IbrahimBadamasiBabangidaUniversity_IgG_GenPop_UnAdj,8/5/2020,Hussaini Majiya,Regional,Nigeria,"Niger State; Nigeria
(Ibrahim Badamasi Babangida University)",06/26 - 06/30,Household and community samples,Multiple groups,185,25.4% (NR),Stratified probability,"Cambridge Network; IgG; Colloidal Gold Immunochromatography Assay (LFIA)
(100%; 100%)",Moderate,Preprint,https://www.medrxiv.org/content/10.1101/2020.08.04.20168112v1.full.pdf,10/14/2020,3/1/2021
200615_Bergen_UniversityofBergen_HouseholdMembers,6/15/2020,Rebecca Cox,Local,Norway,"Bergen; Western Norway; Norway
(University of Bergen)",02/28 - 04/04,Contacts of COVID patients,Not reported,77,31% (NR),Entire sample,"Amant et al.; IgM, IgG, IgA; ELISA
(0%; 0%)",High,Journal Article (Peer-Reviewed),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7295487/,7/19/2020,3/1/2021
200626_Norway_NorwegianInstituteofPublicHealth_OverallAdj,6/26/2020,Gro Tunheim,National,Norway,"Norway
(Norwegian Institute of Public Health)",04/20 - 05/17,Residual sera,Multiple groups,900,1% (0.1-2.4%),Sequential,""" Department of Immunology, Oslo University Hospital""; IgG; Flow cytometry assay
(86%; 100%)",Moderate,Institutional Report,https://www.fhi.no/globalassets/dokumenterfiler/rapporter/2020/covid-19/seroprevalence-of-sars-cov-2-in-the-norwegian-population_report-26-06-2020.pdf,10/6/2020,3/1/2021
201104_Norway_UniversityOfBergen_HouseholdContacts_Overall,11/4/2020,Kanika Kuwelker,Local,Norway,"Bergen; Hordaland; Norway
(University of Bergen)",02/28 - 04/04,Contacts of COVID patients,Multiple groups,179,45.3% (NR),Convenience,"N/A - Author Designed; NR
(0%; 0%)",High,Preprint,https://www.medrxiv.org/content/10.1101/2020.11.02.20224485v1,1/20/2021,3/2/2021
201128_Bergen_UniversityofBergen_primaryest_HCW,11/28/2020,Mai-Chi Trieu,Local,Norway,"Bergen; Midhordland; Norway
(University of Bergen)",03/06 - 04/09,Health care workers and caregivers,Multiple groups,607,3% (NR),Convenience,"Sigma-Aldrich; NR
(0%; 0%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1093/infdis/jiaa737,1/29/2021,3/1/2021
210115_Norway_NorwegianArmedForcesJointMedicalServices_primary,1/15/2021,Einar Kristian Borud,National,Norway,"Norway
(Norwegian Armed Forces Joint Medical Services)",04/19 - 04/27,Essential non-healthcare workers,Adults (18-64 years),1170,0.7% (NR),Convenience,"Roche; NR
(0%; 0%)",Moderate,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1002/hsr2.233,2/27/2021,3/1/2021
200902_Palestine_ArabAmericanUniversityRandomPop,9/2/2020,Nouar Qutob,Regional,"occupied Palestinian territory, including east Jerusalem","West Bank; occupied Palestinian territory, including east Jerusalem
(Arab American University)",06/15 - 06/30,Household and community samples,Multiple groups,1355,NA,Stratified probability,"Roche Diagnostics; Not reported; Immunoassay
(100%; 99.81%)",High,Preprint,https://www.medrxiv.org/content/10.1101/2020.08.28.20180083v3,10/13/2020,3/1/2021
200902_Palestine_ArabAmericanUniversityLabReferral,9/2/2020,Nouar Qutob,Regional,"occupied Palestinian territory, including east Jerusalem","West Bank; occupied Palestinian territory, including east Jerusalem
(Arab American University)",05/01 - 07/09,Residual sera,Multiple groups,1136,0.4% (0-1%),Sequential,"Roche Diagnostics; Not reported; Immunoassay
(100%; 99.81%)",High,Preprint,https://www.medrxiv.org/content/10.1101/2020.08.28.20180083v3,10/13/2020,3/17/2021
210107_WestBank_ArabAmericanUniversity_Households,1/7/2021,Nouar Qutob,Local,"occupied Palestinian territory, including east Jerusalem","West Bank; occupied Palestinian territory, including east Jerusalem
(Arab American University )",06/15 - 06/30,Multiple populations,Adults (18-64 years),1355,NA,Stratified probability,"Roche; NR
(83.87%; 100%)",Low,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1136/bmjopen-2020-044552,2/18/2021,3/1/2021
210107_WestBank_ArabAmericanUniversity_LabReferrals,1/7/2021,Nouar Qutob,Local,"occupied Palestinian territory, including east Jerusalem","West Bank; occupied Palestinian territory, including east Jerusalem
(Arab American University )",05/01 - 07/09,Multiple populations,Adults (18-64 years),1136,0.4% (0-0%),Self-referral,"Roche; NR
(100%; 83.87%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1136/bmjopen-2020-044552,2/18/2021,3/1/2021
200720_Lahore_ChughtaiInstituteofPathology_Overall,8/19/2020,Omar Chughtai,Local,Pakistan,"Lahore; Pakistan
(Chughtai Institute of Pathology)",05/20 - 05/30,Essential non-healthcare workers,Adults (18-64 years),154,15.6% (NR),Convenience,"Abbott; IgG; Chemiluminescence Immunoassay
(96.77%; 99%)",High,Journal Article (Peer-Reviewed),https://jcpsp.pk/article-detail/frequency-of-covid19-igg-antibodies-among-special-police-squad-lahore-pakistan,10/3/2020,3/1/2021
200824_Karachi_NationalInstituteofBloodDiseases&BoneMarrowTransplantation_Overall,8/24/2020,Amber Younas,Local,Pakistan,"Karachi; Sindh; Pakistan
(National Institute of Blood Diseases & Bone Marrow Transplantation)",05/15 - 07/15,Blood donors,Adults (18-64 years),370,34.6% (NR),Sequential,"Roche Diagnostics; IgA, IgM, IgG; Electro chemiluminescence immunoassay
(0%; 0%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1016/j.transci.2020.102923,10/20/2020,3/1/2021
200917_Karachi_NationalInstituteofBloodDiseasesandBoneMarrowTransplant_Overall,9/17/2020,Samreen Zaidi,Local,Pakistan,"Karachi; Pakistan
(National Institute of Blood Diseases and Bone Marrow Transplant)",05/15 - 07/15,Multiple populations,Adults (18-64 years),1675,34% (NR),Convenience,"Roche Diagnostics; IgG, IgM, IgA; Electro chemiluminescence immunoassay
(0%; 0%)",High,Journal Article (Peer-Reviewed),http://dx.doi.org/10.1093/pubmed/fdaa170,11/12/2020,3/1/2021
201109_ Peshawar_HayatabadMedicalComplex_Overall,11/9/2020,Mohammad Noor,Sublocal,Pakistan,"Peshawar; Khyber Pakhtunkhwa; Pakistan
(Hayatabad Medical Complex)",07/13 - 07/15,Health care workers and caregivers,Multiple groups,1011,30.8% (NR),Stratified probability,"Roche; NR
(87%; 100%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.7759/cureus.11389,1/17/2021,3/4/2021
200930_PeshawarCity_RiphahInternationalUniversity_Overall,9/30/2020,Mohsina Haq,Local,Pakistan,"Peshawar City; Khyber Pakhtunkhwa; Pakistan
(Riphah International University)",06/15 - 06/29,Health care workers and caregivers,Adults (18-64 years),1011,30.7% (27.8-33.6%),Stratified non-probability,"Roche Diagnostics; NR
(98.8%; 100%)",Moderate,Preprint,https://www.medrxiv.org/content/10.1101/2020.09.29.20203125v1,1/19/2021,3/1/2021
201228_Karachi_AgaKhanUniversity_Phase1DistrictMalir_PopTestAdj,12/28/2020,Muhammad Nisar,Sublocal,Pakistan,"Karachi; Sindh; Pakistan
(Aga Khan University)",04/15 - 04/25,Household and community samples,Multiple groups,500,0.2% (0-0.7%),Simplified probability,"Roche; NR
(100%; 99.8%)",Low,Preprint,https://www.medrxiv.org/content/10.1101/2020.07.28.20163451v4.full.pdf,2/10/2021,3/6/2021
201228_Karachi_AgaKhanUniversity_Phase1_DistrictEast_PopTestAdj,12/28/2020,Muhammad Nisar,Sublocal,Pakistan,"Karachi; Sindh; Pakistan
(Aga Khan University)",04/15 - 04/25,Household and community samples,Multiple groups,500,0.4% (0-1.3%),Simplified probability,"Roche; NR
(100%; 99.8%)",Low,Preprint,https://www.medrxiv.org/content/10.1101/2020.07.28.20163451v4.full.pdf,2/10/2021,3/6/2021
201228_Karachi_AgaKhanUniversity_Phase2DistrictEast_PopTestAdj,12/28/2020,Muhammad Nisar,Sublocal,Pakistan,"Karachi; Sindh; Pakistan
(Aga Khan University)",06/25 - 07/11,Household and community samples,Multiple groups,500,15.1% (9.4-21.7%),Simplified probability,"Roche; NR
(100%; 99.8%)",Low,Preprint,https://www.medrxiv.org/content/10.1101/2020.07.28.20163451v4.full.pdf,2/10/2021,3/6/2021
201228_Karachi_AgakhanUniversity_Phase2DistrictMalir_PopTestAdj,12/28/2020,Muhammad Nisar,Sublocal,Pakistan,"Karachi; Sindh; Pakistan
(Aga Khan University)",06/25 - 07/11,Household and community samples,Multiple groups,504,8.7% (5.1-13.1%),Simplified probability,"Roche; NR
(100%; 99.8%)",Low,Preprint,https://www.medrxiv.org/content/10.1101/2020.07.28.20163451v4.full.pdf,2/10/2021,3/6/2021
201228_Karachi_AgaKhanUniversity_Phase3DistrictEast_PopTestAdj,12/28/2020,Muhammad Nisar,Sublocal,Pakistan,"Karachi; Sindh; Pakistan
(Aga Khan University)",08/17 - 08/22,Household and community samples,Multiple groups,500,21.5% (15.6-28%),Simplified probability,"Roche; NR
(100%; 99.8%)",Low,Preprint,https://www.medrxiv.org/content/10.1101/2020.07.28.20163451v4.full.pdf,2/10/2021,3/6/2021
201228_Karachi_AgaKhanUniversity_Phase3DistrictMalir_PopTestAdj,12/28/2020,Muhammad Nisar,Sublocal,Pakistan,"Karachi; Sindh; Pakistan
(Aga Khan University)",08/17 - 08/22,Household and community samples,Multiple groups,501,12.8% (8.3-17.7%),Simplified probability,"Roche; NR
(100%; 99.8%)",Low,Preprint,https://www.medrxiv.org/content/10.1101/2020.07.28.20163451v4.full.pdf,2/10/2021,3/6/2021
210103_Pakistan_LiaquatUniversity_primary,1/3/2021,Sheeba Ansari,Sublocal,Pakistan,"Pakistan
(Liaquat University)",06/15 - 08/15,Multiple populations,Multiple groups,728,10.8% (NR),Convenience,"nr; NR
(100%; 99.8%)",High,Journal Article (Peer-Reviewed),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7854312/,2/19/2021,3/14/2021
201210_Panama_INDICASAT-AIP_HealthyDonors2_overall,12/10/2020,Alcibiades Villarreal,National,Panama,"Panama, Colon; Panama
(Instituto de Investigaciones Científicas y Servicios de Alta Tecnología (INDICASAT-AIP))",04/30 - 07/07,Blood donors,Multiple groups,255,11.7% (8.3-16.3%),Unclear,"N/A - Author Designed; NR
(87.01%; 98.89%)",High,Preprint,https://www.medrxiv.org/content/10.1101/2020.09.25.20201459v4,3/17/2021,3/19/2021
201210_Panama_INDICASAT-AIP_HCW1_overall,12/10/2020,Alcibiades Villarreal,National,Panama,"Panama, Colon; Panama
(Instituto de Investigaciones Científicas y Servicios de Alta Tecnología (INDICASAT-AIP))",04/30 - 07/07,Health care workers and caregivers,Multiple groups,351,11.6% (8.6-15.4%),Unclear,"N/A - Author Designed; NR
(87.01%; 98.89%)",High,Preprint,https://www.medrxiv.org/content/10.1101/2020.09.25.20201459v4,3/17/2021,3/19/2021
200726_Peru_NationalCenterforEpidemiology_Overall,"7/27/2020, 7/27/2020, 7/26/2020","Peruvian Government, Centro Nacional de Epidemiologia, Ministerio de Salud",Local,Peru,"Lima, Callao; Metropolitan Lima and Callao; Peru
(National Center for Epidemiology, Prevention and Control of Diseases)",06/28 - 07/09,Household and community samples,Multiple groups,3118,21.6% (18.7-24.6%),Stratified probability,"Not reported; IgG, IgM; Rapid immunochromatographic test
(40%; 0%)",High,"News and Media, News and Media, News and Media","https://gestion.pe/peru/coronavirus-peru-minsa-divulga-ficha-tecnica-del-estudio-que-revela-que-el-253-de-lima-y-callao-adquirio-el-covid-19-cuarentena-estado-de-emergencia-nndc-noticia/, https://www.dge.gob.pe/portalnuevo/informativo/prensa/estudio-de-prevalencia-determina-que-el-253-de-la-poblacion-de-lima-y-callao-adquirio-la-infeccion-por-sars-cov2/, https://www.gob.pe/institucion/minsa/noticias/216013-estudio-de-prevalencia-determina-que-el-25-3-de-la-poblacion-de-lima-y-callao-estaria-infectada-de-covid-19",10/20/2020,3/1/2021
201129_Lima_INS_unadj,9/9/2020,Yolanda Angulo-Bazán,Local,Peru,"Lima; Lima; Peru
(National Institute of Health (INS))",04/23 - 05/02,Household and community samples,Multiple groups,236,53% (NR),Stratified non-probability,"Core Technology Co. Ltd; NR
(97.6%; 100%)",Moderate,Preprint,https://www.medrxiv.org/content/10.1101/2020.09.06.20189456v2,1/13/2021,3/1/2021
210120_Cusco_UniversidadCientíficadelSur_PopAdj,1/20/2021,Charles Huamaní,Regional,Peru,"Cusco; Peru
(Universidad Científica del Sur)",09/12 - 09/27,Household and community samples,Multiple groups,1924,33.1% (30.1-36.4%),Stratified probability,"Roche Diagnostics; NR
(99.8%; 99.5%)",Low,Preprint,https://www.medrxiv.org/content/10.1101/2021.01.17.21249990v1,2/6/2021,3/1/2021
210120_Iquitos_DIRESA_baseline_overall_adj,1/20/2021,Carlos Álvarez-Antonio,Local,Peru,"Iquitos; Peru
(Universidad de Ingeniería y Tecnología)",07/15 - 08/15,,Multiple groups,716,70% (67-73.4%),Stratified probability,"Zhejiang Orient Gene (Biotech Co LTD, China); NR
(95.8%; 100%)",Low,Preprint,https://www.medrxiv.org/content/10.1101/2021.01.17.21249913v1,2/12/2021,3/17/2021
210120_Iquitos_DIRESA_1monthFollowUp_overall_adj,1/20/2021,Carlos Álvarez-Antonio,Local,Peru,"Iquitos; Peru
(Universidad de Ingeniería y Tecnología)",07/15 - 08/15,,Multiple groups,621,66% (62-70.1%),Stratified probability,"Zhejiang Orient Gene (Biotech Co LTD, China); NR
(95.8%; 100%)",,Preprint,https://www.medrxiv.org/content/10.1101/2021.01.17.21249913v1,2/12/2021,3/17/2021
201130_Warsaw_TheChildrensMemorialHealthInstitute_HCW,11/30/2020,Beata Kasztelewicz,Sublocal,Poland,"Warsaw; Masovia; Poland
(The Children’s Memorial Health Institute)",07/01 - 08/09,Health care workers and caregivers,Adults (18-64 years),1879,0.9% (NR),Convenience,"Abbott Laboratories; NR
(100%; 99%)",Moderate,Preprint,https://www.medrxiv.org/content/10.1101/2020.11.28.20239848v1,1/23/2021,3/1/2021
201011_Mazowieckie_MedicalUniversityofWarsaw_IgG_Overall,10/11/2020,Mariusz Gujski,Regional,Poland,"Mazowieckie Province; Poland
(Medical University of Warsaw)",06/22 - 07/08,Essential non-healthcare workers,Multiple groups,5082,4.3% (3.7-4.9%),Stratified probability,"Vircell S.L; NR
(97%; 94%)",Moderate,Journal Article (Peer-Reviewed),http://dx.doi.org/10.3390/jcm9103245,1/29/2021,3/1/2021
210205_Poland_CentralClinicalHospital_IBDPatients_IgG,2/5/2021,Michał Łodyga,National,Poland,"Poland
(Central Clinical Hospital of the Ministry of the Interior and Administration)",05/01 - 06/15,Patients seeking care for non-COVID-19 reasons,Not reported,432,4.6% (NR),Sequential,"Vircell Microbiologists; NR
(0%; 0%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.20452/pamw.15796,2/23/2021,3/1/2021
210205_Poland_CentralClinicalHospital_HCWs_IgG,2/5/2021,Michał Łodyga,National,Poland,"Poland
(Central Clinical Hospital of the Ministry of the Interior and Administration)",05/01 - 06/15,Health care workers and caregivers,Not reported,432,1.6% (NR),Stratified non-probability,"Vircell Microbiologists; NR
(0%; 0%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.20452/pamw.15796,2/23/2021,3/1/2021
201222_Warsaw_CentralClinicalHospitalMSWiA,12/22/2020,Piotr Ciechanowicz,Sublocal,Poland,"Warsaw; Poland
(Central ClinicalHospital MSWiA)",04/01 - 10/31,Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),61,16.4% (NR),Sequential,"Vircell Microbiologist, Granada, Spain:; NR
(100%; 95%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1080/09546634.2020.1861177,3/7/2021,3/7/2021
200731_Portugal_InstitutoNacionaldeSaúdeDoutorRicardoJorge_Overall_Popadj,7/31/2020,Ana Paula Rodrigues,National,Portugal,"Portugal
(Instituto Nacional de Saúde Doutor Ricardo Jorge)",05/21 - 07/08,Household and community samples,Multiple groups,2301,2.9% (2-4.2%),Stratified non-probability,"EUROIMMUN, Wantai Biological Pharmacy Enterprise; IgG, IgM; ELISA
(92%; 98%)",Moderate,Institutional Report,http://www.insa.min-saude.pt/resultados-preliminares-do-primeiro-inquerito-serologico-nacional-covid-19-relatorio/,10/15/2020,3/1/2021
200902_Lisbon_UniversityofLisbon_Overall,9/2/2020,Patricia Figueiredo-Campos,Sublocal,Portugal,"Lisbon; Estremadura; Portugal
(University of Lisbon)",05/13 - 07/10,Non-essential workers and unemployed persons,Adults (18-64 years),2571,1.5% (NR),Convenience,"Krammer, et al. [Independent third party]; IgG, IgM, IgA; ELISA
(94.74%; 98%)",Moderate,Preprint,https://www.medrxiv.org/content/10.1101/2020.08.30.20184309v1,10/19/2020,3/1/2021
201218_Lisbon_NovaUniversityofLisbon,12/18/2020,Juliana Gonçalves,Sublocal,Portugal,"Lisbon; Lisbon; Portugal
(NOVA University of Lisbon)",06/15 - 06/30,Non-essential workers and unemployed persons,Multiple groups,1636,3.1% (NR),Convenience,"NOVA University of Lisbon; NR
(94.74%; 99.53%)",Moderate,Journal Article (Peer-Reviewed),https://dx.doi.org/10.3389/fmed.2020.603996,1/23/2021,3/9/2021
210201_Portugal_InstitutoNacionalDeSaúdeDoutorRicardoJorge_overall_TestAdj_PopAdj,2/1/2020,Irina Kislaya,National,Portugal,"health regions: North, Centre, Lisbon and Tagus Valley, Alentejo, Algarve, and the Autonomous regions of Madeira and Azores; Portugal
( Instituto Nacional de Saúde Doutor Ricardo Jorge)",05/21 - 07/08,Residual sera,Multiple groups,2301,1.7% (0-3.3%),Stratified non-probability,"1) Wantai

2) EUROIMMUN; NR
(96%; 98.7%)",Moderate,Institutional Report,https://actamedicaportuguesa.com/revista/index.php/amp/article/view/15122,3/11/2021,3/17/2021
200928_Qatar_CornellUniversity_Overall,9/28/2020,Andrew Jeremijenko,National,Qatar,"Qatar
(Cornell University )",06/21 - 09/09,Non-essential workers and unemployed persons,Adults (18-64 years),4970,64.4% (63-65.7%),Self-referral,"Roche Diagnostics; NR
(0%; 99.8%)",High,Preprint,https://www.medrxiv.org/content/10.1101/2020.09.24.20200543v2,1/19/2021,3/17/2021
201124_Qatar_MinistryofPublicHealth_Overall_popadj,11/24/2020,MohamedH.Al-Thani,National,Qatar,"Qatar
(Ministry of Public Health)",07/26 - 09/09,Non-essential workers and unemployed persons,Multiple groups,2641,55.3% (53.3-57.3%),Stratified probability,"Roche, Switzerland; NR
(95%; 99.8%)",Low,Preprint,https://www.medrxiv.org/content/10.1101/2020.11.24.20237719v1,1/23/2021,3/1/2021
201214_Qatar_CornellUniversity-Qatar_Overall,12/14/2020,Gheyath Nasrallah,National,Qatar,"Qatar
(Cornell University - Qatar)",07/26 - 09/09,Essential non-healthcare workers,Adults (18-64 years),394,46.5% (41.6-51.4%),Self-referral,"Roche, Switzerland
Shenzhen Mindray Bio-Medical Electronics Co., China
BioMérieux, Marcy-l’Etoile, France; NR
(88.6%; 99.9%)",High,Preprint,https://www.medrxiv.org/content/10.1101/2020.12.14.20248163v1.full,1/23/2021,3/1/2021
210106_Qatar_HamadMedicalCorporation_overall,1/6/2021,Peter V. Coyle,Sublocal,Qatar,"Doha; Qatar
(Hamad Medical Corporation)",05/12 - 09/09,Residual sera,Multiple groups,112941,13.3% (13.1-13.6%),Sequential,"Roche; NR
(0%; 0%)",Moderate,Preprint,10.1101/2021.01.05.21249247,2/2/2021,3/1/2021
200709_Korea_KoreaCentersforDiseaseControlandPrevention_Total,"7/9/2020, 7/10/2020","Ock Hyun-ju, Yang Ji-Ho",National,Republic of Korea,"Korea; Republic of Korea
(Korea Centers for Disease Control and Prevention)",NR - 07/09,Household and community samples,Not reported,3055,0% (NR),Unclear,"Not reported; Not reported; Not reported
(0%; 0%)",Unclear,"News and Media, News and Media","https://www.google.com/url?rct=j&sa=t&url=http://www.koreaherald.com/view.php%3Fud%3D20200709000787&ct=ga&cd=CAAYEDIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNG8AlCeBcx2rR4FfgC726ll5TtgUw, http://english.chosun.com/site/data/html_dir/2020/07/10/2020071001864.html",7/31/2020,3/1/2021
200716_Daegu_DaeguCatholicUniversityHospital_Overall,7/16/2020,Suk-Kyoon Song,Local,Republic of Korea,"Daegu; North Gyeongsang; Republic of Korea
(Daegu Catholic University Hospital)",05/25 - 06/05,Multiple populations,Multiple groups,198,7.6% (NR),Convenience,"Shin Jin Medics Inc; IgG; Solid phase immunochromatography
(100%; 92%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.3346/jkms.2020.35.e269,9/26/2020,3/17/2021
200824_Seoul_KoreaUniversity_Overall,8/24/2020,Ji Noh,Local,Republic of Korea,"Seoul; Republic of Korea
(Korea University)",05/25 - 05/29,Residual sera,Multiple groups,1500,0.1% (NR),Convenience,"Roche elecsys; IgG; Chemiluminescence Immunoassay
(99.5%; 99.8%)",High,Journal Article (Peer-Reviewed),https://jkms.org/DOIx.php?id=10.3346/jkms.2020.35.e311,10/4/2020,3/1/2021
201120_SouthKorea_SungkyunkwanUniversitySchoolofMedicine_DesHCW_ELISA1,11/20/2020,Jae-Hoon Ko,National,Republic of Korea,"Republic of Korea
(Sungkyunkwan University School of Medicine)",04/26 - 05/09,Health care workers and caregivers,Adults (18-64 years),309,0.3% (NR),Convenience,"PCL Inc; NR
(98.2%; 100%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.3389/fmicb.2020.587613,2/24/2021,3/5/2021
201120_SouthKorea_SungkyunkwanUniversitySchoolofMedicine_NonDesHCW_ELISA1,11/20/2020,Jae-Hoon Ko,National,Republic of Korea,"Republic of Korea
(Sungkyunkwan University School of Medicine)",04/26 - 05/09,Health care workers and caregivers,Adults (18-64 years),123,NA,Convenience,"PCL Inc; NR
(98.2%; 100%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.3389/fmicb.2020.587613,2/24/2021,3/5/2021
201123_Korea_KoreaDiseaseControlAndPreventionAgency_genpop,11/23/2020,KBS World,National,Republic of Korea,"Republic of Korea
(Korea Disease Control and Prevention Agency)",08/15 - 10/15,Household and community samples,Multiple groups,1379,0.1% (NR),Unclear,"NR; NR
(0%; 0%)",Unclear,News and Media,https://world.kbs.co.kr/service/news_view.htm?lang=e&Seq_Code=157801,3/7/2021,3/7/2021
201123_Korea_KoreaDiseaseControlAndPreventionAgency_genpop copy,11/23/2020,KBS World,National,Republic of Korea,"Republic of Korea
(Korea Disease Control and Prevention Agency)",08/15 - 10/15,Essential non-healthcare workers,Adults (18-64 years),6900,0.2% (NR),Unclear,"NR; NR
(0%; 0%)",Unclear,News and Media,https://world.kbs.co.kr/service/news_view.htm?lang=e&Seq_Code=157801,3/7/2021,3/7/2021
200424_Romania_MedLife_HCW,4/24/2020,MedLife,National,Romania,"Bucharest, Arad, Brasov, Sibiu, Piatra Neamt, Braila, Timisoara, Pitesti, Galati, Targoviste, Ploiesti; Nord-Est, Sud-Est, Sud-Mutenia, Sud-Vest Oltenia, Vest, Nord-Vest, Centru, Bucuresti-Ilfov; Romania
(MedLife)",03/24 - 04/21,Health care workers and caregivers,Multiple groups,371,3% (NR),Convenience,"Abbott, Maglumi, YHLO; IgG, IgM; Chemiluminescence, ELISA
(0%; 0%)",Unclear,Institutional Report,https://www.medlife.ro/comunicat-de-presa/concluzii-preliminare-studiu-medlife-cel-mai-probabil-populatia-nu-are-imunitate-dobandita-natural-pentru-covid-19-respectarea-masurilor-de-protectie-si-extinderea-testarii-reprezinta-sansa-noastra-de-a-functiona-in-siguranta-si-de-a,6/27/2020,3/1/2021
210104_Romania_CarolDavilaUniversityofMedicineAndPharmacy_Overall_adj,1/4/2021,,Sublocal,Romania,"Bucharest; Romania
(Carol Davila University of Medicine and Pharmacy)",05/17 - 12/01,Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),546,6% (NR),Convenience,"LIAISON; NR
(90.7%; 98.6%)",High,Preprint,10.20944/preprints202101.0024.v1,1/23/2021,3/22/2021
210107_Romania_UniversityCollegeLondon_PaediatricHCW,1/27/2021,D. Goldblatt,Sublocal,Romania,"Romania
(University College London)",05/14 - 05/27,Health care workers and caregivers,Adults (18-64 years),124,0.8% (0.1-4.3%),Convenience,"Epitope Diagnostics; NR
(100%; 88.7%)",High,Journal Article (Peer-Reviewed),http://dx.doi.org/10.1016/j.jhin.2020.12.019,3/13/2021,3/16/2021
200611_Russia_NationalCouncilCombatingCoronavirus_GenPop,6/10/2020,Sergei Kiselyov,National,Russian Federation,"Russian Federation
(Russian National Council for Combating Coronavirus)",NR - 06/10,Household and community samples,Multiple groups,650000,14% (NR),Unclear,"Invitro; Not reported; Not reported
(95%; 98%)",Moderate,News and Media,https://www.themoscowtimes.com/2020/06/10/1-in-7-russians-have-coronavirus-immunity-official-a70540 ; https://www.interfax.ru/russia/712617,6/27/2020,3/1/2021
200626_Moscow_CityofMoscow,6/26/2020,Jonny Tickle,Local,Russian Federation,"Moscow; Central Russia; Russian Federation
(City of Moscow)",06/05 - 06/18,Household and community samples,Not reported,90000,19.9% (NR),Simplified probability,"Not reported; Not reported; Not reported
(0%; 0%)",High,News and Media,https://www.google.com/url?rct=j&sa=t&url=https://www.rt.com/russia/493055-moscow-mass-antibody-testing/&ct=ga&cd=CAEYESoUMTExMTExNDMxMTUyMzY3OTYzMDcyGjkwZGVhOTg5OTRlOTE4NTk6Y29tOmVuOlVT&usg=AFQjCNHh2eLjbkaY212mSAjMBempJCE7bA,7/31/2020,3/1/2021
201007_MinistryofHealthofRussianFederation_employees,10/7/2020,LV Krechetova,Sublocal,Russian Federation,"Moscow; Russian Federation
(Ministry of Health of Russia)",04/15 - 06/15,Health care workers and caregivers,Adults (18-64 years),1589,8.9% (NR),Unclear,"""NMITs Hematology"" Ministry of Health of the Russian Federation; NR
(0%; 0%)",Unclear,Journal Article (Peer-Reviewed),http://dx.doi.org/10.18565/aig.2020.7.122-128,1/16/2021,3/1/2021
201104_SaintPetersburg_EuropeanUniversity_ELISA_Overall_PopTestAdj,11/4/2020,Anton Barchuk,Local,Russian Federation,"Saint Petersburg; Russian Federation
(European University At St Petersburg)",05/27 - 06/26,Household and community samples,Multiple groups,988,7.2% (NR),Simplified probability,"Genetico; NR
(98.7%; 100%)",Low,Preprint,https://www.medrxiv.org/content/10.1101/2020.11.02.20221309v1,1/23/2021,3/15/2021
210205_Ekaterinburg_RussianAcademyOfSciences_overall,2/5/2021,M. Sarapultseva,Local,Russian Federation,"Ekaterinburg; Russian Federation
(Russian Academy of Sciences)",05/15 - 08/15,Health care workers and caregivers,Adults (18-64 years),157,11.5% (NR),Convenience,"VECTOR-BEST; NR
(0%; 0%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1177/2380084421993099,2/20/2021,3/1/2021
200920_Leningrad_Saint-PetersburgPasteurResearchInstitute_Overall,9/16/2020,A.Yu. Popova,Regional,Russian Federation,"Northwestern Region; Russian Federation
(Saint-Petersburg Pasteur Research Institute of Epidemiology and Microbiology)",06/23 - 06/26,Household and community samples,Multiple groups,3130,20.7% (NR),Simplified probability,"State Scientific Center of Applied Microbiology and Biotechnology (Obolensk); NR
(0%; 0%)",High,Journal Article (Peer-Reviewed),https://journal.microbe.ru/jour/article/view/1371/1150#,3/11/2021,3/15/2021
201019_Irkutsk_IrkutskResearchAnti-PlagueInstitute,10/10/2020,A.Yu. Popova,Regional,Russian Federation,"Irkutsk Region; Russian Federation
(Irkutsk Research Anti-Plague Institute)",06/28 - 07/19,Household and community samples,Multiple groups,2674,5.8% (5.4-6.3%),Simplified probability,"State Scientific Center Applied Microbiology and Biotechnology, Obolensk; NR
(0%; 0%)",Moderate,Journal Article (Peer-Reviewed),https://journal.microbe.ru/jour/article/view/1370/1149,3/14/2021,3/20/2021
200923_Saint-Petersburg_Saint-PetersburgPasteurResearchInstituteofEpidemiologyandMicrobiology_Overall,9/23/2020,A.Yu. Popova,Local,Russian Federation,"Saint-Petersburg; Russian Federation
(Saint-Petersburg Pasteur Research Institute of Epidemiology and Microbiology)",06/15 - 06/20,Household and community samples,Multiple groups,2713,26% (NR),Unclear,"State Scientific Center for Applied Microbiology and Biotechnologies (Obolensk); NR
(0%; 0%)",Unclear,Journal Article (Peer-Reviewed),https://journal.microbe.ru/jour/article/view/1372/1151,3/20/2021,3/21/2021
201001_TyumenRegion_SaintPetersburgPasteurInstitute,10/1/2020,Anna Yu. Popova,Regional,Russian Federation,"Tyumen region; Russian Federation
(Saint Petersburg Pasteur Institute)",06/07 - 06/20,Household and community samples,Multiple groups,2758,24.5% (22.9-26.1%),Simplified probability,"State Research Center for Applied Microbiology and Biotechnology of Rospotrebnadzor.; NR
(0%; 0%)",High,Journal Article (Peer-Reviewed),https://microbiol.elpub.ru/jour/article/view/890/520,3/20/2021,3/21/2021
200906_Madinah_KingFahadGeneralHospital_HCWs_Overall,9/6/2020,Suliman Alharbi,Local,Saudi Arabia,"Madinah; Hejaz; Saudi Arabia
(King Fahad General Hospital)",04/18 - 06/17,Health care workers and caregivers,Adults (18-64 years),330,24.2% (NR),Unclear,"Vircell Microbiologists; IgM, IgA, IgG; ELISA
(0%; 0%)",High,Journal Article (Peer-Reviewed),https://assets.cureus.com/uploads/original_article/pdf/39817/1599507536-20200907-8365-icotwh.pdf,9/28/2020,3/1/2021
201120_SaudiArabia_SaudiCDC_Overall,11/20/2020,Haleema Ali Alserehi,National,Saudi Arabia,"Hail, Najran, Baha, Qassim, Norther Border, Jazan, Riyadh, Eastern Region, Aseer, Madinah, Makkah; Saudi Arabia
(Saudi Center for Disease Prevention and Control)",05/20 - 05/30,Health care workers and caregivers,Adults (18-64 years),12621,2.4% (NR),Convenience,"Abbott Laboratories; NR
(0%; 0%)",Moderate,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1016/j.diagmicrobio.2020.115273,1/23/2021,3/1/2021
210112_Dammam_KingFahadSpecialistHospital_Overall,1/12/2021,Alanoud Alshami,Local,Saudi Arabia,"Dammam; Eastern Province; Saudi Arabia
(King Fahad Specialist Hospital)",08/15 - 10/12,Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),72,12.5% (NR),Sequential,"DIasorine, Abbott Laboratories; NR
(97.6%; 99.3%)",High,Preprint,https://assets.researchsquare.com/files/rs-140932/v1/a7cb2461-27b8-4eca-bf34-171b60bb1272.pdf,2/5/2021,3/14/2021
210116_SaudiArabia_MinistryofHealth_overall,1/16/2021,Ayman Banjar,National,Saudi Arabia,"Saudi Arabia
(Ministry of Health (Saudi Arabia))",05/20 - 05/25,Blood donors,Adults (18-64 years),837,1.4% (NR),Sequential,"Roche Diagnostics; NR
(99.8%; 99.5%)",Moderate,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1016/j.ijid.2021.01.028,2/7/2021,3/1/2021
210105_SaudiArabia_KingAbdulazizUniversity_overall,1/5/2021,Thamir Alandijany,Sublocal,Saudi Arabia,"Jeddah; Saudi Arabia
(King Abdulaziz University)",01/01 - 05/31,Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),956,0% (NR),Convenience,"Authors; NR
(100%; 98.4%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.3390/healthcare9010051,2/10/2021,3/1/2021
201206_Al-Madinah_TaibahUniversity_Overall,12/6/2020,Waleed Mahallawi,Sublocal,Saudi Arabia,"Al-Madinah; Saudi Arabia
(Taibah University)",05/15 - 07/15,Blood donors,Adults (18-64 years),1212,19.3% (17.1-21.6%),Convenience,"In-house; NR
(0%; 0%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1016/j.sjbs.2020.12.009,2/17/2021,3/1/2021
210131_Riyadh_KingAbdullahInternationalMedicalResearchCenter_HCW_overall,1/31/2021,Naif Khalaf Alharbi,Local,Saudi Arabia,"Riyadh city; Saudi Arabia
(King Abdullah International Medical Research Center)",06/15 - 11/15,Health care workers and caregivers,Adults (18-64 years),,7.5% (5-10.2%),Unclear,"N/A - Author designed; NR
(0%; 0%)",Unclear,Preprint,10.1101/2021.01.28.21250598,3/4/2021,3/4/2021
200429_Singapore_NCID_GeneralPopulation,4/29/2020,Rei Kurohi,Local,Singapore,"Singapore; Singapore
(Singapore National Centre for Infectious Diseases)",02/15 - 04/15,Household and community samples,Multiple groups,774,NA,Unclear,"Not reported; Not reported; Not reported
(0%; 0%)",Unclear,News and Media,https://www.straitstimes.com/singapore/health/coronavirus-community-transmission-in-spore-very-low-but-so-is-herd-immunity-says,5/3/2020,3/1/2021
200429_Singapore_Singapore_NCID_HCW,4/29/2020,Rei Kurohi,Sublocal,Singapore,"Singapore; Singapore
(Singapore National Centre for Infectious Diseases)",02/15 - 04/15,Health care workers and caregivers,Not reported,1096,NA,Unclear,"Not reported; Not reported; Not reported
(0%; 0%)",Unclear,News and Media,https://www.straitstimes.com/singapore/health/coronavirus-community-transmission-in-spore-very-low-but-so-is-herd-immunity-says,5/3/2020,3/1/2021
210209_Singapore_MinistryOfHealthSingapore,2/9/2021,Iain Tan,Sublocal,Singapore,"Singapore; Singapore
(Ministry of Health Singapore)",03/25 - 07/25,Multiple populations,Adults (18-64 years),135760,60.1% (NR),Entire sample,"Siemens, Abbott, or Roche; NR
(0%; 0%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jama.2020.24071,3/6/2021,3/6/2021
201102_Singapore_NationalCentreForInfectiousDiseases_overall,11/2/2020,Oon Tek Ng,National,Singapore,"Singapore
(National Centre for Infectious Diseases, Singapore)",01/23 - 04/03,Contacts of COVID patients,Multiple groups,1150,3.8% (NR),Entire sample,"N/A - author designed; NR
(98.9%; 100%)",Moderate,Journal Article (Peer-Reviewed),https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(20)30833-1/fulltext?dgcid=raven_jbs_etoc_email,3/12/2021,3/13/2021
201228_CapeTown_StellenboschUniversity_overall,12/28/2020,Jane Alexandra Shaw,Sublocal,South Africa,"Cape Town; South Africa
(StellenboschUniversity)",08/17 - 09/04,Essential non-healthcare workers,Adults (18-64 years),405,23.7% (NR),Simplified probability,"Abbott Laboratories; NR
(0%; 98.54%)",Moderate,Preprint,10.21203/rs.3.rs-136543/v1,1/31/2021,3/8/2021
200928_CapeTown_UniversityofCapeTown_overall_testadj,9/20/2020,Marvin Hsiao,Local,South Africa,"Cape Town; South Africa
( University of Cape Town)",06/15 - 08/07,Residual sera,Adults (18-64 years),2791,44.6% (42.6-46.6%),Sequential,"Roche Diagnostics; NR
(91.2%; 99.7%)",Moderate,Institutional Report,https://www.nicd.ac.za/wp-content/uploads/2020/09/COVID-19-Special-Public-Health-Surveillance-Bulletin_Issue-5.pdf,3/3/2021,3/7/2021
210107_CapeTown_UniversityCollegeLondon_PaediatricHCW,1/27/2021,D. Goldblatt,Sublocal,South Africa,"Cape Town; South Africa
(University College London)",06/10 - 08/17,Health care workers and caregivers,Adults (18-64 years),222,10.4% (7-15.1%),Convenience,"Epitope Diagnostics; NR
(100%; 88.7%)",High,Journal Article (Peer-Reviewed),http://dx.doi.org/10.1016/j.jhin.2020.12.019,3/13/2021,3/14/2021
200530_Madrid_UniversitarioFundacionAlcorcon_hcw,5/29/2020,Isabel Galan,Sublocal,Spain,"Madrid; Community of Madrid; Spain
(Hospital Universitario Fundación Alcorcón)",04/14 - 04/27,Health care workers and caregivers,Adults (18-64 years),2590,31.6% (NR),Convenience,"Diapro; IgG; ELISA
(90.8%; 0%)",High,Preprint,https://www.medrxiv.org/content/10.1101/2020.05.29.20116731v1,6/1/2020,3/1/2021
200616_Madrid_UniversidadAutónomadeMadrid_TotalPop,6/16/2020,Vicente Soriano,Local,Spain,"Madrid; Community of Madrid; Spain
( Universidad Autónoma de Madrid)",04/26 - 05/16,Multiple populations,Multiple groups,674,13.8% (NR),Sequential,"PCL Inc.; IgG, IgM; Rapid immunochromatographic test
(0%; 0%)",High,Journal Article (Peer-Reviewed),https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciaa769/5858269,6/18/2020,3/17/2021
200626_Barcelona_InstitutCatala_HCWOverall,6/26/2020,Gema Fernández-Rivas,Local,Spain,"Barcelona; Catalonia; Spain
(Institut Catala de la Salut)",05/04 - 05/22,Health care workers and caregivers,Adults (18-64 years),7563,9.4% (NR),Self-referral,"DiaSorin LIAISON; IgG; Chemiluminescence Immunoassay
(0%; 0%)",Moderate,Preprint,https://www.medrxiv.org/content/10.1101/2020.06.24.20135673v1,7/18/2020,3/1/2021
200706_Spain_InstituteofHealthCarlosIII_GeneralPopulation_ImmunoAssay,7/6/2020,Marina Pollán,National,Spain,"Spain
(Institute of Health Carlos III)",04/27 - 05/11,Household and community samples,Multiple groups,51958,4.6% (4.3-5%),Stratified probability,"Abbott; IgG; Chemiluminescence Immunoassay
(89.7%; 100%)",Low,Journal Article (Peer-Reviewed),https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31483-5/fulltext,7/21/2020,3/1/2021
200606_Leon_UniversidadedeLeon_HCWs_TestAdj2,6/6/2020,Vicente Martin,Local,Spain,"Léon; Léon; Spain
(Gerencia de Atención Primaria del Área de Salud de León, Spain)",04/01 - 04/15,Health care workers and caregivers,Adults (18-64 years),676,7.4% (5.5-10%),Convenience,"Hangzhou All Test Biotech Co Ltd; IgG, IgM; RDT
(0%; 0%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1016/j.semerg.2020.05.014,7/30/2020,3/1/2021
200806_Valencia_HospitalClínicoUniversitario_HCWs_IgG_and_IgM,8/6/2020,Arantxa Valdivia,Local,Spain,"Valencia; Valencia; Spain
(Hospital Clínico Universitario)",04/13 - 04/30,Health care workers and caregivers,Adults (18-64 years),1153,3.5% (NR),Unclear,"Snibe Diagnostic; IgG, IgM; Chemiluminescence Immunoassay
(95.6%; 96%)",High,Journal Article (Peer-Reviewed),https://onlinelibrary.wiley.com/doi/full/10.1002/jmv.26400,9/27/2020,3/1/2021
200729_Fuenlabrada_HospitalUniversitariodeFuenlabrada_IgG,7/29/2020,Javier Fernandez,Sublocal,Spain,"Fuenlabrada; Spain
(Hospital Universitario de Fuenlabrada)",04/14 - 05/13,Health care workers and caregivers,Adults (18-64 years),2439,16.9% (NR),Convenience,"Snibe Diagnostic; IgG; Chemiluminescence Immunoassay
(0%; 0%)",High,Preprint,https://www.medrxiv.org/content/10.1101/2020.07.26.20162529v1,9/28/2020,3/1/2021
200810_Spain_CostadelSolHospital_HCW_IgGANDORIgM,8/10/2020,Julián Olalla,Sublocal,Spain,"Marbella; Spain
( Hospital Costa del Sol )",04/15 - 04/25,Health care workers and caregivers,Adults (18-64 years),498,2.2% (NR),Self-referral,"""Zhejiang Orient Gene Biotech Co., LTD""; IgG, IgM; Solid phase immunochromatography
(0%; 0%)",High,Journal Article (Peer-Reviewed),http://dx.doi.org/10.1093/qjmed/hcaa238,10/3/2020,3/1/2021
200617_TorrejonDeArdoz_MunicipalityOfTorrejonDeArdoz_IgGIgM,6/17/2020,Daniel Flores,Local,Spain,"Torrejon de Ardoz; Spain
(Municipality of Torrejon de Ardoz)",05/29 - 06/03,Household and community samples,Multiple groups,104299,23.1% (NR),Entire sample,"Not reported; IgG, IgM; Not reported
(0%; 0%)",Moderate,Institutional Report,https://www.rtve.es/noticias/20200617/test-serologicos-torrejon-ardoz-arrojan-2018-habitantes-tiene-anticuerpos-coronavirus/2018787.shtml,10/8/2020,3/17/2021
200831_Madrid_HospitalGeneralUniversitarioGregorioMaranon_Overall_UnAdj,8/31/2020,Luis Cabezón-Gutiérrez,Sublocal,Spain,"Torrejon de Ardoz; Community of Madrid; Spain
(Hospital General Universitario Gregorio Maranon)",06/01 - 06/19,Patients seeking care for non-COVID-19 reasons,Multiple groups,229,31.4% (NR),Convenience,"Hangzhou Testsea Biotechnology; IgG, IgM; Not reported
(96%; 100%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1016/j.ctrv.2020.102102,10/20/2020,3/1/2021
200918_Madrid_UniversityHospitalGregorioMarañón_Overall,9/18/2020,Maria Viñuela,Local,Spain,"Madrid; Spain
(University Hospital Gregorio Marañón)",05/06 - 05/21,Pregnant or parturient women,Adults (18-64 years),100,13% (NR),Sequential,"Abbott; IgG; Chemiluminsescent microparticle immunoassay
(0%; 0%)",High,Journal Article (Peer-Reviewed),http://dx.doi.org/10.37201/req/088.2020,11/12/2020,3/17/2021
200806_Barcelona_UniversitatdeBarcelona_PregnantWomen_Overall,8/6/2020,Francesca Crovetto,Sublocal,Spain,"Barcelona; Spain
(Universitat de Barcelona)",04/14 - 05/05,Pregnant or parturient women,Adults (18-64 years),874,14% (NR),Convenience,"Vircell Microbiologist, Ortho Clinical Diagnostics; NR
(0%; 0%)",High,Journal Article (Peer-Reviewed),https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31714-1/fulltext,1/3/2021,3/1/2021
200911_Santiago_HospitalClinicoUniversitariodeSantiagodeCompostela_Overall,9/11/2020,Ana Dacosta-Urbieta,Sublocal,Spain,"Santiago de Compostela; Galicia; Spain
(Hospital Clinico Universitario de Santiago de Compostela)",04/14 - 04/16,Health care workers and caregivers,Adults (18-64 years),175,4% (1.1-6.9%),Convenience,"Genobio Pharmaceutical, Shanghai, China; NR
(0%; 0%)",High,Journal Article (Peer-Reviewed),http://dx.doi.org/10.3389/fped.2020.00547,1/5/2021,3/1/2021
201021_Spain_IVIRMA_Overall,9/1/2020,Nicolás Prados,National,Spain,"Spain
(IVIRMA Global Headquarters)",04/27 - 06/26,Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),6140,0.7% (NR),Convenience,"Epitope Diagnostics; NR
(0%; 0%)",Unclear,Journal Article (Peer-Reviewed),http://dx.doi.org/10.1016/j.fertnstert.2020.09.077,1/8/2021,3/1/2021
200911_Barcelona_SardenyaPrimaryHealthCareCenter_Overall,9/11/2020,Patricia Montenegro,Local,Spain,"Barcelona; Catalonia; Spain
( Sardenya Primary Health Care Center)",04/21 - 04/24,Household and community samples,Multiple groups,311,5.5% (3.4-8.6%),Stratified probability,"Livzlon, Lysine and Sure Screen; NR
(0%; 0%)",High,Journal Article (Peer-Reviewed),http://dx.doi.org/10.1093/fampra/cmaa096,1/8/2021,3/1/2021
201024_Madrid_HospitalUniversitarioPrincipeDeAsturias_HCW_Overall,10/29/2020,Felipe Perez-Garcia ,Sublocal,Spain,"Madrid; Spain
(Hospital Universitario Príncipe de Asturias)",05/01 - 05/30,Health care workers and caregivers,Adults (18-64 years),2424,22.4% (NR),Convenience,"AllTest Biotech; NR
(88%; 100%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1017/ice.2020.1303,1/8/2021,3/1/2021
201111_Barcelona_UniversityofBarcelona_HCW,11/11/2020,Gemma Moncunill,Sublocal,Spain,"Barcelona; Spain
(University of Barcelona)",04/27 - 05/06,Health care workers and caregivers,Not reported,565,14.5% (NR),Simplified probability,"Luminex Corporation; NR
(0%; 0%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1093/infdis/jiaa696,1/20/2021,3/9/2021
201112_Barcelona_UniversityHospitalSantJoandeDeu_HHC_primaryest,11/12/2020,Pedro Brotons,Local,Spain,"Barcelona; Catalonia; Spain
(University Hospital Sant Joan de Deu)",04/28 - 06/03,Contacts of COVID patients,Multiple groups,1084,18.1% (NR),Convenience,"Innovita Tangshan Biological Technology Co; NR
(83.3%; 0%)",Moderate,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1093/cid/ciaa1721,1/23/2021,3/7/2021
201125_Valencia_HospitalArnauDeVilanova_Overall,11/25/2020,Javier Garde-Noguera,Local,Spain,"Valencia; Valencia; Spain
(Hospital Arnau de Vilanova de Valencia, Spain)",05/02 - 06/30,Patients seeking care for non-COVID-19 reasons,Multiple groups,166,1.8% (NR),Sequential,"DiaSorin; NR
(0%; 0%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.3390/cancers12123513,1/23/2021,3/1/2021
201130_Spain_UniversityofZaragoza_unadj,11/30/2020,Ricardo Savirón-Cornudella,Sublocal,Spain,"Madrid; Spain
(University of Zaragoza)",03/31 - 08/31,Pregnant or parturient women,Adults (18-64 years),260,6.9% (NR),Sequential,"Biozek
Abbott
Vircell; NR
(89%; 91%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1016/j.ejogrb.2020.11.069,1/23/2021,3/17/2021
201026_Zaragoza_HospitalSanJuandeDios_HCW_primary,11/13/2020,Luis Antonio Moreno Borraz,Sublocal,Spain,"Zaragoza; Aragon; Spain
(Hospital San Juan de Dios)",03/20 - 04/21,Health care workers and caregivers,Adults (18-64 years),289,5.9% (NR),Convenience,"Master Labor S.L., Madrid; NR
(100%; 98%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1016/j.regg.2020.10.005,1/27/2021,3/5/2021
201026_Zaragoza_HospitalSanJuandeDios_patients_primary,11/13/2020,Luis Antonio Moreno Borraz,Sublocal,Spain,"Zaragoza; Aragon; Spain
(Hospital San Juan de Dios)",03/20 - 04/21,Patients seeking care for non-COVID-19 reasons,Multiple groups,229,7% (NR),Convenience,"Master Labor S.L., Madrid; NR
(100%; 98%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1016/j.regg.2020.10.005,1/27/2021,3/5/2021
201014_Alicante_COVID-19GroupoftheInfectionsCommission,10/14/2020,Paula Gras-Valentí,Sublocal,Spain,"Alicante; Alacant; Spain
(COVID-19 Group of the Infections Commission)",04/24 - 05/08,Health care workers and caregivers,Adults (18-64 years),4179,6.6% (5.8-7.3%),Unclear,"NR; NR
(0%; 0%)",Unclear,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1016/j.eimc.2020.09.015,1/29/2021,3/6/2021
201228_Barcelona_InstitutCatalàdelaSalut_HCW_primary,12/28/2020,Jaume Barallat,Local,Spain,"Barcelona; Spain
(Institut Català de la Salut)",05/04 - 05/22,Health care workers and caregivers,Multiple groups,7563,10.3% (NR),Self-referral,"DiaSorin, Vercelli, Italy; Abbott Diagnostics, Sligo, Italy; NR
(0%; 0%)",Moderate,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1371/journal.pone.0244348,1/30/2021,3/16/2021
201202_Tenerife_ QuironsaludTenerifeHospital_patients_primary,12/2/2020,Alejandro Hernández Camba,Sublocal,Spain,"Tenerife; Canary Islands; Spain
( Quironsalud Tenerife Hospital)",04/27 - 06/15,Patients seeking care for non-COVID-19 reasons,Multiple groups,211,1.9% (0.1-4.8%),Sequential,"Roche Diagnostics; NR
(99.5%; 99.8%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.17235/reed.2020.7434/2020,1/31/2021,3/1/2021
201130_Madrid_UniversidadComplutensedeMadrid,11/30/2020,Cecilia Villalaın,Sublocal,Spain,"Madrid; Spain
(The Universidad Complutense de Madrid)",02/28 - 05/10,Pregnant or parturient women,Adults (18-64 years),769,11.2% (NR),Sequential,"NR; NR
(0%; 0%)",Unclear,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1371/journal.pone.0243029,1/31/2021,3/1/2021
210114_Fuenlabrada_HospitalUniversitariodeFuenlabrada_HCW_IgG,1/14/2021,Javier Fernandez,Sublocal,Spain,"Fuenlabrada; Spain
(Hospital Universitario de Fuenlabrada)",05/13 - 04/14,Health care workers and caregivers,Adults (18-64 years),2439,16.9% (NR),Convenience,"Snibe diagnostic; NR
(100%; 0%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1371/journal.pone.0245001,2/4/2021,3/21/2021
210112_Spain_HMHospitales_overall,1/12/2021,Jose F. Varona,National,Spain,"Spain
(HM Hospidales)",04/15 - 06/30,Health care workers and caregivers,Multiple groups,6038,11% (NR),Convenience,"Snibe Diagnostic; NR
(91.21%; 97.66%)",Moderate,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1093/ije/dyaa277,2/6/2021,3/1/2021
201221_Spain_HospitalClínicoUniversitarioLozanoBlesa,12/21/2020,M Fabre,Sublocal,Spain,"Zaragoza; Zaragoza; Spain
(Hospital Clínico Universitario Lozano Blesa)",04/27 - 05/29,Pregnant or parturient women,Adults (18-64 years),169,8.3% (NR),Unclear,"Guangzhou Wondfo Biotech Co.; NR
(0%; 0%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1177/0004563220980495,2/7/2021,3/7/2021
210127_Madrid_UH-FundacionJimenezDiazUAM_primary,1/27/2021,Maria Soledad Pizarro-Sánchez,Sublocal,Spain,"Madrid; Spain
(UH-Fundacion Jimenez Diaz UAM)",03/01 - 03/30,Patients seeking care for non-COVID-19 reasons,Not reported,28,42.9% (NR),Convenience,"Vircell; NR
(0%; 0%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1159/000512535,2/27/2021,3/1/2021
210209_Madrid_HospitalUniversitarioVirgendelRocio,2/9/2021,Ana Mendez-Echevarria,Local,Spain,"Madrid; Community of Madrid; Spain
(Hospital Universitario Virgen del Rocio)",03/01 - 05/31,Contacts of COVID patients,Children and Youth (0-17 years),113,41.6% (NR),Convenience,"Vircell; NR
(0%; 0%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1097/INF.0000000000003088,3/11/2021,3/11/2021
210119_Madrid_HospitalInfantilUniversitarioNiñoJesús,1/19/2021,Eva Escribano Ceruelo,Sublocal,Spain,"Madrid; Community of Madrid; Spain
(Hospital Infantil Universitario Niño Jesús)",04/13 - 04/30,Health care workers and caregivers,Adults (18-64 years),1292,17.2% (15.2-19.4%),Convenience,"All Test; NR
(0%; 0%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1016/j.eimc.2020.12.011,3/16/2021,3/19/2021
210318_Barcelona_UniversitatDeBarcelona_overall,3/18/2021,Francesca Crovetto,Local,Spain,"Barcelona; Spain
(Universitat de Barcelona)",03/05 - 05/31,Pregnant or parturient women,Adults (18-64 years),2225,14.1% (NR),Sequential,"1) Vircell

2) Ortho Clinical Diagnostics

3) N/A - institution designed; NR
(0%; 0%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1093/cid/ciab104,3/18/2021,3/18/2021
200623_Sweden_DanderydHospital_HealthCareWorkers,6/23/2020,Ann-Sofie Rudberg,Local,Sweden,"Stockholm; Uppland; Sweden
(Danderyd Hospital)",04/14 - 05/08,Health care workers and caregivers,Adults (18-64 years),2149,19.1% (NR),Convenience,"Author-designed; IgG; Multiplex immunoassay
(99.4%; 99.1%)",Moderate,Preprint,https://www.medrxiv.org/content/10.1101/2020.06.22.20137646v1,6/25/2020,3/1/2021
200702_Stockhom_KTHRoyalInstituteofTechnology_genpop,7/2/2020,Niclas Roxhed,Local,Sweden,"Stockholm; Uppland; Sweden
(KTH Royal Institute of Technology)",04/01 - 05/21,Household and community samples,Multiple groups,878,5.4% (NR),Simplified probability,"Author-designed; IgG, IgM; Multiplex immunoassay
(100%; 100%)",Moderate,Preprint,https://www.medrxiv.org/content/10.1101/2020.07.01.20143966v1,7/14/2020,3/1/2021
200720_Uppsala_UppsalaUniversity_Total,7/20/2020,Anna-Karin Lidström,Regional,Sweden,"Uppsala; Sweden
(Uppsala University )",05/27 - 06/25,Health care workers and caregivers,Multiple groups,8679,6.6% (NR),Entire sample,"Abbott; IgG; Chemiluminescence Immunoassay
(0%; 0%)",Moderate,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1080/03009734.2020.1793039,8/1/2020,3/1/2021
200723_Sweden_Werlabs_GenPop,7/23/2020,The Local,Local,Sweden,"Stockholm, Gothenburg, Malmo; Skåne, Västra Götaland, Uppland; Sweden
(Werlabs)",07/01 - 07/22,Household and community samples,Not reported,83000,14.4% (NR),Unclear,"Werlabs; Not reported; Not reported
(0%; 0%)",High,News and Media,https://www.google.com/url?rct=j&sa=t&url=https://www.thelocal.se/20200723/14-of-antibody-tests-positive-in-sweden&ct=ga&cd=CAAYBzIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNHl1If-XI0aCeB5tGakbaJvFktByQ,8/2/2020,3/1/2021
200805_Stockholm_UppsalaUniversity_CaregiversOverall_IgGORIgM,8/5/2020,Johanna Lindahl,Local,Sweden,"Stockholm; Sweden
(Uppsala University )",04/01 - 04/20,Health care workers and caregivers,Adults (18-64 years),1005,23.3% (20.4-25.7%),Convenience,"Zhejiang Orient Gene Biotech Co Ltd; IgG, IgM; LFIA: Lateral flow immunoassay
(0%; 0%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1080/20008686.2020.1789036,10/14/2020,3/1/2021
200811_Stockholm_UppsalaUniversity_Djurgårdsstaden_TotalAbpositive,8/11/2020,Åke Lundkvist,Sublocal,Sweden,"Stockholm; Södermanland, Uppland; Sweden
(Uppsala University )",06/17 - 06/18,Household and community samples,Adults (18-64 years),123,4.1% (0.6-7.6%),Simplified probability,"Zhejiang Orient Gene Biotech Co Ltd; IgG, IgM; Rapid point-of care
(100%; 95.5%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1080/20008686.2020.1806505,10/16/2020,3/1/2021
200811_Stockholm_UppsalaUniversity_Tensta_TotalAbPositive,8/11/2020,Åke Lundkvist,Sublocal,Sweden,"Stockholm; Södermanland, Uppland; Sweden
(Uppsala University )",06/17 - 06/18,Household and community samples,Adults (18-64 years),90,30% (20.3-39.7%),Simplified probability,"Zhejiang Orient Gene Biotech Co Ltd; IgG, IgM; Rapid point-of care
(100%; 95.5%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1080/20008686.2020.1806505,10/16/2020,3/1/2021
200426_Sweden_SwedishPublicHealthAgency_Outpatients_Week17_Overall,6/18/2020,Swedish Public Health Agency,National,Sweden,"Jämtland-Härjedalen, Jönköping, Kalmar, Skåne, Stockholm, Uppsala, Västerbotten Västra Götaland, Örebro; Sweden
(Sweden Public Health Authority)",04/20 - 04/26,Residual sera,Multiple groups,1200,5.2% (3.8-6.9%),Stratified non-probability,"Sci LifeLab / KTH; Not reported; Multiplex immunoassay
(99.4%; 0%)",High,Institutional Report,https://www.folkhalsomyndigheten.se/contentassets/376f9021a4c84da08de18ac597284f0c/pavisning-antikroppar-genomgangen-covid-19-blodgivare-delrapport-2.pdf,10/24/2020,3/1/2021
200426_Sweden_SwedishPublicHealthAgency_Outpatients_Week18_Overall,6/18/2020,Swedish Public Health Agency,National,Sweden,"Jämtland-Härjedalen, Jönköping, Kalmar, Skåne, Stockholm, Uppsala, Västerbotten Västra Götaland, Örebro; Sweden
(Sweden Public Health Authority)",04/27 - 05/03,Residual sera,Multiple groups,1200,4.1% (2.8-5.6%),Stratified non-probability,"Sci LifeLab / KTH; Not reported; Multiplex immunoassay
(99.4%; 0%)",High,Institutional Report,https://www.folkhalsomyndigheten.se/contentassets/376f9021a4c84da08de18ac597284f0c/pavisning-antikroppar-genomgangen-covid-19-blodgivare-delrapport-2.pdf,10/25/2020,3/1/2021
200426_Sweden_SwedishPublicHealthAgency_Outpatients_Week19_Overall,6/18/2020,Swedish Public Health Agency,National,Sweden,"Jämtland-Härjedalen, Jönköping, Kalmar, Skåne, Stockholm, Uppsala, Västerbotten Västra Götaland, Örebro; Sweden
(Sweden Public Health Authority)",05/04 - 05/10,Residual sera,Multiple groups,1200,4.1% (2.9-5.6%),Stratified non-probability,"Sci LifeLab / KTH; Not reported; Multiplex immunoassay
(99.4%; 0%)",High,Institutional Report,https://www.folkhalsomyndigheten.se/contentassets/376f9021a4c84da08de18ac597284f0c/pavisning-antikroppar-genomgangen-covid-19-blodgivare-delrapport-2.pdf,10/25/2020,3/1/2021
200426_Sweden_SwedishPublicHealthAgency_Outpatients_Week20_Overall,6/18/2020,Swedish Public Health Agency,National,Sweden,"Jämtland-Härjedalen, Jönköping, Kalmar, Skåne, Stockholm, Uppsala, Västerbotten Västra Götaland, Örebro; Sweden
(Sweden Public Health Authority)",05/11 - 05/17,Residual sera,Multiple groups,1200,4.6% (3.2-6.2%),Stratified non-probability,"Sci LifeLab / KTH; Not reported; Multiplex immunoassay
(99.4%; 0%)",High,Institutional Report,https://www.folkhalsomyndigheten.se/contentassets/376f9021a4c84da08de18ac597284f0c/pavisning-antikroppar-genomgangen-covid-19-blodgivare-delrapport-2.pdf,10/25/2020,3/1/2021
200426_Sweden_SwedishPublicHealthAgency_Outpatients_Week21_Overall,6/18/2020,Swedish Public Health Agency,National,Sweden,"Jämtland-Härjedalen, Jönköping, Kalmar, Skåne, Stockholm, Uppsala, Västerbotten Västra Götaland, Örebro; Sweden
(Sweden Public Health Authority)",05/18 - 05/24,Residual sera,Multiple groups,1200,5.4% (3.9-7.2%),Stratified non-probability,"Sci LifeLab / KTH; Not reported; Multiplex immunoassay
(99.4%; 0%)",High,Institutional Report,https://www.folkhalsomyndigheten.se/contentassets/376f9021a4c84da08de18ac597284f0c/pavisning-antikroppar-genomgangen-covid-19-blodgivare-delrapport-2.pdf,10/25/2020,3/1/2021
200426_Sweden_SwedishPublicHealthAgency_Outpatients_Week22_Overall,6/18/2020,Swedish Public Health Agency,National,Sweden,"Jämtland-Härjedalen, Jönköping, Kalmar, Skåne, Stockholm, Uppsala, Västerbotten Västra Götaland, Örebro; Sweden
(Sweden Public Health Authority)",05/25 - 05/31,Residual sera,Multiple groups,1200,5.6% (4-7.6%),Stratified non-probability,"Sci LifeLab / KTH; Not reported; Multiplex immunoassay
(99.4%; 0%)",High,Institutional Report,https://www.folkhalsomyndigheten.se/contentassets/376f9021a4c84da08de18ac597284f0c/pavisning-antikroppar-genomgangen-covid-19-blodgivare-delrapport-2.pdf,10/25/2020,3/1/2021
200426_Sweden_SwedishPublicHealthAgency_Outpatients_Week23_Overall,6/18/2020,Swedish Public Health Agency,National,Sweden,"Jämtland-Härjedalen, Jönköping, Kalmar, Skåne, Stockholm, Uppsala, Västerbotten Västra Götaland, Örebro; Sweden
(Sweden Public Health Authority)",06/01 - 06/07,Residual sera,Multiple groups,1200,7% (5.3-9%),Stratified non-probability,"Sci LifeLab / KTH; Not reported; Multiplex immunoassay
(99.4%; 0%)",High,Institutional Report,https://www.folkhalsomyndigheten.se/contentassets/376f9021a4c84da08de18ac597284f0c/pavisning-antikroppar-genomgangen-covid-19-blodgivare-delrapport-2.pdf,10/25/2020,3/1/2021
200426_Sweden_SwedishPublicHealthAgency_Outpatients_Week24_Overall,6/18/2020,Swedish Public Health Agency,National,Sweden,"Jämtland-Härjedalen, Jönköping, Kalmar, Skåne, Stockholm, Uppsala, Västerbotten Västra Götaland, Örebro; Sweden
(Sweden Public Health Authority)",06/08 - 06/14,Residual sera,Multiple groups,1200,5.6% (4.1-7.3%),Stratified non-probability,"Sci LifeLab / KTH; Not reported; Multiplex immunoassay
(99.4%; 0%)",High,Institutional Report,https://www.folkhalsomyndigheten.se/contentassets/376f9021a4c84da08de18ac597284f0c/pavisning-antikroppar-genomgangen-covid-19-blodgivare-delrapport-2.pdf,10/25/2020,3/1/2021
200716_Stockholm_RegionStockholm,7/16/2020,Stockholm Region,Local,Sweden,"Stockholm; Uppland; Sweden
(Sweden Public Health Authority)",06/15 - 07/15,Household and community samples,Multiple groups,149616,17.6% (NR),Self-referral,"Not reported; Not reported; Not reported
(0%; 0%)",High,Institutional Report,https://www.sll.se/verksamhet/halsa-och-vard/nyheter-halsa-och-vard/2020/07/16-juli-lagesrapport-om-arbetet-med-det-nya-coronaviruset/,10/25/2020,3/1/2021
200928_Sweden_CopenhagenUniversityHospital_Overall ,9/28/2020,Jannie Laursen,National,Sweden,"Sweden
(Copenhagen University Hospital)",06/22 - 08/10,Multiple populations,Multiple groups,1248,8.3% (NR),Self-referral,"Livzon Diagnostics; IgG, IgM; LFIA: Lateral flow immunoassay
(82.58%; 99.54%)",High,Preprint,https://www.medrxiv.org/content/10.1101/2020.09.26.20202259v1,11/26/2020,3/1/2021
201008_Stockholm_DanderydHospital,10/8/2020,Ann-Sofie Rudberg,Sublocal,Sweden,"Stockholm; Sodermanland; Sweden
(Danderyd Hospital)",04/14 - 05/08,Health care workers and caregivers,Adults (18-64 years),2149,19.1% (NR),Convenience,"Author designed; NR
(99.2%; 99.8%)",Moderate,Journal Article (Peer-Reviewed),http://dx.doi.org/10.1038/s41467-020-18848-0,12/10/2020,3/1/2021
201226_Stockholm_KarolinskaInstitutet,12/26/2020,Xaquin Castro Dopico,Local,Sweden,"Stockholm; Uppland; Sweden
(Karolinska Institutet)",03/14 - 12/11,Multiple populations,Adults (18-64 years),4100,14.8% (12.2-18%),Simplified probability,"Nunc Mixosorp; NR
(0%; 0%)",High,Preprint,https://www.medrxiv.org/content/10.1101/2020.12.24.20248821v1,2/4/2021,3/9/2021
210129_Stockholm_KarolinskaInstitutet_HCW,1/29/2021,Susanna Klevebro,Sublocal,Sweden,"Stockholm; Sweden
(Karolinska Institutet)",05/11 - 06/11,Health care workers and caregivers,Adults (18-64 years),3981,17.7% (NR),Convenience,"NR; NR
(99.2%; 99.8%)",High,Preprint,https://doi.org/10.1101/2021.01.28.21250664,2/21/2021,3/1/2021
201124_Vasteras_HospitalofVastmanland_HCW,11/24/2020,Mulki Rashid-Abdi,Sublocal,Sweden,"Vasteras; Sweden
(The Hospital of Vastmanland )",05/04 - 08/19,Health care workers and caregivers,Adults (18-64 years),131,19.1% (NR),Convenience,"Abbott; NR
(100%; 99.9%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1080/23744235.2020.1849787,2/23/2021,3/1/2021
210121_Sweden_CopenhagenUniversityHospital_Sweden,1/21/2021,Jannie Laursen,National,Sweden,"Sweden
(Copenhagen University Hospital)",06/22 - 08/10,Health care workers and caregivers,,1248,8.3% (NR),Convenience,"Livson Diagnostics, Zhuhai, Gunangdong, China; NR
(82.58%; 99.54%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.3390/ijerph18030923,2/25/2021,3/1/2021
200717_Switzerland_UniversityofLausanne_GenPop_LuminexAssay,7/17/2020,Craig Fenwick,Regional,Switzerland,"Vaud; Switzerland
(University of Lausanne)",05/04 - 06/27,Household and community samples,Multiple groups,311,6.4% (NR),Simplified probability,"Author-designed; IgG; Multiplex immunoassay
(97%; 100%)",High,Preprint,https://www.medrxiv.org/content/10.1101/2020.07.14.20153536v1,7/18/2020,3/1/2021
200918_Zurich_UniversityofZurich_AdultSampleOverall,9/18/2020,Agne Ulyte,Local,Switzerland,"Zurich; Canton of Zurich; Switzerland
(University of Zurich)",06/16 - 07/09,Household and community samples,Adults (18-64 years),577,3.3% (1.4-5.5%),Simplified probability,"Centre Hospitalier Universitaire Vaudois, Swiss Federal Institute of Technology in Lausanne, Swiss Vaccine Center; NR
(98.3%; 98.4%)",Moderate,Preprint,https://www.medrxiv.org/content/10.1101/2020.09.18.20191254v1,1/12/2021,3/1/2021
201213_Switzerland_CantonalHospitalStGallen_hcw_primaryest,12/13/2020,Christian R. Kahlert,Regional,Switzerland,"Canton of St. Gallen; Switzerland
(Cantonal Hospital St Gallen)",06/22 - 08/15,Health care workers and caregivers,Multiple groups,4664,3% (NR),Convenience,"ECLIA: Roche Diagnostics, Rotkreuz, Switzerland
ELISA: Euroimmune, Germany; NR
(0%; 0%)",Moderate,Preprint,https://www.medrxiv.org/content/10.1101/2020.11.10.20229005v3,1/13/2021,3/15/2021
201008_StGallen_CantonalHospitalStGallen_hcw,10/8/2020,Phillipp Kohler,Regional,Switzerland,"St. Gallen; St. Gallen; Switzerland
(Cantonal Hospital St. Gallen)",03/19 - 04/03,Health care workers and caregivers,Adults (18-64 years),1012,1% (NR),Convenience,"lateral flow immunochromatographic assay
(LFIA, Sugentech, Yuseong-gu, Daejeon, Republic of Korea), a
chemiluminescence microparticle immunoassay (CMIA, Abbott
Diagnostics, Lake Bluff, IL), and an electro-chemiluminescence
immunoassay (ECLIA, Roche Diagnostics, Basel, Switzerland); NR
(0%; 0%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1017/ice.2020.1244,1/17/2021,3/1/2021
201108_Geneva_GenevaUniversityHospital_Overall,11/8/2020,Klara Posfay-Barbe,Sublocal,Switzerland,"Geneva; Switzerland
(Geneva University Hospital)",04/01 - 04/30,Residual sera,Children and Youth (0-17 years),208,8.7% (NR),Sequential,"Euroimmun, N/A, N/A; NR
(0%; 0%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1093/cid/ciaa1702,1/17/2021,3/1/2021
201104_Geneva_JohnHopkins_Overall,1/16/2021,Qifang Bi,Regional,Switzerland,"Geneva; Switzerland
(Johns Hopkins Bloomberg School of Public Health)",04/03 - 06/30,Household and community samples,Multiple groups,4534,6.6% (6-7%),Convenience,"Euroimmun; NR
(93%; 99%)",High,Journal Article (Peer-Reviewed),https://www.medrxiv.org/content/10.1101/2020.11.04.20225573v2,1/18/2021,3/15/2021
201103_Vaud_UniversityofLausanne_GenPop1_Luminex,11/3/2020,Craig Fenwick,Regional,Switzerland,"Vaud; Switzerland
(Lausanne University Hospital and University of Lausanne)",05/04 - 06/27,Household and community samples,Multiple groups,311,6.4% (NR),Simplified probability,"Luminex; NR
(97%; 100%)",High,Journal Article (Peer-Reviewed),http://dx.doi.org/10.1128/JVI.01828-20,1/23/2021,3/1/2021
201103_Vaud_UniversityofLausanne_CloseContacts2_Luminex,11/3/2020,Craig Fenwick,Regional,Switzerland,"Vaud; Switzerland
(Lausanne University Hospital and University of Lausanne)",05/04 - 06/27,Contacts of COVID patients,Multiple groups,177,36.2% (NR),Unclear,"Luminex; NR
(97%; 100%)",High,Journal Article (Peer-Reviewed),http://dx.doi.org/10.1128/JVI.01828-20,1/23/2021,3/1/2021
201130_Vaud_ UniversityofLausanne_Household1_adj,11/30/2020,Julien Dupraz,Regional,Switzerland,"Vaud; Switzerland
(University of Lausanne)",05/04 - 06/27,Contacts of COVID patients,Multiple groups,302,57.2% (49.5-64.3%),Simplified probability,"Lausanne University Hospital, Switzerland; NR
(96.7%; 99.2%)",Moderate,Preprint,https://www.medrxiv.org/content/10.1101/2020.11.27.20239244v1,1/23/2021,3/1/2021
201130_Vaud_ UniversityofLausanne_CloseContactsOutsideHousehold2_adj,11/30/2020,Julien Dupraz,Regional,Switzerland,"Vaud; Switzerland
(University of Lausanne)",05/04 - 06/27,Contacts of COVID patients,Multiple groups,69,19% (10-33.2%),Simplified probability,"Lausanne University Hospital, Switzerland; NR
(96.7%; 99.2%)",Moderate,Preprint,https://www.medrxiv.org/content/10.1101/2020.11.27.20239244v1,1/23/2021,3/1/2021
201222_Zurich_UniversityofZurich_OverallAdj,12/22/2020,Agne Ulyte,Regional,Switzerland,"Zurich; Canton of Zurich; Switzerland
(University of Zurich)",06/16 - 11/19,Household and community samples,Children and Youth (0-17 years),2507,7.8% (6.2-9.5%),Stratified probability,"Institute of Medical Virology (IMV) of the University of Zurich; NR
(94.3%; 99%)",Low,Preprint,https://www.medrxiv.org/content/10.1101/2020.12.19.20248513v1,2/27/2021,3/1/2021
210201_Geneva_GenevaUniversityHospitals_overall_adj,2/1/2021,Silvia Stringhini,Local,Switzerland,"Geneva; Switzerland
(Geneva University Hospitals)",11/23 - 12/23,Household and community samples,Multiple groups,4000,21.1% (19.2-23.1%),Stratified probability,"Roche; NR
(0%; 0%)",Low,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1016/S1473-3099(21)00054-2,2/28/2021,3/1/2021
210201_Geneva_GenevaUniversityHospitals_age65-74,2/1/2021,Silvia Stringhini,Local,Switzerland,"Geneva; Switzerland
(Geneva University Hospitals)",11/23 - 12/23,Household and community samples,Seniors (65+ years),276,14.9% (10.9-19.5%),Stratified probability,"Roche; NR
(0%; 0%)",Low,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1016/S1473-3099(21)00054-2,2/28/2021,3/1/2021
210201_Geneva_GenevaUniversityHospitals_age50-64,2/1/2021,Silvia Stringhini,Local,Switzerland,"Geneva; Switzerland
(Geneva University Hospitals)",11/23 - 12/23,Household and community samples,Adults (18-64 years),729,21.2% (18.1-24.6%),Stratified probability,"Roche; NR
(0%; 0%)",Low,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1016/S1473-3099(21)00054-2,2/28/2021,3/1/2021
210201_Geneva_GenevaUniversityHospitals_age35-49,2/1/2021,Silvia Stringhini,Local,Switzerland,"Geneva; Switzerland
(Geneva University Hospitals)",11/23 - 12/23,Household and community samples,Adults (18-64 years),1237,23.6% (20.8-26.4%),Stratified probability,"Roche; NR
(0%; 0%)",Low,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1016/S1473-3099(21)00054-2,2/28/2021,3/1/2021
210201_Geneva_GenevaUniversityHospitals_age25-34,2/1/2021,Silvia Stringhini,Local,Switzerland,"Geneva; Switzerland
(Geneva University Hospitals)",11/23 - 12/23,Household and community samples,Adults (18-64 years),336,25.9% (21.8-30.2%),Stratified probability,"Roche; NR
(0%; 0%)",Low,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1016/S1473-3099(21)00054-2,2/28/2021,3/1/2021
210201_Geneva_GenevaUniversityHospitals_age18-24,2/1/2021,Silvia Stringhini,Local,Switzerland,"Geneva; Switzerland
(Geneva University Hospitals)",11/23 - 12/23,Household and community samples,Adults (18-64 years),206,25.4% (19.8-31.5%),Stratified probability,"Roche; NR
(0%; 0%)",Low,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1016/S1473-3099(21)00054-2,2/28/2021,3/1/2021
210201_Geneva_GenevaUniversityHospitals_age12-17,2/1/2021,Silvia Stringhini,Local,Switzerland,"Geneva; Switzerland
(Geneva University Hospitals)",11/23 - 12/23,Household and community samples,Children and Youth (0-17 years),400,23.6% (19.6-28%),Stratified probability,"Roche; NR
(0%; 0%)",Low,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1016/S1473-3099(21)00054-2,2/28/2021,3/1/2021
210201_Geneva_GenevaUniversityHospitals_age6-11,2/1/2021,Silvia Stringhini,Local,Switzerland,"Geneva; Switzerland
(Geneva University Hospitals)",11/23 - 12/23,Household and community samples,Children and Youth (0-17 years),395,22.8% (18.7-27.1%),Stratified probability,"Roche; NR
(0%; 0%)",Low,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1016/S1473-3099(21)00054-2,2/28/2021,3/1/2021
210201_Geneva_GenevaUniversityHospitals_age0-5,2/1/2021,Silvia Stringhini,Local,Switzerland,"Geneva; Switzerland
(Geneva University Hospitals)",11/23 - 12/23,Household and community samples,Children and Youth (0-17 years),219,14.9% (10.7-19.6%),Stratified probability,"Roche; NR
(0%; 0%)",Low,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1016/S1473-3099(21)00054-2,2/28/2021,3/1/2021
210201_Geneva_GenevaUniversityHospitals_female,2/1/2021,Silvia Stringhini,Local,Switzerland,"Geneva; Switzerland
(Geneva University Hospitals)",11/23 - 12/23,Household and community samples,Multiple groups,2134,20.4% (18.3-22.5%),Stratified probability,"Roche; NR
(0%; 0%)",Low,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1016/S1473-3099(21)00054-2,2/28/2021,3/1/2021
210201_Geneva_GenevaUniversityHospitals_male,2/1/2021,Silvia Stringhini,Local,Switzerland,"Geneva; Switzerland
(Geneva University Hospitals)",11/23 - 12/23,Household and community samples,Multiple groups,1866,21.9% (19.6-24.3%),Stratified probability,"Roche; NR
(0%; 0%)",Low,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1016/S1473-3099(21)00054-2,2/28/2021,3/1/2021
210201_Geneva_GenevaUniversityHospitals_age75+,2/1/2021,Silvia Stringhini,Local,Switzerland,"Geneva; Switzerland
(Geneva University Hospitals)",11/23 - 12/23,Household and community samples,Seniors (65+ years),202,9.3% (5.5-13.7%),Stratified probability,"Roche; NR
(0%; 0%)",Low,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1016/S1473-3099(21)00054-2,2/28/2021,3/1/2021
201130_Fribourg_UniversitéDeFribourg_overall,11/30/2020,Daniela Anker,Regional,Switzerland,"Canton of Fribourg; Switzerland
(Université de Fribourg)",07/08 - 10/14,Household and community samples,Multiple groups,418,8% (4-12%),Simplified probability,"N/A - institutionally designed (Centre Hospitalier Universitaire Vaudois (CHUV), l'École Polytechnique Fédérale de Lausanne (EPFL) et l’Institut Suisse de Recherche sur les Vaccins); NR
(96.6%; 99.7%)",Moderate,Institutional Report,https://www.unifr.ch/med/imf/fr/assets/public/images/COVID-19/2020-PopHealthLab-Corona-Immunitas-E1.pdf,3/13/2021,3/15/2021
201218_Geneva_GenevaUniversityHospitals_overall_adj,12/18/2020,Aude Richard,Regional,Switzerland,"Canton of Geneva; Switzerland
(Geneva University Hospital)",04/06 - 06/30,Household and community samples,Multiple groups,8344,7.8% (6.8-8.9%),Stratified probability,"Euroimmun; NR
(93%; 100%)",Low,Preprint,https://www.medrxiv.org/content/10.1101/2020.12.16.20248180v1.full.pdf,3/21/2021,3/21/2021
200704_Thailand_ChulalongkornUniversity_OverallAdj,7/4/2020,Tanawin Nopsopon,National,Thailand,"Thailand
(Chulalongkorn University)",04/08 - 06/26,Multiple populations,Adults (18-64 years),857,6.3% (NR),Convenience,"Baiya Phytopharm; IgM; Rapid immunochromatographic test
(94.1%; 98%)",Moderate,Preprint,https://www.medrxiv.org/content/10.1101/2020.06.24.20139188v3,10/8/2020,3/1/2021
200717_Ranong_ChulalongkornUniversity_overall,,"Tanawin Nopsopon,",Sublocal,Thailand,"Ranong; Thailand
(Chulalongkorn University)",04/17 - 05/17,Health care workers and caregivers,Adults (18-64 years),844,NA,Convenience,"Baya Phytopharm, Thailand; NR
(94.1%; 98%)",Moderate,Preprint,https://www.medrxiv.org/content/10.1101/2020.07.13.20151944v1,3/20/2021,3/20/2021
200520_England_RutherfordHealth_HCW_IgG,5/20/2020,Karol Sikora,Local,The United Kingdom,"Reading, Newport, Liverpool, Bedlington; England; The United Kingdom
(Rutherford Health)",04/14 - 04/24,Health care workers and caregivers,Adults (18-64 years),161,1.2% (NR),Convenience,"Sugentech; IgG; Colloidal Gold Immunochromatography Assay (LFIA)
(0%; 0%)",High,Preprint,https://www.medrxiv.org/content/10.1101/2020.05.16.20099408v1.full.pdf+html,5/21/2020,3/1/2021
200519_BirminghamUK_UniversityofBirmingham_Healthcareworkers,5/19/2020,Adrian Shields,Local,The United Kingdom,"Birmingham; England; The United Kingdom
(University of Birmingham)",04/25 - 04/26,Health care workers and caregivers,Adults (18-64 years),516,24.4% (NR),Convenience,"University of Birmingham; IgA, IgG, IgM; ELISA
(0%; 0%)",High,Preprint,https://www.medrxiv.org/content/10.1101/2020.05.18.20105197v1.external-links.html,5/26/2020,3/1/2021
200617_Gibraltar_GibraltarGovernment_HCW,6/17/2020,Priya Gulraj,Regional,The United Kingdom,"Gibraltar; The United Kingdom
(Gibraltar Government )",06/03 - 06/17,Health care workers and caregivers,Adults (18-64 years),1247,1.4% (NR),Convenience,"Not reported; IgG; Not reported
(0%; 0%)",Unclear,News and Media,https://www.google.com/url?rct=j&sa=t&url=https://www.chronicle.gi/after-in-house-gha-screening-programme-govt-rethinks-its-plans-for-anti-body-tests/&ct=ga&cd=CAAYBjIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNHWZarBh_XNDZ6O6KvR5YUdioFyGg,6/23/2020,3/16/2021
200821_England_PHE_SeroepiUnitPaedsSurvey_Under20_TestAdj_FebMarch,8/21/2020,Public Health England,National,The United Kingdom,"England; The United Kingdom
(Public Health England)",02/01 - 03/31,Residual sera,Children and Youth (0-17 years),443,0.8% (0-2.5%),Stratified probability,"Abbott; IgG; ELISA
(95.7%; 99.1%)",Moderate,Institutional Report,https://www.gov.uk/government/publications/national-covid-19-surveillance-reports,7/18/2020,3/1/2021
200821_England_PHE_WhatsTheStory_TestAdj_FebMarch,8/21/2020,Public Health England,National,The United Kingdom,"England; The United Kingdom
(Public Health England)",02/01 - 03/31,Household and community samples,Children and Youth (0-17 years),106,0.5% (0-3.6%),Stratified probability,"Abbott; IgG; ELISA
(95.7%; 99.1%)",Moderate,Institutional Report,https://www.gov.uk/government/publications/national-covid-19-surveillance-reports,7/18/2020,3/1/2021
200717_England_PHE_BloodDonor_GenPop_Overall_TestPopAdj_Week24to28,7/9/2020,Public Health England,National,The United Kingdom,"England; The United Kingdom
(Public Health England)",06/08 - 07/06,Blood donors,Multiple groups,11385,7.1% (6.5-7.8%),Stratified probability,"EUROIMMUN; IgG; ELISA
(82.5%; 99.1%)",Moderate,Institutional Report,https://www.gov.uk/government/publications/national-covid-19-surveillance-reports,7/18/2020,3/17/2021
200717_England_PHE_BloodDonor_GenPop_Overall_TestPopAdj_Week20to23,7/9/2020,Public Health England,National,The United Kingdom,"England; The United Kingdom
(Public Health England)",05/13 - 06/07,Blood donors,Adults (18-64 years),7777,8.2% (7.4-9%),Stratified probability,"EUROIMMUN; IgG; ELISA
(82.5%; 99.1%)",Moderate,Institutional Report,https://www.gov.uk/government/publications/national-covid-19-surveillance-reports,7/18/2020,3/1/2021
200717_England_PHE_BloodDonor_GenPop_London_TestPopAdj_Week13,8/28/2020,Public Health England,Regional,The United Kingdom,"London; England; The United Kingdom
(Public Health England)",03/26 - 03/27,Blood donors,Adults (18-64 years),757,2.6% (1.1-4.4%),Stratified probability,"EUROIMMUN; IgG; ELISA
(82.5%; 99.1%)",Moderate,Institutional Report,https://www.gov.uk/government/publications/national-covid-19-surveillance-reports,7/18/2020,3/1/2021
200709_England_PHE_BloodDonor_GenPop_Overall_TestPopAdj_Week23to27,7/9/2020,Public Health England,National,The United Kingdom,"England; The United Kingdom
(Public Health England)",06/01 - 06/28,Blood donors,Multiple groups,10318,7.2% (6.6-7.8%),Stratified probability,"EUROIMMUN; IgG; ELISA
(82.5%; 99.1%)",Moderate,Institutional Report,https://www.gov.uk/government/publications/national-covid-19-surveillance-reports,7/18/2020,3/17/2021
200709_England_PHE_BloodDonor_GenPop_Overall_TestPopAdj_Week19to22,7/9/2020,Public Health England,National,The United Kingdom,"England; The United Kingdom
(Public Health England)",05/04 - 05/31,Blood donors,Adults (18-64 years),7686,8.3% (7.5-9.2%),Stratified probability,"EUROIMMUN; IgG; ELISA
(82.5%; 99.1%)",Moderate,Institutional Report,https://www.gov.uk/government/publications/national-covid-19-surveillance-reports,7/18/2020,3/1/2021
200709_England_PHE_BloodDonor_GenPop_London_TestPopAdj_Week15to16,8/28/2020,Public Health England,Regional,The United Kingdom,"London; England; The United Kingdom
(Public Health England)",04/09 - 04/13,Blood donors,Adults (18-64 years),1085,11.1% (8.9-13.6%),Stratified probability,"EUROIMMUN; IgG; ELISA
(82.5%; 99.1%)",Moderate,Institutional Report,https://www.gov.uk/government/publications/national-covid-19-surveillance-reports,7/19/2020,3/1/2021
200702_England_PHE_BloodDonor_GenPop_Overall_TestPopAdj_Week22to26,7/9/2020,Public Health England,National,The United Kingdom,"England; The United Kingdom
(Public Health England)",05/28 - 06/22,Blood donors,Adults (18-64 years),12302,7.8% (8.6-9.1%),Stratified probability,"EUROIMMUN; IgG; ELISA
(82.5%; 99.1%)",Moderate,Institutional Report,https://www.gov.uk/government/publications/national-covid-19-surveillance-reports,7/19/2020,3/1/2021
200702_England_PHE_BloodDonor_GenPop_Overall_TestPopAdj_Week18to21,7/9/2020,Public Health England,National,The United Kingdom,"England; The United Kingdom
(Public Health England)",04/30 - 05/22,Blood donors,Adults (18-64 years),7694,8.6% (7.8-9.4%),Stratified probability,"EUROIMMUN; IgG; ELISA
(82.5%; 99.1%)",Moderate,Institutional Report,https://www.gov.uk/government/publications/national-covid-19-surveillance-reports,7/19/2020,3/1/2021
200807_England_PHE_RCGP_GenPop_TestPopAdj_Overall_euroimmun,8/7/2020,Public Health England,National,The United Kingdom,"England; The United Kingdom
(Public Health England)",03/16 - 06/30,Residual sera,Seniors (65+ years),6000,3.9% (NR),Stratified probability,"EUROIMMUN; IgG; ELISA
(0%; 0%)",Moderate,Institutional Report,https://www.gov.uk/government/publications/national-covid-19-surveillance-reports,7/19/2020,3/1/2021
200617_England_PHE_BloodDonor_GenPop_Midlands_TestPopAdj_Week14,8/28/2020,Public Health England,Regional,The United Kingdom,"England; The United Kingdom
(Public Health England)",04/02 - 04/03,Blood donors,Adults (18-64 years),916,2.4% (1-4%),Stratified probability,"EUROIMMUN; IgG; ELISA
(82.5%; 99.1%)",Moderate,Institutional Report,https://www.gov.uk/government/publications/national-covid-19-surveillance-reports,7/19/2020,3/1/2021
200617_England_PHE_BloodDonor_GenPop_Midlands_TestPopAdj_Week17_Mid,8/28/2020,Public Health England,Regional,The United Kingdom,"England; The United Kingdom
(Public Health England)",04/23 - 04/24,Blood donors,Adults (18-64 years),1043,7.3% (5.4-9.4%),Stratified probability,"EUROIMMUN; IgG; ELISA
(82.5%; 99.1%)",Moderate,Institutional Report,https://www.gov.uk/government/publications/national-covid-19-surveillance-reports,7/19/2020,3/1/2021
200603_England_PHE_BloodDonor_GenPop_Southwest_TestPopAdj_Week17_South,8/28/2020,Public Health England,Regional,The United Kingdom,"England; The United Kingdom
(Public Health England)",04/24 - 04/26,Blood donors,Adults (18-64 years),865,5% (3.2-7%),Stratified probability,"EUROIMMUN; IgG; ELISA
(82.5%; 99.1%)",Moderate,Institutional Report,https://www.gov.uk/government/publications/national-covid-19-surveillance-reports,7/19/2020,3/1/2021
200527_England_PHE_BloodDonor_GenPop_Northeast_TestPopAdj_Week16,8/28/2020,Public Health England,Regional,The United Kingdom,"England; The United Kingdom
(Public Health England)",04/14 - 04/16,Blood donors,Adults (18-64 years),1017,4.6% (3-6.4%),Stratified probability,"EUROIMMUN; IgG; ELISA
(79%; 99%)",Moderate,Institutional Report,https://www.gov.uk/government/publications/national-covid-19-surveillance-reports,7/19/2020,3/1/2021
200527_England_PHE_BloodDonor_GenPop_Northwest_TestPopAdj_Week16to17,8/28/2020,Public Health England,Regional,The United Kingdom,"England; The United Kingdom
(Public Health England)",04/15 - 04/20,Blood donors,Adults (18-64 years),936,6.2% (4.4-8.4%),Stratified probability,"EUROIMMUN; IgG; ELISA
(79%; 99%)",Moderate,Institutional Report,https://www.gov.uk/government/publications/national-covid-19-surveillance-reports,7/19/2020,3/1/2021
200821_England_PHE_SeroepiUnitPaedsSurvey_Under20_TestAdj_May,9/11/2020,Public Health England,National,The United Kingdom,"England; The United Kingdom
(Public Health England)",05/01 - 05/31,Residual sera,Children and Youth (0-17 years),1061,7.3% (5.6-9.2%),Stratified probability,"Abbott; IgG; ELISA
(95.7%; 99.1%)",Moderate,Institutional Report,https://www.gov.uk/government/publications/national-covid-19-surveillance-reports,7/19/2020,3/1/2021
200821_England_PHE_WhatsTheStory_TestAdj_April,8/21/2020,Public Health England,National,The United Kingdom,"England; The United Kingdom
(Public Health England)",04/01 - 04/30,Household and community samples,Children and Youth (0-17 years),201,3.8% (1.2-7.5%),Stratified probability,"Abbott; IgG; ELISA
(95.7%; 99.1%)",Moderate,Institutional Report,https://www.gov.uk/government/publications/national-covid-19-surveillance-reports,7/19/2020,3/1/2021
200821_England_PHE_SeroepiUnitPaedsSurvey_Under20_TestAdj_April,8/21/2020,Public Health England,National,The United Kingdom,"England; The United Kingdom
(Public Health England)",04/01 - 04/30,Residual sera,Children and Youth (0-17 years),647,6.1% (4.1-8.4%),Stratified probability,"Abbott; IgG; ELISA
(95.7%; 99.1%)",Moderate,Institutional Report,https://www.gov.uk/government/publications/national-covid-19-surveillance-reports,7/19/2020,3/1/2021
200707_NorthWestEngland_SalfordRoyalNHSFoundationTrust_HCW,7/7/2020,Dimitrios Poulikakos,Sublocal,The United Kingdom,"England; The United Kingdom
(Salford Royal NHS Foundation Trust)",05/04 - 05/06,Health care workers and caregivers,Adults (18-64 years),281,6% (NR),Convenience,"Snibe Diagnostic; IgG; Chemiluminescence Immunoassay
(0%; 0%)",High,Journal Article (Peer-Reviewed),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7338856/,7/20/2020,3/1/2021
200709_London_UniversityCollegeLondonHospitals_HCW,7/9/2020,Catherine Houlihan,Sublocal,The United Kingdom,"London; England; The United Kingdom
(University College London Hospitals)",03/26 - 04/08,Health care workers and caregivers,Adults (18-64 years),181,45% (NR),Convenience,"Not reported; IgG, IgA, IgM; ELISA, Flow cytometry assay
(0%; 0%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1016/S0140-6736(20)31484-7,7/30/2020,3/1/2021
200717_England_OfficeofNationalStatistics_GenPop_PopAdj,,,National,The United Kingdom,"England; The United Kingdom
(Office of National Statistics)",04/26 - 07/08,Household and community samples,Multiple groups,4309,6.3% (5-7.8%),Stratified probability,"University of Oxford; IgG; ELISA
(99.1%; 99%)",Moderate,,,8/2/2020,3/1/2021
200715_Scotland_PublicHealthScotland_ResidualSera_Overall,7/15/2020,Public Health Scotland,National,The United Kingdom,"Scotland; The United Kingdom
(Public Health Scotland)",04/20 - 06/21,Residual sera,Multiple groups,4744,4.3% (4.2-4.5%),Sequential,"Not reported; Not reported; Not reported
(0%; 0%)",High,Institutional Report,https://beta.isdscotland.org/find-publications-and-data/population-health/covid-19/enhanced-surveillance-of-covid-19-in-scotland/,8/15/2020,3/1/2021
200729_Scotland_UniversityofOxford_Total,7/29/2020,Craig  Thompson,Regional,The United Kingdom,"Scotland; The United Kingdom
(University of Oxford)",03/17 - 05/18,Blood donors,Multiple groups,3500,3.2% (NR),Sequential,"Author-designed; Not reported; Pseudotyping Particle-based Neutralization Titer
(94.11%; 100%)",High,Preprint,https://www.medrxiv.org/content/10.1101/2020.04.13.20060467v2,9/25/2020,3/1/2021
201004_SEEngland_King’sCollegeLondon,10/14/2020,Philippa M Wells,Regional,The United Kingdom,"South East England; The United Kingdom
(King’s College London)",04/27 - 06/02,Household and community samples,Multiple groups,431,12% (9.1-15.2%),Unclear,"Imperial College London; IgG, IgM; ELISA
(90%; 100%)",High,Journal Article (Peer-Reviewed),http://dx.doi.org/10.1016/j.jinf.2020.10.011,9/28/2020,3/1/2021
200725_UK_TheQueenElizabethHospital_HealthCareWorkers_UnAdj,7/25/2020,D.M. Favara,Sublocal,The United Kingdom,"King's Lynn; England; The United Kingdom
(The Queen Elizabeth Hospital)",06/01 - 06/07,Health care workers and caregivers,Adults (18-64 years),70,21.4% (NR),Unclear,"Unclear; IgG; Luminex
(84%; 100%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1016/j.clon.2020.07.015,9/29/2020,3/1/2021
200808_UK_PortlandHospitalforWomenandChildren_HCW,8/8/2020,Asma Khalil,Sublocal,The United Kingdom,"London; England; The United Kingdom
(St George’s University of London)",05/15 - 05/28,Health care workers and caregivers,Adults (18-64 years),190,22% (NR),Convenience,"Abbott; IgG; ELISA
(96.9%; 99.9%)",High,Journal Article (Peer-Reviewed),http://dx.doi.org/10.1093/cid/ciaa893,10/3/2020,3/1/2021
200810_London_UniversityCollegeLondon_Total,8/10/2020,S. Bampoe,Sublocal,The United Kingdom,"London; England; The United Kingdom
(University College London)",05/11 - 06/05,Health care workers and caregivers,Multiple groups,200,14.5% (9.9-20.1%),Unclear,"Abbott; IgG; Chemiluminescence Immunoassay
(100%; 99.6%)",High,Journal Article (Peer-Reviewed),https://associationofanaesthetists-publications.onlinelibrary.wiley.com/doi/full/10.1111/anae.15229,10/4/2020,3/1/2021
200729_London_WhittingtonHealthNHSTrust_Overall,8/4/2020,Joseph Grant,Sublocal,The United Kingdom,"London; England; The United Kingdom
(Whittington Health NHS Trust)",05/15 - 06/05,Health care workers and caregivers,Multiple groups,2004,31.6% (NR),Self-referral,"Roche Diagnostics; IgG, IgM; Electro chemiluminescence immunoassay
(0%; 99.8%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1017/ice.2020.402,10/5/2020,3/1/2021
200821_England_ImperialCollegeLondon_Overall_PopAdj,8/21/2020,Helen Ward,Regional,The United Kingdom,"England; The United Kingdom
(Imperial College London)",06/20 - 07/13,Household and community samples,Multiple groups,99908,6% (5.8-6.1%),Stratified probability,"Fortress Diagnostics; IgG; LFIA: Lateral flow immunoassay
(84.4%; 98.6%)",Low,Preprint,https://www.medrxiv.org/content/10.1101/2020.08.12.20173690v2,10/9/2020,3/1/2021
200922_Gateshead_NHSFoundationTrust_Overall,9/22/2020,Salman Razvi,Sublocal,The United Kingdom,"Gateshead; England; The United Kingdom
(Gateshead Health NHS Foundation Trust)",05/28 - 06/08,Health care workers and caregivers,Adults (18-64 years),2521,19.4% (NR),Convenience,"Roche; IgG, IgM; Chemiluminescence Immunoassay
(0%; 0%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.7861/clinmed.2020-0566,10/14/2020,3/17/2021
200821_Oxford_OxfordUniversityHospitals_Overall,8/21/2020,David Eyre,Local,The United Kingdom,"Oxford; England; The United Kingdom
(Oxford University Hospital)",04/23 - 06/08,Health care workers and caregivers,Adults (18-64 years),9958,10.7% (NR),Convenience,"Abbott, University of Oxford; IgG; Chemiluminescence Immunoassay, ELISA
(0%; 0%)",Moderate,Journal Article (Peer-Reviewed),https://dx.doi.org/10.7554/eLife.60675,10/14/2020,3/1/2021
200731_England_OfficeofNationalStatistics,,,National,The United Kingdom,"England; The United Kingdom
(Office of National Statistics)",04/26 - 07/26,Household and community samples,Multiple groups,4840,6.2% (5-7.6%),Stratified probability,"University of Oxford; IgG; ELISA
(99.1%; 99%)",Moderate,,,10/19/2020,3/1/2021
200814_England_OfficeofNationalStatistics,,,National,The United Kingdom,"England; The United Kingdom
(Office of National Statistics)",04/26 - 07/26,Household and community samples,Multiple groups,5248,6.2% (5.1-7.5%),Stratified probability,"University of Oxford; IgG; ELISA
(99.1%; 99%)",Moderate,,,10/19/2020,3/1/2021
200723_England_PHE_BloodDonor_GenPop_Overall_TestPopAdj_Week30,8/7/2020,Public Health England,National,The United Kingdom,"England; The United Kingdom
(Public Health England)",07/13 - 07/21,Blood donors,Multiple groups,11351,6.8% (6.2-7.5%),Stratified probability,"EUROIMMUN; IgG; ELISA
(83%; 99.3%)",Moderate,Institutional Report,https://www.gov.uk/government/publications/national-covid-19-surveillance-reports,10/19/2020,3/1/2021
200723_England_PHE_BloodDonor_GenPop_Overall_TestPopAdj_Week21to24,7/9/2020,Public Health England,National,The United Kingdom,"England; The United Kingdom
(Public Health England)",05/22 - 06/08,Blood donors,Adults (18-64 years),5893,8.2% (7.4-9%),Stratified probability,"EUROIMMUN; IgG; ELISA
(82.5%; 99.1%)",Moderate,Institutional Report,https://www.gov.uk/government/publications/national-covid-19-surveillance-reports,10/19/2020,3/1/2021
200731_England_PHE_BloodDonor_GenPop_Overall_TestPopAdj_Week26to30,8/7/2020,Public Health England,National,The United Kingdom,"England; The United Kingdom
(Public Health England)",06/22 - 07/20,Blood donors,Multiple groups,9220,6.1% (5.5-6.7%),Stratified probability,"EUROIMMUN; IgG; ELISA
(83%; 99.3%)",Moderate,Institutional Report,https://www.gov.uk/government/publications/national-covid-19-surveillance-reports,10/19/2020,3/1/2021
200807_England_PHE_BloodDonor_GenPop_Overall_TestPopAdj_Week27to31,8/7/2020,Public Health England,National,The United Kingdom,"England; The United Kingdom
(Public Health England)",06/29 - 07/28,Blood donors,Multiple groups,9388,5.9% (5.3-6.5%),Stratified probability,"EUROIMMUN; IgG; ELISA
(83%; 99.3%)",Moderate,Institutional Report,https://www.gov.uk/government/publications/national-covid-19-surveillance-reports,10/19/2020,3/1/2021
200821_England_PHE_BloodDonor_GenPop_Overall_TestPopAdj_Week29to32,8/7/2020,Public Health England,National,The United Kingdom,"England; The United Kingdom
(Public Health England)",07/13 - 08/07,Blood donors,Multiple groups,8538,5.4% (4.8-6%),Stratified probability,"EUROIMMUN; IgG; ELISA
(83%; 99.3%)",Moderate,Institutional Report,https://www.gov.uk/government/publications/national-covid-19-surveillance-reports,10/19/2020,3/1/2021
200828_England_PHE_BloodDonor_GenPop_Overall_TestPopAdj_Week30to33,9/11/2020,Public Health England,National,The United Kingdom,"England; The United Kingdom
(Public Health England)",07/20 - 08/16,Blood donors,Multiple groups,8940,5.5% (4.9-6.1%),Stratified probability,"EUROIMMUN; IgG; ELISA
(83%; 99.3%)",Moderate,Institutional Report,https://www.gov.uk/government/publications/national-covid-19-surveillance-reports,10/19/2020,3/1/2021
200930_Scotland_PublicHealthScotland_BloodDonors_Overall,7/15/2020,Public Health Scotland,National,The United Kingdom,"Scotland; The United Kingdom
(Public Health Scotland)",06/29 - 08/09,Blood donors,Multiple groups,3220,3.1% (2.5-3.8%),Sequential,"Not reported; Not reported; Not reported
(0%; 0%)",High,Institutional Report,https://beta.isdscotland.org/find-publications-and-data/population-health/covid-19/enhanced-surveillance-of-covid-19-in-scotland/,10/25/2020,3/1/2021
200729_Scotland_UniversityofOxford_GlasglowAnalysis,7/29/2020,Craig  Thompson,Local,The United Kingdom,"Scotland; The United Kingdom
(University of Oxford)",04/18 - 04/20,Blood donors,Multiple groups,490,8.6% (NR),Sequential,"Author-designed; Not reported; Pseudotyping Particle-based Neutralization Titer
(94.11%; 100%)",High,Preprint,https://www.medrxiv.org/content/10.1101/2020.04.13.20060467v2,10/28/2020,3/1/2021
200724_UK_ChelseaandWestminsterHospital_HCW,7/24/2020,Scott Pallett,Local,The United Kingdom,"London; England; The United Kingdom
(Chelsea and Westminster Hospital NHS Trust)",04/08 - 06/12,Health care workers and caregivers,Multiple groups,504,10.6% (7.6-13.6%),Convenience,"CTK Biotech , Zhuhai Encode Medical Engineering; IgG, IgM; LFIA: Lateral flow immunoassay
(0%; 0%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1016/S2213-2600(20)30315-5,10/28/2020,3/1/2021
200911_Birmingham_UniversityHospitalsBirminghamNHSFoundationTrust_Overall,9/11/2020,Adrian Shields,Sublocal,The United Kingdom,"Birmingham; England; The United Kingdom
(University Hospitals Birmingham NHS Foundation Trust)",04/24 - 04/25,Health care workers and caregivers,Adults (18-64 years),516,24.4% (NR),Self-referral,"University of Birmingham Clinical Immunology Service; IgA, IgG, IgM; ELISA
(100%; 97.8%)",High,Journal Article (Peer-Reviewed),http://dx.doi.org/10.1136/thoraxjnl-2020-215414,11/3/2020,3/1/2021
200730_London_ImperialCollegeLondon_Overall,7/30/2020,Candice Clarke,Sublocal,The United Kingdom,"London; England; The United Kingdom
(Imperial College London)",04/27 - 05/07,Patients seeking care for non-COVID-19 reasons,Multiple groups,356,36.2% (NR),Convenience,"Abbott; IgG; Chemiluminescence Immunoassay
(93.9%; 100%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1681/ASN.2020060827,11/3/2020,3/1/2021
200920_EasternUK_CambridgeUniversityHospitalsNHSFoundationTrust_Day1Luminex,9/20/2020,David Favara,Regional,The United Kingdom,"Eastern Region; The United Kingdom
(Cambridge University Hospitals NHS Foundation Trust)",06/15 - 06/15,Health care workers and caregivers,Adults (18-64 years),434,18.4% (NR),Convenience,"Cambridge University Hospitals; NR
(84%; 100%)",High,Preprint,https://www.medrxiv.org/content/10.1101/2020.09.18.20197590v1,1/14/2021,3/1/2021
201113_London_ImperialCollegeLondon_KidneyTransplantPatients,11/13/2020,Michelle Willicombe,Sublocal,The United Kingdom,"London; Greater London; The United Kingdom
(Imperial College London)",06/01 - 07/03,Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),855,10.4% (NR),Sequential,"Abbott; NR
(0%; 0%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1097/TP.0000000000003526,1/16/2021,3/4/2021
201113_Cambridge_RoyalPapworthHospitalNHSTrust_HCW,11/13/2020,Helen Baxendale,Sublocal,The United Kingdom,"Cambridge; England; The United Kingdom
(Royal Papworth Hospital NHS Trust)",04/20 - 06/10,Health care workers and caregivers,Adults (18-64 years),500,14% (NR),Convenience,"Addenbrookes Hospital NHS Trust; NR
(97%; 100%)",Unclear,Preprint,https://www.medrxiv.org/content/10.1101/2020.11.12.20145318v1,1/16/2021,3/8/2021
201012_UnitedKingdom_RoyalBelfastHospitalForSickChildren,11/10/2020,Thomas Waterfield,National,The United Kingdom,"Belfast, Cardiff, Glasgow, london, Manchester; Ireland, Wales, Scotland, England; The United Kingdom
(Royal Belfast Hospital for Sick Children)",04/16 - 07/03,Family of essential workers,Children and Youth (0-17 years),992,6.9% (5.4-8.6%),Convenience,"Abbott, Roche, DiaSorin; NR
(0%; 0%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1136/archdischild-2020-320558,1/17/2021,3/6/2021
201002_Tayside_NinewellsHospitalandMedicalSchool_HCWOverall,10/2/2020,Hani Abo-Leyah,Regional,The United Kingdom,"Scotland; The United Kingdom
(Ninewells Hospital and Medical School)",05/28 - 09/02,Health care workers and caregivers,Adults (18-64 years),2062,14.5% (NR),Convenience,"Siemens; NR
(95%; 0%)",High,Preprint,https://www.medrxiv.org/content/10.1101/2020.10.02.20205641v1,1/19/2021,3/1/2021
201002_Tayside_NinewellsHospitalandMedicalSchool_GenPop,10/2/2020,Hani Abo-Leyah,Regional,The United Kingdom,"Scotland; The United Kingdom
(Ninewells Hospital and Medical School)",05/28 - 09/02,Residual sera,Adults (18-64 years),231,4.8% (NR),Stratified probability,"Siemens; NR
(95%; 0%)",High,Preprint,https://www.medrxiv.org/content/10.1101/2020.10.02.20205641v1,1/19/2021,3/1/2021
201022_Oxford_UniversityOfOxford_unadj,10/22/2020,Sheila F Lumley,Local,The United Kingdom,"Oxford; The United Kingdom
(University of Oxford)",04/14 - 06/15,Pregnant or parturient women,Adults (18-64 years),1000,5.3% (4-6.9%),Sequential,"University of Oxford; NR
(99.1%; 99%)",Low,Journal Article (Peer-Reviewed),https://dx.doi.org/10.2807/1560-7917.ES.2020.25.41.2001721,1/21/2021,3/17/2021
201027_England_ImperialCollegeLondon_SamplingPeriod1_TotalAdj,10/27/2020,Helen Ward,National,The United Kingdom,"The United Kingdom
(Imperial College London)",06/20 - 07/13,Household and community samples,Multiple groups,99908,6% (5.8-6.1%),Simplified probability,"Fortress Diagnostics, Northern Ireland; NR
(84.4%; 98.6%)",Moderate,Preprint,10.1101/2020.10.26.20219725,1/21/2021,3/1/2021
201027_England_ImperialCollegeLondon_SamplingPeriod2_TotalAdj,10/27/2020,Helen Ward,National,The United Kingdom,"The United Kingdom
(Imperial College London)",07/31 - 08/13,Household and community samples,Multiple groups,105829,4.8% (4.7-5%),Simplified probability,"Fortress Diagnostics, Northern Ireland; NR
(84.4%; 98.6%)",Moderate,Preprint,10.1101/2020.10.26.20219725,1/21/2021,3/1/2021
201027_England_ImperialCollegeLondon_SamplingPeriod3_TotalAdj,10/27/2020,Helen Ward,National,The United Kingdom,"The United Kingdom
(Imperial College London)",09/15 - 09/28,Household and community samples,Multiple groups,159367,4.4% (4.3-4.5%),Simplified probability,"Fortress Diagnostics, Northern Ireland; NR
(84.4%; 98.6%)",Moderate,Preprint,10.1101/2020.10.26.20219725,1/21/2021,3/1/2021
201117_UK_ImmunisationAndCountermeasuresDivision_ChildrenOfHCW,11/17/2020,Shamez Ladhani,National,The United Kingdom,"Belfast, Cardiff, Glasgow, London, Manchester; The United Kingdom
(Immunisation and Countermeasures Division)",05/01 - 05/31,Contacts of COVID patients,Children and Youth (0-17 years),44,36.2% (9-63.4%),Convenience,"Abbott Commerce; NR
(0%; 0%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1093/cid/ciaa1737,1/22/2021,3/15/2021
200904_England_PHE_BloodDonors_Overall_TestPopAdj_Week31to35,9/11/2020,Public Health England,National,The United Kingdom,"England; The United Kingdom
(Public Health England)",07/27 - 08/30,Blood donors,Multiple groups,8764,5.3% (4.8-5.8%),Stratified probability,"EUROIMMUN; NR
(83%; 99.3%)",Moderate,Institutional Report,https://www.gov.uk/government/publications/national-covid-19-surveillance-reports,1/23/2021,3/1/2021
201103_London_PHE_LTCStaff,11/3/2020,Thomas Rowland,Sublocal,The United Kingdom,"London; Greater London; The United Kingdom
(Public Health England)",06/03 - 06/30,Health care workers and caregivers,Multiple groups,327,47.1% (NR),Convenience,"Abbott; NR
(93.9%; 100%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1016/j.jinf.2020.10.035,1/23/2021,3/1/2021
201223_Oxford_OxfordUniversityHospitals_HCW_Spike,12/23/2020,Sheila Lumley,Local,The United Kingdom,"The United Kingdom
(Oxford University Hospitals)",04/23 - 11/30,Health care workers and caregivers,Multiple groups,12541,10.1% (NR),Entire sample,"University of Oxford; NR
(99.1%; 99%)",Moderate,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1056/NEJMoa2034545,1/23/2021,3/2/2021
201119_UK_QueensUniversityBelfast_adj,11/19/2020,Cathal Roarty,National,The United Kingdom,"Belfast, Cardiff, Glasgow, London, Manchester; The United Kingdom
(Queens University Belfast)",06/26 - 08/15,Family of essential workers,Children and Youth (0-17 years),849,7.7% (6.1-9.6%),Convenience,"Roche, Basel, Switzerland; DiaSorin, Saluggia, Italy; NR
(0%; 0%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1016/S1473-3099(20)30884-7,1/23/2021,3/17/2021
200911_England_PHE_WhatsTheStory_Summary_5_May_August,9/11/2020,Public Health England,National,The United Kingdom,"England; The United Kingdom
(Public Health England)",05/01 - 08/05,Household and community samples,Children and Youth (0-17 years),568,5.2% (3.2-7.8%),Stratified probability,"Abbott; NR
(95.7%; 99.1%)",Moderate,Institutional Report,https://www.gov.uk/government/publications/national-covid-19-surveillance-reports,1/23/2021,3/1/2021
201002_England_PHE_BloodDonors_Summary_Final,10/2/2020,Public Health England,National,The United Kingdom,"England; The United Kingdom
(Public Health England)",08/24 - 09/18,Blood donors,Multiple groups,8230,6.1% (5.4-6.8%),Stratified probability,"EUROIMMUN; NR
(83%; 99.3%)",Moderate,Institutional Report,https://www.gov.uk/government/publications/national-covid-19-surveillance-reports,1/23/2021,3/1/2021
200918_England_PHE_BloodDonors_Summary15_Week33to36,9/11/2020,Public Health England,National,The United Kingdom,"England; The United Kingdom
(Public Health England)",08/13 - 09/06,Blood donors,Multiple groups,7899,5.5% (4.9-6.1%),Stratified probability,"EUROIMMUN; NR
(83%; 99.3%)",Moderate,Institutional Report,https://www.gov.uk/government/publications/national-covid-19-surveillance-reports,1/23/2021,3/1/2021
201002_England_PHE_RCGP_Collection_Summary_Final_week25to33_abbott,10/2/2020,Public Health England,National,The United Kingdom,"England; The United Kingdom
(Public Health England)",06/15 - 08/16,Residual sera,Seniors (65+ years),4315,6.5% (5.5-7.6%),Stratified probability,"Abbott; NR
(95.7%; 99.1%)",Moderate,Institutional Report,https://www.gov.uk/government/publications/national-covid-19-surveillance-reports,1/23/2021,3/1/2021
201002_England_PHE_SeroepiUnitPaedsSurvey_6_Final_week25to33_Abbott,10/2/2020,Public Health England,National,The United Kingdom,"England; The United Kingdom
(Public Health England)",06/15 - 08/16,Residual sera,Multiple groups,1212,5.2% (3.9-7%),Stratified probability,"Abbott; NR
(95.7%; 99.1%)",Low,Institutional Report,https://www.gov.uk/government/publications/national-covid-19-surveillance-reports,1/23/2021,3/1/2021
200925_England_PHE_BloodDonors_Summary_week34to37,10/2/2020,Public Health England,National,The United Kingdom,"England; The United Kingdom
(Public Health England)",08/19 - 09/13,Blood donors,Multiple groups,7888,6.1% (5.4-6.8%),Stratified probability,"EUROIMMUN; NR
(83%; 99.3%)",Moderate,Institutional Report,https://www.gov.uk/government/publications/national-covid-19-surveillance-reports,1/23/2021,3/1/2021
200826_London_ImperialCollegeLondon_LTC,8/26/2020,Neil Graham,Sublocal,The United Kingdom,"London; Greater London; The United Kingdom
(Imperial College London)",06/01 - 06/30,Assisted living and long-term care facilities,Seniors (65+ years),241,71.8% (66-77%),Convenience,"Abbott; NR
(93.9%; 100%)",High,Journal Article (Peer-Reviewed),https://www.journalofinfection.com/article/S0163-4453(20)30574-0/fulltext,1/23/2021,3/1/2021
201109_UK_WatfordGeneralHospital_ACU,11/9/2020,Muhammad Arif,Sublocal,The United Kingdom,"Watford; NR; The United Kingdom
(Watford General Hospital)",03/27 - 06/08,Residual sera,Multiple groups,443,1.6% (NR),Sequential,"NR; NR
(0%; 0%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.7759/cureus.11398,1/23/2021,3/17/2021
201125_London_ImperialCollegeLondon_kidneytransplant,11/25/2020,Maria Prendecki,Sublocal,The United Kingdom,"London; NA; The United Kingdom
(Imperial College London)",06/01 - 06/30,Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),855,8.1% (6.4-10.1%),Sequential,"Abbott; NR
(68.4%; 100%)",Moderate,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1681/ASN.2020081152,1/23/2021,3/17/2021
201215_Leicester_UniversityHospitalsofLeicesterNHSTrust,12/15/2020,John Black,Sublocal,The United Kingdom,"Leicester ; England; The United Kingdom
(University Hospitals of Leicester NHS Trust)",05/29 - 08/03,Health care workers and caregivers,Adults (18-64 years),200,12% (NR),Convenience,"Abbott Laboratories; NR
(92.7%; 100%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1111/tri.13791,1/27/2021,3/7/2021
201207_London_King'sCollegeLondon_overall,12/7/2020,Katrina A. S. Davis,Sublocal,The United Kingdom,"London; England; The United Kingdom
(King's College London)",06/01 - 06/30,Non-essential workers and unemployed persons,Multiple groups,1882,6.6% (5.6-7.8%),Convenience,"SureScreen Diagnostics COVID-19 IgG/IgM Rapid Test Cassette; NR
(89%; 100%)",High,Preprint,https://www.medrxiv.org/content/10.1101/2020.12.07.20245183v1.full,1/29/2021,3/1/2021
201106_London_UniversityCollegeLondon,11/6/2020, Manisty C,Local,The United Kingdom,"London; The United Kingdom
(University College London)",03/23 - 05/07,Health care workers and caregivers,Adults (18-64 years),729,21.5% (NR),Convenience,"Roche
Euroimmun; NR
(0%; 0%)",High,Preprint,https://www.medrxiv.org/content/10.1101/2020.11.04.20225920v2,1/30/2021,3/7/2021
201130_Bristol_NorthBristolNHSTrust_hcw,11/30/2020,Christopher Jones,Sublocal,The United Kingdom,"Bristol, South Gloucestershire and North Somerset,; England; The United Kingdom
(North Bristol NHS Trust)",01/15 - 06/15,Health care workers and caregivers,Multiple groups,6858,9.3% (NR),Self-referral,"Abbott laboratories; RocheDiagnostics; NR
(0%; 0%)",High,Journal Article (Peer-Reviewed),https://www.journalofinfection.com/article/S0163-4453(20)30755-6/fulltext,1/31/2021,3/1/2021
201222_Newcastle_Newcastle-upon-TyneHospitalsNHSTrust,12/22/2020,Aidan Hanrath,Sublocal,The United Kingdom,"Newcastle-Upon-Tyne; England ; The United Kingdom
(Newcastle-upon-Tyne Hospitals NHS Trust)",05/29 - 07/06,Health care workers and caregivers,Adults (18-64 years),11103,8.4% (NR),Convenience,"Roche Diagnostics; NR
(0%; 0%)",Moderate,Preprint,https://www.medrxiv.org/content/10.1101/2020.12.22.20242362v1,2/2/2021,3/3/2021
201211_London_RichmondPharmacologyLtd,12/11/2020,Jorg Taubel,Local,The United Kingdom,"London; England; The United Kingdom
(Richmond Pharmacology Ltd)",03/19 - 12/02,Multiple populations,Multiple groups,6061,6.4% (NR),Unclear,"NR; NR
(0%; 0%)",High,Preprint,https://www.medrxiv.org/content/10.1101/2020.12.08.20245894v2,2/4/2021,3/11/2021
201226_Glasgow_FrancisCrickInstitute_primaryadj,12/26/2020,Ellen C. Hughes,Local,The United Kingdom,"Glasgow; Scotland; The United Kingdom
(The Francis Crick Institute)",03/16 - 05/24,Residual sera,Multiple groups,6635,5.3% (0.1-15.1%),Sequential,"Francis Crick Institute; NR
(95.31%; 97.2%)",Moderate,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1093/infdis/jiaa788,2/4/2021,3/1/2021
201124_Scotland_PublicHealthScotland_overall,11/24/2020,E. Dickson,National,The United Kingdom,"Scotland; The United Kingdom
(Public Health Scotland)",04/20 - 06/21,Residual sera,Multiple groups,4744,4.3% (4.2-4.5%),Stratified probability,"DiaSorin; NR
(87.5%; 98.6%)",Moderate,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1016/j.puhe.2020.11.014,2/6/2021,3/8/2021
201023_England_PHE_HCW&OfficeStaff&LabStaff_Euroimmun,10/23/2020,Ross Harris,Sublocal,The United Kingdom,"The United Kingdom
(Public Health England)",03/23 - 08/20,Health care workers and caregivers,Adults (18-64 years),2247,12.1% (NR),Convenience,"Euroimmun; NR
(72%; 99%)",High,Preprint,https://doi.org/10.1101/2020.10.21.20216689,2/6/2021,3/1/2021
201022_Scotland_UniversityOfOxford_overall,10/22/2020,Craig P Thompson,Regional,The United Kingdom,"Scotland; The United Kingdom
(University of Oxford)",03/17 - 05/18,Blood donors,Adults (18-64 years),3500,3.2% (NR),Simplified probability,"N/A - Author designed; NR
(94%; 100%)",Moderate,Journal Article (Peer-Reviewed),https://dx.doi.org/10.2807/1560-7917.ES.2020.25.42.2000685,2/6/2021,3/1/2021
210111_UK_PublicHealthEngland_Round1_overall,1/20/2021, Shamez Ladhani,National,The United Kingdom,"England; The United Kingdom
(Public Health England)",06/01 - 06/15,Multiple populations,Multiple groups,2198,13.6% (12.4-15.1%),Simplified probability,"Abbott; NR
(0%; 0%)",Moderate,Preprint,https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3764198,2/11/2021,3/1/2021
210111_UK_PublicHealthEngland_Round2_overall ,1/20/2021, Shamez Ladhani,National,The United Kingdom,"England; The United Kingdom
(Public Health England)",07/07 - 07/21,Household and community samples,Multiple groups,1431,12.1% (10.5-13.9%),Simplified probability,"Abbott; NR
(0%; 0%)",Moderate,Preprint,https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3764198,2/11/2021,3/1/2021
210111_UK_PublicHealthEngland_Round3_overall,1/20/2021, Shamez Ladhani,National,The United Kingdom,"England; The United Kingdom
(Public Health England)",11/17 - 11/30,Household and community samples,Multiple groups,1216,10.4% (8.8-12.3%),Simplified probability,"Abbott; NR
(0%; 0%)",Moderate,Preprint,https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3764198,2/11/2021,3/1/2021
201104_Cambridge_CambridgeUniversityHospitalsNHSFoundationTrust_HCW&HospitalStaff,11/4/2020,Daniel Cooper,Sublocal,The United Kingdom,"Cambridge; England; The United Kingdom
(Cambridge University Hospitals NHS Foundation Trust)",06/10 - 08/07,Health care workers and caregivers,Multiple groups,5698,7.2% (NR),Convenience,"Siemens Healthcare Limited; NR
(98.1%; 99.9%)",Moderate,Preprint,https://doi.org/10.1101/2020.11.03.20220699,2/13/2021,3/3/2021
201116_Leicester_UniversityofLeicester_HCW,11/16/2020,Christopher Martin,Sublocal,The United Kingdom,"Leicester; East Midlands; The United Kingdom
(University of Leicester)",05/29 - 07/13,Health care workers and caregivers,Adults (18-64 years),10457,10.8% (NR),Convenience,"Abbott; NR
(93.5%; 100%)",Moderate,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1093/pubmed/fdaa199,2/13/2021,3/1/2021
210203_England_TheUniversityofNottingham_HCW_primary,2/3/2021,Simon Craxford,Sublocal,The United Kingdom,"East Midlands; The United Kingdom
(The University of Nottingham)",04/24 - 07/10,Health care workers and caregivers,Adults (18-64 years),633,18% (NR),Convenience,"Study authors; NR
(0%; 0%)",High,Preprint,https://www.medrxiv.org/content/10.1101/2021.02.01.21250950v1,2/17/2021,3/16/2021
210203_England_TheUniversityofNottingham_HHC_primary,2/3/2021,Simon Craxford,Local,The United Kingdom,"England; The United Kingdom
(The University of Nottingham)",09/01 - 09/30,Health care workers and caregivers,Adults (18-64 years),178,7.3% (NR),Convenience,"Study authors; NR
(0%; 0%)",High,Preprint,https://www.medrxiv.org/content/10.1101/2021.02.01.21250950v1,2/17/2021,3/16/2021
201021_London_BartsHealthNHSTrust_primary,10/21/2020,Kieran McCafferty,Sublocal,The United Kingdom,"London; The United Kingdom
(Barts Health NHS Trust )",05/01 - 06/04,Patients seeking care for non-COVID-19 reasons,Not reported,1253,18% (NR),Convenience,"Roche; NR
(0%; 0%)",High,Journal Article (Peer-Reviewed),http://dx.doi.org/10.1111/hdi.12883,2/24/2021,3/1/2021
210126_London_ImperialCollegeLondon_HemodialysisPt_Overall,1/26/2021,Candice Clarke,Sublocal,The United Kingdom,"London; England; The United Kingdom
(Imperial College London)",02/24 - 01/01,Patients seeking care for non-COVID-19 reasons,Not reported,301,2.6% (NR),Unclear,"Abbott
Imperial College London; NR
(0%; 0%)",High,Preprint,10.1101/2021.01.22.21249865,2/25/2021,3/1/2021
210203_UK_LondonSchoolofHygiene&TropicalMedicine_OrthodoxJews,2/3/2021,Katherine Gaskell,Sublocal,The United Kingdom,"The United Kingdom
(London School of Hygiene & Tropical Medicine)",10/17 - 12/13,Household and community samples,Multiple groups,1242,64.3% (61.6-67%),Simplified probability,"MSD; NR
(96.2%; 97.4%)",Moderate,Preprint,https://doi.org/10.1101/2021.02.01.21250839,2/27/2021,3/13/2021
210101_London_LewishamGreenwichNHSTrust_HCW_Overall,1/1/2021,Mehool Patel,Local,The United Kingdom,"Lewisham, Greenwich ; England; The United Kingdom
(Lewisham and greenwich NHS Trust )",05/27 - 06/24,Health care workers and caregivers,Adults (18-64 years),6212,26% (NR),Convenience,"Abbott; NR
(99%; 100%)",Moderate,Journal Article (Peer-Reviewed),https://dx.doi.org/10.7861/clinmed.2020-0619,3/1/2021,3/1/2021
201101_London_PublicHealthEngland_Overall,"11/1/2020, 10/2/2020","Shamez Ladhani, Joan Shang",Local,The United Kingdom,"London; England; The United Kingdom
(Public Health England)",04/10 - 04/13,Assisted living and long-term care facilities,Multiple groups,394,77.9% (73.6-81.7%),Convenience,"In House: PHE England; NR
(0%; 0%)",High,"Journal Article (Peer-Reviewed), Journal Article (Peer-Reviewed)","https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(20)30341-2/fulltext, http://dx.doi.org/10.1038/s41577-020-00463-1",3/5/2021,3/6/2021
0717_QueenElizabethHospital_QueenElizabethHospital_unadj_overall,,D M Favara,Sublocal,The United Kingdom,"Kings Lynn; The United Kingdom
(Queen Elizabeth Hospital)",06/01 - 06/05,Multiple populations,Adults (18-64 years),70,21.4% (NR),Convenience,"Unknown; NR
(84%; 100%)",High,Journal Article (Peer-Reviewed),10.1016/j.clon.2020.07.015,3/9/2021,3/9/2021
200626_UK_OfficeforNationalStatistics_May_June2020_England_Genpop,6/25/2020,Office for National Statistics,Regional,The United Kingdom,"England; The United Kingdom
(Office of National Statistics)",05/08 - 06/04,Household and community samples,Multiple groups,1575,6.3% (4.5-8.7%),Stratified probability,"University of Oxford; NR
(99%; 99.1%)",Moderate,Institutional Report,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020,3/12/2021,3/18/2021
200726_UK_OfficeforNationalStatistics_June_July2020_England_Genpop,7/31/2020,Office for National Statistics,Regional,The United Kingdom,"England; The United Kingdom
(Office of National Statistics)",06/05 - 07/02,Household and community samples,Multiple groups,2279,6.5% (4.8-8.6%),Stratified probability,"University of Oxford; NR
(99%; 99.1%)",Moderate,Institutional Report,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020,3/12/2021,3/18/2021
200826_UK_OfficeforNationalStatistics_July_020_England_genpop,8/28/2020,Office for National Statistics,Regional,The United Kingdom,"England; The United Kingdom
(Office of National Statistics)",07/03 - 07/30,Household and community samples,Multiple groups,3236,6.5% (5.2-8.1%),Stratified probability,"University of Oxford; NR
(99%; 99.1%)",Moderate,Institutional Report,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020,3/12/2021,3/18/2021
200826_UK_OfficeforNationalStatistics_July_August2020_England_genpop,8/28/2020,Office for National Statistics,Regional,The United Kingdom,"England; The United Kingdom
(Office of National Statistics)",07/31 - 08/27,Household and community samples,Multiple groups,6189,5.6% (4.7-6.5%),Stratified probability,"University of Oxford; NR
(99%; 99.1%)",Moderate,Institutional Report,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020,3/12/2021,3/18/2021
200926_UK_OfficeforNationalStatistics_August_Sept2020_England_genpop,9/25/2020,Office for National Statistics,Regional,The United Kingdom,"England; The United Kingdom
(Office of National Statistics)",08/28 - 09/24,Household and community samples,Multiple groups,8742,5.8% (5.1-6.5%),Stratified probability,"University of Oxford; NR
(99%; 99.1%)",Moderate,Institutional Report,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020,3/12/2021,3/18/2021
201026_UK_OfficeforNationalStatistics_Sept_Oct2020_England_Genpop,10/23/2020,Office for National Statistics,Regional,The United Kingdom,"England; The United Kingdom
(Office of National Statistics)",09/25 - 10/22,Household and community samples,Multiple groups,15687,6.9% (6.4-7.5%),Stratified probability,"University of Oxford; NR
(99%; 99.1%)",Moderate,Institutional Report,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020,3/12/2021,3/18/2021
201126_UK_OfficeforNationalStatistics_Oct_Nov2020_England_genpop,11/26/2020,Office for National Statistics,Regional,The United Kingdom,"England; The United Kingdom
(Office of National Statistics)",10/23 - 11/19,Household and community samples,Multiple groups,15834,8.7% (8.1-9.4%),Stratified probability,"University of Oxford; NR
(99%; 99.1%)",Moderate,Institutional Report,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020,3/12/2021,3/18/2021
201226_UK_OfficeforNationalStatistics_Nov_Dec2020_England_genpop,12/24/2020,Office for National Statistics,Regional,The United Kingdom,"England; The United Kingdom
(Office of National Statistics)",11/20 - 12/17,Household and community samples,Multiple groups,21684,10.1% (9.6-10.6%),Stratified probability,"University of Oxford; NR
(99%; 99.1%)",Moderate,Institutional Report,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020,3/12/2021,3/18/2021
210126_UK_OfficeforNationalStatistics_Dec_Jan20_21_England_Genpop,1/29/2021,Office for National Statistics,Regional,The United Kingdom,"England; The United Kingdom
(Office of National Statistics)",12/18 - 01/14,Household and community samples,Multiple groups,24150,15.3% (14.7-15.9%),Stratified probability,"University of Oxford; NR
(99%; 99.1%)",Moderate,Institutional Report,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020,3/12/2021,3/18/2021
210226_UK_OfficeforNationalStatistics_Jan_Feb2021_England_genpop,2/26/2021,Office for National Statistics,Regional,The United Kingdom,"England; The United Kingdom
(Office of National Statistics)",01/15 - 02/11,Household and community samples,Multiple groups,30345,23.3% (22.7-23.9%),Stratified probability,"University of Oxford; NR
(99%; 99.1%)",Moderate,Institutional Report,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/antibodydatafortheukjanuary2021,3/12/2021,3/18/2021
200926_UK_OfficeforNationalStatistics_August_Sept2020_Wales_Genpop,9/25/2020,Office for National Statistics,Regional,The United Kingdom,"Wales; The United Kingdom
(Office of National Statistics)",08/28 - 09/24,Household and community samples,Multiple groups,236,4.7% (2-9.2%),Stratified probability,"University of Oxford; NR
(99%; 99.1%)","High, High, High",Institutional Report,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020,3/12/2021,3/18/2021
201026_UK_OfficeforNationalStatistics_Sept_Oct2020_NorthernIreland_genpop,10/23/2020,Office for National Statistics,Regional,The United Kingdom,"Northern Ireland; The United Kingdom
(Office of National Statistics)",09/25 - 10/22,Household and community samples,Multiple groups,249,2.8% (1.2-5.5%),Stratified probability,"University of Oxford; NR
(99%; 99.1%)",High,Institutional Report,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020,3/12/2021,3/18/2021
201026_UK_OfficeforNationalStatistics_Sept_Oct2020_Scotland_Genpop,10/23/2020,Office for National Statistics,Regional,The United Kingdom,"Scotland
; The United Kingdom
(Office of National Statistics)",09/25 - 10/22,Household and community samples,Multiple groups,383,6.8% (4.3-10.2%),Stratified probability,"University of Oxford; NR
(99%; 99.1%)",High,Institutional Report,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020,3/12/2021,3/18/2021
201026_UK_OfficeforNationalStatistics_Sept_Oct2020_Wales_Genpop,10/23/2020,Office for National Statistics,Regional,The United Kingdom,"Wales; The United Kingdom
(Office of National Statistics)",09/25 - 10/22,Household and community samples,Multiple groups,473,4.7% (2.9-7.3%),Stratified probability,"University of Oxford; NR
(99%; 99.1%)","High, High, High",Institutional Report,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020,3/12/2021,3/18/2021
201126_UK_OfficeforNationalStatistics_Oct_Nov2020 _Scotland_Genpop,11/26/2020,Office for National Statistics,Regional,The United Kingdom,"Scotland
; The United Kingdom
(Office of National Statistics)",10/23 - 11/19,Household and community samples,Multiple groups,397,7.8% (5-11.7%),Stratified probability,"University of Oxford; NR
(99%; 99.1%)",High,Institutional Report,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020,3/12/2021,3/18/2021
201126_UK_OfficeforNationalStatistics_Oct_Nov2020_NorthernIreland_Genpop,11/26/2020,Office for National Statistics,Regional,The United Kingdom,"Northern Ireland; The United Kingdom
(Office of National Statistics)",10/23 - 11/19,Household and community samples,Multiple groups,333,3.5% (1.6-6.4%),Stratified probability,"University of Oxford; NR
(99%; 99.1%)",High,Institutional Report,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020,3/12/2021,3/18/2021
201126_UK_OfficeforNationalStatistics_Oct_Nov2020_Wales_genpop,11/26/2020,Office for National Statistics,Regional,The United Kingdom,"Wales; The United Kingdom
(Office of National Statistics)",10/23 - 11/19,Household and community samples,Multiple groups,497,6.1% (4-9%),Stratified probability,"University of Oxford; NR
(99%; 99.1%)","High, High, High",Institutional Report,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020,3/12/2021,3/18/2021
201226_UK_OfficeforNationalStatistics_Nov_Dec2020_NortherIreland_genpop,12/24/2020,Office for National Statistics,Regional,The United Kingdom,"Northern Ireland; The United Kingdom
(Office of National Statistics)",11/20 - 12/17,Household and community samples,Multiple groups,248,3.7% (1.7-7.1%),Stratified probability,"University of Oxford; NR
(99%; 99.1%)",High,Institutional Report,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020,3/12/2021,3/18/2021
201226_UK_OfficeforNationalStatistics_Nov_Dec2020_Scotland_genpop,12/24/2020,Office for National Statistics,Regional,The United Kingdom,"Scotland; The United Kingdom
(Office of National Statistics)",11/20 - 12/17,Household and community samples,Multiple groups,1034,5.9% (4.4-7.6%),Stratified probability,"University of Oxford; NR
(99%; 99.1%)",Moderate,Institutional Report,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020,3/12/2021,3/18/2021
201226_UK_OfficeforNationalStatistics_Nov_Dec2020_Wales_genpop,12/24/2020,Office for National Statistics,Regional,The United Kingdom,"Wales; The United Kingdom
(Office of National Statistics)",11/20 - 12/17,Household and community samples,Multiple groups,631,7.2% (5.1-9.9%),Stratified probability,"University of Oxford; NR
(99%; 99.1%)","Moderate, Moderate, Moderate",Institutional Report,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020,3/12/2021,3/18/2021
210126_UK_OfficeforNationalStatistics_Dec_Jan20_21_NortherIreland_genpop,1/29/2021,Office for National Statistics,Regional,The United Kingdom,"Northern Ireland; The United Kingdom
(Office of National Statistics)",12/18 - 01/14,Household and community samples,Multiple groups,313,12% (7.8-17.4%),Stratified probability,"University of Oxford; NR
(99%; 99.1%)",High,Institutional Report,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020,3/12/2021,3/18/2021
210126_UK_OfficeforNationalStatistics_Dec_Jan20_21_Scotland_genpop,1/29/2021,Office for National Statistics,Regional,The United Kingdom,"Scotland
; The United Kingdom
(Office of National Statistics)",12/18 - 01/14,Household and community samples,Multiple groups,1832,10.7% (9.1-12.4%),Stratified probability,"University of Oxford; NR
(99%; 99.1%)",Moderate,Institutional Report,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020,3/12/2021,3/18/2021
210126_UK_OfficeforNationalStatistics_Dec_Jan20_21_Wales_genpop,1/29/2021,Office for National Statistics,Regional,The United Kingdom,"Wales; The United Kingdom
(Office of National Statistics)",12/18 - 01/14,Household and community samples,Multiple groups,732,11.5% (8.6-14.9%),Stratified probability,"University of Oxford; NR
(99%; 99.1%)","Moderate, Moderate, Moderate",Institutional Report,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/december2020,3/12/2021,3/18/2021
210226_UK_OfficeforNationalStatistics_Jan_Feb2021_NorthernIreland_genpop,2/26/2021,Office for National Statistics,Regional,The United Kingdom,"Northern Ireland; The United Kingdom
(Office of National Statistics)",01/15 - 02/11,Household and community samples,Multiple groups,575,15.9% (12.8-19.5%),Stratified probability,"University of Oxford; NR
(99%; 99.1%)",Moderate,Institutional Report,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/antibodydatafortheukjanuary2021,3/12/2021,3/18/2021
210226_UK_OfficeforNationalStatistics_Jan_Feb2021_Scotland_genpop,2/26/2021,Office for National Statistics,Regional,The United Kingdom,"Scotland
; The United Kingdom
(Office of National Statistics)",01/15 - 02/11,Household and community samples,Multiple groups,2632,13.1% (11.6-14.7%),Stratified probability,"University of Oxford; NR
(99%; 99.1%)",Moderate,Institutional Report,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/antibodydatafortheukjanuary2021,3/12/2021,3/18/2021
210226_UK_OfficeforNationalStatistics_Jan_Feb2021_Wales_genpop,2/26/2021,Office for National Statistics,Regional,The United Kingdom,"Wales; The United Kingdom
(Office of National Statistics)",01/15 - 02/11,Household and community samples,Multiple groups,1268,16.4% (14-19%),Stratified probability,"University of Oxford; NR
(99%; 99.1%)","Moderate, Moderate, Moderate",Institutional Report,https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsinthecommunityinengland/antibodydatafortheukjanuary2021,3/12/2021,3/18/2021
210107_London_UniversityCollegeLondon_June_PaediatricHCW,1/27/2021,D. Goldblatt,Sublocal,The United Kingdom,"London; The United Kingdom
(University College London)",06/01 - 06/30,Health care workers and caregivers,Adults (18-64 years),1134,16.9% (14.9-19.2%),Convenience,"Epitope Diagnostics; NR
(100%; 88.7%)",High,Journal Article (Peer-Reviewed),http://dx.doi.org/10.1016/j.jhin.2020.12.019,3/13/2021,3/14/2021
210107_London_UniversityCollegeLondon_May_PaediatricHCW,1/27/2021,D. Goldblatt,Sublocal,The United Kingdom,"London; The United Kingdom
(University College London)",05/01 - 05/31,Health care workers and caregivers,Adults (18-64 years),1754,15.3% (13.7-17.1%),Convenience,"Epitope Diagnostics; NR
(100%; 88.7%)",High,Journal Article (Peer-Reviewed),http://dx.doi.org/10.1016/j.jhin.2020.12.019,3/13/2021,3/14/2021
210210_England_ImperialCollegeLondon_Overall_TestAdjPopAdj,2/10/2021,Helen Ward,Regional,The United Kingdom,"England; The United Kingdom
(Imperial College London)",06/20 - 07/13,Multiple populations,Multiple groups,99908,6% (5.8-6.1%),Simplified probability,"Fortress Diagnostics, Northern Ireland; NR
(84.4%; 98.6%)",Low,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1038/s41467-021-21237-w,3/14/2021,3/14/2021
210219_England_PHE_UniversityStudents_Overall,2/19/2021,Amoolya Vusirikala,Regional,The United Kingdom,"England; The United Kingdom
(Public Health England)",12/02 - 12/11,Students and Daycares,Adults (18-64 years),2905,17.8% (16.5-19.3%),Convenience,"Abbott Laboratories; In-House (PHE); NR
(92.7%; 99.9%)",Moderate,Preprint,https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3787684,3/15/2021,3/19/2021
210127_UK_UniversityCollegeLondon_overall,1/27/2021,Ana Valdes,Regional,The United Kingdom,"Nottingham; London; England; The United Kingdom
(University College London)",03/23 - 06/13,Health care workers and caregivers,Adults (18-64 years),1364,19.9% (NR),Convenience,"Euroimmun; Roche Diagnostics; In House ELISA; NR
(96.2%; 100%)",High,Preprint,https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3754805,3/17/2021,3/19/2021
210115_UK_UKBiobank_Overall,1/15/2021,UK Biobank,National,The United Kingdom,"England, Scotland, Wales; The United Kingdom
(UK Biobank)",05/27 - 12/04,Household and community samples,Multiple groups,18893,9% (NR),Convenience,"NR; NR
(0%; 0%)",Unclear,Institutional Report,https://www.ukbiobank.ac.uk/media/x0nd5sul/ukb_serologystudy_report_revised_6months_jan21.pdf,3/19/2021,3/19/2021
210301_London_King’sCollegeHospital_primary,3/1/2021,Kat El Bouzidi,Sublocal,The United Kingdom,"London; The United Kingdom
(King’s College Hospital)",04/22 - 04/24,Health care workers and caregivers,Adults (18-64 years),625,21% (NR),Convenience,"NR; NR
(0%; 0%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1097/CCM.0000000000004878,3/19/2021,3/19/2021
210127_London_King'sCollegeLondon_June_PostgradStudents&Staff,1/27/2021,Daniel Leightley,Sublocal,The United Kingdom,"London; The United Kingdom
(King's College London)",06/01 - 06/30,Students and Daycares,Adults (18-64 years),1882,6.5% (NR),Convenience,"SureScreen Diagnostics; NR
(0%; 0%)",High,Preprint,https://doi.org/10.1101/2021.01.26.21249744,3/21/2021,3/21/2021
210127_London_King'sCollegeLondon_September_PostgradStudents&Staff,1/27/2021,Daniel Leightley,Sublocal,The United Kingdom,"London; The United Kingdom
(King's College London)",09/01 - 09/30,Students and Daycares,Adults (18-64 years),1675,5.4% (NR),Convenience,"SureScreen Diagnostics; NR
(0%; 0%)",High,Preprint,https://doi.org/10.1101/2021.01.26.21249744,3/21/2021,3/21/2021
200807_Lome_UniversiteDeLome_Overall,8/7/2020,Wemboo Halatoko,Local,Togo,"Lome; Togo
(Universite de Lome)",04/23 - 05/08,Non-essential workers and unemployed persons,Adults (18-64 years),955,0.9% (0.4-1.8%),Convenience,"""Hangzhou Clongene Biotech Co, Ltd.""; IgM, IgG; LFIA: Lateral flow immunoassay
(77.1%; 95.4%)",High,Journal Article (Peer-Reviewed),https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0242124,9/23/2020,3/1/2021
200822_Turkey_UniversityofHealthSciences_HCWOverall,8/22/2020,Gizem Alkurt,Local,Turkey,"Istanbul, Darica; Turkey
(University of Health Sciences)",05/30 - 06/06,Health care workers and caregivers,Adults (18-64 years),813,2.7% (NR),Convenience,"Abbott; IgG; Chemiluminsescent microparticle immunoassay
(0%; 0%)",Moderate,Preprint,https://www.medrxiv.org/content/10.1101/2020.08.19.20178095v1,10/12/2020,3/1/2021
200430_SantaClaraCounty_UniversityofStanford_GenPop_PopTestAdj,4/30/2020,Eran Bendavid,Local,United States of America,"California; United States of America
(University of Stanford)",04/03 - 04/04,Household and community samples,Multiple groups,3330,2.8% (1.3-4.7%),Stratified probability,"Premier Biotech; IgG, IgM; LFIA: Lateral flow immunoassay
(82.8%; 99.5%)",High,Preprint,https://www.medrxiv.org/content/10.1101/2020.04.14.20062463v2,4/23/2020,3/1/2021
200424_Brevard_OMNI_GeneralPopulation,"4/24/2020, 4/17/2020","Alessandro Sassoon, Jim Waymer",Local,United States of America,"Florida; United States of America
(OMNI Healthcare)",04/17 - 04/24,Household and community samples,Not reported,1000,1% (NR),Self-referral,"Not reported; IgM, IgG; LFIA: Lateral flow immunoassay
(100%; 100%)",High,"News and Media, News and Media","https://www.floridatoday.com/story/news/2020/04/24/omni-covid-19-immunity-testing-data-brevard-county-florida-antibody/3022571001/, https://www.floridatoday.com/story/news/2020/04/17/omni-healthcare-announces-coronavirus-immunity-testing/5147092002/",5/2/2020,3/1/2021
200423_BatonRouge_BatonRougeGeneralHospital_GenPop,4/28/2020,Blake Paterson,Local,United States of America,"Baton Rouge; Louisiana; United States of America
(Baton Rouge General Hospital)",NR - 04/21,Household and community samples,Not reported,432,4.4% (NR),Unclear,"Mayo Clinic; Not reported; Not reported
(0%; 98.6%)",Unclear,News and Media,https://www.theadvocate.com/baton_rouge/news/coronavirus/article_b499efa0-8983-11ea-a3f1-af936ecb1d2c.html,5/3/2020,3/1/2021
200508_Seattle_UniversityofWashington_Adults,5/8/2020,Anne Schuchat,Local,United States of America,"Seattle; Washington; United States of America
(University of Washington)",03/01 - 03/31,Residual sera,Adults (18-64 years),221,0.4% (NR),Convenience,"Not reported; Not reported; Not reported
(0%; 0%)",High,Institutional Report,https://www.cdc.gov/mmwr/volumes/69/wr/pdfs/mm6918e2-H.pdf,5/3/2020,3/1/2021
200503_SaltLakeCity_UniversityofUtah_HCW,5/3/2020,Troy Madsen,Sublocal,United States of America,"Salt Lake City; Utah; United States of America
(University of Utah)",04/13 - 04/19,Health care workers and caregivers,Adults (18-64 years),270,5.9% (NR),Self-referral,"EUROIMMUN; IgG; ELISA
(95.4%; 98.3%)",High,Journal Article (Peer-Reviewed),https://www.ajemjournal.com/article/S0735-6757(20)30306-5/fulltext,5/14/2020,3/1/2021
200506_Atlanta_GeorgiaStateUniversity_GeneralPop_IgG,5/6/2020,Jun Zou,Local,United States of America,"Atlanta; Georgia; United States of America
(Georgia State University)",04/17 - 04/27,Household and community samples,Not reported,127,2.4% (NR),Convenience,"Author-designed; IgG; ELISA
(0%; 0%)",High,Preprint,https://www.medrxiv.org/content/10.1101/2020.05.01.20087478v1,5/14/2020,3/1/2021
200515_Winona_WinonaHealth_GeneralPopulation,5/15/2020,Mal Meyer,Local,United States of America,"Winona; Minnesota; United States of America
(Winona Health)",05/10 - 05/15,Household and community samples,Multiple groups,1000,7% (NR),Self-referral,"NR; IgG; Not reported
(0%; 0%)",High,News and Media,https://www.google.com/url?rct=j&sa=t&url=https://www.news8000.com/new-covid-19-antibody-testing-in-winona-gives-health-officials-a-better-picture-of-the-spread/&ct=ga&cd=CAEYDyoTMTE4NjM1MjEyMTUyMjIzNTE5ODIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNE5fpVM7tRmIsEhSRedRkru-TpZOA,5/18/2020,3/1/2021
200513_Indiana_IndianaUniversity_Wave1GenPop_PopAdj,"7/24/2020, 5/13/2020, 5/17/2020","Nir Menachemi, Aaron Carroll, Dariush Shafa",Regional,United States of America,"Indiana; United States of America
(Indiana University Fairbanks School of Public Health)",04/25 - 04/29,Household and community samples,Multiple groups,3518,1.1% (0.8-1.5%),Stratified probability,"Not reported; IgG; Chemiluminescence Immunoassay
(100%; 99.6%)",Moderate,"Institutional Report, News and Media, News and Media","https://www.cdc.gov/mmwr/volumes/69/wr/mm6929e1.htm?s_cid=mm6929e1_w, https://www.nytimes.com/2020/05/13/opinion/indiana-reopening-coronavirus-testing.html, https://www.google.com/url?rct=j&sa=t&url=https://www.perrycountynews.com/content/study-projects-only-9-covid-19-cases-detected&ct=ga&cd=CAAYHDIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNEf69_TglEJjU9g7rkvZNMTUfoqoQ",5/19/2020,3/1/2021
200518_LosAngelesCounty_StanfordUniversity_GenPopWeighted_TestAdj,5/18/2020,Neeraj Sood,Local,United States of America,"California; United States of America
(Stanford University School of Medicine)",04/10 - 04/14,Household and community samples,Multiple groups,863,4.7% (2.5-7.1%),Stratified probability,"Premier Biotech; IgG, IgM; LFIA: Lateral flow immunoassay
(82.7%; 99.5%)",Moderate,Journal Article (Peer-Reviewed),https://jamanetwork.com/journals/jama/fullarticle/2766367,5/21/2020,3/1/2021
200515_Boston_BostonPublicHealthCommission_BostonGenPop,"5/15/2020, 5/18/2020","Adam Gaffin, City of Boston",Local,United States of America,"Boston; Massachusetts; United States of America
(Boston Public Health Commission )",NR - 05/15,Household and community samples,Adults (18-64 years),750,9.9% (NR),Simplified probability,"Not reported; Not reported; Not reported
(0%; 0%)",Moderate,"News and Media, News and Media","https://www.universalhub.com/2020/initial-antibody-testing-four-zip-codes-shows-one, https://www.boston.gov/news/results-released-antibody-and-covid-19-testing-boston-residents",5/23/2020,3/1/2021
200523_SouthCarolina_MUSCHealthLancaster_HCW,5/23/2020,Lisa Geraci ,Sublocal,United States of America,"Lancaster; South Carolina; United States of America
(MUSC Health-Lancaster)",NR - 05/20,Health care workers and caregivers,Adults (18-64 years),230,2.2% (NR),Unclear,"Abbott; Not reported; Not reported
(0%; 0%)",High,News and Media,https://www.google.com/url?rct=j&sa=t&url=https://www.thelancasternews.com/content/antibody-tests-show-just-2-exposure-rate-covid-19&ct=ga&cd=CAEYFSoSNjI0MTExNTA1MzQ0Mjc2MzA2Mho5MGRlYTk4OTk0ZTkxODU5OmNvbTplbjpVUw&usg=AFQjCNEYxEO1T-WE8tAinlY5KZVTRufQSA,5/26/2020,3/1/2021
200520_Iowa_IowaDepartmentofPublicHealth_IowaStateGeneralPopulation,5/20/2020,Jeff Montgomery,Regional,United States of America,"Iowa; United States of America
(Iowa Department of Public Health)",NR - 05/20,Household and community samples,Adults (18-64 years),18160,10% (NR),Self-referral,"Not reported; IgG; Not reported
(0%; 0%)",High,News and Media,https://www.google.com/url?rct=j&sa=t&url=https://www.telegraphherald.com/coronavirus/article_b5f56348-317d-5f49-abee-0e7cff653cbb.html&ct=ga&cd=CAAYBDIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNG6tWk8Wg2dbYV27AKz5iI4DLM97Q,5/30/2020,3/1/2021
200617_NewYork_StateUniversityofNewYork_GeneralPopTestPopAdj,6/17/2020,Eli Rosenberg,Regional,United States of America,"New York; United States of America
(New York State Department of Health)",04/19 - 04/28,Household and community samples,Multiple groups,15101,14% (13.3-14.7%),Convenience,"NYSDOH Wadsworth Center; IgG; Microsphere immunoassay
(87.9%; 99.75%)",Moderate,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1016/j.annepidem.2020.06.004,5/30/2020,3/1/2021
200510_US_StanfordUniversity_MajorLeagueBaseballEmployees,"5/10/2020, 5/11/2020","Susan Slusser, John McCormack",National,United States of America,"United States of America
(Stanford University)",04/08 - 04/21,Non-essential workers and unemployed persons,Adults (18-64 years),5603,0.7% (0.3-1.2%),Convenience,"Not reported; Not reported; Not reported
(0%; 0%)",Unclear,"News and Media, News and Media","https://www.sfchronicle.com/athletics/article/MLB-antibody-study-7-percent-exposed-to-15260314.php, https://www.nationalreview.com/2020/05/coronavirus-antibody-study-major-league-baseball-herd-immunity/",6/2/2020,3/1/2021
200601_LongHillTownship_SummitMedicalCenter_FirstResponders,6/1/2020,Alex Parker-Magyar,Sublocal,United States of America,"Long Hill Township; New Jersey; United States of America
(Summit Medical Center)",05/01 - 05/14,Essential non-healthcare workers,Adults (18-64 years),70,4.3% (NR),Self-referral,"Not reported; Not reported; Not reported
(0%; 0%)",High,News and Media,https://www.google.com/url?rct=j&sa=t&url=https://www.newjerseyhills.com/echoes-sentinel/news/few-among-long-hill-first-responders-test-positive-for-covid-19-antibodies/article_007ac367-b3b2-5375-b471-f0a817998f62.html&ct=ga&cd=CAAYFDIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNHWg839bXiyzOxO1Y7-QOECGMRCMw,6/3/2020,3/1/2021
200602_NewYork_IcahnSchoolofMedicineatMountSinai_HealthCareWorkers,6/3/2020,Mayce Mansour,Local,United States of America,"New York City; New York; United States of America
(Icahn School of Medicine at Mount Sinai)",03/24 - 04/04,Health care workers and caregivers,Multiple groups,285,33% (NR),Self-referral,"Not reported; IgG; ELISA
(0%; 0%)",High,Journal Article (Peer-Reviewed),https://link.springer.com/article/10.1007/s11606-020-05926-8,6/4/2020,3/1/2021
200602_HumboldtCounty_HumboldtCountyDepartmentofHealthandHumanServices_GenPop,6/2/2020,Shomik Mukherjee ,Local,United States of America,"California; United States of America
(Humboldt County Department of Health and Human Services)",NR - 05/26,Household and community samples,Not reported,1000,1% (NR),Unclear,"Not reported; Not reported; Not reported
(0%; 0%)",High,News and Media,https://www.google.com/url?rct=j&sa=t&url=https://www.times-standard.com/1-of-early-humboldt-county-coronavirus-tests-show-antibodies&ct=ga&cd=CAAYDjIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNFdl7jBbUfA1cB9ZXhwgAM8IvQmrA,6/7/2020,3/1/2021
200612_Guam_USNavy,6/12/2020,Daniel Payne,Sublocal,United States of America,"Guam; United States of America
(US Navy)",04/20 - 04/24,Essential non-healthcare workers,Adults (18-64 years),382,59.7% (NR),Convenience,"CDC; IgG, IgM, IgA; ELISA
(0%; 0%)",High,Journal Article (Peer-Reviewed),https://www.cdc.gov/mmwr/volumes/69/wr/mm6923e4.htm,6/12/2020,3/1/2021
200612_NewJersey_MonmouthMedicalCentre_HealthCareWorkersUnadj,6/12/2020,Mohsin Mughal ,Sublocal,United States of America,"Long Branch; New Jersey; United States of America
(Monmouth Medical Centre)",05/14 - 05/19,Health care workers and caregivers,Adults (18-64 years),121,0.8% (NR),Convenience,"SD Biosensor; IgG; LFIA: Lateral flow immunoassay
(96.2%; 96.6%)",High,Journal Article (Peer-Reviewed),https://www.cambridge.org/core/journals/infection-control-and-hospital-epidemiology/article/prevalence-of-sarscov2-igg-antibodies-in-intensive-care-unit-icu-healthcare-personnel-hcp-and-its-implications-a-singlecenter-prospective-pilot-study/296957BF678E512283D4A3770467FFB7,6/13/2020,3/1/2021
200614_SteamboatSprings_RouttCountyBoardofHealth_GenPop,6/14/2020,Kari Harden ,Local,United States of America,"Steamboat Springs; Colorado; United States of America
(Routt County Board of Health)",NR - 06/10,Household and community samples,Not reported,649,2.6% (NR),Self-referral,"Not reported; Not reported; Not reported
(0%; 0%)",High,News and Media,https://www.google.com/url?rct=j&sa=t&url=https://www.steamboatpilot.com/news/one-new-positive-covid-19-case-in-routt-county-antibody-testing-ramping-up/&ct=ga&cd=CAEYBSoTNzg3MTAwMjkzNzU0ODU4ODgzODIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNGVI81Ue1Rqm7AhmKKlvb0xWvQDKQ,6/15/2020,3/1/2021
200617_Indiana_IndianaUniversity_Wave2GenPop,6/17/2020,Shari Rudavsky,Regional,United States of America,"Indiana; United States of America
(Indiana University Fairbanks School of Public Health)",06/03 - 06/08,Household and community samples,Multiple groups,3600,1.5% (NR),Stratified probability,"Not reported; Not reported; Not reported
(0%; 0%)",Unclear,News and Media,https://www.google.com/url?rct=j&sa=t&url=https://www.indystar.com/story/news/health/2020/06/17/indiana-coronavirus-fairbanks-study-indicates-spread-has-slowed/3208509001/&ct=ga&cd=CAAYETIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNH4O6wDIVkk1hAyMEzD78OGtB7YoQ,6/23/2020,3/1/2021
200622_TruckeeMeadows_TruckeeMeadowsFireProtectionDistrict_FirstResponders,6/22/2020,Anh Gray,Sublocal,United States of America,"Nevada; United States of America
(Truckee Meadows Fire Protection District)",05/01 - 05/31,Essential non-healthcare workers,Adults (18-64 years),132,14% (NR),Convenience,"Not reported; Not reported; Not reported
(0%; 0%)",High,News and Media,https://www.kunr.org/post/prevalence-covid-19-antibodies-washoe-co-expected-be-low#stream/0,6/24/2020,3/1/2021
200504_SouthCarolina_MedicalUniversitySouthCarolina_HealthcareWorkers_FirstResponders,5/4/2020,Nick Reagan,Sublocal,United States of America,"Charleston; South Carolina; United States of America
(Medical University South Carolina)",04/27 - 05/02,Multiple populations,Adults (18-64 years),920,2% (NR),Unclear,"Abbott; Not reported; Not reported
(0%; 0%)",High,News and Media,https://www.live5news.com/2020/05/04/results-show-tested-musc-staff-have-covid-antibodies/,6/27/2020,3/17/2021
200523_CoralSprings_CoralSpringsCityGovernment_CityEmployees,5/22/2020,Jenny Staletovich,Local,United States of America,"Coral Springs; Florida; United States of America
(Coral Springs City Government)",05/17 - 05/23,Essential non-healthcare workers,Not reported,700,NA,Self-referral,"Cellex; Not reported; Not reported
(0%; 0%)",Unclear,News and Media,https://www.google.com/url?rct=j&sa=t&url=https://www.wlrn.org/post/south-florida-cities-begin-testing-employees-covid-19-antibodies&ct=ga&cd=CAAYDjIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNHc4oWG79OOMovZOpWOY8qd-gm3kw,6/27/2020,3/1/2021
200520_LosAngeles_UniSouthernCalifornia_GenPop,5/20/2020,CBS Los Angeles,Local,United States of America,"California; United States of America
(University of Southern California)",05/08 - 05/12,Household and community samples,Not reported,1014,2.1% (NR),Self-referral,"Not reported; Not reported; Not reported
(0%; 0%)",Unclear,News and Media,https://www.google.com/url?rct=j&sa=t&url=https://losangeles.cbslocal.com/2020/05/20/la-county-still-far-away-from-herd-immunity-new-antibody-numbers-show/&ct=ga&cd=CAAYCDIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNGRZYAUZKxAbfGM7Yh_03xi5M8tDg,6/27/2020,3/1/2021
200520_Madison_UWHealth_UniWisconsinHealthClinic,5/20/2020,Michelle Alfini,Local,United States of America,"Madison; Wisconsin; United States of America
(UW Health)",05/13 - 05/20,Household and community samples,Not reported,5303,1.5% (NR),Self-referral,"Not reported; Not reported; Not reported
(0%; 0%)",Unclear,News and Media,https://www.google.com/url?rct=j&sa=t&url=https://wkow.com/2020/05/20/antibody-tests-for-coronavirus-so-far-trend-overwhelmingly-negative/&ct=ga&cd=CAAYATIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNHstyT58meN6_pst9Z3Iu6amuxEQQ,6/27/2020,3/1/2021
200520_Madison_UWHealth_UnityPointClinic,5/20/2020,Michelle Alfini,Local,United States of America,"Madison; Wisconsin; United States of America
(UW Health)",05/13 - 05/20,Household and community samples,Not reported,433,0.3% (NR),Self-referral,"Not reported; Not reported; Not reported
(0%; 0%)",Unclear,News and Media,https://www.google.com/url?rct=j&sa=t&url=https://wkow.com/2020/05/20/antibody-tests-for-coronavirus-so-far-trend-overwhelmingly-negative/&ct=ga&cd=CAAYATIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNHstyT58meN6_pst9Z3Iu6amuxEQQ,6/27/2020,3/1/2021
200624_BaskingRidge_FellowshipVillage_Residents2_Overall,6/24/2020,Tim Regan,Sublocal,United States of America,"Basking Ridge; New Jersey; United States of America
(Fellowship Village)",04/15 - 05/06,Assisted living and long-term care facilities,Seniors (65+ years),371,34.8% (NR),Entire sample,"NR; NR
(0%; 0%)",High,News and Media,https://www.google.com/url?rct=j&sa=t&url=https://seniorhousingnews.com/2020/06/24/fellowship-village-benefits-from-covid-19-antibody-tests-juniper-plans-pilot/&ct=ga&cd=CAEYAyoTMTA4MjA1OTc5ODY3MTIyMzk1NTIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNFY2y-eZOXQXVuQzcKPUzRHkiG26g,6/29/2020,3/1/2021
201103_NewYorkCity_MountSinai_RoutineCare_1 _Overall,11/3/2020,Daniel Stadlbauer,Local,United States of America,"New York City; New York; United States of America
(Icahn School of Medicine at Mount Sinai)",02/02 - 07/05,Residual sera,Multiple groups,6590,11.1% (NR),Sequential,"Mount Sinai Hospital New York; IgG; ELISA
(95%; 100%)",High,Journal Article (Peer-Reviewed),http://dx.doi.org/10.1038/s41586-020-2912-6,6/29/2020,3/6/2021
200630_Seattle_FredHutchinsonResearchCenter_Overall,6/30/2020,Adam Dingens,Local,United States of America,"Seattle; Washington; United States of America
(Fred Hutchinson Cancer Research Center)",03/03 - 04/24,Residual sera,Children and Youth (0-17 years),1076,0.7% (NR),Convenience,"Abbott; IgG; Chemiluminescence Immunoassay
(100%; 99.9%)",High,Preprint,https://www.medrxiv.org/content/10.1101/2020.05.26.20114124v3,7/2/2020,3/1/2021
200529_NorthCarolina_Psalms/SolidRockMedicineGroup_GenPop,5/29/2020,Steve Ohnesorge,Local,United States of America,"North Carolina; United States of America
(Psalms/Solid Rock Medicine Group)",05/29 - 05/29,Household and community samples,Not reported,329,1.5% (NR),Self-referral,"Not reported; Not reported; Not reported
(0%; 0%)",Unclear,News and Media,https://www.google.com/url?rct=j&sa=t&url=https://www.wbtv.com/2020/05/29/antibody-testing-continues-burke-county/&ct=ga&cd=CAAYGTIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNEvSO7bk5TLI9MT5-BeF8ILKdseXA,7/4/2020,3/1/2021
200529_CoachellaValley_Desert Healthcare District_GenPop,5/29/2020,Nicole Hayden,Local,United States of America,"California; United States of America
(Desert Healthcare District)",NR - 05/28,Household and community samples,Not reported,896,6% (NR),Self-referral,"Phamatech; IgG, IgM; LFIA: Lateral flow immunoassay
(0%; 0%)",Unclear,News and Media,https://www.google.com/url?rct=j&sa=t&url=https://www.desertsun.com/story/news/health/2020/05/29/coachella-valley-far-covid-19-herd-immunity-preliminary-antibody-tests-show/5280021002/&ct=ga&cd=CAAYKzIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNFQxOqwjTX2Kz2_mnj1RV7Upa8rEg,7/4/2020,3/1/2021
200528_Michigan_MichiganDepartmentofCorrections_ParnallCFa,5/28/2020,Angie Jackson,Sublocal,United States of America,"Michigan; United States of America
(Michigan Department of Corrections )",05/14 - 05/22,Persons who are incarcerated,Not reported,1248,92% (NR),Convenience,"Not reported; Not reported; Not reported
(0%; 0%)",Unclear,News and Media,https://www.google.com/url?rct=j&sa=t&url=https://www.petoskeynews.com/news/state-region/almost-everyone-at-one-michigan-prison-tests-positive-for-covid-19-antibodies/article_423c1ef0-a018-5b50-b746-c93fcb82f71f.html&ct=ga&cd=CAAYEDIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNGW46yu1TPu2kCI0JVHs2BTsuSgjw,7/6/2020,3/1/2021
200528_Michigan_MichiganDepartmentofCorrections_MacombCF,5/28/2020,Angie Jackson,Sublocal,United States of America,"Lenox Township; Michigan; United States of America
(Michigan Department of Corrections )",05/14 - 05/22,Persons who are incarcerated,Not reported,1201,66% (NR),Convenience,"Not reported; Not reported; Not reported
(0%; 0%)",Unclear,News and Media,https://www.google.com/url?rct=j&sa=t&url=https://www.petoskeynews.com/news/state-region/almost-everyone-at-one-michigan-prison-tests-positive-for-covid-19-antibodies/article_423c1ef0-a018-5b50-b746-c93fcb82f71f.html&ct=ga&cd=CAAYEDIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNGW46yu1TPu2kCI0JVHs2BTsuSgjw,7/6/2020,3/1/2021
200528_Michigan_MichiganDepartmentofCorrections_DetroitRC,5/28/2020,Angie Jackson,Sublocal,United States of America,"Detroit; Michigan; United States of America
(Michigan Department of Corrections )",05/14 - 05/22,Persons who are incarcerated,Not reported,57,35% (NR),Convenience,"Not reported; Not reported; Not reported
(0%; 0%)",Unclear,News and Media,https://www.google.com/url?rct=j&sa=t&url=https://www.petoskeynews.com/news/state-region/almost-everyone-at-one-michigan-prison-tests-positive-for-covid-19-antibodies/article_423c1ef0-a018-5b50-b746-c93fcb82f71f.html&ct=ga&cd=CAAYEDIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNGW46yu1TPu2kCI0JVHs2BTsuSgjw,7/6/2020,3/1/2021
200528_Michigan_MichiganDepartmentofCorrections_GRobertCottonCF,5/28/2020,Angie Jackson,Sublocal,United States of America,"Michigan; United States of America
(Michigan Department of Corrections )",05/14 - 05/22,Persons who are incarcerated,Not reported,867,12% (NR),Convenience,"Not reported; Not reported; Not reported
(0%; 0%)",Unclear,News and Media,https://www.google.com/url?rct=j&sa=t&url=https://www.petoskeynews.com/news/state-region/almost-everyone-at-one-michigan-prison-tests-positive-for-covid-19-antibodies/article_423c1ef0-a018-5b50-b746-c93fcb82f71f.html&ct=ga&cd=CAAYEDIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNGW46yu1TPu2kCI0JVHs2BTsuSgjw,7/6/2020,3/1/2021
200707_Lousiana_TulaneUniversity_AllChildren,7/8/2020,Monika Dietrich,Local,United States of America,"Orleans; Louisiana; United States of America
(Tulane University)",03/18 - 05/15,Residual sera,Children and Youth (0-17 years),812,7.6% (NR),Convenience,"Author-designed; IgG; ELISA
(0%; 0%)",High,Preprint,https://www.medrxiv.org/content/10.1101/2020.07.07.20147884v1,7/9/2020,3/17/2021
200729_Philadelphia_UniversityofPennsylvania_TotalSampleTestAdj,7/29/2020,Dustin Flannery,Local,United States of America,"Philadelphia; Pennsylvania; United States of America
(University of Pennsylvania)",04/04 - 06/03,Pregnant or parturient women,Adults (18-64 years),1293,5.2% (NR),Sequential,"Author-designed; IgG, IgM; ELISA
(100%; 98.9%)",Moderate,Preprint,https://immunology.sciencemag.org/content/5/49/eabd5709,7/13/2020,3/1/2021
200514_Indianapolis_IcahnSchoolofMedicine_HCW_IGMorIGG,5/14/2020,David Hains,Sublocal,United States of America,"Indianapolis; Indiana; United States of America
(Icahn School of Medicine at Mount Sinai)",04/01 - 04/15,Health care workers and caregivers,Adults (18-64 years),25,44% (NR),Convenience,"Abnova; IgM, IgG; ELISA
(0%; 0%)",High,Journal Article (Peer-Reviewed),https://jamanetwork.com/journals/jama/fullarticle/2766215,7/15/2020,3/1/2021
200514_Indianapolis_IcahnSchoolofMedicine_PedDialysisPatients_IGMorIGG,5/14/2020,David Hains,Sublocal,United States of America,"Indianapolis; Indiana; United States of America
(Icahn School of Medicine at Mount Sinai)",04/01 - 04/15,Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),13,23% (NR),Convenience,"Abnova; IgM, IgG; ELISA
(0%; 0%)",High,Journal Article (Peer-Reviewed),https://jamanetwork.com/journals/jama/fullarticle/2766215,7/15/2020,3/17/2021
200529_Washington_CDC_KnownContacts,5/29/2020,Victoria Chu,Regional,United States of America,"Washington; United States of America
(US Centers for Disease Control and Prevention)",01/20 - 02/03,Contacts of COVID patients,Multiple groups,32,NA,Convenience,"Author-designed; Not reported; ELISA
(96%; 99%)",High,Journal Article (Peer-Reviewed),https://wwwnc.cdc.gov/eid/article/26/8/20-1423_article,7/16/2020,3/1/2021
200706_Nashville_VanderbiltUniversityMedicalCenter_Overall,7/6/2020,William Stubblefield,Sublocal,United States of America,"Nashville; Tennessee; United States of America
(Vanderbilt University Medical Center)",04/03 - 04/13,Health care workers and caregivers,Multiple groups,249,7.6% (NR),Convenience,"CDC; IgM, IgG, IgA; ELISA
(96%; 99%)",High,Journal Article (Peer-Reviewed),https://pmlegacy.ncbi.nlm.nih.gov/pubmed/32628750,7/18/2020,3/1/2021
200507_Boise_UniversityofWashington_GenPop,5/7/2020,Andrew Bryan,Local,United States of America,"Boise; Idaho; United States of America
(University of Washington School of Medicine)",04/20 - 04/26,Household and community samples,Multiple groups,4856,1.8% (NR),Self-referral,"Abbott; IgG; Chemiluminescence Immunoassay
(100%; 100%)",High,Journal Article (Peer-Reviewed),https://jcm.asm.org/content/early/2020/05/07/JCM.00941-20,7/19/2020,3/1/2021
200509_NewYork_ColumbiaUniversityIrvingMedicalCenter_HCW,6/9/2020,Miguel Morcuende,Sublocal,United States of America,"New York City; New York; United States of America
(Columbia University Irving Medical Center)",03/01 - 04/21,Health care workers and caregivers,Adults (18-64 years),91,12.1% (NR),Convenience,"""Zhejiang Orient Gene Biotech Co., LTD""; IgG, IgM; LFIA: Lateral flow immunoassay
(93.1%; 99.2%)",High,Journal Article (Peer-Reviewed),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7302070/,7/19/2020,3/1/2021
200721_Washington_CDC_Overall_PopAdjTestAdj,7/21/2020,Fiona Havers,Regional,United States of America,"Washington; United States of America
(US Centers for Disease Control and Prevention)",03/23 - 04/01,Residual sera,Multiple groups,3264,1.1% (0.7-1.9%),Convenience,"CDC; IgG; ELISA
(96%; 99.3%)",Moderate,Journal Article (Peer-Reviewed),https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2768834,7/29/2020,3/1/2021
200721_NewYork_CDC_Overall_PopAdjTestAdj,7/21/2020,Fiona Havers,Regional,United States of America,"New York; United States of America
(US Centers for Disease Control and Prevention)",03/23 - 04/01,Residual sera,Multiple groups,2482,6.9% (5-8.9%),Convenience,"CDC; IgG; ELISA
(96%; 99.3%)",Moderate,Journal Article (Peer-Reviewed),https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2768834,7/29/2020,3/1/2021
200721_Louisiana_CDC_Overall_PopAdjTestAdj,7/21/2020,Fiona Havers,Regional,United States of America,"Louisiana; United States of America
(US Centers for Disease Control and Prevention)",04/01 - 04/08,Residual sera,Multiple groups,1184,5.8% (3.9-8.2%),Convenience,"CDC; IgG; ELISA
(96%; 99.3%)",Moderate,Journal Article (Peer-Reviewed),https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2768834,7/29/2020,3/1/2021
200721_SouthFlorida_CDC_Overall_PopAdj_TestAdj,7/21/2020,Fiona Havers,Regional,United States of America,"Florida; United States of America
(US Centers for Disease Control and Prevention)",04/05 - 04/10,Residual sera,Multiple groups,1742,1.9% (1-3.2%),Convenience,"CDC; IgG; ELISA
(96%; 99.3%)",Moderate,Journal Article (Peer-Reviewed),https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2768834,7/29/2020,3/1/2021
200721_Pennsylvania_CDC_Overall_PopAdjTestAdj,7/21/2020,Fiona Havers,Regional,United States of America,"Pennsylvania; United States of America
(US Centers for Disease Control and Prevention)",04/13 - 04/25,Residual sera,Multiple groups,824,3.2% (1.7-5.2%),Convenience,"CDC; IgG; ELISA
(96%; 99.3%)",Moderate,Journal Article (Peer-Reviewed),https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2768834,7/29/2020,3/1/2021
200721_Missouri_CDC_Overall_PopAdjTestAdj,7/21/2020,Fiona Havers,Regional,United States of America,"Missouri; United States of America
(US Centers for Disease Control and Prevention)",04/20 - 04/26,Residual sera,Multiple groups,1882,2.7% (1.7-3.9%),Convenience,"CDC; IgG; ELISA
(96%; 99.3%)",Moderate,Journal Article (Peer-Reviewed),https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2768834,7/29/2020,3/1/2021
200721_Utah_CDC_Overall_PopAdjTestAdj,7/21/2020,Fiona Havers,Regional,United States of America,"Utah; United States of America
(US Centers for Disease Control and Prevention)",04/20 - 05/03,Residual sera,Multiple groups,1132,2.2% (1.2-3.4%),Convenience,"CDC; IgG; ELISA
(96%; 99.3%)",Moderate,Journal Article (Peer-Reviewed),https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2768834,7/29/2020,3/1/2021
200721_California_CDC_Overall_PopAdjTestAdj,7/21/2020,Fiona Havers,Regional,United States of America,"California; United States of America
(US Centers for Disease Control and Prevention)",04/23 - 04/27,Residual sera,Multiple groups,1224,1% (0.3-2.4%),Convenience,"CDC; IgG; ELISA
(96%; 99.3%)",Moderate,Journal Article (Peer-Reviewed),https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2768834,7/29/2020,3/1/2021
200721_Connecticut_CDC_Overall_PopAdjTestAdj,7/21/2020,Fiona Havers,Regional,United States of America,"Connecticut; United States of America
(US Centers for Disease Control and Prevention)",04/26 - 05/03,Residual sera,Multiple groups,1431,4.9% (3.6-6.5%),Convenience,"CDC; IgG; ELISA
(96%; 99.3%)",Moderate,Journal Article (Peer-Reviewed),https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2768834,7/29/2020,3/1/2021
200721_Minnesota_CDC_Overall_PopAdjTestAdj,7/21/2020,Fiona Havers,Regional,United States of America,"Minnesota; United States of America
(US Centers for Disease Control and Prevention)",04/30 - 05/12,Residual sera,Multiple groups,860,2.4% (1-4.5%),Convenience,"CDC; IgG; ELISA
(96%; 99.3%)",Moderate,Journal Article (Peer-Reviewed),https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2768834,7/29/2020,3/1/2021
200717_Chittenden_UniversityVermont_GenPop,7/17/2020,Cat Viglienzoni,Local,United States of America,"Vermont; United States of America
(University of Vermont)",NR - 06/30,Household and community samples,Not reported,500,2.2% (NR),Convenience,"University of Vermont; Not reported; Not reported
(0%; 0%)",High,News and Media,https://www.google.com/url?rct=j&sa=t&url=https://www.wcax.com/2020/07/17/early-results-of-uvm-research-tracking-covids-spread-in-vermont/&ct=ga&cd=CAAYCzIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNEblNmlKeakOFmkRkZMbbLnjhptxw,8/1/2020,3/1/2021
200708_WashoeCounty_WashoeCountyHealthDistrict_GenPop,7/8/2020,Mary Hynes,Local,United States of America,"Nevada; United States of America
(Washoe County Health District)",06/09 - 06/10,Household and community samples,Adults (18-64 years),234,2.3% (NR),Stratified probability,"Abbott; Not reported; Not reported
(0%; 99.6%)",High,News and Media,https://www.google.com/url?rct=j&sa=t&url=https://www.reviewjournal.com/local/local-nevada/nevada-covid-19-infection-rate-5-times-higher-antibody-tests-show-2070094/&ct=ga&cd=CAAYBzIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNGG4t16ng9mGv7ghgkKQP4Qm3hotw,8/1/2020,3/1/2021
200614_Ohio_OhioStateUniversity_Period 2,6/14/2020,Miranda Kiefer,Sublocal,United States of America,"Columbus; Ohio; United States of America
(Ohio State University College of Medicine)",04/23 - 04/23,Health care workers and caregivers,Adults (18-64 years),110,20% (NR),Convenience,"Epitope Diagnostics; IgG, IgM; ELISA
(0%; 0%)",High,Journal Article (Peer-Reviewed),https://www.ajog.org/article/S0002-9378(20)30649-9/fulltext,8/2/2020,3/1/2021
200715_WashintonDC_DCPublicHealth_GenPop,7/15/2020,Julie Zauzmer,Local,United States of America,"Washington DC; District of Columbia; United States of America
(Washington DC Public Health)",06/15 - 07/15,Household and community samples,Not reported,13706,5.9% (NR),Self-referral,"DiaSorin LIAISON, Abbot Alinity i; Not reported; Chemiluminescence Immunoassay
(0%; 0%)",High,News and Media,https://www.google.com/url?rct=j&sa=t&url=https://www.washingtonpost.com/dc-md-va/2020/07/15/dc-health-lab-has-tested-13706-blood-samples-only-809-people-carried-coronavirus-antibodies/&ct=ga&cd=CAAYKTIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNFVGZ6aDeXqXAEUfikIfjfhDgkSVw,8/2/2020,3/1/2021
200715_Massachusetts_HarvardMedicalSchool_Overall_IgG/IgM,7/15/2020,Scott Goldberg,Sublocal,United States of America,"Massachusetts; United States of America
(Harvard Medical School)",04/01 - 04/06,Assisted living and long-term care facilities,Multiple groups,140,0.1% (NR),Convenience,"BioMedomics; IgG, IgM; LFIA: Lateral flow immunoassay
(90.1%; 99.74%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1093/cid/ciaa991,8/2/2020,3/17/2021
200721_Idaho_UniversityofWashington_TotalPopTestAdj,7/21/2020,Colleen McLaughlin,Local,United States of America,"Idaho; United States of America
( University of Washington)",05/04 - 05/19,Household and community samples,Multiple groups,917,23.1% (19.8-26.5%),Self-referral,"Abbott; IgG; Chemiluminescence Immunoassay
(92.9%; 99.6%)",Moderate,Preprint,https://www.medrxiv.org/content/10.1101/2020.07.19.20157198v1,8/3/2020,3/1/2021
200513_Indiana_IndianaUniversity_Wave1_NonRandom_PopAdj,"7/24/2020, 5/13/2020, 5/17/2020","Nir Menachemi, Aaron Carroll, Dariush Shafa",Local,United States of America,"Indianapolis; Indiana; United States of America
(Indiana University Fairbanks School of Public Health)",05/02 - 05/03,Household and community samples,Multiple groups,898,5.8% (NR),Self-referral,"Not reported; IgG; Chemiluminescence Immunoassay
(100%; 99.6%)",High,"Institutional Report, News and Media, News and Media","https://www.cdc.gov/mmwr/volumes/69/wr/mm6929e1.htm?s_cid=mm6929e1_w, https://www.nytimes.com/2020/05/13/opinion/indiana-reopening-coronavirus-testing.html, https://www.google.com/url?rct=j&sa=t&url=https://www.perrycountynews.com/content/study-projects-only-9-covid-19-cases-detected&ct=ga&cd=CAAYHDIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNEf69_TglEJjU9g7rkvZNMTUfoqoQ",8/4/2020,3/1/2021
201028_Connecticut_YaleSchoolOfMedicine_GenPop1_Overall_PopAdj,10/28/2020,Shiwani Mahajan,Regional,United States of America,"Connecticut; United States of America
(Yale School of Medicine)",06/04 - 06/23,Household and community samples,Multiple groups,567,4% (2-6%),Simplified probability,"Ortho-Clinical Diagnostics; IgG; Chemiluminescence Immunoassay
(90%; 100%)",Moderate,Journal Article (Peer-Reviewed),http://dx.doi.org/10.1016/j.amjmed.2020.09.024,9/24/2020,3/13/2021
200804_Miami_DaVitaClinicalResearch_HemodialysisPatients_Overall,8/4/2020,Dena Cohen,Local,United States of America,"Miami; Florida; United States of America
(DaVita Clinical Research)",04/23 - 04/30,Patients seeking care for non-COVID-19 reasons,Multiple groups,677,5.6% (4-7.6%),Convenience,"Diazyme Laboratories Inc; IgG, IgM; Chemiluminescence Immunoassay
(57.1%; 85%)",High,Preprint,https://doi.org/10.1101/2020.08.03.20163642,9/24/2020,3/17/2021
200729_RiversideCounty_RiversideUniversityHealthSystem_GenPop,"7/27/2020, 7/29/2020, 7/27/2020","Nicole Hayden, Rob McMillan, ABC7.com staff",Local,United States of America,"California; United States of America
(Riverside University Health System)",07/06 - 07/20,Household and community samples,Not reported,1726,5.9% (NR),Simplified probability,"NR; Not reported; Not reported
(0%; 0%)",Unclear,"News and Media, News and Media, News and Media","https://eu.desertsun.com/story/news/health/2020/07/27/riverside-county-estimates-175-000-residents-could-have-been-infected/5522612002/, https://abc7.com/riverside-county-covid-update-coronavirus-ie-covid-19/6340600/, https://abc7.com/health/riverside-county-may-have-100000-covid-19-cases-study-says/6337677/",9/26/2020,3/1/2021
200721_NewYork_ShermanAbramsLaboratory_Overall,7/21/2020,Josh Reifer,Local,United States of America,"New York; New York; United States of America
(Sherman Abrams Laboratory )",05/15 - 06/15,Residual sera,Multiple groups,28523,44% (NR),Unclear,"DiaSorin LIAISON; IgG; Chemiluminescence Immunoassay
(0%; 0%)",Unclear,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1016/j.diagmicrobio.2020.115128,9/26/2020,3/17/2021
200725_California_HoagMemorialHospitalPresbyterian_Healthcareworkers_TestAdj,7/25/2020,Michael Brant-Zawadzki,Local,United States of America,"California; United States of America
(Hoag Memorial Hospital Presbyterian)",05/15 - 06/15,Health care workers and caregivers,Adults (18-64 years),2932,1.1% (0.8-1.6%),Convenience,"Ortho-Clinical Diagnostics; IgG; Not reported
(93.6%; 100%)",High,Preprint,https://www.medrxiv.org/content/10.1101/2020.07.20.20158329v1,9/27/2020,3/1/2021
200726_RhodeIsland_NewYorkBloodCenter_BloodDonors,7/26/2020,Daniel Nesbitt,Regional,United States of America,"Rhode Island; United States of America
(New York Blood Center)",04/27 - 05/11,Blood donors,Multiple groups,1996,3.9% (NR),Sequential,"Ortho-Clinical Diagnostics, SD Biosensor; IgG, IgM; Chemiluminescence Immunoassay, LFIA: Lateral flow immunoassay
(0%; 0%)",Moderate,Preprint,https://www.medrxiv.org/content/10.1101/2020.07.20.20157743v1,9/27/2020,3/1/2021
200904_USA_CDC_HCWs_Overall,9/4/2020,Wesley Self,National,United States of America,"Bronx, Springfield, Nashville, Aurora, Boston, Los Angeles, Seattle, Minneapolis, Baltimore, Portland, Winston-Salem, Murray, Columbus; New York, Massachusetts, Tennessee, Colorado, California, Washington, Minnesota, Maryland, Oregon, North Carolina, Utah, Ohio; United States of America
(CDC COVID-19 Response Team)",04/03 - 06/19,Health care workers and caregivers,Adults (18-64 years),3248,6% (NR),Convenience,"Not reported; IgA, IgM, IgG; ELISA
(96%; 99%)",Moderate,Journal Article (Peer-Reviewed),https://www.cdc.gov/mmwr/volumes/69/wr/mm6935e2.htm,9/28/2020,3/1/2021
200723_JeffersonCounty_UniversityofLouisville_genpop,7/23/2020,Spectrum News Staff,Local,United States of America,"Kentucky; United States of America
( University of Louisville)",06/10 - 06/19,Household and community samples,Multiple groups,2237,4% (NR),Self-referral,"Not reported; Not reported; Not reported
(0%; 0%)",High,News and Media,https://spectrumnews1.com/ky/louisville/news/2020/07/23/uofl-coimmunity-project-phase-2-results,9/30/2020,3/1/2021
200724_DeKalbFulton_CDCCOVID-19ResponseTeam_Overall_PopAdj,7/24/2020,Holly Biggs,Local,United States of America,"Georgia; United States of America
(CDC COVID-19 Response Team)",04/28 - 05/03,Household and community samples,Multiple groups,696,2.5% (1.4-4.5%),Stratified probability,"Ortho-Clinical Diagnostics; IgG, IgA, IgM; Not reported
(93.2%; 99%)",Low,Journal Article (Peer-Reviewed),https://dx.doi.org/10.15585/mmwr.mm6929e2,10/2/2020,3/1/2021
200803_Indiana_IndianaUniversity_healthcareworkers,8/3/2020,Benton Hunter,Regional,United States of America,"Indianapolis; Indiana; United States of America
( Indiana University)",04/29 - 05/08,Health care workers and caregivers,Adults (18-64 years),734,1.6% (NR),Convenience,"Abbott; IgG; Chemiluminescence Immunoassay
(100%; 99.6%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1017/ice.2020.390,10/4/2020,3/1/2021
200730_Louisiana_OschnerClinicFoundation_Overall_PopWeighted,7/30/2020,Amy K Feehan,Local,United States of America,"Louisiana; United States of America
(Oschner Clinic Foundation)",05/09 - 05/15,Household and community samples,Adults (18-64 years),2640,6.9% (6.8-6.9%),Stratified probability,"Abbott; IgG; Chemiluminescence Immunoassay
(0%; 0%)",Moderate,Journal Article (Peer-Reviewed),https://dx.doi.org/10.3201/eid2611.203029,10/5/2020,3/1/2021
200814_NewYorkCity_MemorialSloanKetteringCancerCenter_CancerPatients,8/14/2020,Sean McBride,Sublocal,United States of America,"New York City; New York; United States of America
(Memorial Sloan Kettering Cancer Center)",05/07 - 06/25,Patients seeking care for non-COVID-19 reasons,Multiple groups,952,5.5% (NR),Convenience,"Abbott; IgG; chemiluminescent microparticle immunoassay
(0%; 0%)",High,Preprint,https://www.medrxiv.org/content/10.1101/2020.08.11.20172551v1,10/9/2020,3/17/2021
200806_Florida_UniversityofMiamiMillerSchoolofMedicine_FirstResponders_UnAdj,8/6/2020,Alberto J Caban-Martinez,Sublocal,United States of America,"Florida; United States of America
(University of Miami)",04/16 - 04/17,Essential non-healthcare workers,Multiple groups,203,8.9% (NR),Convenience,"BioMedomics; IgG, IgM; LFIA: Lateral flow immunoassay
(88.66%; 90.63%)",High,Journal Article (Peer-Reviewed),http://dx.doi.org/10.1136/oemed-2020-106676,10/10/2020,3/16/2021
200811_NewYork_StFrancisHospital_Overall,8/11/2020,Allen Jeremias,Sublocal,United States of America,"New York City; New York; United States of America
(St Francis Hospital)",03/01 - 04/30,Health care workers and caregivers,Adults (18-64 years),1699,9.8% (NR),Convenience,"EUROIMMUN, Abbott; IgG; Not reported
(0%; 0%)",High,Journal Article (Peer-Reviewed),http://dx.doi.org/10.1001/jamainternmed.2020.4214,10/10/2020,3/1/2021
200814_Oregon_OregonHealthAuthority_Overall_UnAdj,8/14/2020,Melissa Sutton,Regional,United States of America,"Oregon; United States of America
(Oregon Health Authority)",05/11 - 06/15,Residual sera,Multiple groups,897,1% (0.2-1.8%),Stratified probability,"Abbott; IgG; chemiluminescent microparticle immunoassay
(96.8%; 99.1%)",High,Journal Article (Peer-Reviewed),https://www.cdc.gov/mmwr/volumes/69/wr/mm6932a4.htm,10/10/2020,3/1/2021
200816_Tucson_UniversityofArizona_genpop_RBD,8/16/2020,Tyler Ripperger,Local,United States of America,"Tucson; Arizona; United States of America
(University of Arizona)",04/30 - 05/07,Multiple populations,Multiple groups,5882,1.2% (NR),Self-referral,"Author-designed; IgG; ELISA
(0%; 0%)",High,Preprint,https://www.medrxiv.org/content/10.1101/2020.08.14.20174490v1,10/13/2020,3/17/2021
200918_UnitedStates_Vitalant_Overall,9/18/2020,Ralph Vassallo ,National,United States of America,"Albuquerque, Billings, Cheyenne, denver, El Paso, Fargo, Lafayette, Las Vegas, Lubbock, McAllen, Memphis, Phoenix, Rapid City, Reno, Sacramento, San Francisco, Spokane, Tupelo, ventura, Newark; New Mexico, Montana, Wyoming, Colorado, Texas, North Dakota, Louisiana, Nevada, Tennessee, Arizona, South Dakota, California, Washington, Mississippi; United States of America
(Vitalant)",06/01 - 07/31,Blood donors,Multiple groups,252882,1.8% (NR),Entire sample,"Ortho-Clinical Diagnostics; IgA, IgG, IgM, Total Antibody; Chemiluminescence Immunoassay
(0%; 0%)",Moderate,Preprint,https://www.medrxiv.org/content/10.1101/2020.09.17.20195131v1.full.pdf,10/13/2020,3/1/2021
200815_Bolinas_UniversityofCaliforniaSanFrancisto_AbbottElisaBolinasResidents,8/15/2020,Ayesha Appa,Local,United States of America,"Bolinas; California; United States of America
(University of California, San Francisco)",04/20 - 04/24,Household and community samples,Multiple groups,1312,0.2% (0-0.5%),Self-referral,"Abbott, Author-designed; IgG; ELISA, chemiluminescent microparticle immunoassay
(99.6%; 99.61%)",High,Preprint,https://www.medrxiv.org/content/10.1101/2020.08.15.20175786v1,10/15/2020,3/20/2021
200818_Cambridge_CambridgeHealthAllianceOverall,8/18/2020,Robert Stavert,Sublocal,United States of America,"Cambridge; Massachusetts; United States of America
(Cambridge Health Alliance)",04/13 - 05/24,Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),24,16% (NR),Convenience,"Abbott, DiaSorin, EUROIMMUN; IgG, IgA, IgM; Not reported
(0%; 0%)",High,Journal Article (Peer-Reviewed),http://dx.doi.org/10.1016/j.jaad.2020.08.049,10/15/2020,3/17/2021
200818_SanFrancisco_UniversityofCaliforniaSanFrancisco,8/21/2020,Gabriel Chamie,Local,United States of America,"San Francisco; California; United States of America
(University of California, San Francisco)",04/25 - 04/28,Household and community samples,Multiple groups,3861,3.4% (2.9-4.1%),Self-referral,"Abbott; IgG; chemiluminescent microparticle immunoassay
(0%; 0%)",High,Journal Article (Peer-Reviewed),http://dx.doi.org/10.1093/cid/ciaa1234,10/17/2020,3/1/2021
200818_Oregon_EarleA.ChilesResearchInstitute_Overall,8/18/2020,Rom Leidner,Regional,United States of America,"Portland, Oregon City, Medford, Seaside, Hood River, Newberg, Milwaukie; Oregon; United States of America
(Chiles Research Institute)",04/08 - 05/22,Health care workers and caregivers,Multiple groups,10019,2.5% (NR),Convenience,"Author-designed; IgG; ELISA
(80%; 100%)",High,Preprint,https://www.medrxiv.org/content/10.1101/2020.08.16.20176107v1,10/18/2020,3/17/2021
200826_NewYorkCity_JacobiMedicalCenter_HealthCareWorkers,8/26/2020,Elana Sydney,Sublocal,United States of America,"New York City; New York; United States of America
(Jacobi Medical Center)",04/28 - 05/04,Health care workers and caregivers,Multiple groups,1700,19.2% (NR),Convenience,"Abbott; IgG; chemiluminescent microparticle immunoassay
(100%; 99.6%)",High,Journal Article (Peer-Reviewed),http://dx.doi.org/10.1017/ice.2020.437,10/21/2020,3/1/2021
200828_LosAngeles_VeteransAffairsHealthcareSystem_Residents,8/28/2020,Amy V Dora,Sublocal,United States of America,"Los Angeles; California; United States of America
(Veterans Affairs Healthcare System)",06/05 - 06/12,Assisted living and long-term care facilities,Multiple groups,150,17.3% (NR),Convenience,"DiaSorin; IgG; Chemiluminescence Immunoassay
(92%; 98%)",High,Journal Article (Peer-Reviewed),http://dx.doi.org/10.1093/cid/ciaa1286,10/21/2020,3/1/2021
200909_Chelsea_MassachusettsGeneralHospital_Overall_TestAdj,9/9/2020,Vivek Naranbhai,Local,United States of America,"Chelsea; Massachusetts; United States of America
(Massachusetts General Hospital)",04/14 - 04/15,Household and community samples,Adults (18-64 years),200,32.8% (27.2-38.8%),Convenience,"BioMedomics; IgM, IgG; ELISA
(90%; 99%)",Moderate,Journal Article (Peer-Reviewed),http://dx.doi.org/10.1093/infdis/jiaa579,10/21/2020,3/1/2021
200911_UnitedStates_ClinicalReferenceLaboratories_Overall,9/11/2020,Steven Rigatti,National,United States of America,"United States of America
(Clinical Reference Laboratories)",05/12 - 06/25,Household and community samples,Multiple groups,50025,3% (NR),Convenience,"Roche Diagnostics; Not reported; Electro chemiluminescence immunoassay
(100%; 99.8%)",High,Preprint,https://www.medrxiv.org/content/10.1101/2020.09.09.20191296v1,10/23/2020,3/1/2021
200806_NewYork_NorthwellHealth_hcw,8/6/2020,Joseph Muscola,Local,United States of America,"New York; New York; United States of America
(Northwell Health)",04/20 - 06/23,Health care workers and caregivers,Adults (18-64 years),40329,13.7% (NR),Convenience,"EUROIMMUN, Abbott, AnshLabs, Ortho-Clinical Diagnostics, DiaSorin, Roche; IgG; ELISA, Chemiluminescence Immunoassay, Electro chemiluminescence immunoassay, Immunometric
(0%; 0%)",Moderate,Journal Article (Peer-Reviewed),http://dx.doi.org/10.1001/jama.2020.14765,10/24/2020,3/16/2021
200821_NewYorkCityHealthSystem_AlbertEinsteinCollegeofMedicine,8/21/2020,Ariel D. Stock,Local,United States of America,"New York City; New York; United States of America
(Albert Einstein College of Medicine)",04/04 - 04/20,Health care workers and caregivers,Adults (18-64 years),98,15.3% (NR),Convenience,"Epitope Diagnostics; IgG; ELISA
(0%; 0%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.3389/fmed.2020.00471,10/24/2020,3/1/2021
200920_NewYorkState_DonaldAndBarbaraZuckerSchoolOfMedicine_Patients_Overall,9/2/2020,Lylach Haizler-Cohen,Regional,United States of America,"New York; United States of America
(Donald and Barbara Zucker School of Medicine)",05/27 - 07/24,Pregnant or parturient women,Adults (18-64 years),1671,16.1% (NR),Unclear,"Roch Elecsys; NR
(0%; 0%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1016/j.ajog.2020.09.022,10/30/2020,3/17/2021
200911_NewYorkCity_WeillCornellMedicine_IgGorIgM,9/11/2020,Sabrina Racine-Brzostek,Local,United States of America,"New York City; New York; United States of America
(Weill Cornell Medicine)",04/17 - 05/07,Health care workers and caregivers,Adults (18-64 years),2274,35.4% (NR),Convenience,"ET Healthcare; IgG, IgM; Cyclic enhanced fluorescence assay (CEFA)
(0%; 98.8%)",Moderate,Journal Article (Peer-Reviewed),http://dx.doi.org/10.1093/ajcp/aqaa142,11/2/2020,3/1/2021
201023_BatonRouge_OchsnerClinicFoundation_Overall_Popadj,10/23/2020,Amy K. Feehan,Local,United States of America,"Baton Rouge; Louisiana; United States of America
(Louisiana State University)",07/15 - 07/31,Household and community samples,Multiple groups,2138,3.6% (2.8-4.4%),Stratified probability,"Abbott; IgG; Chemiluminescence Immunoassay
(0%; 0%)",Moderate,Journal Article (Peer-Reviewed),https://dx.doi.org/10.3201/eid2701.203808,11/4/2020,3/1/2021
200917_SanFrancisco_UniversityofCalifornia_BloodDonors,9/17/2020,Dianna Ng,Local,United States of America,"San Francisco; California; United States of America
(University of California, San Francisco)",03/01 - 03/31,Blood donors,Multiple groups,1000,0.1% (0-0.6%),Sequential,"Abbott, Ortho-Clinical Diagnostics; IgG; Chemiluminescence Immunoassay, Neutralization assay
(99%; 99.8%)",Moderate,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1038/s41467-020-18468-8,11/6/2020,3/1/2021
200917_SanFrancisco_UniversityofCalifornia_Patients,9/17/2020,Dianna Ng,Local,United States of America,"San Francisco; California; United States of America
(University of California, San Francisco)",03/17 - 04/13,Residual sera,Multiple groups,387,0.3% (0-0.8%),Convenience,"Abbott; IgG, IgM; Chemiluminescence Immunoassay
(99%; 99.8%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1038/s41467-020-18468-8,11/6/2020,3/1/2021
200925_UnitedStates_StanfordUniversity_OverallPopAdj,9/25/2020,Shuchi Anand,National,United States of America,"United States of America
(Stanford University)",06/15 - 06/15,Residual sera,Multiple groups,28503,9.3% (8.8-9.9%),Stratified probability,"Siemens Healthineers; Total Antibody; Chemiluminescence
(100%; 99.8%)",Low,Journal Article (Peer-Reviewed),https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)32009-2/fulltext,11/22/2020,3/17/2021
200923_AnnArbor_VeteransAffairsAnnArborHealthcareSystem,9/23/2020,Derek Dimcheff,Local,United States of America,"Michigan; United States of America
(Veterans Affairs Ann Arbor Healthcare System)",06/08 - 07/08,Health care workers and caregivers,Multiple groups,1476,4.9% (3.8-6.1%),Self-referral,"Abbott; IgG; Chemiluminsescent microparticle immunoassay
(100%; 99%)",Moderate,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1017/ice.2020.1220,11/23/2020,3/1/2021
200918_Arizona_VincereCancerCenter_Total,9/18/2020,Vershalee Shukla,Regional,United States of America,"Phoenix, Tempe, Glendale, Surprise, Peoria, Chandler; Arizona; United States of America
(Vincere Cancer Center)",04/24 - 05/21,Essential non-healthcare workers,Multiple groups,3326,1.5% (NR),Self-referral,"Ray Biotech; IgG; LFIA: Lateral flow immunoassay
(90.4%; 98.3%)",Unclear,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1097/JOM.0000000000002027,11/23/2020,3/1/2021
200914_UnitedStates_AmericanRedCrossScientificAffairs_Overall,9/14/2020,Roger Dodd,National,United States of America,"United States of America
(American Red Cross Scientific Affairs)",06/15 - 06/15,Blood donors,Multiple groups,953926,1.8% (NR),Sequential,"Ortho-Clinical Diagnostics; Total Antibody; Not reported
(90%; 100%)",Moderate,Journal Article (Peer-Reviewed),http://dx.doi.org/10.1001/jama.2020.18598,11/23/2020,3/1/2021
200917_Nashville_VanderbiltUniversityMedicalCenter_BaselineOverall,9/17/2020,Manish Patel,Sublocal,United States of America,"Nashville; Tennessee; United States of America
(Vanderbilt University Medical Center)",04/03 - 04/13,Health care workers and caregivers,Multiple groups,249,7.6% (NR),Convenience,"Not reported; Not reported; ELISA
(99%; 96%)",High,Journal Article (Peer-Reviewed),http://dx.doi.org/10.1001/jama.2020.18796,11/24/2020,3/1/2021
200921_Detroit_Region2SouthHealthcareCoalition_Overall,9/21/2020,Lara Akinbami,Local,United States of America,"Detroit; Michigan; United States of America
(Region 2 South Healthcare Coalition)",05/18 - 06/13,Health care workers and caregivers,Adults (18-64 years),16397,6.9% (6.5-7.3%),Convenience,"Ortho Clinical Diagnostics; NR
(90%; 100%)",Moderate,Journal Article (Peer-Reviewed),https://dx.doi.org/10.3201/eid2612.203764,12/4/2020,3/1/2021
200929_NorthCarolina_UniversityofNorthCarolinaChapelHill_ScreenNC2_Overall,9/29/2020,Amir Barzin,Regional,United States of America,"North Carolina; United States of America
(University of North Carolina Chapel Hill)",03/03 - 06/04,Residual sera,Adults (18-64 years),1449,0.7% (NR),Unclear,"Abbott Laboratories; NR
(100%; 98.9%)",High,Journal Article (Peer-Reviewed),http://dx.doi.org/10.1128/mBio.02426-20,12/7/2020,3/17/2021
200929_NorthCarolina_UniversityofNorthCarolinaChapelHill_ScreenNC_OverallAdj,9/29/2020,Amir Barzin,Regional,United States of America,"North Carolina; United States of America
(University of North Carolina Chapel Hill)",04/28 - 06/19,Residual sera,Adults (18-64 years),2973,NA,Unclear,"Abbott Laboratories; NR
(100%; 98.9%)",Moderate,Journal Article (Peer-Reviewed),http://dx.doi.org/10.1128/mBio.02426-20,12/7/2020,3/17/2021
201012_OrangeCounty_UniversityofCaliforniaIrvine_OverallPopAdj,10/12/2020,Tim Bruckner,Local,United States of America,"California; United States of America
(University of California Irvine)",07/10 - 08/16,Household and community samples,Adults (18-64 years),2979,11.5% (10.5-12.4%),Stratified probability,"NR; NR
(94%; 100%)",Low,Preprint,https://www.medrxiv.org/content/10.1101/2020.10.07.20208660v1,12/9/2020,3/1/2021
201001_Atlanta_EmoryUniversity_OverallHCW,10/1/2020,C. R. Morris,Sublocal,United States of America,"Atlanta; Georgia; United States of America
(Emory University)",04/16 - 05/18,Health care workers and caregivers,Adults (18-64 years),300,4.7% (NR),Unclear,"NR; NR
(0%; 0%)",Unclear,Journal Article (Peer-Reviewed),http://dx.doi.org/10.1016/j.annemergmed.2020.09.336,12/15/2020,3/1/2021
200816_SaltLakeCityMilwaukee_CentersforDiseaseControl_householdcontacts,8/16/2020,Nathaniel M. Lewis,Local,United States of America,"Salt Lake City, Milwaukee; Utah, Wisconsin; United States of America
(Centers for Disease Control )",03/22 - 04/25,Contacts of COVID patients,Multiple groups,188,28% (NR),Convenience,"CDC; NR
(0%; 0%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1093/cid/ciaa1166,12/16/2020,3/1/2021
201216_Seattle_WashingtonUniversity_fishermen_unadjusted,10/21/2020,Amin Addetia,Sublocal,United States of America,"Seattle; Washington; United States of America
(University of Washington)",05/01 - 05/31,Essential non-healthcare workers,Adults (18-64 years),120,5% (NR),Entire sample,"Abbott; NR
(0%; 0%)",High,Journal Article (Peer-Reviewed),https://jcm.asm.org/content/58/11/e02107-20,12/16/2020,3/1/2021
201127_Utah_UniversityOfUtah_GenPop_testadj_popadj,10/27/2020,Matthew Samore,Regional,United States of America,"Utah; United States of America
(University of Utah)",05/04 - 06/30,Household and community samples,Multiple groups,8108,0.8% (0.1-1.6%),Stratified probability,"Abbott; NR
(86.4%; 99.6%)",Moderate,Preprint,https://www.medrxiv.org/content/10.1101/2020.10.26.20219907v1,12/16/2020,3/17/2021
201112_OrangeCounty_HoagMemorialHospitalPresbyterian_OverallTestAdj,11/12/2020,Michael Brant-Zawadzki,Sublocal,United States of America,"California; United States of America
(Hoag Memorial Presbyterian Hospital)",05/15 - 06/15,Health care workers and caregivers,Adults (18-64 years),2924,1.1% (0.8-1.6%),Convenience,"Ortho Clinical Diagnostics; NR
(93.6%; 100%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1371/journal.pone.0240006,12/16/2020,3/1/2021
201116_Tennessee_VanderbiltUniversity_HCW_Overall,11/16/2020,Peter Rebeiro,Regional,United States of America,"Tennessee; United States of America
(Vanderbilt University)",05/15 - 06/15,Health care workers and caregivers,Adults (18-64 years),11787,1% (NR),Convenience,"Abbott; NR
(0%; 0%)",High,Preprint,https://www.medrxiv.org/content/10.1101/2020.11.12.20230912v1,12/16/2020,3/1/2021
201105_Michigan_OaklandUniversity_testadj,11/5/2020,Matthew D Sims,Sublocal,United States of America,"Dearborn, Farmington Hills, Grosse Pointe, Royal Oak, Taylor, Trenton, Troy, Wayne, Canton; Michigan; United States of America
(Oakland University)",04/13 - 05/28,Health care workers and caregivers,Multiple groups,20614,8.1% (6.8-8.9%),Convenience,"EUROIMMUN Lübeck; NR
(98.14%; 99.35%)",Moderate,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1093/cid/ciaa1684,12/17/2020,3/4/2021
201030_Indianapolis_IndianaUniversity_Overall,10/30/2020,Corina Nailescu,Local,United States of America,"Indianapolis ; Indiana; United States of America
(Indiana University )",05/01 - 06/30,Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),31,3.2% (NR),Convenience,"Abnova, Eli Lilly and Co & IUSM, Mount Sinai medical center; NR
(94.4%; 98.5%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.3389/fped.2020.601327,12/17/2020,3/1/2021
201201_NewHeaven_Yale_SchoolofMedicine_newborns,12/12/2020,Feimei  Liu,Sublocal,United States of America,"New Haven; Conneticut; United States of America
(Yale School of Medicine)",02/19 - 05/26,Residual sera,Children and Youth (0-17 years),3048,5.9% (NR),Sequential,"; NR
(0%; 0%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1097/INF.0000000000002918,12/18/2020,3/1/2021
201021_NewYork_Serimmune_Overall,10/21/2020,Kathy Kamath,Local,United States of America,"New York City; New York; United States of America
(Serimmune)",03/01 - 07/07,Blood donors,Multiple groups,1559,4.4% (NR),Sequential,"Serimmune; NR
(91%; 99.3%)",High,Preprint,https://www.medrxiv.org/content/10.1101/2020.10.19.20215368v1,12/18/2020,3/1/2021
201107_Lubbock_TexasTechUniversity_Overall,11/7/2020,Kenneth Iwuji,Local,United States of America,"Lubbock; Texas; United States of America
(Texas Tech University)",05/12 - 05/13,Essential non-healthcare workers,Multiple groups,683,0.7% (NR),Convenience,"Abbott; NR
(100%; 99.9%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1177/2150132720971390,12/18/2020,3/1/2021
201107_NewYorkCity_NewYorkBloodCenter_BloodDonors_OrthoAND/ORAbbot_,11/7/2020,Daniel Jin,Sublocal,United States of America,"New York City; New York; United States of America
(New York Blood Centre)",06/15 - 07/15,Blood donors,Multiple groups,1000,12.8% (NR),Sequential,"Ortho Clinical Diagnostics, Abbott Labs; NR
(0%; 0%)",High,Preprint,https://www.medrxiv.org/content/10.1101/2020.11.06.20220087v1,12/18/2020,3/1/2021
201013_PimaCounty_UniversityofArizona_Overall,10/13/2020,Tyler Ripperger,Local,United States of America,"Arizona; United States of America
(University of Arizona)",04/30 - 05/07,Household and community samples,Multiple groups,5882,1.2% (NR),Self-referral,"NR; NR
(97.6%; 100%)",High,Journal Article (Peer-Reviewed),http://dx.doi.org/10.1016/j.immuni.2020.10.004,12/18/2020,3/17/2021
200901_UtahMassachusetts_IgenomixUS_Overall,9/1/2020,Russell Foulk,Regional,United States of America,"Utah and Massachusetts; United States of America
(Igenomix US)",06/18 - 07/30,Multiple populations,Multiple groups,337,1.5% (NR),Sequential,"Abbott; NR
(0%; 0%)",High,Journal Article (Peer-Reviewed),http://dx.doi.org/10.1016/j.fertnstert.2020.09.069,12/18/2020,3/1/2021
201015_NewYorkCity_NYCHealth+Hospitals/Lincoln_Overall,10/15/2020,Usha Venugopal,Local,United States of America,"New York City; New York; United States of America
(NYC Health + Hospitals/Lincoln)",03/01 - 05/01,Health care workers and caregivers,Adults (18-64 years),500,27% (NR),Convenience,"Abbott Laboratories; NR
(100%; 99.6%)",Moderate,Journal Article (Peer-Reviewed),http://dx.doi.org/10.1016/j.ijid.2020.10.036,12/19/2020,3/1/2021
201030_Cleveland_CaseWesternReserveUniversity_Overall,10/30/2020,Yasir Tarabichi,Local,United States of America,"Cleveland; Ohio; United States of America
(Case Western Reserve University)",04/20 - 05/19,Essential non-healthcare workers,Adults (18-64 years),296,5.4% (3.1-8.6%),Convenience,"Epitope Diagnostics, Inc; NR
(0%; 0%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1080/10903127.2020.1831668,12/21/2020,3/1/2021
201103_Atlanta_EmoryUniversity_Overall,11/3/2020,Julia Baker,Local,United States of America,"Atlanta; Georgia; United States of America
(Emory University)",04/19 - 06/26,Health care workers and caregivers,Multiple groups,10275,5.7% (5.2-6.1%),Convenience,"Emory Medical Laboratory; NR
(0%; 0%)",High,Journal Article (Peer-Reviewed),https://www.medrxiv.org/content/10.1101/2020.10.30.20222877v1,12/21/2020,3/6/2021
201118_Chicago_NorthwesternUniversity_Overall,11/18/2020,Alexis Demonbreun,Local,United States of America,"Chicago; Illinois; United States of America
(Northwestern University)",06/24 - 09/06,Household and community samples,Adults (18-64 years),1545,19.8% (NR),Convenience,"In-House; NR
(0%; 0%)",High,Preprint,https://www.medrxiv.org/content/10.1101/2020.11.17.20233452v1,12/22/2020,3/1/2021
201026_UpstateNewYork_BassettMedicalCenter_Overall,10/26/2020,Wendy M. Brunner,Local,United States of America,"Rural upstate New York; New York; United States of America
(Bassett Medical Center)",05/04 - 05/29,Health care workers and caregivers,Multiple groups,764,2% (NR),Unclear,"Abbott Laboratories; NR
(100%; 99.6%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1017/ice.2020.1296,12/28/2020,3/16/2021
201027_Indiana_Harvard_Overall_testadj,11/27/2020,Lilah Lopez,Sublocal,United States of America,"Indiana; United States of America
(Harvard Medical School)",07/15 - 07/20,Essential non-healthcare workers,Multiple groups,753,1.7% (0.3-3.3%),Self-referral,"Abbott Alinity; NR
(100%; 99%)",Low,Preprint,https://www.medrxiv.org/content/10.1101/2020.10.23.20218651v1,1/5/2021,3/1/2021
201119_LosAngeles_CedarsSinaiMedicalCenter_Overall,11/19/2020,Magali Rivas,Local,United States of America,"Los Angeles; California; United States of America
(Cedars-Sinai Medical Center)",05/11 - 06/28,Health care workers and caregivers,Adults (18-64 years),6201,3.5% (NR),Self-referral,"Abbott; NR
(96.9%; 99.9%)",Moderate,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1172/JCI145157,1/5/2021,3/5/2021
201004_USA_RedCross_genpop_unadj,10/4/2020,Bryan Spencer,National,United States of America,"United States of America
(American Red Cross)",06/15 - 07/27,Blood donors,Multiple groups,573586,1.5% (NR),Sequential,"Ortho; NR
(0%; 0%)",High,Journal Article (Peer-Reviewed),https://aabb.confex.com/aabb/2020/meetingapp.cgi/Paper/8581,1/6/2021,3/17/2021
200810_USA_Illinois_PhysicianPractice_Overall,8/6/2020,Gerald Osher,Sublocal,United States of America,"Chicago; Illinois; United States of America
(BioSolutions Services LLC)",04/22 - 05/26,Residual sera,Multiple groups,113,15.9% (NR),Convenience,"CLUNGENE; NR
(0%; 0%)",High,Journal Article (Peer-Reviewed),https://lymphosign.com/doi/full/10.14785/lymphosign-2020-0007,1/6/2021,3/17/2021
201027_Illinois_CDC_Contacts,10/27/2020,Tristan McPherson,Sublocal,United States of America,"Illinois; United States of America
(US Centers for Disease Control and Prevention)",03/03 - 03/06,Contacts of COVID patients,Adults (18-64 years),59,NA,Convenience,"NR; NR
(96%; 99%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1177/0033354920966064,1/7/2021,3/16/2021
201013_Pittsburgh_UniversityPittsburgh_PedImmunocompPatients_Overall,10/13/2020,Megan Freeman,Sublocal,United States of America,"Pittsburgh; Pennsylvania; United States of America
(University of Pittsburgh School of Medicine)",03/15 - 07/04,Residual sera,Children and Youth (0-17 years),485,1% (0.3-2.4%),Convenience,"Euroimmun, Beckman Coulter, Siemens; NR
(0%; 0%)",High,Journal Article (Peer-Reviewed),http://dx.doi.org/10.1093/jpids/piaa123,1/7/2021,3/1/2021
201201_LosAngeles_UniversityofSouthernCalifornia_UniversityStudents_Overall,12/1/2020,Kimberly Tilley,Sublocal,United States of America,"Los Angeles; California; United States of America
(University of Southern California)",04/29 - 05/08,Students and Daycares,Adults (18-64 years),790,4% (3-5.1%),Convenience,"EUROIMMUN; NR
(90%; 100%)",Moderate,Journal Article (Peer-Reviewed),http://dx.doi.org/10.1016/j.jadohealth.2020.09.001,1/7/2021,3/5/2021
200624_BaskingRidge_FellowshipVillage_Staff1_Overall,6/24/2020,Tim Regan,Sublocal,United States of America,"Basking Ridge; New Jersey; United States of America
(Fellowship Village)",04/15 - 05/06,Assisted living and long-term care facilities,Adults (18-64 years),305,23.6% (NR),Entire sample,"NR; NR
(0%; 0%)",High,News and Media,https://www.google.com/url?rct=j&sa=t&url=https://seniorhousingnews.com/2020/06/24/fellowship-village-benefits-from-covid-19-antibody-tests-juniper-plans-pilot/&ct=ga&cd=CAEYAyoTMTA4MjA1OTc5ODY3MTIyMzk1NTIaOTBkZWE5ODk5NGU5MTg1OTpjb206ZW46VVM&usg=AFQjCNFY2y-eZOXQXVuQzcKPUzRHkiG26g,1/9/2021,3/1/2021
201015_BronxNY_AlbertEinsteinCollegeofMedicine_KidneyTransplantlPatients,10/15/2020,Yorg Azzi,Sublocal,United States of America,"New York City; New York; United States of America
(Albert Einstein College of Medicine)",05/03 - 07/29,Residual sera,Adults (18-64 years),912,16.7% (NR),Convenience,"Abbott; NR
(100%; 100%)",High,Journal Article (Peer-Reviewed),http://dx.doi.org/10.1016/j.kint.2020.10.004,1/13/2021,3/1/2021
210105_USA_ClinicalReferenceLaboratory_GenPop_Overall,1/5/2021,Robert Stout,National,United States of America,"United States of America
(Clinical Reference Laboratory Inc.)",05/12 - 12/06,Residual sera,Multiple groups,126587,5.9% (NR),Convenience,"Roche; NR
(100%; 99.8%)",High,Preprint,https://www.medrxiv.org/content/10.1101/2020.11.10.20215145v3.full.pdf,1/18/2021,3/1/2021
201120_LosAngeles_TheLundquistInstitute_genpop,11/25/2020,Khadije Ahmad,Local,United States of America,"California; United States of America
(The Lundquist Institute )",04/21 - 05/22,Multiple populations,Not reported,244,20.9% (NR),Unclear,"NR; NR
(96%; 100%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1007/s10096-020-04111-3,1/19/2021,3/17/2021
201130_USA_AmericanRedCross_BloodDonors,11/30/2020,Sridhar V. Basavaraju,National,United States of America,"Massachusetts, California, Connecticut, Iowa, Michigan, Oregon, Rhode Island, Washington, Wisconsin.; United States of America
(American Red Cross)",12/13 - 01/17,Blood donors,Multiple groups,7389,1.4% (NR),Sequential,"CDC; NR
(96%; 99.3%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1093/cid/ciaa1785,1/20/2021,3/1/2021
201123_OrangeCounty_StJudeMedicalCenter_Overall,11/23/2020,Jason Yamaki,Local,United States of America,"Fullerton; California; United States of America
(St. Jude Medical Center)",07/15 - 07/27,Residual sera,Multiple groups,865,9.4% (8-12%),Sequential,"Abbott Laboratories; NR
(100%; 100%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1007/s40615-020-00918-0,1/21/2021,3/17/2021
201121_LosAngeles_UniversityofCaliforniaLosAngeles_HCW,11/21/2020,Megan Halbrook,Local,United States of America,"California; United States of America
(University of California Los Angeles)",04/08 - 08/31,Health care workers and caregivers,Multiple groups,1108,3.9% (NR),Unclear,"NR; NR
(0%; 0%)",Moderate,Preprint,https://www.medrxiv.org/content/10.1101/2020.11.18.20234211v1,1/21/2021,3/4/2021
201121_LosAngeles_UniversityofCaliforniaLosAngeles_FirstResponders,11/21/2020,Megan Halbrook,Local,United States of America,"California; United States of America
(University of California Los Angeles)",04/08 - 08/31,Essential non-healthcare workers,Multiple groups,679,8.1% (NR),Unclear,"NR; NR
(0%; 0%)",Moderate,Preprint,https://www.medrxiv.org/content/10.1101/2020.11.18.20234211v1,1/21/2021,3/4/2021
201127_DistrictofColumbia_DCHealth_Overall,11/27/2020,Jacqueline Reuben,Local,United States of America,"Washington; United States of America
(District of Columbia Department of Health (DC Health))",05/28 - 07/15,Essential non-healthcare workers,Adults (18-64 years),310,3.6% (NR),Self-referral,"DiaSorin Inc.; NR
(97%; 0%)",High,Preprint,https://www.medrxiv.org/content/10.1101/2020.11.25.20225490v1,1/21/2021,3/1/2021
201130_SanFrancisco_StanfordUniversity_Overall,11/30/2020,Catherine Hogan,Local,United States of America,"San Francisco; California; United States of America
(Stanford University)",04/20 - 06/08,Health care workers and caregivers,Adults (18-64 years),12418,0.9% (0.7-1.1%),Self-referral,"Stanford Health Care; NR
(0%; 99.75%)",Moderate,Journal Article (Peer-Reviewed),https://dx.doi.org/10.3201/eid2701.203892,1/22/2021,3/1/2021
201127_USA_CDCCOVID-19ResponseTeam_HCW,11/27/2020,Wesley H. Self,National,United States of America,"United States of America
(CDC COVID-19 Response Team)",04/03 - 06/19,Health care workers and caregivers,Adults (18-64 years),3248,6% (NR),Convenience,"CDC; NR
(96%; 99%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.15585/mmwr.mm6947a2,1/22/2021,3/1/2021
200622_Brooklyn_ColumbiaUniversityMedicalCenter_Overall,6/22/2020,Jordan Jeong,Sublocal,United States of America,"New York City; New York; United States of America
(Columbia University Medical Center)",02/01 - 04/30,Health care workers and caregivers,Adults (18-64 years),50,46% (NR),Convenience,"Abbott Laboratories; NR
(0%; 0%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1016/j.annemergmed.2020.06.038,1/22/2021,3/1/2021
201210_Atlanta_CDC_Community_OverallPopTestAdj,12/10/2020,Kristina Bajema,Local,United States of America,"Atlanta; Georgia; United States of America
(Centers for Disease Control and Prevention)",04/28 - 05/03,Household and community samples,Multiple groups,669,3.2% (1.5-6.7%),Stratified probability,"Centers for Disease Control and Prevention (CDC); NR
(96%; 99.3%)",Low,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1093/cid/ciaa1804,1/22/2021,3/16/2021
201210_Atlanta_CDC_Lab_OverallPopTestAdj,12/10/2020,Kristina Bajema,Local,United States of America,"Atlanta; Georgia; United States of America
(Centers for Disease Control and Prevention)",04/27 - 05/01,Residual sera,Multiple groups,1343,4.9% (3.3-6.6%),Convenience,"Centers for Disease Control and Prevention (CDC); NR
(96%; 99.3%)",Moderate,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1093/cid/ciaa1804,1/22/2021,3/16/2021
201215_SanDiego_SharpHealthCare_Overall,12/15/2020,Norihiro Yogo,Local,United States of America,"San Diego; California; United States of America
(Sharp Healthcare)",05/20 - 06/08,Health care workers and caregivers,Multiple groups,1770,2.2% (NR),Convenience,"Roche Diagnostics; NR
(100%; 99.8%)",Moderate,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1017/ice.2020.1370,1/23/2021,3/1/2021
210101_Seattle_SeattleChildren'sResearchInstitute_Baseline_Overall,1/1/2021,Yekaterina Tokareva,Sublocal,United States of America,"Seattle; Washington State; United States of America
(Seattle Childrens Research Institute)",05/04 - 06/02,Health care workers and caregivers,Adults (18-64 years),530,0.9% (NR),Convenience,"Abbott; NR
(100%; 0%)",High,Preprint,https://dx.doi.org/10.1542/hpeds.2020-003517,1/23/2021,3/1/2021
201119_USA_QuestDiagnostics_Overall,11/19/2020,Harvey W. Kaufman,National,United States of America,"United States of America
(Quest Diagnostics)",04/21 - 07/10,Household and community samples,Multiple groups,2367628,11.8% (NR),Sequential,"Abbott Laboratories, Ortho-Clinical Diagnostics, EUROIMMUN; NR
(0%; 0%)",High,Journal Article (Peer-Reviewed),http://dx.doi.org/10.1089/pop.2020.0256,1/23/2021,3/17/2021
201214_VirginaUSA_VirginiaCommonwealthUniversity_Overall,12/14/2020,Emily Godbout,Sublocal,United States of America,"Richmond; Virgina; United States of America
(Virginia Commonwealth University)",07/27 - 10/02,Health care workers and caregivers,Multiple groups,1962,1.4% (NR),Convenience,"Abbott Laboratories; NR
(0%; 0%)",Moderate,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1017/ice.2020.1374,1/23/2021,3/3/2021
201207_Massachusetts_MassachusettsGeneralHospital_Cohabitants,12/7/2020,E. Klawiter,Sublocal,United States of America,"Boston; Massachusetts; United States of America
(Massachusetts General Hospital)",05/29 - 07/23,Multiple populations,Multiple groups,143,6.3% (NR),Sequential,"Massachusetts General Hospital; NR
(99.7%; 100%)",High,Journal Article (Peer-Reviewed),https://journals.sagepub.com/doi/10.1177/1352458520974938#_i1,1/27/2021,3/1/2021
201207_Massachusetts_MassachusettsGeneralHospital_MS,12/7/2020,E. Klawiter,Local,United States of America,"Boston; Massachusetts; United States of America
(Massachusetts General Hospital)",05/29 - 07/23,Patients seeking care for non-COVID-19 reasons,Multiple groups,227,3.5% (NR),Sequential,"Massachusetts General Hospital; NR
(99.7%; 100%)",High,Journal Article (Peer-Reviewed),https://journals.sagepub.com/doi/10.1177/1352458520974938#_i1,1/27/2021,3/1/2021
201203_AraphoeCounty_UniversityofColorado,12/3/2020,Katherine Sabourin,Local,United States of America,"Colorado; United States of America
(University of Colorado)",07/15 - 08/15,Essential non-healthcare workers,Adults (18-64 years),264,4% (NR),Convenience,"Exsera BioLabs; NR
(85%; 98.6%)",High,Journal Article (Peer-Reviewed),https://pubmed.ncbi.nlm.nih.gov/33298759/,1/28/2021,3/1/2021
200901_NewYorkCity_NorthwellHealthCOVID-19ResearchConsortium,12/8/2020,Joseph Moscola,Local,United States of America,"New York City; New York ; United States of America
(Northwell Health COVID-19 Research Consortium)",04/20 - 06/23,Health care workers and caregivers,Multiple groups,40329,13.7% (NR),Convenience,"Euroimmun, AnshLabs, Abbott Laboratories, Ortho Clinical Diagnostics, DiaSorin, Roche; NR
(0%; 0%)",High,Journal Article (Peer-Reviewed),https://pubmed.ncbi.nlm.nih.gov/32780804/,1/28/2021,3/10/2021
201230_SanDiego_ScrippsClinic_Overall,12/30/2020,Laura Nicholson,Local,United States of America,"San Diego; California; United States of America
(Scripps Clinic)",04/14 - 07/28,Health care workers and caregivers,Adults (18-64 years),11993,0.9% (NR),Convenience,"Diazyme, Abbott Laboratories; NR
(0%; 0%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1016/j.ajic.2020.12.017,1/29/2021,3/9/2021
201222_Wisconsin_UniversityofWisconsin_WaveI_overall_popadj,12/22/2020,Kristen Maleck,Regional,United States of America,"Wisconsin; United States of America
(University of Wisconsin)",07/01 - 08/31,Household and community samples,Multiple groups,996,1.6% (0.6-2.5%),Stratified probability,"Abbott; NR
(0%; 99.6%)",Moderate,Preprint,https://doi.org/10.1101/2020.12.18.20248479,2/3/2021,3/4/2021
201222_Wisconsin_UniversityofWisconsin_WaveII_overall_popadj,12/22/2020,Kristen Maleck,Regional,United States of America,"Wisconsin; United States of America
(University of Wisconsin)",07/01 - 08/31,Household and community samples,Multiple groups,994,6.8% (4.3-9.4%),Stratified probability,"Abbott; NR
(0%; 99.6%)",Moderate,Preprint,https://doi.org/10.1101/2020.12.18.20248479,2/3/2021,3/4/2021
210105_USA_MayoClinic_overall,1/5/2021,Sarayna S. McGuire,Sublocal,United States of America,"Rochester; Minnesota; United States of America
(Mayo Clinic)",05/16 - 05/17,Essential non-healthcare workers,Adults (18-64 years),255,1.2% (NR),Convenience,"N/A  - Author designed; NR
(88.1%; 99.6%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1017/S1049023X2000151X,2/3/2021,3/1/2021
201209_SantaClara_StanfordHealthCare,12/9/2020,Joelle Rosser,Local,United States of America,"San Francisco Bay Area; California; United States of America
(Stanford Health Care)",04/20 - 05/20,Health care workers and caregivers,Adults (18-64 years),10449,1.3% (NR),Convenience,"Stanford Clinical Laboratory; NR
(87%; 99.75%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1017/ice.2020.1358,2/4/2021,3/11/2021
201223_NewYork_MemorialSloanKetteringCancerCenter,12/23/2020,Lauren Jimenez-Kurlander,Sublocal,United States of America,"New York City; New York; United States of America
(Memorial Sloan Kettering Cancer Center)",05/05 - 09/10,Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),257,7.8% (NR),Sequential,"NR; NR
(0%; 0%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1002/pbc.28857,2/4/2021,3/1/2021
210119_NewJersey_CooperUniversityHospital_overall,1/19/2021,Snehal Gandhi,Sublocal,United States of America,"New Jersey ; United States of America
(Cooper University Hospital)",06/10 - 08/31,Health care workers and caregivers,Adults (18-64 years),172,5.2% (2.4-9.7%),Convenience,"1) Roche 2) EUROIMMUN; NR
(0%; 0%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1007/s11606-020-06462-1,2/4/2021,3/1/2021
210102_MontereyCounty_UniversityofCaliforniaBerkeley_Overall,1/2/2021,Joseph A. Lewnard,Sublocal,United States of America,"California; United States of America
(University of California, Berkeley)",07/16 - 11/30,Essential non-healthcare workers,Adults (18-64 years),1058,19% (NR),Self-referral,"Authors; NR
(94.02%; 98.47%)",High,Preprint,10.1101/2020.12.27.20248894,2/4/2021,3/1/2021
201106_Utah_UniversityofUtah_immunosupressed_primary,11/6/2020,Quinn Pritchett,Sublocal,United States of America,"Utah; United States of America
(University of Utah)",04/18 - 05/21,Patients seeking care for non-COVID-19 reasons,Multiple groups,39,2.6% (NR),Unclear,"in house - ARUP; NR
(0%; 0%)",Unclear,Preprint,https://acrabstracts.org/abstract/assessing-cytokine-profiles-and-covid-serology-in-patients-on-immunosuppression-to-guide-care-recommendations/,2/4/2021,3/16/2021
210111_Michigan_ UniversityofMichigan_overall,1/11/2021,Jeffrey J. Fletcher,Sublocal,United States of America,"Michigan; United States of America
(Metro Health University of Michigan Health)",08/17 - 09/04,Health care workers and caregivers,Adults (18-64 years),1385,1.9% (NR),Convenience,"Siemens; NR
(100%; 99.8%)",Moderate,Journal Article (Peer-Reviewed),http://dx.doi.org/10.1017/ice.2020.1438,2/4/2021,3/1/2021
201031_NewJersey_RutgersRobertWoodJohnsonMedicalSchool,10/31/2020,Emily Barrett,Sublocal,United States of America,"New Brunswick, Somerville; New Jersey; United States of America
(Rutgers Robert Wood Johnson Medical School)",04/28 - 06/30,Health care workers and caregivers,Adults (18-64 years),3907,9.6% (NR),Convenience,"Abbott Laboratories; NR
(96.9%; 99.6%)",Moderate,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1093/ofid/ofaa534,2/5/2021,3/1/2021
210120_USA_BostonHeartDiagnostics_IgG,1/20/2021,Ernst J. Schaefer,National,United States of America,"United States of America
(Boston Heart Diagnostics )",04/06 - 09/01,Household and community samples,Adults (18-64 years),79005,5.3% (NR),Unclear,"Diazyme Laboratories; NR
(98.4%; 97.4%)",Unclear,Preprint,https://www.medrxiv.org/content/10.1101/2021.01.19.21249604v1.full-text,2/10/2021,3/1/2021
210115_Massachusetts_HarvardUniversity_Overall,1/15/2021,Aishani Aatresh,Regional,United States of America,"Massachusetts; United States of America
(Harvard University)",06/16 - 08/24,Multiple populations,Multiple groups,1872,3.2% (NR),Convenience,"Euroimmun; NR
(0%; 0%)",Moderate,Preprint,10.1101/2021.01.14.21249824,2/11/2021,3/1/2021
210202_Indiana_IndianaUniversity_GenPop_PopAdjTestAdj,2/2/2021,Constantin Yiannoutsos,Regional,United States of America,"Indiana; United States of America
(Indiana University)",04/25 - 04/29,Household and community samples,Multiple groups,3625,2.6% (2.1-3.4%),Stratified probability,"Abbott; NR
(0%; 0%)",Moderate,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1073/pnas.2013906118,2/13/2021,3/1/2021
201216_Seattle_WashingtonUniversity_fishermen_unadjusted copy,10/21/2020,Amin Addetia,Sublocal,United States of America,"Seattle; Washington; United States of America
(University of Washington)",05/01 - 05/31,Essential non-healthcare workers,Adults (18-64 years),120,2.5% (NR),Entire sample,"Abbott, unclear; NR
(0%; 0%)",High,Journal Article (Peer-Reviewed),https://jcm.asm.org/content/58/11/e02107-20,2/17/2021,3/1/2021
201209_Chicago_NorthwesternUniversity_OverallPopAdj,12/9/2020,John T. Wilkins,Local,United States of America,"Chicago; Illinois; United States of America
(Northwestern University )",05/28 - 06/30,Health care workers and caregivers,Multiple groups,6510,5.3% (4.8-5.9%),Convenience,"Abbott; NR
(100%; 99.6%)",Moderate,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1093/ofid/ofaa582,2/19/2021,3/1/2021
210129_Philadelphia_UniversityofPennsylvania_overallmother_unadj,1/29/2021,Dustin D Flannery,Local,United States of America,"Philadelphia; Pennsylvania; United States of America
(University of Pennsylvania)",04/09 - 08/08,Patients seeking care for non-COVID-19 reasons,Adults (18-64 years),1471,6% (NR),Convenience,"Authors; NR
(0%; 0%)",Moderate,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamapediatrics.2021.0038,2/20/2021,3/1/2021
210201_Utah_UniversityofUtah_GenPop,2/1/2021,Damon Toth,Regional,United States of America,"Utah; United States of America
(University of Utah)",05/01 - 07/31,Household and community samples,,13712,1.2% (NR),Stratified probability,"Abbott; NR
(86.4%; 99.6%)",Moderate,Preprint,https://doi.org/10.1101/2021.01.29.20248797,2/21/2021,3/1/2021
210131_USA_NIH_primary,1/31/2021,Heather Kalish,National,United States of America,"United States of America
(National Institute of Health)",04/01 - 08/04,Household and community samples,Multiple groups,8058,4.6% (2.6-6.5%),Stratified non-probability,"N/A - author designed; NR
(0%; 0%)",Moderate,Preprint,10.1101/2021.01.27.21250570,2/22/2021,3/1/2021
210129_NorthCarolina_WakeForestUniversity_primary,1/29/2021, David Herrington,Local,United States of America,"Wake Forest, Charlotte; North Carolina; United States of America
(Wake Forest University )",04/16 - 01/04,Household and community samples,Multiple groups,11468,10.2% (NR),Convenience,"1) Syntron Bioresearch Inc.

2) Innovita Biological Technology Co.; NR
(96.7%; 97.5%)",High,Preprint,10.1101/2021.01.27.21250615,2/23/2021,3/16/2021
210204_SanFrancisco_UniversityofCaliforniaSanFrancisco_primary_adj,2/4/2021,Isobel Routledge,Local,United States of America,"San Francisco; California; United States of America
(University of California San Fransisco)",03/28 - 06/26,Residual sera,Multiple groups,4735,4.2% (2.1-6.3%),Stratified non-probability,"1: N/A - Author designed
2: Luminex; NR
(94%; 99.8%)",Low,Preprint,10.21203/rs.3.rs-180966/v1,2/23/2021,3/16/2021
210204_SanFrancisco_UniversityofCaliforniaSanFrancisco_male,2/4/2021,Isobel Routledge,Local,United States of America,"San Francisco; California; United States of America
(University of California San Fransisco)",03/28 - 06/26,Residual sera,Multiple groups,2231,5.3% (3.7-6.6%),Stratified non-probability,"N/A - Author designed
2: luminex; NR
(94%; 99.8%)",Low,Preprint,10.21203/rs.3.rs-180966/v1,2/23/2021,3/16/2021
210204_SanFrancisco_UniversityofCaliforniaSanFrancisco_80+,2/4/2021,Isobel Routledge,Local,United States of America,"San Francisco; California; United States of America
(University of California San Fransisco)",03/28 - 06/26,Residual sera,Seniors (65+ years),481,3.6% (1.6-5.8%),Stratified non-probability,"N/A - Author designed
2: luminex; NR
(94%; 99.8%)",Low,Preprint,10.21203/rs.3.rs-180966/v1,2/23/2021,3/16/2021
210204_SanFrancisco_UniversityofCaliforniaSanFrancisco_60-79,2/4/2021,Isobel Routledge,Local,United States of America,"San Francisco; California; United States of America
(University of California San Fransisco)",03/28 - 06/26,Residual sera,Seniors (65+ years),1390,2.8% (1.1-4%),Stratified non-probability,"N/A - Author designed
2: luminex; NR
(94%; 99.8%)",Low,Preprint,10.21203/rs.3.rs-180966/v1,2/23/2021,3/16/2021
210204_SanFrancisco_UniversityofCaliforniaSanFrancisco_40-59,2/4/2021,Isobel Routledge,Local,United States of America,"San Francisco; California; United States of America
(University of California San Fransisco)",03/28 - 06/26,Residual sera,Adults (18-64 years),1322,5.5% (3.6-7.1%),Stratified non-probability,"1: N/A - author designed
2:luminex; NR
(94%; 99.8%)",Low,Preprint,10.21203/rs.3.rs-180966/v1,2/23/2021,3/16/2021
210204_SanFrancisco_UniversityofCaliforniaSanFrancisco_20-39,2/4/2021,Isobel Routledge,Local,United States of America,"San Francisco; California; United States of America
(University of California San Fransisco)",03/28 - 06/26,Residual sera,Adults (18-64 years),1261,4% (2.3-5.5%),Stratified non-probability,"N/A - Author designed
2: luminex; NR
(94%; 99.8%)",Low,Preprint,10.21203/rs.3.rs-180966/v1,2/23/2021,3/16/2021
210204_SanFrancisco_UniversityofCaliforniaSanFrancisco_0-19,2/4/2021,Isobel Routledge,Local,United States of America,"San Francisco; California; United States of America
(University of California San Fransisco)",03/28 - 06/26,Residual sera,Children and Youth (0-17 years),281,4.1% (1.6-6.9%),Stratified non-probability,"N/A - Author designed
2: luminex; NR
(94%; 99.8%)",Low,Preprint,10.21203/rs.3.rs-180966/v1,2/23/2021,3/16/2021
210204_SanFrancisco_UniversityofCaliforniaSanFrancisco_female,2/4/2021,Isobel Routledge,Local,United States of America,"San Francisco; California; United States of America
(University of California San Fransisco)",03/28 - 06/26,Residual sera,Multiple groups,2491,2.7% (1.1-3.6%),Stratified non-probability,"N/A - Author designed
2: luminex; NR
(94%; 99.8%)",Low,Preprint,10.21203/rs.3.rs-180966/v1,2/23/2021,3/16/2021
201026_UpstateNewYork_BassettMedicalCenter_Overall copy,10/26/2020,Wendy M. Brunner,Local,United States of America,"Rural upstate New York; New York; United States of America
(Bassett Medical Center)",05/04 - 05/29,Health care workers and caregivers,Adults (18-64 years),762,4.5% (NR),Unclear,"Abbott Laboratories; NR
(100%; 99.6%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1017/ice.2020.1296,2/27/2021,3/17/2021
210129_ParrisIsland_IcahnSchoolOfMedicine,1/29/2021,Andrew Letizia,Sublocal,United States of America,"Port Royal; South Carolina; United States of America
(Icahn School of Medicine at Mount Sinai)",05/03 - 08/03,Multiple populations,Adults (18-64 years),,7.3% (NR),Convenience,"Author designed; NR
(0%; 100%)",High,Preprint,10.1101/2021.01.26.21250535,3/3/2021,3/13/2021
0201_Washington_ChildrensNationalHospital_Overall_TestAdj,2/1/2021,Burak Bahar,Local,United States of America,"Washington D.C Metropolitan Area; Washington, D.C, Maryland, Virginia, West Virginia; United States of America
(Children's National Hospital)",07/07 - 10/29,Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),385,9.5% (6.7-13%),Convenience,"Diasorin; NR
(97.6%; 99.3%)",High,Journal Article (Peer-Reviewed),https://www.medrxiv.org/content/10.1101/2021.01.30.21250830v1.full-text,3/4/2021,3/19/2021
210203_NewYorkCity_IcahnSchoolOfMedicine_Overall,2/3/2021,Nina Molenaar,Sublocal,United States of America,"New York City; New York; United States of America
(Icahn School of Medicine at Mount Sinai)",04/20 - 08/15,Pregnant or parturient women,Adults (18-64 years),696,15% (NR),Convenience,"Icahn School of Medicine at Mount Sinai (FDA EUA); NR
(95%; 100%)",Moderate,Preprint,10.1101/2021.02.01.21250943,3/4/2021,3/13/2021
210125_NewYork_CDC+NewYorkCity_Total,1/25/2021,Samira Sami,Local,United States of America,"New York City; New York; United States of America
(CDC and New York City Department of Health and Mental Hygiene)",05/18 - 07/02,Essential non-healthcare workers,,22647,22.5% (21.9-23%),Convenience,"ORTHO Clinical Diagnostics Inc., https://www.orthoclinicaldiagnostics.com; NR
(90%; 100%)",Moderate,Journal Article (Peer-Reviewed),https://dx.doi.org/10.3201/eid2703.204340,3/5/2021,3/15/2021
201220_NorthCarolina_WakeForestBaptistMedicalCenter_overall,12/20/2020,Richard Craver,Regional,United States of America,"North Carolina; United States of America
(Wake Forest Baptist Medical Center)",04/15 - 12/09,Household and community samples,Multiple groups,8006,9.3% (NR),Stratified probability,"NR; NR
(0%; 0%)",Unclear,News and Media,https://journalnow.com/news/local/wake-forest-baptists-covid-19-antibodies-study-expands-to-triangle-eastern-n-c/article_b8e94704-3e1e-11eb-8742-470dc9941f17.html,3/6/2021,3/7/2021
201214_Maricopa_MaricopaCountyDepartmentOfPublicHealth_overall,12/14/2020,Fountain Hills Times,Local,United States of America,"Arizona; United States of America
(Maricopa County Department of Public Health)",09/11 - 09/21,Household and community samples,Multiple groups,260,10.7% (NR),Stratified probability,"NR; NR
(0%; 0%)",Unclear,News and Media,https://www.fhtimes.com/news/local_news/maricopa-county-covid-19-serosurvey-results-reported/article_6be4ab0a-3983-11eb-ab22-a3b73c8957c7.html,3/6/2021,3/7/2021
201203_Florida_FloridaDepartmentOfHealth_primary,12/3/2020,Frank Jolley,Regional,United States of America,"Florida; United States of America
(Florida Department of Health)",05/01 - 11/30,Household and community samples,Multiple groups,630838,11% (NR),Self-referral,"NR; NR
(0%; 0%)",Unclear,News and Media,https://www.dailycommercial.com/story/news/2020/12/03/area-residents-covid-antibody-below-state-average/6475413002/,3/7/2021,3/7/2021
201005_Wisconsin_UW-Madison_overall,10/5/2020,Madeline Heim,Regional,United States of America,"Wisconsin; United States of America
(UW-Madison)",07/01 - 08/15,Household and community samples,Multiple groups,1056,1.6% (NR),Stratified probability,"NR; NR
(0%; 0%)",Unclear,News and Media,https://www.postcrescent.com/story/news/2020/10/05/wisconsin-covid-19-less-than-2-of-state-population-have-antibodies/3457334001/,3/7/2021,3/7/2021
200830_VenturaCounty_OxnardFireDepartment_overall,8/30/2020,Jeremy Childs,Local,United States of America,"California; United States of America
(Oxnard Fire Department)",06/22 - 07/06,Household and community samples,Multiple groups,6794,1.3% (NR),Self-referral,"1) Abbott

2) Bio-Rad; NR
(0%; 0%)",High,News and Media,https://www.vcstar.com/story/news/2020/08/30/covid-19-data-coronavirus-antibodies-ventura-county/3436858001/,3/7/2021,3/9/2021
200824_Louiseville_UniversityOfLouiseville_HCW_July,8/24/2020,Betty Coffman,Local,United States of America,"Louiseville; Kentucky; United States of America
(University of Louiseville )",07/01 - 07/31,Health care workers and caregivers,Adults (18-64 years),1100,2.2% (NR),Convenience,"NR; NR
(0%; 0%)",Unclear,News and Media,http://www.uoflnews.com/post/uofltoday/new-co-immunity-project-data-show-covid-19-infection-among-health-care-workers-may-be-lower-than-the-general-population/,3/8/2021,3/9/2021
201124_JeffersonCounty_UniversityofLouiseville_ProbabilitySampling,11/24/2020,Betty Coffman,Local,United States of America,"Kentucky; United States of America
(University of Louiseville )",11/09 - 11/16,Household and community samples,Not reported,1091,2% (NR),Stratified probability,"NR; NR
(0%; 0%)",Unclear,News and Media,https://www.uoflnews.com/post/uofltoday/co-immunity-project-shows-covid-19-infection-rate-in-jefferson-county-increased-tenfold-since-september/,3/8/2021,3/9/2021
201124_JeffersonCounty_UniversityofLouiseville_SelfReferal_overall,11/24/2020,Betty Coffman,Local,United States of America,"Kentucky; United States of America
(University of Louiseville )",11/09 - 11/16,Household and community samples,Not reported,1709,3.3% (NR),Self-referral,"NR; NR
(0%; 0%)",Unclear,News and Media,https://www.uoflnews.com/post/uofltoday/co-immunity-project-shows-covid-19-infection-rate-in-jefferson-county-increased-tenfold-since-september/,3/8/2021,3/9/2021
200824_Louiseville_UniversityOfLouiseville_HCW_AprilMay,8/24/2020,Betty Coffman,Local,United States of America,"Louiseville; Kentucky; United States of America
(University of Louiseville )",04/01 - 05/31,Health care workers and caregivers,Adults (18-64 years),1372,1% (NR),Convenience,"NR; NR
(0%; 0%)",Unclear,News and Media,http://www.uoflnews.com/post/uofltoday/new-co-immunity-project-data-show-covid-19-infection-among-health-care-workers-may-be-lower-than-the-general-population/,3/9/2021,3/9/2021
210123_Norfolk_NavalMedicalCenterPortsmouth_Overall,1/23/2021,Tahaniyat Lalani,Sublocal,United States of America,"Norfolk; Virginia; United States of America
(Naval Medical Center Portsmouth)",04/28 - 05/12,Essential non-healthcare workers,Adults (18-64 years),432,3% (1.6-5.1%),Convenience,"LakePharma, Inc; NR
(98%; 100%)",Moderate,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1093/ofid/ofaa654,3/13/2021,3/15/2021
201028_Connecticut_YaleSchoolOfMedicine_Black2Overall_PopAdj,10/28/2020,Shiwani Mahajan,Regional,United States of America,"Connecticut; United States of America
(Yale School of Medicine)",06/23 - 07/22,Household and community samples,Multiple groups,148,6.4% (0.9-11.9%),Simplified probability,"Ortho-Clinical Diagnostics; NR
(90%; 100%)",High,Journal Article (Peer-Reviewed),http://dx.doi.org/10.1016/j.amjmed.2020.09.024,3/13/2021,3/16/2021
201028_Connecticut_YaleSchoolOfMedicine_Hispanic3_Overall_PopAdj,10/28/2020,Shiwani Mahajan,Regional,United States of America,"Connecticut; United States of America
(Yale School of Medicine)",06/23 - 07/22,Household and community samples,Multiple groups,171,19.9% (13.2-26.6%),Simplified probability,"Ortho-Clinical Diagnostics; NR
(90%; 100%)",High,Journal Article (Peer-Reviewed),http://dx.doi.org/10.1016/j.amjmed.2020.09.024,3/13/2021,3/13/2021
210122_USA_YourCareChoice_GenPop,1/22/2021,Robert Morlock,National,United States of America,"United States of America
(YourCareChoice)",04/24 - 05/13,Household and community samples,Adults (18-64 years),407,21.6% (NR),Stratified probability,"NR; NR
(0%; 0%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1371/journal.pone.0245586,3/13/2021,3/13/2021
210203_StLouis_WashingtonUniversitySchoolofMedicine_Children_overall_adj,2/3/2021,Brittany K Smith,Sublocal,United States of America,"St Louis; Missouri; United States of America
(Washington University School of Medicine)",04/14 - 05/08,Patients seeking care for non-COVID-19 reasons,Children and Youth (0-17 years),15,1.7% (0-3.4%),Sequential,"Authors; NR
(98.2%; 98.7%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1128/mSphere.01207-20,3/13/2021,3/14/2021
210203_StLouis_WashingtonUniversitySchoolofMedicine_Adults_overall_adj,2/3/2021,Brittany K Smith,Sublocal,United States of America,"St Louis; Missouri; United States of America
(Washington University School of Medicine)",04/27 - 05/12,Patients seeking care for non-COVID-19 reasons,Multiple groups,21,3.1% (0.9-5.3%),Sequential,"Authors; NR
(98.2%; 98.7%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1128/mSphere.01207-20,3/13/2021,3/14/2021
210127_BatonRouge_OchsnerClinicFoundation_overall,1/27/2021,Amy K. Feehan,Local,United States of America,"Baton Rouge; Louisiana; United States of America
(Ochsner Clinic Foundation)",07/15 - 07/31,Household and community samples,Multiple groups,2138,3.6% (2.8-4.4%),Stratified non-probability,"Abbott Laboratories; NR
(0%; 0%)",Moderate,Journal Article (Peer-Reviewed),https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7774581/,3/13/2021,3/15/2021
210212_Arizona_KingmanRegionalMedicalCenter_Overall,2/12/2021,Anthony Santarelli,Local,United States of America,"Kingman; Arizona; United States of America
(Kingman Regional Medical Center)",09/28 - 10/09,Household and community samples,Adults (18-64 years),566,8% (NR),Convenience,"Ortho-Clinical Diagnostics Inc.; NR
(87.5%; 100%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1515/jom-2020-0287,3/14/2021,3/15/2021
210120_NorthDakota_NorthDakotaStateUniversity_PharmacyPersonnel,1/20/2021,Amanda Johnson,Regional,United States of America,"Fargo, Grand Forks; North Dakota; United States of America
(North Dakota State University)",07/01 - 07/31,Health care workers and caregivers,Adults (18-64 years),247,14.6% (10.4-19.6%),Convenience,"BioSys Laboratories; NR
(93.5%; 100%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1016/j.japh.2021.01.023,3/14/2021,3/21/2021
210225_Denver_UniversityofColorado_NewOnsetDiabetes,2/25/2021,Xiaofan Jia,Sublocal,United States of America,"Denver; Colorado; United States of America
(University of Colorado)",01/03 - 10/16,Patients seeking care for non-COVID-19 reasons,Multiple groups,129,0.8% (0.1-4.2%),Convenience,"NA; NR
(100%; 99.9%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1089/dia.2020.0609,3/14/2021,3/14/2021
210225_Denver_UniversityofColorado_EstablishedDiabetes,2/25/2021,Xiaofan Jia,Sublocal,United States of America,"Denver; Colorado; United States of America
(University of Colorado)",01/03 - 10/16,Patients seeking care for non-COVID-19 reasons,Multiple groups,94,4.3% (1.7-10.4%),Convenience,"NA; NR
(100%; 99.9%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1089/dia.2020.0609,3/14/2021,3/14/2021
210225_Denver_UniversityofColorado_GenPopChildren,2/25/2021,Xiaofan Jia,Local,United States of America,"Denver; Colorado; United States of America
(University of Colorado)",07/08 - 10/23,Household and community samples,Children and Youth (0-17 years),562,2.8% (1.8-4.6%),Convenience,"NA; NR
(100%; 99.9%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1089/dia.2020.0609,3/14/2021,3/14/2021
210225_Denver_UniversityofColorado_GenPopAdults,2/25/2021,Xiaofan Jia,Local,United States of America,"Denver; Colorado; United States of America
(University of Colorado)",07/08 - 10/23,Household and community samples,Adults (18-64 years),102,3.9% (1.5-9.7%),Convenience,"NA; NR
(100%; 99.9%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1089/dia.2020.0609,3/14/2021,3/14/2021
210208_Mississippi_CDCCOVID-19ResponseTeam_Overall,2/8/2021,Charlotte Hobbs,Regional,United States of America,"Mississippi; United States of America
(CDC COVID-19 Response Team)",05/17 - 09/19,Residual sera,Children and Youth (0-17 years),1603,10.9% (9.4-12.4%),Sequential,"Ortho Clinical Diagnostics; Centers for Disease and Control (CDC In-House); NR
(0%; 0%)",High,Preprint,https://www.medrxiv.org/content/10.1101/2021.02.05.21250792v1,3/16/2021,3/16/2021
210209_Atlanta_EmoryUniversity,2/9/2021,Jessica Howard-Anderson,Local,United States of America,"Atlanta; Georgia; United States of America
(Emory University)",05/06 - 06/12,Health care workers and caregivers,Adults (18-64 years),353,6.5% (NR),Convenience,"NR; NR
(86.7%; 99.3%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1017/ice.2021.54,3/17/2021,3/17/2021
210216_USA_CityUniversityOfNewYork_overall_TestAdj,2/16/2021,Denis Nash,National,United States of America,"United States of America
(City University of New York)",05/15 - 01/15,Household and community samples,Multiple groups,4459,6.3% (5.5-7.1%),Stratified non-probability,"1) Bio-Rad Platelia

2) EUROIMMUN; NR
(98%; 99.3%)",Moderate,Preprint,10.1101/2021.02.12.21251659,3/17/2021,3/18/2021
210202_ParrisIsland_IcahnSchoolofMedicineatMountSinai,2/2/2021,Andrew Letizia,Sublocal,United States of America,"Parris Island; North Carolina; United States of America
(Icahn School of Medicine at Mount Sinai)",05/11 - 09/07,Essential non-healthcare workers,Adults (18-64 years),3196,9% (NR),Convenience,"Independent authors, Amanat et al; NR
(96.08%; 97.14%)",Moderate,Journal Article (Peer-Reviewed),http://dx.doi.org/10.3201/eid2704.204732,3/17/2021,3/17/2021
210226_CentreCounty_PennsylvaniaStateUniversity_Students,2/26/2021,Callum Arnold,Sublocal,United States of America,"Pennsylvania; United States of America
(Pennsylvania State University)",10/26 - 11/23,Students and Daycares,Adults (18-64 years),625,31.2% (NR),Convenience,"In-House: Pennsylvania State University; NR
(93.3%; 99%)",Moderate,Preprint,https://www.medrxiv.org/content/10.1101/2021.02.17.21251942v3,3/17/2021,3/17/2021
210226_CentreCounty_PennsylvaniaStateUniversity_Community,2/26/2021,Callum Arnold,Local,United States of America,"Pennsylvania; United States of America
(Pennsylvania State University)",08/07 - 12/20,Household and community samples,Adults (18-64 years),345,8.2% (NR),Convenience,"In-House: Pennsylvania State University; NR
(93.3%; 99%)",High,Preprint,https://www.medrxiv.org/content/10.1101/2021.02.17.21251942v3,3/17/2021,3/17/2021
201125_LosAngelesCounty_UCLAMedicalCenter_overall,11/25/2020,Khadije Ahmad,Local,United States of America,"California; United States of America
(UCLA Medical Center)",04/21 - 05/22,Multiple populations,Multiple groups,244,20.9% (NR),Unclear,"Getein Biotech Inc; NR
(96%; 100%)",High,Journal Article (Peer-Reviewed),http://dx.doi.org/10.1007/s10096-020-04111-3,3/18/2021,3/19/2021
210204_UnitedStates_DaVitaClinicalResearch_Overall,2/4/2021,Adam Walker,National,United States of America,"United States of America
(DaVita Clinical Research)",05/27 - 07/01,Residual sera,Multiple groups,12932,NA,Simplified probability,"Diazyme Laboratories, Inc; NR
(0%; 0%)",Moderate,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1016/j.xkme.2021.01.002,3/18/2021,3/18/2021
210201_NewYorkCity_ColumbiaUniversity,2/1/2021,Caitlin Baptiste,Sublocal,United States of America,"New York City; New York
; United States of America
(Columbia University)",06/24 - 07/16,Pregnant or parturient women,Adults (18-64 years),47,40.4% (NR),Sequential,"NR; NR
(92%; 0%)",High,Journal Article (Peer-Reviewed),http://dx.doi.org/10.1016/j.ajog.2020.12.944,3/18/2021,3/18/2021
210208_Virginia_UniversityOfVirginia_Overall_PopAdj,2/8/2021,Elizabeth T. Rogawski McQuade,Regional,United States of America,"Virginia; United States of America
(University of Virginia
)",06/01 - 08/14,Residual sera,Multiple groups,4675,2.4% (1.8-3.1%),Convenience,"Abbott; NR
(92.7%; 99.9%)",Moderate,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamanetworkopen.2020.35234,3/18/2021,3/19/2021
210130_USA_UniversityofArizona_primary,1/30/2021,Lara J Akinbami,Local,United States of America,"Detroit, Michigan, metropolitan area and in New York City; United States of America
(University of Arizona )",05/17 - 07/02,Health care workers and caregivers,Multiple groups,40938,16.2% (15.9-16.6%),Self-referral,"VITROS Immunodiagnostic Products; NR
(0%; 0%)",Moderate,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1093/cid/ciab080,3/19/2021,3/19/2021
210129_Atlanta_EmoryUniversityHospital_primary,1/29/2021,Julia M. Baker,Local,United States of America,"Atlanta; Georgia; United States of America
(Emory University Hospital)",04/19 - 06/26,Health care workers and caregivers,Adults (18-64 years),10275,3.8% (3.4-4.3%),Self-referral,"Emory University; NR
(97.5%; 98%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.7326/M20-7145,3/19/2021,3/19/2021
210218_WashingtonDC_GovernmentOfTheDistrictOfColumbia_overall,2/18/2021,Adrienne Sherman,Local,United States of America,"Washington DC; United States of America
(Government of the District of Columbia)",07/27 - 08/21,Household and community samples,Multiple groups,671,7.6% (5.7-9.9%),Convenience,"DiaSorin; NR
(97%; 0%)",High,Preprint,10.1101/2021.02.15.21251764,3/19/2021,3/19/2021
201231_NewYorkCity_MemorialSloanKetteringCancerCenter_Overall,12/23/2020,Lauren Jimenez‐Kurlander,Sublocal,United States of America,"New York City; New York; United States of America
(Memorial Sloan Kettering Cancer Center)",05/05 - 09/10,Patients seeking care for non-COVID-19 reasons,Multiple groups,257,7.8% (NR),Sequential,"NR; NR
(0%; 0%)",High,Journal Article (Peer-Reviewed),http://dx.doi.org/10.1002/pbc.28857,3/20/2021,3/20/2021
210129_NewYork_NorthwellHealth,1/29/2021,Lylach Haizler-Cohen,Regional,United States of America,"New York; United States of America
(Northwell Health)",05/27 - 08/23,Pregnant or parturient women,Adults (18-64 years),2930,15.3% (NR),Sequential,"NR; NR
(0%; 0%)",Unclear,Journal Article (Peer-Reviewed),http://dx.doi.org/10.1016/j.ajog.2020.12.631,3/20/2021,3/20/2021
201124_USA_CDC_July/August1_Alaska,11/24/2020,Kristina Bajema,Regional,United States of America,"Alaska; United States of America
(CDC COVID-19 Response)",08/06 - 08/11,Residual sera,Multiple groups,242,0.3% (0-1.1%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_August2_Alaska,11/24/2020,Kristina Bajema,Regional,United States of America,"Alaska; United States of America
(CDC COVID-19 Response)",08/12 - 08/26,Residual sera,Multiple groups,704,1.3% (0.5-2.3%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_August/September3_Alaska,11/24/2020,Kristina Bajema,Regional,United States of America,"Alaska; United States of America
(CDC COVID-19 Response)",08/26 - 09/09,Residual sera,Multiple groups,610,1% (0.2-2.2%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_September4_Alaska,11/24/2020,Kristina Bajema,Regional,United States of America,"Alaska; United States of America
(CDC COVID-19 Response)",09/09 - 09/18,Residual sera,Multiple groups,681,0.4% (0.1-0.8%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_August/September3_Alabama,11/24/2020,Kristina Bajema,Regional,United States of America,"Alabama; United States of America
(CDC COVID-19 Response)",08/26 - 09/08,Residual sera,Multiple groups,955,9.9% (7.2-12.8%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_August/September3_Arkansas,11/24/2020,Kristina Bajema,Regional,United States of America,"Arkansas; United States of America
(CDC COVID-19 Response)",08/24 - 09/08,Residual sera,Multiple groups,992,4.9% (3.5-6.4%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_August/September3_Arizona,11/24/2020,Kristina Bajema,Regional,United States of America,"Arizona; United States of America
(CDC COVID-19 Response)",08/26 - 09/09,Residual sera,Multiple groups,1030,4.9% (3.1-7.1%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_August/September3_California,11/24/2020,Kristina Bajema,Regional,United States of America,"California; United States of America
(CDC COVID-19 Response)",08/28 - 09/09,Residual sera,Multiple groups,983,6% (4.2-7.8%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_August/September3_Connecticut,11/24/2020,Kristina Bajema,Regional,United States of America,"Connecticut; United States of America
(CDC COVID-19 Response)",08/26 - 09/04,Residual sera,Multiple groups,983,4.3% (2.9-5.7%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_August/September3_Colorado,11/24/2020,Kristina Bajema,Regional,United States of America,"Colorado; United States of America
(CDC COVID-19 Response)",08/24 - 09/04,Residual sera,Multiple groups,1025,3.6% (2.3-5.1%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_August/September3_Washington D.C,11/24/2020,Kristina Bajema,Regional,United States of America,"Washington D.C; United States of America
(CDC COVID-19 Response)",08/27 - 09/10,Residual sera,Multiple groups,643,5% (2.8-7.6%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_August/September3_Florida,11/24/2020,Kristina Bajema,Regional,United States of America,"Florida; United States of America
(CDC COVID-19 Response)",08/27 - 09/09,Residual sera,Multiple groups,981,5.7% (3.9-7.5%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_August/September3_Iowa,11/24/2020,Kristina Bajema,Regional,United States of America,"Iowa; United States of America
(CDC COVID-19 Response)",08/25 - 09/10,Residual sera,Multiple groups,1006,8.4% (6.2-10.7%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_August/September3_Delaware,11/24/2020,Kristina Bajema,Regional,United States of America,"Delaware; United States of America
(CDC COVID-19 Response)",08/26 - 09/10,Residual sera,Multiple groups,914,4.5% (2.4-7.1%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_August/September3_Georgia,11/24/2020,Kristina Bajema,Regional,United States of America,"Georgia; United States of America
(CDC COVID-19 Response)",08/25 - 09/10,Residual sera,Multiple groups,1020,8.7% (6.7-11.1%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_August/September3_Idaho,11/24/2020,Kristina Bajema,Regional,United States of America,"Idaho; United States of America
(CDC COVID-19 Response)",08/26 - 09/10,Residual sera,Multiple groups,790,5.7% (2.9-9.7%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_August/September3_Maine,11/24/2020,Kristina Bajema,Regional,United States of America," Maine; United States of America
(CDC COVID-19 Response)",08/26 - 09/10,Residual sera,Multiple groups,759,1.5% (0.4-3.2%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_August/September3_Kansas,11/24/2020,Kristina Bajema,Regional,United States of America,"Kansas; United States of America
(CDC COVID-19 Response)",08/24 - 09/03,Residual sera,Multiple groups,1025,2.9% (1.6-4.3%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_August/September3_Massachusetts,11/24/2020,Kristina Bajema,Regional,United States of America," Massachusetts; United States of America
(CDC COVID-19 Response)",08/27 - 09/05,Residual sera,Multiple groups,981,3.6% (2.4-5.1%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_August/September3_Indiana,11/24/2020,Kristina Bajema,Regional,United States of America,"Indiana; United States of America
(CDC COVID-19 Response)",08/26 - 09/09,Residual sera,Multiple groups,984,2.4% (1.4-3.5%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_August/September3_Maryland,11/24/2020,Kristina Bajema,Regional,United States of America," Maryland; United States of America
(CDC COVID-19 Response)",08/26 - 09/08,Residual sera,Multiple groups,980,7.9% (5.7-10.4%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_August/September3_Minnesota,11/24/2020,Kristina Bajema,Regional,United States of America," Minnesota; United States of America
(CDC COVID-19 Response)",08/26 - 09/08,Residual sera,Multiple groups,974,9.2% (6.7-12%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_August/September3_Michigan,11/24/2020,Kristina Bajema,Regional,United States of America," Michigan; United States of America
(CDC COVID-19 Response)",08/26 - 09/03,Residual sera,Multiple groups,976,3.4% (2.2-5%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_August/September3_Illinois,11/24/2020,Kristina Bajema,Regional,United States of America,"Illinois; United States of America
(CDC COVID-19 Response)",08/26 - 09/03,Residual sera,Multiple groups,979,5.6% (3.9-7.7%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_August/September3_Missouri,11/24/2020,Kristina Bajema,Regional,United States of America," Missouri; United States of America
(CDC COVID-19 Response)",08/24 - 09/10,Residual sera,Multiple groups,1024,2.9% (1.7-4.2%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_August/September3_Louisiana,11/24/2020,Kristina Bajema,Regional,United States of America," Louisiana; United States of America
(CDC COVID-19 Response)",08/26 - 09/08,Residual sera,Multiple groups,1001,8.6% (6.7-11.3%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_August/September3_Kentucky,11/24/2020,Kristina Bajema,Regional,United States of America," Kentucky; United States of America
(CDC COVID-19 Response)",08/26 - 09/08,Residual sera,Multiple groups,983,3.1% (1.9-4.3%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_August/September3_Mississippi,11/24/2020,Kristina Bajema,Regional,United States of America," Mississippi; United States of America
(CDC COVID-19 Response)",08/26 - 09/10,Residual sera,Multiple groups,987,8.4% (4.9-12.7%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_August/September3_NewHampshire,11/24/2020,Kristina Bajema,Regional,United States of America," New Hampshire; United States of America
(CDC COVID-19 Response)",08/26 - 09/03,Residual sera,Multiple groups,1147,1.6% (0.7-2.8%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_August/September3_Ohio,11/24/2020,Kristina Bajema,Regional,United States of America," Ohio; United States of America
(CDC COVID-19 Response)",08/27 - 09/10,Residual sera,Multiple groups,983,5% (3.2-7.1%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_August/September3_Nebraska,11/24/2020,Kristina Bajema,Regional,United States of America," Nebraska; United States of America
(CDC COVID-19 Response)",08/24 - 09/10,Residual sera,Multiple groups,938,6.3% (4.5-8.3%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_August/September3_Virginia,11/24/2020,Kristina Bajema,Regional,United States of America," Virginia; United States of America
(CDC COVID-19 Response)",08/26 - 09/08,Residual sera,Multiple groups,1007,3.5% (2-5.3%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_August/September3_NewMexico,11/24/2020,Kristina Bajema,Regional,United States of America," New Mexico; United States of America
(CDC COVID-19 Response)",08/25 - 09/08,Residual sera,Multiple groups,985,3.7% (2.3-5.6%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_August/September3_Vermont,11/24/2020,Kristina Bajema,Regional,United States of America," Vermont; United States of America
(CDC COVID-19 Response)",08/26 - 09/10,Residual sera,Multiple groups,485,0.4% (0-0.9%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_August/September3_Oregon,11/24/2020,Kristina Bajema,Regional,United States of America," Oregon; United States of America
(CDC COVID-19 Response)",08/26 - 09/10,Residual sera,Multiple groups,968,1.9% (0.9-2.9%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_August/September3_PuertoRico,11/24/2020,Kristina Bajema,Regional,United States of America,"Puerto Rico; United States of America
(CDC COVID-19 Response)",08/24 - 09/03,Residual sera,Multiple groups,980,2.5% (1.4-3.8%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_August/September3_NewJersey,11/24/2020,Kristina Bajema,Regional,United States of America," New Jersey; United States of America
(CDC COVID-19 Response)",08/26 - 09/07,Residual sera,Multiple groups,944,12.8% (10.5-15.4%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_August/September3_SouthDakota,11/24/2020,Kristina Bajema,Regional,United States of America," South Dakota; United States of America
(CDC COVID-19 Response)",08/26 - 09/10,Residual sera,Multiple groups,97,0.7% (0-2.5%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_August/September3_NewYork,11/24/2020,Kristina Bajema,Regional,United States of America," New York; United States of America
(CDC COVID-19 Response)",08/26 - 09/10,Residual sera,Multiple groups,1043,19.5% (16.9-22.4%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_August/September3_Montana,11/24/2020,Kristina Bajema,Regional,United States of America," Montana; United States of America
(CDC COVID-19 Response)",08/24 - 09/09,Residual sera,Multiple groups,518,0.9% (0.2-1.8%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_August/September3_Nevada,11/24/2020,Kristina Bajema,Regional,United States of America," Nevada; United States of America
(CDC COVID-19 Response)",08/27 - 08/29,Residual sera,Multiple groups,980,6.5% (4.6-8.6%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_August/September3_NorthCarolina,11/24/2020,Kristina Bajema,Regional,United States of America," North Carolina; United States of America
(CDC COVID-19 Response)",08/26 - 09/09,Residual sera,Multiple groups,982,3.8% (2.3-5.3%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_August/September3_Tennessee,11/24/2020,Kristina Bajema,Regional,United States of America," Tennessee; United States of America
(CDC COVID-19 Response)",08/25 - 09/08,Residual sera,Multiple groups,950,5.4% (3.6-7.3%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_August/September3_SouthCarolina,11/24/2020,Kristina Bajema,Regional,United States of America," South Carolina; United States of America
(CDC COVID-19 Response)",08/26 - 09/10,Residual sera,Multiple groups,927,7.2% (5.1-9.6%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_August/September3_RhodeIsland,11/24/2020,Kristina Bajema,Regional,United States of America," Rhode Island; United States of America
(CDC COVID-19 Response)",08/27 - 09/10,Residual sera,Multiple groups,786,3.1% (1.7-4.6%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_August/September3_Oklahoma,11/24/2020,Kristina Bajema,Regional,United States of America," Oklahoma; United States of America
(CDC COVID-19 Response)",08/24 - 09/01,Residual sera,Multiple groups,979,5.4% (3.8-7.3%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_August/September3_Utah,11/24/2020,Kristina Bajema,Regional,United States of America," Utah; United States of America
(CDC COVID-19 Response)",08/24 - 09/08,Residual sera,Multiple groups,1104,4.9% (2.8-7.7%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_August/September3_NorthDakota,11/24/2020,Kristina Bajema,Regional,United States of America," North Dakota; United States of America
(CDC COVID-19 Response)",08/26 - 09/09,Residual sera,Multiple groups,109,0.2% (0-1%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_August/September3_Texas,11/24/2020,Kristina Bajema,Regional,United States of America," Texas; United States of America
(CDC COVID-19 Response)",08/25 - 09/02,Residual sera,Multiple groups,979,5.8% (4-7.9%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_August/September3_Pennsylvania,11/24/2020,Kristina Bajema,Regional,United States of America," Pennsylvania; United States of America
(CDC COVID-19 Response)",08/26 - 09/09,Residual sera,Multiple groups,845,9.5% (6.6-13.6%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_August/September3_Washington,11/24/2020,Kristina Bajema,Regional,United States of America," Washington; United States of America
(CDC COVID-19 Response)",08/25 - 09/10,Residual sera,Multiple groups,820,4.5% (2.6-6.9%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_August/September3_Wisconsin,11/24/2020,Kristina Bajema,Regional,United States of America," Wisconsin; United States of America
(CDC COVID-19 Response)",08/25 - 09/10,Residual sera,Multiple groups,976,2.6% (1.5-4%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_August/September3_WestVirginia,11/24/2020,Kristina Bajema,Regional,United States of America," West Virginia; United States of America
(CDC COVID-19 Response)",08/26 - 09/10,Residual sera,Multiple groups,1128,1.5% (0.8-2.4%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_August2_Minnesota,11/24/2020,Kristina Bajema,Regional,United States of America," Minnesota; United States of America
(CDC COVID-19 Response)",08/11 - 08/27,Residual sera,Multiple groups,978,4.5% (3.1-5.9%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_August2_WestVirginia,11/24/2020,Kristina Bajema,Regional,United States of America," West Virginia; United States of America
(CDC COVID-19 Response)",08/13 - 08/27,Residual sera,Multiple groups,637,2.2% (0.5-4.9%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_August2_Wisconsin,11/24/2020,Kristina Bajema,Regional,United States of America," Wisconsin; United States of America
(CDC COVID-19 Response)",08/12 - 08/27,Residual sera,Multiple groups,838,3.3% (2-4.7%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_August2_Washington,11/24/2020,Kristina Bajema,Regional,United States of America," Washington; United States of America
(CDC COVID-19 Response)",08/12 - 08/27,Residual sera,Multiple groups,1238,3% (1.8-4.5%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_August2_Arizona,11/24/2020,Kristina Bajema,Regional,United States of America,"Arizona; United States of America
(CDC COVID-19 Response)",08/12 - 08/26,Residual sera,Multiple groups,1304,4.7% (2.7-7.6%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_August2_Pennsylvania,11/24/2020,Kristina Bajema,Regional,United States of America," Pennsylvania; United States of America
(CDC COVID-19 Response)",08/10 - 08/26,Residual sera,Multiple groups,887,10.1% (7.5-13.7%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_August2_California,11/24/2020,Kristina Bajema,Regional,United States of America,"California; United States of America
(CDC COVID-19 Response)",08/13 - 08/19,Residual sera,Multiple groups,980,4.3% (2.9-6.1%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_August2_Missouri,11/24/2020,Kristina Bajema,Regional,United States of America," Missouri; United States of America
(CDC COVID-19 Response)",08/12 - 08/21,Residual sera,Multiple groups,1021,3.5% (2.2-5.1%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_August2_Iowa,11/24/2020,Kristina Bajema,Regional,United States of America,"Iowa; United States of America
(CDC COVID-19 Response)",08/12 - 08/27,Residual sera,Multiple groups,980,9.4% (7.1-11.6%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_August2_Georgia,11/24/2020,Kristina Bajema,Regional,United States of America,"Georgia; United States of America
(CDC COVID-19 Response)",08/13 - 08/26,Residual sera,Multiple groups,1031,7.4% (5.5-9.5%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_August2_NewYork,11/24/2020,Kristina Bajema,Regional,United States of America," New York; United States of America
(CDC COVID-19 Response)",08/10 - 08/26,Residual sera,Multiple groups,1122,20.6% (18-23.1%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_August2_NewJersey,11/24/2020,Kristina Bajema,Regional,United States of America," New Jersey; United States of America
(CDC COVID-19 Response)",08/10 - 08/26,Residual sera,Multiple groups,1127,12.2% (10.2-14.5%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_August2_Nevada,11/24/2020,Kristina Bajema,Regional,United States of America," Nevada; United States of America
(CDC COVID-19 Response)",08/12 - 08/26,Residual sera,Multiple groups,972,7.9% (6.1-9.8%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_August2_Indiana,11/24/2020,Kristina Bajema,Regional,United States of America,"Indiana; United States of America
(CDC COVID-19 Response)",08/12 - 08/26,Residual sera,Multiple groups,906,3.1% (1.5-4.8%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_August2_Ohio,11/24/2020,Kristina Bajema,Regional,United States of America," Ohio; United States of America
(CDC COVID-19 Response)",08/12 - 08/27,Residual sera,Multiple groups,985,2.1% (1.1-3.3%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_August2_Idaho,11/24/2020,Kristina Bajema,Regional,United States of America,"Idaho; United States of America
(CDC COVID-19 Response)",08/12 - 08/26,Residual sera,Multiple groups,651,4.6% (1.7-9.1%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_August2_NorthDakota,11/24/2020,Kristina Bajema,Regional,United States of America," North Dakota; United States of America
(CDC COVID-19 Response)",08/12 - 08/26,Residual sera,Multiple groups,135,0.6% (0-1.5%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_August2_Florida,11/24/2020,Kristina Bajema,Regional,United States of America,"Florida; United States of America
(CDC COVID-19 Response)",08/14 - 08/14,Residual sera,Multiple groups,978,4.5% (3.2-6.1%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_August2_Alabama,11/24/2020,Kristina Bajema,Regional,United States of America,"Alabama; United States of America
(CDC COVID-19 Response)",08/12 - 08/26,Residual sera,Multiple groups,974,7.6% (5.3-9.8%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_August2_Vermont,11/24/2020,Kristina Bajema,Regional,United States of America," Vermont; United States of America
(CDC COVID-19 Response)",08/13 - 08/27,Residual sera,Multiple groups,382,0.3% (0-0.8%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_August2_SouthCarolina,11/24/2020,Kristina Bajema,Regional,United States of America," South Carolina; United States of America
(CDC COVID-19 Response)",08/12 - 08/27,Residual sera,Multiple groups,1063,6% (4.4-8%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_August2_Virginia,11/24/2020,Kristina Bajema,Regional,United States of America," Virginia; United States of America
(CDC COVID-19 Response)",08/10 - 08/26,Residual sera,Multiple groups,1243,4.7% (2.5-7.2%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_August2_PuertoRico,11/24/2020,Kristina Bajema,Regional,United States of America,"Puerto Rico; United States of America
(CDC COVID-19 Response)",08/10 - 08/17,Residual sera,Multiple groups,986,2.2% (1.2-3.3%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_August2_Massachusetts,11/24/2020,Kristina Bajema,Regional,United States of America," Massachusetts; United States of America
(CDC COVID-19 Response)",08/12 - 08/27,Residual sera,Multiple groups,980,3.7% (2.3-5.2%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_August2_RhodeIsland,11/24/2020,Kristina Bajema,Regional,United States of America," Rhode Island; United States of America
(CDC COVID-19 Response)",08/12 - 08/27,Residual sera,Multiple groups,570,3.6% (1.7-5.9%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_August2_Delaware,11/24/2020,Kristina Bajema,Regional,United States of America,"Delaware; United States of America
(CDC COVID-19 Response)",08/12 - 08/27,Residual sera,Multiple groups,1004,8.5% (5.8-11.3%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_August2_Texas,11/24/2020,Kristina Bajema,Regional,United States of America," Texas; United States of America
(CDC COVID-19 Response)",08/12 - 08/24,Residual sera,Multiple groups,1001,6.5% (4.7-8.5%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_August2_Michigan,11/24/2020,Kristina Bajema,Regional,United States of America," Michigan; United States of America
(CDC COVID-19 Response)",08/12 - 08/25,Residual sera,Multiple groups,983,4.2% (2.9-5.8%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_August2_Oregon,11/24/2020,Kristina Bajema,Regional,United States of America," Oregon; United States of America
(CDC COVID-19 Response)",08/10 - 08/27,Residual sera,Multiple groups,1086,2.4% (1.4-3.6%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_August2_Kansas,11/24/2020,Kristina Bajema,Regional,United States of America,"Kansas; United States of America
(CDC COVID-19 Response)",08/11 - 08/25,Residual sera,Multiple groups,1016,3.7% (2-5.5%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_August2_Maine,11/24/2020,Kristina Bajema,Regional,United States of America," Maine; United States of America
(CDC COVID-19 Response)",08/12 - 08/27,Residual sera,Multiple groups,609,0.6% (0-1.4%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_August2_Montana,11/24/2020,Kristina Bajema,Regional,United States of America," Montana; United States of America
(CDC COVID-19 Response)",08/12 - 08/24,Residual sera,Multiple groups,383,1.3% (0.4-2.5%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_August2_Maryland,11/24/2020,Kristina Bajema,Regional,United States of America," Maryland; United States of America
(CDC COVID-19 Response)",08/10 - 08/26,Residual sera,Multiple groups,1174,7% (4.9-9.3%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_August2_Tennessee,11/24/2020,Kristina Bajema,Regional,United States of America," Tennessee; United States of America
(CDC COVID-19 Response)",08/12 - 08/26,Residual sera,Multiple groups,1029,6.7% (5.1-8.6%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_August2_NorthCarolina,11/24/2020,Kristina Bajema,Regional,United States of America," North Carolina; United States of America
(CDC COVID-19 Response)",08/11 - 08/27,Residual sera,Multiple groups,982,3.8% (2.3-5.3%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_August2_Kentucky,11/24/2020,Kristina Bajema,Regional,United States of America," Kentucky; United States of America
(CDC COVID-19 Response)",08/12 - 08/26,Residual sera,Multiple groups,1126,3.1% (2.1-4.5%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_August2_NewMexico,11/24/2020,Kristina Bajema,Regional,United States of America," New Mexico; United States of America
(CDC COVID-19 Response)",08/10 - 08/27,Residual sera,Multiple groups,976,2.5% (1.5-3.8%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_August2_Mississippi,11/24/2020,Kristina Bajema,Regional,United States of America," Mississippi; United States of America
(CDC COVID-19 Response)",08/12 - 08/27,Residual sera,Multiple groups,968,10% (6.7-14.7%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_August2_Oklahoma,11/24/2020,Kristina Bajema,Regional,United States of America," Oklahoma; United States of America
(CDC COVID-19 Response)",08/10 - 08/18,Residual sera,Multiple groups,979,4% (2.7-5.5%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_August2_Utah,11/24/2020,Kristina Bajema,Regional,United States of America," Utah; United States of America
(CDC COVID-19 Response)",08/15 - 08/25,Residual sera,Multiple groups,871,5.5% (2.9-8.7%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_August2_Colorado,11/24/2020,Kristina Bajema,Regional,United States of America,"Colorado; United States of America
(CDC COVID-19 Response)",08/10 - 08/25,Residual sera,Multiple groups,1019,3.3% (1.8-4.8%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_August2_NewHampshire,11/24/2020,Kristina Bajema,Regional,United States of America," New Hampshire; United States of America
(CDC COVID-19 Response)",08/13 - 08/25,Residual sera,Multiple groups,1125,0.8% (0.3-1.2%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_August2_Washington D.C,11/24/2020,Kristina Bajema,Regional,United States of America,"Washington D.C; United States of America
(CDC COVID-19 Response)",08/13 - 08/27,Residual sera,Multiple groups,781,6.8% (4.6-9.2%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_August2_Louisiana,11/24/2020,Kristina Bajema,Regional,United States of America," Louisiana; United States of America
(CDC COVID-19 Response)",08/12 - 08/25,Residual sera,Multiple groups,989,11.8% (9.3-14.8%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_August2_SouthDakota,11/24/2020,Kristina Bajema,Regional,United States of America," South Dakota; United States of America
(CDC COVID-19 Response)",08/12 - 08/26,Residual sera,Multiple groups,83,NA,Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_August2_Wyoming,11/24/2020,Kristina Bajema,Regional,United States of America," Wyoming; United States of America
(CDC COVID-19 Response)",08/13 - 08/24,Residual sera,Multiple groups,86,0.8% (0-3.1%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_August2_Illinois,11/24/2020,Kristina Bajema,Regional,United States of America,"Illinois; United States of America
(CDC COVID-19 Response)",08/12 - 08/27,Residual sera,Multiple groups,985,4.9% (3.4-6.7%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_August2_Connecticut,11/24/2020,Kristina Bajema,Regional,United States of America,"Connecticut; United States of America
(CDC COVID-19 Response)",08/11 - 08/24,Residual sera,Multiple groups,983,2.4% (1.5-3.5%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_August2_Arkansas,11/24/2020,Kristina Bajema,Regional,United States of America,"Arkansas; United States of America
(CDC COVID-19 Response)",08/11 - 08/25,Residual sera,Multiple groups,998,3% (1.8-4.4%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_August2_Nebraska,11/24/2020,Kristina Bajema,Regional,United States of America," Nebraska; United States of America
(CDC COVID-19 Response)",08/11 - 08/25,Residual sera,Multiple groups,990,7.9% (5.5-10.6%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_July/August1_Pennsylvania,11/24/2020,Kristina Bajema,Regional,United States of America," Pennsylvania; United States of America
(CDC COVID-19 Response)",07/31 - 08/11,Residual sera,Multiple groups,575,10.2% (5.7-17.2%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_July/August1_SouthCarolina,11/24/2020,Kristina Bajema,Regional,United States of America," South Carolina; United States of America
(CDC COVID-19 Response)",07/30 - 08/13,Residual sera,Multiple groups,840,8.1% (5.8-10.7%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_July/August1_NewJersey,11/24/2020,Kristina Bajema,Regional,United States of America," New Jersey; United States of America
(CDC COVID-19 Response)",07/31 - 08/11,Residual sera,Multiple groups,871,14.8% (12.2-17.6%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_July/August1_Texas,11/24/2020,Kristina Bajema,Regional,United States of America," Texas; United States of America
(CDC COVID-19 Response)",07/29 - 08/05,Residual sera,Multiple groups,986,5.9% (4-8%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_July/August1_NewYork,11/24/2020,Kristina Bajema,Regional,United States of America," New York; United States of America
(CDC COVID-19 Response)",07/31 - 08/11,Residual sera,Multiple groups,846,23.3% (20.1-26.3%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_July/August1_Montana,11/24/2020,Kristina Bajema,Regional,United States of America," Montana; United States of America
(CDC COVID-19 Response)",07/29 - 08/10,Residual sera,Multiple groups,199,0.5% (0-1.7%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_July/August1_PuertoRico,11/24/2020,Kristina Bajema,Regional,United States of America,"Puerto Rico; United States of America
(CDC COVID-19 Response)",07/27 - 08/07,Residual sera,Multiple groups,984,1.1% (0.4-1.8%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_July/August1_Washington D.C,11/24/2020,Kristina Bajema,Regional,United States of America,"Washington D.C; United States of America
(CDC COVID-19 Response)",07/30 - 08/13,Residual sera,Multiple groups,717,3.9% (2.2-5.8%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_July/August1_Vermont,11/24/2020,Kristina Bajema,Regional,United States of America," Vermont; United States of America
(CDC COVID-19 Response)",07/30 - 08/11,Residual sera,Multiple groups,346,0.5% (0-1.8%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_July/August1_Maine,11/24/2020,Kristina Bajema,Regional,United States of America," Maine; United States of America
(CDC COVID-19 Response)",07/30 - 08/11,Residual sera,Multiple groups,598,0.5% (0-1.2%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_July/August1_NewHampshire,11/24/2020,Kristina Bajema,Regional,United States of America," New Hampshire; United States of America
(CDC COVID-19 Response)",07/30 - 08/11,Residual sera,Multiple groups,809,0.8% (0.2-1.5%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_July/August1_Nevada,11/24/2020,Kristina Bajema,Regional,United States of America," Nevada; United States of America
(CDC COVID-19 Response)",07/30 - 08/02,Residual sera,Multiple groups,979,5.1% (3.6-6.7%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_July/August1_NorthCarolina,11/24/2020,Kristina Bajema,Regional,United States of America," North Carolina; United States of America
(CDC COVID-19 Response)",07/29 - 08/10,Residual sera,Multiple groups,928,2.5% (1.3-3.7%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_July/August1_Idaho,11/24/2020,Kristina Bajema,Regional,United States of America,"Idaho; United States of America
(CDC COVID-19 Response)",08/04 - 08/11,Residual sera,Multiple groups,246,4.5% (1.8-8%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_July/August1_Colorado,11/24/2020,Kristina Bajema,Regional,United States of America,"Colorado; United States of America
(CDC COVID-19 Response)",07/30 - 08/07,Residual sera,Multiple groups,1001,2.4% (0.9-4.5%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_July/August1_Florida,11/24/2020,Kristina Bajema,Regional,United States of America,"Florida; United States of America
(CDC COVID-19 Response)",07/31 - 08/03,Residual sera,Multiple groups,980,4.3% (2.8-5.9%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_July/August1_Nebraska,11/24/2020,Kristina Bajema,Regional,United States of America," Nebraska; United States of America
(CDC COVID-19 Response)",07/28 - 08/13,Residual sera,Multiple groups,954,7.4% (5.3-9.8%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_July/August1_Kentucky,11/24/2020,Kristina Bajema,Regional,United States of America," Kentucky; United States of America
(CDC COVID-19 Response)",07/30 - 08/13,Residual sera,Multiple groups,975,2.4% (1.3-3.6%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_July/August1_WestVirginia,11/24/2020,Kristina Bajema,Regional,United States of America," West Virginia; United States of America
(CDC COVID-19 Response)",07/30 - 08/13,Residual sera,Multiple groups,317,1.2% (0.2-2.5%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_July/August1_Alabama,11/24/2020,Kristina Bajema,Regional,United States of America,"Alabama; United States of America
(CDC COVID-19 Response)",07/29 - 08/13,Residual sera,Multiple groups,938,5.8% (4.2-7.7%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_July/August1_Mississippi,11/24/2020,Kristina Bajema,Regional,United States of America," Mississippi; United States of America
(CDC COVID-19 Response)",07/30 - 08/13,Residual sera,Multiple groups,769,7.1% (3.8-11.1%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_July/August1_Louisiana,11/24/2020,Kristina Bajema,Regional,United States of America," Louisiana; United States of America
(CDC COVID-19 Response)",07/28 - 08/13,Residual sera,Multiple groups,1002,9.6% (6.9-12.3%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_July/August1_Kansas,11/24/2020,Kristina Bajema,Regional,United States of America,"Kansas; United States of America
(CDC COVID-19 Response)",07/29 - 08/08,Residual sera,Multiple groups,962,1.6% (0.7-2.8%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_July/August1_Massachusetts,11/24/2020,Kristina Bajema,Regional,United States of America," Massachusetts; United States of America
(CDC COVID-19 Response)",07/30 - 08/10,Residual sera,Multiple groups,978,4.2% (2.9-5.8%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_July/August1_Indiana,11/24/2020,Kristina Bajema,Regional,United States of America,"Indiana; United States of America
(CDC COVID-19 Response)",07/31 - 08/11,Residual sera,Multiple groups,579,2.2% (1.1-3.6%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_July/August1_Oklahoma,11/24/2020,Kristina Bajema,Regional,United States of America," Oklahoma; United States of America
(CDC COVID-19 Response)",07/28 - 08/04,Residual sera,Multiple groups,979,1.6% (0.9-2.5%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_July/August1_Wisconsin,11/24/2020,Kristina Bajema,Regional,United States of America," Wisconsin; United States of America
(CDC COVID-19 Response)",07/30 - 08/13,Residual sera,Multiple groups,814,1.8% (0.8-3.2%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_July/August1_Delaware,11/24/2020,Kristina Bajema,Regional,United States of America,"Delaware; United States of America
(CDC COVID-19 Response)",07/29 - 08/13,Residual sera,Multiple groups,804,5.7% (3.6-8.2%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_July/August1_Iowa,11/24/2020,Kristina Bajema,Regional,United States of America,"Iowa; United States of America
(CDC COVID-19 Response)",07/29 - 08/13,Residual sera,Multiple groups,811,8.6% (6-11.3%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_July/August1_Maryland,11/24/2020,Kristina Bajema,Regional,United States of America," Maryland; United States of America
(CDC COVID-19 Response)",07/31 - 08/11,Residual sera,Multiple groups,783,9.7% (7.3-12.9%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_July/August1_Connecticut,11/24/2020,Kristina Bajema,Regional,United States of America,"Connecticut; United States of America
(CDC COVID-19 Response)",07/30 - 08/03,Residual sera,Multiple groups,994,3.4% (2-4.7%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_July/August1_Michigan,11/24/2020,Kristina Bajema,Regional,United States of America," Michigan; United States of America
(CDC COVID-19 Response)",07/30 - 08/11,Residual sera,Multiple groups,982,3.4% (2.2-4.8%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_July/August1_NewMexico,11/24/2020,Kristina Bajema,Regional,United States of America," New Mexico; United States of America
(CDC COVID-19 Response)",07/29 - 08/13,Residual sera,Multiple groups,964,2% (1.1-3%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_July/August1_Arizona,11/24/2020,Kristina Bajema,Regional,United States of America,"Arizona; United States of America
(CDC COVID-19 Response)",07/31 - 08/11,Residual sera,Multiple groups,591,8.2% (4.1-13.6%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_July/August1_Missouri,11/24/2020,Kristina Bajema,Regional,United States of America," Missouri; United States of America
(CDC COVID-19 Response)",07/28 - 08/10,Residual sera,Multiple groups,979,2.5% (1.4-3.6%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_July/August1_Tennessee,11/24/2020,Kristina Bajema,Regional,United States of America," Tennessee; United States of America
(CDC COVID-19 Response)",07/30 - 08/11,Residual sera,Multiple groups,1003,6.3% (4.4-8.3%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_July/August1_Washington,11/24/2020,Kristina Bajema,Regional,United States of America," Washington; United States of America
(CDC COVID-19 Response)",07/29 - 08/11,Residual sera,Multiple groups,684,2.1% (0.8-3.7%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_July/August1_Virginia,11/24/2020,Kristina Bajema,Regional,United States of America," Virginia; United States of America
(CDC COVID-19 Response)",07/31 - 08/11,Residual sera,Multiple groups,730,4.1% (1.8-6.9%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_July/August1_Georgia,11/24/2020,Kristina Bajema,Regional,United States of America,"Georgia; United States of America
(CDC COVID-19 Response)",08/02 - 08/11,Residual sera,Multiple groups,985,6.8% (4.8-8.8%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_July/August1_RhodeIsland,11/24/2020,Kristina Bajema,Regional,United States of America," Rhode Island; United States of America
(CDC COVID-19 Response)",07/30 - 08/11,Residual sera,Multiple groups,684,3% (1.2-5.5%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_July/August1_Illinois,11/24/2020,Kristina Bajema,Regional,United States of America,"Illinois; United States of America
(CDC COVID-19 Response)",07/29 - 08/10,Residual sera,Multiple groups,1004,3.9% (2.5-5.2%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_July/August1_NorthDakota,11/24/2020,Kristina Bajema,Regional,United States of America," North Dakota; United States of America
(CDC COVID-19 Response)",07/29 - 08/12,Residual sera,Multiple groups,121,7.3% (1.3-14.3%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_July/August1_Arkansas,11/24/2020,Kristina Bajema,Regional,United States of America,"Arkansas; United States of America
(CDC COVID-19 Response)",07/29 - 08/13,Residual sera,Multiple groups,937,4.1% (2.7-5.6%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_July/August1_Utah,11/24/2020,Kristina Bajema,Regional,United States of America," Utah; United States of America
(CDC COVID-19 Response)",07/30 - 08/11,Residual sera,Multiple groups,880,3.2% (1.7-5%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_July/August1_Ohio,11/24/2020,Kristina Bajema,Regional,United States of America," Ohio; United States of America
(CDC COVID-19 Response)",07/29 - 08/11,Residual sera,Multiple groups,786,2.3% (1.1-3.6%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_July/August1_California,11/24/2020,Kristina Bajema,Regional,United States of America,"California; United States of America
(CDC COVID-19 Response)",07/30 - 08/05,Residual sera,Multiple groups,980,5.7% (4.1-7.8%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_July/August1_Minnesota,11/24/2020,Kristina Bajema,Regional,United States of America," Minnesota; United States of America
(CDC COVID-19 Response)",07/29 - 08/13,Residual sera,Multiple groups,879,3.5% (2.1-5%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_July/August1_Oregon,11/24/2020,Kristina Bajema,Regional,United States of America," Oregon; United States of America
(CDC COVID-19 Response)",08/05 - 08/11,Residual sera,Multiple groups,658,2.3% (1-3.8%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_September4_Connecticut,11/24/2020,Kristina Bajema,Regional,United States of America,"Connecticut; United States of America
(CDC COVID-19 Response)",09/09 - 09/14,Residual sera,Multiple groups,982,3.1% (2.1-4.4%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_September4_Wisconsin,11/24/2020,Kristina Bajema,Regional,United States of America," Wisconsin; United States of America
(CDC COVID-19 Response)",09/09 - 09/24,Residual sera,Multiple groups,976,3.8% (2.2-5.7%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_September4_NorthCarolina,11/24/2020,Kristina Bajema,Regional,United States of America," North Carolina; United States of America
(CDC COVID-19 Response)",09/09 - 09/17,Residual sera,Multiple groups,925,6.8% (4.8-8.9%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_September4_NewHampshire,11/24/2020,Kristina Bajema,Regional,United States of America," New Hampshire; United States of America
(CDC COVID-19 Response)",09/09 - 09/17,Residual sera,Multiple groups,1034,0.7% (0.3-1.3%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_September4_Ohio,11/24/2020,Kristina Bajema,Regional,United States of America," Ohio; United States of America
(CDC COVID-19 Response)",09/10 - 09/22,Residual sera,Multiple groups,978,2.8% (1.7-4.2%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_September4_PuertoRico,11/24/2020,Kristina Bajema,Regional,United States of America,"Puerto Rico; United States of America
(CDC COVID-19 Response)",09/08 - 09/15,Residual sera,Multiple groups,970,3% (1.8-4.3%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_September4_NorthDakota,11/24/2020,Kristina Bajema,Regional,United States of America," North Dakota; United States of America
(CDC COVID-19 Response)",09/09 - 09/24,Residual sera,Multiple groups,113,1.2% (0-3.4%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_September4_Michigan,11/24/2020,Kristina Bajema,Regional,United States of America," Michigan; United States of America
(CDC COVID-19 Response)",09/08 - 09/22,Residual sera,Multiple groups,980,3.7% (2.5-4.9%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_September4_Minnesota,11/24/2020,Kristina Bajema,Regional,United States of America," Minnesota; United States of America
(CDC COVID-19 Response)",09/09 - 09/23,Residual sera,Multiple groups,1033,8% (4.7-11.4%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_September4_SouthCarolina,11/24/2020,Kristina Bajema,Regional,United States of America," South Carolina; United States of America
(CDC COVID-19 Response)",09/09 - 09/18,Residual sera,Multiple groups,975,7.8% (5.6-10.2%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_September4_Florida,11/24/2020,Kristina Bajema,Regional,United States of America,"Florida; United States of America
(CDC COVID-19 Response)",09/11 - 09/11,Residual sera,Multiple groups,979,8.5% (6.6-10.7%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_September4_Washington D.C,11/24/2020,Kristina Bajema,Regional,United States of America,"Washington D.C; United States of America
(CDC COVID-19 Response)",09/08 - 09/24,Residual sera,Multiple groups,976,6.5% (4.5-8.3%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_September4_WestVirginia,11/24/2020,Kristina Bajema,Regional,United States of America," West Virginia; United States of America
(CDC COVID-19 Response)",09/09 - 09/22,Residual sera,Multiple groups,968,1.3% (0.5-2.2%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_September4_NewMexico,11/24/2020,Kristina Bajema,Regional,United States of America," New Mexico; United States of America
(CDC COVID-19 Response)",09/08 - 09/24,Residual sera,Multiple groups,1014,2.4% (1.2-3.7%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_September4_Arkansas,11/24/2020,Kristina Bajema,Regional,United States of America,"Arkansas; United States of America
(CDC COVID-19 Response)",09/09 - 09/18,Residual sera,Multiple groups,990,6.3% (4.6-8%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_September4_Nevada,11/24/2020,Kristina Bajema,Regional,United States of America," Nevada; United States of America
(CDC COVID-19 Response)",09/09 - 09/12,Residual sera,Multiple groups,979,7.8% (5.9-10%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_September4_NewYork,11/24/2020,Kristina Bajema,Regional,United States of America," New York; United States of America
(CDC COVID-19 Response)",09/11 - 09/24,Residual sera,Multiple groups,1168,17% (14.7-19.2%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_September4_Maryland,11/24/2020,Kristina Bajema,Regional,United States of America," Maryland; United States of America
(CDC COVID-19 Response)",09/10 - 09/23,Residual sera,Multiple groups,1242,10.2% (7.9-12.7%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_September4_Colorado,11/24/2020,Kristina Bajema,Regional,United States of America,"Colorado; United States of America
(CDC COVID-19 Response)",09/09 - 09/18,Residual sera,Multiple groups,1032,3.3% (1.9-4.9%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_September4_Oregon,11/24/2020,Kristina Bajema,Regional,United States of America," Oregon; United States of America
(CDC COVID-19 Response)",09/08 - 09/22,Residual sera,Multiple groups,971,2.6% (1.5-4.1%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_September4_Oklahoma,11/24/2020,Kristina Bajema,Regional,United States of America," Oklahoma; United States of America
(CDC COVID-19 Response)",09/09 - 09/18,Residual sera,Multiple groups,980,5% (3.4-6.5%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_September4_Montana,11/24/2020,Kristina Bajema,Regional,United States of America," Montana; United States of America
(CDC COVID-19 Response)",09/09 - 09/23,Residual sera,Multiple groups,508,2.2% (0.7-4.4%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_September4_Kansas,11/24/2020,Kristina Bajema,Regional,United States of America,"Kansas; United States of America
(CDC COVID-19 Response)",09/09 - 09/19,Residual sera,Multiple groups,1007,3.5% (2.3-4.8%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_September4_Alabama,11/24/2020,Kristina Bajema,Regional,United States of America,"Alabama; United States of America
(CDC COVID-19 Response)",09/09 - 09/18,Residual sera,Multiple groups,905,8.7% (6.2-11.3%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_September4_Maine,11/24/2020,Kristina Bajema,Regional,United States of America," Maine; United States of America
(CDC COVID-19 Response)",09/08 - 09/24,Residual sera,Multiple groups,987,0.5% (0.1-0.9%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_September4_Georgia,11/24/2020,Kristina Bajema,Regional,United States of America,"Georgia; United States of America
(CDC COVID-19 Response)",09/09 - 09/18,Residual sera,Multiple groups,1100,13% (10.5-15.8%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_September4_Massachusetts,11/24/2020,Kristina Bajema,Regional,United States of America," Massachusetts; United States of America
(CDC COVID-19 Response)",09/09 - 09/15,Residual sera,Multiple groups,988,3.7% (2.2-5.2%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_September4_Wyoming,11/24/2020,Kristina Bajema,Regional,United States of America," Wyoming; United States of America
(CDC COVID-19 Response)",09/09 - 09/24,Residual sera,Multiple groups,111,1.5% (0-4%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_September4_Vermont,11/24/2020,Kristina Bajema,Regional,United States of America," Vermont; United States of America
(CDC COVID-19 Response)",09/09 - 09/24,Residual sera,Multiple groups,497,1.7% (0.3-4.2%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_September4_Illinois,11/24/2020,Kristina Bajema,Regional,United States of America,"Illinois; United States of America
(CDC COVID-19 Response)",09/08 - 09/17,Residual sera,Multiple groups,992,4.5% (3.1-6.1%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_September4_Nebraska,11/24/2020,Kristina Bajema,Regional,United States of America," Nebraska; United States of America
(CDC COVID-19 Response)",09/09 - 09/18,Residual sera,Multiple groups,976,6.7% (4.8-8.9%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_September4_Arizona,11/24/2020,Kristina Bajema,Regional,United States of America,"Arizona; United States of America
(CDC COVID-19 Response)",09/09 - 09/23,Residual sera,Multiple groups,1208,5.4% (3.1-8.5%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_September4_Texas,11/24/2020,Kristina Bajema,Regional,United States of America," Texas; United States of America
(CDC COVID-19 Response)",09/09 - 09/24,Residual sera,Multiple groups,988,8.2% (6.2-10.5%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_September4_Louisiana,11/24/2020,Kristina Bajema,Regional,United States of America," Louisiana; United States of America
(CDC COVID-19 Response)",09/09 - 09/19,Residual sera,Multiple groups,952,12.5% (10-15.6%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_September4_SouthDakota,11/24/2020,Kristina Bajema,Regional,United States of America," South Dakota; United States of America
(CDC COVID-19 Response)",09/09 - 09/23,Residual sera,Multiple groups,99,1.8% (0-4.8%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_September4_Tennessee,11/24/2020,Kristina Bajema,Regional,United States of America," Tennessee; United States of America
(CDC COVID-19 Response)",09/08 - 09/16,Residual sera,Multiple groups,1028,6.7% (5-8.6%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_September4_Hawaii,11/24/2020,Kristina Bajema,Regional,United States of America,"Hawaii; United States of America
(CDC COVID-19 Response)",09/08 - 09/22,Residual sera,Multiple groups,516,0.8% (0-2.2%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_September4_Indiana,11/24/2020,Kristina Bajema,Regional,United States of America,"Indiana; United States of America
(CDC COVID-19 Response)",09/09 - 09/23,Residual sera,Multiple groups,1155,4% (1.4-8.8%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_September4_Utah,11/24/2020,Kristina Bajema,Regional,United States of America," Utah; United States of America
(CDC COVID-19 Response)",09/09 - 09/18,Residual sera,Multiple groups,1022,5.1% (3.3-7.9%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_September4_RhodeIsland,11/24/2020,Kristina Bajema,Regional,United States of America," Rhode Island; United States of America
(CDC COVID-19 Response)",09/09 - 09/24,Residual sera,Multiple groups,795,2.7% (1.2-4.9%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_September4_Mississippi,11/24/2020,Kristina Bajema,Regional,United States of America," Mississippi; United States of America
(CDC COVID-19 Response)",09/09 - 09/22,Residual sera,Multiple groups,980,7.9% (5.4-10.9%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_September4_California,11/24/2020,Kristina Bajema,Regional,United States of America,"California; United States of America
(CDC COVID-19 Response)",09/10 - 09/16,Residual sera,Multiple groups,979,4.9% (3.2-6.8%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_September4_Virginia,11/24/2020,Kristina Bajema,Regional,United States of America," Virginia; United States of America
(CDC COVID-19 Response)",09/10 - 09/23,Residual sera,Multiple groups,1111,3.2% (1.8-5.1%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_September4_Iowa,11/24/2020,Kristina Bajema,Regional,United States of America,"Iowa; United States of America
(CDC COVID-19 Response)",09/09 - 09/24,Residual sera,Multiple groups,977,7.6% (5.6-10%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_September4_Idaho,11/24/2020,Kristina Bajema,Regional,United States of America,"Idaho; United States of America
(CDC COVID-19 Response)",09/08 - 09/18,Residual sera,Multiple groups,732,5.2% (2.7-8.5%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_September4_Kentucky,11/24/2020,Kristina Bajema,Regional,United States of America," Kentucky; United States of America
(CDC COVID-19 Response)",09/09 - 09/18,Residual sera,Multiple groups,980,3.6% (2.3-5.2%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_September4_Delaware,11/24/2020,Kristina Bajema,Regional,United States of America,"Delaware; United States of America
(CDC COVID-19 Response)",09/09 - 09/24,Residual sera,Multiple groups,980,7.5% (4.9-10.5%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_September4_Missouri,11/24/2020,Kristina Bajema,Regional,United States of America," Missouri; United States of America
(CDC COVID-19 Response)",09/08 - 09/24,Residual sera,Multiple groups,1031,3.5% (2.2-5%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_September4_NewJersey,11/24/2020,Kristina Bajema,Regional,United States of America," New Jersey; United States of America
(CDC COVID-19 Response)",09/09 - 09/23,Residual sera,Multiple groups,1050,15.1% (12.7-17.6%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_September4_Pennsylvania,11/24/2020,Kristina Bajema,Regional,United States of America," Pennsylvania; United States of America
(CDC COVID-19 Response)",09/09 - 09/23,Residual sera,Multiple groups,1341,11.1% (8.9-13.7%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
201124_USA_CDC_September4_Washington,11/24/2020,Kristina Bajema,Regional,United States of America," Washington; United States of America
(CDC COVID-19 Response)",09/09 - 09/22,Residual sera,Multiple groups,968,2.5% (1.3-3.8%),Sequential,"Roche, Abbott, Ortho-Clinical Diagnostics; NR
(100%; 99.6%)",,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1001/jamainternmed.2020.7976,3/20/2021,3/20/2021
210101_Seattle_SeattleChildren'sResearchInstitute_FollowUp_Overall,"1/1/2021, 1/1/2021","Yekaterina Tokareva, Yekaterina Tokareva",Sublocal,"United States of America, United States of America","Seattle; Washington State; United States of AmericaUnited States of America
(Seattle Childrens Research InstituteSeattle Childrens Research Institute)",07/06 - 08/07,Health care workers and caregivers,Adults (18-64 years),481,1% (NR),Convenience,"Abbott; NR
(100%; 0%)",High,"Preprint, Preprint","https://dx.doi.org/10.1542/hpeds.2020-003517, https://dx.doi.org/10.1542/hpeds.2020-003517",1/23/2021,3/17/2021
201118_HoChiMinhCity_OxfordUniversityClinicalResearchUnit_overall,11/18/2020,Nguyen Van Vinh Chau,Sublocal,Viet Nam,"Ho Chi Minh City; Southeast Region; Viet Nam
(Oxford University Clinical Research Unit)",08/23 - 08/30,Health care workers and caregivers,Adults (18-64 years),408,NA,Convenience,"Roche Diagnostics; NR
(97.2%; 99.8%)",High,Journal Article (Peer-Reviewed),https://dx.doi.org/10.1016/j.jinf.2020.11.018,1/23/2021,3/1/2021